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Background: Depression and cardiovascular diseases (CVD) are significant public 
health concerns. Whilst CVD are recognised as the leading cause of death worldwide, 
depression is responsible for a substantial non-fatal disease burden globally. A 
bidirectional association between depression and CVD has been reported in primary 
research and systematic reviews. However, there is an ongoing debate whether the 
evidence base is sufficient to acknowledge depression as an independent risk factor 
for subsequent CVD. Multiple potential mechanisms have been proposed but the 
exact nature of the association remains poorly understood.  
Methods: I conducted a systematic review and meta-analysis to identify and critically 
appraise existing studies of the association between clinical depression or depressive 
symptoms and risk of major cardiovascular events (MCVE). To overcome some of the 
methodological shortcomings of existing studies I carried out quantitative analyses 
of three cohort studies. I performed a retrospective cohort study using Cox 
proportional hazard models to estimate the risk of MCVE among UK Biobank 
participants with depression, antidepressant use, hospital admission with 
depression, and self-reported depression relative to participants without the 
exposure of interest. Furthermore, I investigated the role of selected comorbidities 
and socioeconomic factors as potential effect-modifying factors. Using data from the 
Longitudinal Study on Women’s Health (ALSWH), I used latent process mixed 
modelling to identify subgroups of participants with similar patterns of depressive 
symptoms over time and explored cardiovascular risk factor profiles at baseline and 
end of follow-up. Lastly, using data from the Whitehall II study, I compared 
psychological distress trajectories of individuals prior to diagnosis of cardiovascular 
events to psychological distress trajectories of individuals free from cardiovascular 
events over the same time period. 
Results: The meta-analysis of 51 studies suggested that the risk of MCVE was higher 
among individuals with clinical depression or depressive symptoms relative to non-





shortcomings of existing studies. For example, the role of covariates as potential 
confounding or mediating factors was unclear and studies were prone to information 
bias since they relied on a single measure of clinical depression or depressive 
symptoms at baseline. Using data from the UK Biobank, different measures of 
depression were associated with increased risk of MCVE even after adjustment for a 
wide range of potential confounding factors. The increased risk was particularly high 
among individuals with comorbidities and among individuals from lower 
socioeconomic backgrounds. Using data from the ALSWH, three subgroups of 
women with distinct depressive symptom trajectories were identified. There were 
differences between groups with regards to profiles of key cardiovascular risk factors 
at baseline and end of follow-up. Women with stable moderate and fluctuating 
depressive symptoms had lower educational attainment, found it harder to manage 
on their income, reported more adverse health behaviours and medical conditions 
and gained weight more rapidly than women with stable low depressive symptoms. 
Using data from the Whitehall II study, there was some evidence of small differences 
between mean predicted psychological distress scores among those with and without 
cardiovascular events in the time prior to diagnosis, death, or end-of follow-up but 
no clear evidence for differences in the patterns of psychological distress over time.  
Conclusions: This project addressed a number of shortcomings of the existing 
evidence base. The results of the UK Biobank analysis suggest that it is unlikely that 
residual confounding due to unmeasured covariates alone explained the observed 
associations between different measure of depression and MCVE. In addition, there 
was some evidence that the risk of MCVE might differ between subgroups of 
individuals with clinical depression or depressive symptoms. The analysis of 
ALSWH data highlighted the importance of considering repeat assessments of 
depressive symptoms. Furthermore, it illustrated that latent process mixed modelling 
might be a useful tool to identify potentially clinically meaningful groups with 
different patterns of depressive symptoms over time. The results of the Whitehall II 
analysis suggest that it is unlikely that reverse causation or overlap of symptoms 
 
 
between subclinical CVD and somatic symptoms of depression explained the 
observed association. 
Whilst a number of shortcomings of the existing evidence base could be addressed, 
some alternative explanations of the observed association remain to be investigated. 
For example, iatrogenic effects of psychotropic medications might partly explain the 
observed association between depression and CVD and there might be common risk 
factors including genetic predisposition for depression and CVD. Considering the 
substantial public health burden of both depression and CVD, it should remain a 
public health priority to further advance our understanding of the relationship 










People with depression have higher risks of cardiovascular diseases, such as stroke 
and heart attacks, than people without depression. However, we do not know why 
that is. It might be that depression itself alters the risk of stroke and heart attacks but 
there are a number of potential alternative explanations. For example, depression and 
stroke are both linked to low educational attainment which in turn might explain the 
link between depression and stroke. 
This PhD aimed to improve our understanding of why individuals with depression 
might have higher risks of cardiovascular diseases using data from three large 
research studies. More specifically, I explored two potential alternative explanations 
of the link between depression and cardiovascular diseases. First, previous research 
did not consider all variables that are linked to both depression and stroke. This might 
have led to a spurious link between depression and cardiovascular disease in 
previous research. Second, instead of depression altering the risk of stroke, it might 
actually be the other way around. Even before someone is diagnosed with stroke or 
heart attack, there are undetected or undiagnosed changes in the body of that person. 
If these changes alter the risk of depression, it might explain the link between 
depression and cardiovascular diseases. A further shortcoming of previous research 
was that depression was often measured at one point in time. Since we know that 
depression comes and goes, I identified people with similar patterns of depressive 
symptoms over time. I then investigated if these groups differed with regard to social 
class, health behaviours such as smoking or physical inactivity, and medical 
conditions such as high blood pressure and diabetes. 
In keeping with previous research, my analyses suggested that people with 
depression have higher risks of cardiovascular diseases than people without 
depression. Furthermore, people with depression who live in areas of high 
deprivation, who are less well educated, who have high blood pressure, diabetes, or 
high cholesterol levels were are at particularly high risk of stroke and heart attacks. 





over time. From the age of 20 to 40 years most people had stable low levels of 
depressive symptoms, a considerable number had stable moderate depressive 
symptoms, and some people had fluctuating depressive symptoms over time. These 
patterns of depression over time might be important. People with stable moderate 
and fluctuating depressive symptoms had lower educational levels and found it 
harder to manage on their income than people with stable low depressive symptoms. 
Furthermore, they reported more adverse health behaviours and had more medical 
conditions. The high risk of cardiovascular diseases among people with depression 
was not explained by variables that are linked to both depression and cardiovascular 
diseases. Also, undetected or undiagnosed changes in the body of people prior to 
diagnosis with stroke or heart attack did not seem to explain the altered risk of 
cardiovascular disease among people with depression. 
This PhD addressed a number of shortcomings of previous research but some 
alternative explanations of the high risk of cardiovascular diseases among people 
with depression remain to be investigated. Since both depression and cardiovascular 
diseases affect a large number of people worldwide, it is important to conduct more 
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Chapter 1: Introduction 
Depression and cardiovascular diseases (CVD) are significant public health concerns. 
Whilst CVD are recognised as the leading cause of death worldwide, depression is 
responsible for a substantial non-fatal disease burden globally (GBD 2015 Disease and 
Injury Incidence and Prevalence Collaborators, 2016; GBD 2015 Mortality and Causes 
of Death Collaborators, 2016). Depressive disorders, which were assessed as a sub-
category of all mental and substance use disorders in the Global Burden of Diseases 
Study, were attributable for the largest proportion of all mental and substance use 
disorder burden across all regions of the world (Whiteford et al, 2013).  
A bidirectional association between depression and CVD has been observed in 
primary studies and systematic reviews. It is well established that physical diseases 
such as CVD increase the risk for depression. However, the relationship between 
depression and subsequent CVD remains controversial. Multiple potential 
mechanisms have been proposed, some of which propose causal pathways between 
depression and CVD, others offer alternative explanations (Penninx, 2016b). 
However, the exact nature of the association remains poorly understood 
(Fiedorowicz, 2014; Nemeroff & Goldschmidt-Clermont, 2012; Penninx, 2016a). If 
depression is indeed causally related to subsequent CVD, this will have important 
implications on resource allocation, and it offers possibilities for new preventive 
treatments for CVD if the pathophysiological effect of depression on arteries can be 
identified.  
The aim of this project was to improve our understanding of the relationship between 
depression and subsequent CVD onset. In the following chapter this project is 
embedded in the wider context of existing literature (Chapter 2). The chapter gives 
an overview of depression and CVD, outlines their influence on the global burden of 
disease, and emphasises the importance of considering the comorbidity of mental and 
physical illnesses. Chapter 3 presents a systematic review and meta-analysis of the 
relationship between clinical depression or depressive symptoms and subsequent 





and identify shortcomings of existing studies that could potentially be addressed as 
part of this project. Taking these shortcomings of existing studies into account, 
quantitative analyses of three cohort studies and linkage to administrative datasets 
were used to further our understanding of the relationship.  
The first data analysis was based on the UK Biobank (Chapter 4). Researchers have 
highlighted that the observed association between depression and CVD might be due 
to residual confounding. Making use of unique advantages of the UK Biobank, in this 
project I explored the association between different measure of depression and major 
cardiovascular events (MCVE) whilst taking account of a wide range of potential 
confounding factors. Furthermore, I explored the role of selected comorbidities and 
socioeconomic factors as potential effect-modifying factors.  
The second data analysis was based on the Australian Longitudinal Study on 
Women’s Health (ALSWH) (Chapter 5). One major limitation of existing studies on 
the risk of CVD among individuals with depression is that a single measure of 
depression at baseline was used. Unlike many other cohort studies, the ALSWH has 
assessed depressive symptoms at multiple occasions over several years. Using group-
based trajectory modelling, I aimed to identify subgroups of women with similar 
patterns of depressive symptoms over time. Furthermore, I investigated if these 
groups were characterised by different cardiovascular risk profiles at baseline and 
end of follow-up.  
The third data analysis was based on the Whitehall II study (Chapter 6). One potential 
explanation for the association between clinical depression, depressive symptoms 
and risk of cardiovascular events is that symptoms of subclinical CVD overlap with 
somatic symptoms of depression. If the association between clinical depression, 
depressive symptoms and risk of cardiovascular events was indeed due to 
misclassification of individuals with subclinical CVD, one would expect an increase 
in depressive symptoms before diagnosis of CVD. Therefore, the aim of the work 





individuals prior to diagnosis of cardiovascular events to depressive symptom 
trajectories of individuals free from cardiovascular events over the same time period.  
In Chapter 7 the main findings of this thesis are presented, the contribution of each of 
the projects to our understanding of the relationship between depression and CVD 
are highlighted, strengths and limitations of this thesis are discussed, and 
implications for future research and practice are given. 











Chapter 2: Background 
2.1 Depression 
2.1.1 Introduction to depression 
Major depression is a common mood (affective) disorder. Symptoms include low 
mood, loss of interest, sadness, poor sleep, and fatigue (American Psychiatric 
Association, 2013). Depending on the severity of the disorder, individuals may 
additionally have somatic symptoms, such as loss of libido or appetite, and symptoms 
may impair normal social and occupational functioning. Established risk factors of 
depression are stressful life events such as illness, divorce or bereavement, certain 
personality traits, loneliness, giving birth, and a family history of depression 
(National Health Service, 2016a). It is very likely that there is an interplay between 
different risk factors of depression which adds to the complexity of the disorder. 
2.1.2 Assessment of depression 
2.1.2.1 Clinical diagnosis 
In routine health records most World Health Organisation (WHO) membership 
countries record a diagnosis of depression based on the International Classification 
of Diseases (ICD) (World Health Organisation, 2016a). The current official version is 
the ICD-10 Version: 2016 (World Health Organisation, 2016b). In this version, a 
differentiation is made between a single depressive episode and recurrent depressive 
disorder. Depending on the number and severity of symptoms, depressive episodes 
and recurrent depressive disorders can be rated as mild, moderate, or severe, and 
severe cases can present with or without psychotic symptoms. If depressive 
symptoms are chronic but not sufficiently severe or prolonged to diagnose a mild 
recurrent depressive disorder, patients may be diagnosed with dysthymia. 
Another classification system for mental disorders is the Diagnostic and Statistical 
Manual of Mental disorders (DSM), published by the American Psychiatric 
Association (2013). The newest version of the DSM is DSM-5. In this version, 
depressive disorders are subdivided into disruptive mood dysregulation disorder, 





premenstrual dysphoric disorder, substance/ medication induced depressive 
disorder, depressive disorder due to another medical condition, other specified 
depressive disorder, and unspecified depressive disorder. The category MDD most 
closely resembles the ICD diagnoses of depressive episode and recurrent depressive 
disorder. The DSM-5 describes nine diagnostic criteria that are used to determine the 
presence or absence of a MDD. The nine criteria are: 
1. Depressed mood, 
2. Diminished interest or pleasure, 
3. Significant weight loss or weight gain, or decrease or increase in appetite, 
4. Insomnia or hypersomnia, 
5. Psychomotor agitation or retardation, 
6. Fatigue or loss of energy, 
7. Feeling of worthlessness or excessive or inappropriate guilt, 
8. Diminished ability to think or concentrate, or indecisiveness, and 
9. Recurrent thoughts of death (American Psychiatric Association, 2013). 
In order to qualify for a depressive episode diagnosis, at least five out of nine criteria 
need to be present in the same two-week period and need to represent a change from 
previous functioning. In contrast to the ICD, a depressive disorder diagnosis further 
requires the presence of at least one out of two main criteria (depressed mood and/ 
or diminished interest or pleasure). If symptoms additionally cause significant 
impairment in important areas of the person’s life, and the episode is not due to 
physiological effects of a substance or an underlying medical condition, the episode 
will be referred to as major depressive episode (MDE). In keeping with the ICD, a 
differentiation is made between mild, moderate and severe depressive episodes that 
can occur once (single episode) or multiple times (recurrent episodes). The DSM 
describes dysthymia as persistent depressive disorder with depressed mood being 
present for most of the day, for more days than not, for at least two years among 
adults. An individual may have both diagnoses at the same time, a MDD diagnosis 





depressive disorders, such as depressive disorder with melancholic or atypical 
features. Patients with a depressive disorder with atypical and melancholic features 
differ in their capacity of mood reactivity. Whilst patients with atypical depression 
might experience pleasure in the presence of positive events, patients with 
melancholic depression do not show improved mood in these situations (American 
Psychiatric Association, 2013). The DSM depression diagnosis is meant to be based 
on a semi-structured clinical interview administered by a clinician or trained mental 
health professional (First et al, 2015). The structured clinical interview for DSM-5 
disorders was published as clinical version, research version, and clinical trials 
version. 
Whilst the assessment of depression through a structured clinical interview based on 
DSM criteria is often seen as the gold standard for the assessment of depression, there 
also has been criticism of the criteria. The proposed diagnostic criteria of most mental 
disorders described in the DSM are based on diagnostic criteria proposed by a group 
of clinicians in 1972 (Feighner et al, 1972). The MDD criteria date back to a list of 
criteria published by Cassidy et al (1957). The group of clinicians working on the 
Feighner criteria changed the criteria proposed by Cassidy et al (1957) without giving 
a reason or empirical support (Zimmerman et al, 2015). As a result, some researchers 
have questioned the diagnostic reliability and validity of the proposed criteria, 
especially since only minor changes have been made in newer versions of the DSM 
(Fried & Nesse, 2015a; Lux & Kendler, 2010; Zimmerman et al, 2015). In addition, 
Zimmerman et al (2015) has highlighted that there are 227 ways to meet the nine DSM 
diagnostic criteria and two patients with the same diagnosis might not share a single 
symptom. Furthermore, Zimmerman et al (2015) emphasised that the large number 
of potential combinations led to immense diagnostic heterogeneity in practice. Of 
note, the researchers used a conservative approach by counting symptoms profiles 
according to the nine DSM criteria. Had they taken into account all sub-symptoms 
(e.g. weight loss and weight gain), there would have been 14,528 possible 
combinations. In a similar project, Fried & Nesse (2015a) investigated the degree of 





3,703 outpatients at the beginning of a randomised controlled trial (RCT). Similar to 
Zimmerman et al (2015), Fried & Nesse (2015a) found that only 2% of the sample had 
the most common symptom profile, and 14% of the participants showed unique 
symptoms profiles not shared with anyone else in the sample. 
2.1.2.2 Rating scales 
Rating scales measure the occurrence of a pre-specified set of depressive symptoms 
and/ or depressive symptom frequency. The severity of depressive symptoms is 
determined by adding up symptom scores to create a sum score. This sum score is 
usually compared against a pre-defined threshold that establishes the presence or 
absence of depressive symptoms. Rating scales are frequently used in 
epidemiological research because they require fewer financial resources, they can be 
used by lay interviewers, and they can assess the presence and/ or severity of 
depressive symptoms among individuals who do not use or have access to health care 
services.  
A disadvantage of using rating scales is that different scales might measure different 
concepts of depressive symptomatology. It has been highlighted that different rating 
scales should not be used interchangeably (Skorikov & Vandervoort, 2003) since 
different rating scales collect information on different depressive symptoms, they 
were developed for the use in different samples, and they use different look-back 
periods. For example, the Centre for Epidemiological Studies Depression Scale (CES-
D) was developed as an instrument to assess the frequency of 20 depressive 
symptoms in the general population in the past week (Radloff, 1977). In contrast, the 
Beck Depression Inventory was developed to measure the severity of 21 depressive 
symptoms in clinically depressed individuals at the present time (Beck et al, 1961). 
Other authors agree with the argument made by Skorikov & Vandervoort (2003). 
Fried (2017a) investigated the content overlap of seven common depression scales. 
Out of 125 items across seven scales the researcher identified 52 distinct depressive 
symptoms. Furthermore, 21 of the 52 depressive symptoms appeared in only one of 





scales. Fried (2017a) concluded that the low content overlap might lead to research 
that is specific to the particular scale used. Additionally, he argued that the use of 
depressive symptom sum scores implies that all symptoms measure the same 
underlying concept. Considering how many different symptoms were identified, this 
assumption might not hold and depressive symptom sum scores might be a 
composite score of psychological problems rather than scores of depressive symptom 
severity (Fried et al, 2016). As a consequence, it has been argued that there should be 
more emphasis on individual depressive symptoms rather than on sum scores of 
rating scales (Fried & Nesse, 2015b; Fried et al, 2016). Whilst this is an interesting 
approach, it has remained challenging in practice since rating scales were neither 
developed nor validated to measure individual depressive symptoms (Fried et al, 
2016).  
Due to the range of different tools to assess depression and depressive symptoms, 
people who share related symptoms but have different aetiological and biological 
mechanisms might be grouped together (Navrady et al, 2018). This phenomenon is 
known as covert heterogeneity (Fried et al, 2014). Lux & Kendler (2010) investigated 
to what extent different depressive symptoms were associated with different clinical 
characteristics among patients with a DSM depression diagnosis. The researchers 
found that each of the nine unique DSM criteria showed varying associations with 
different comorbidities, demographic characteristics, and personality traits.  The 
differences were partly explained by a distinction between cognitive and 
neurovegetative symptoms. However, it has proven difficult to identify subgroups 
that replicate in different populations. If there are indeed differences between 
subgroups, covert heterogeneity might have slowed down depression research. For 
example, Kapur et al (2012) argued that the lack of a biological test for depression 
might be due to the fact that one test cannot identify all subgroups of patients with 
depression. Similarly, Sullivan et al (2012) argued that covert heterogeneity hindered 
the identification of genetic variants as well as the replication of findings of genetic 
studies in different populations (see section 7.3.4.2 The need to investigate genetic 





2.1.3 The global burden of depression 
Depression is responsible for a substantial burden globally. The Global Burden of 
Diseases Study provides estimates of disability adjusted life years (DALYs) which is 
the sum of all years of life lost (YLL) due to premature mortality and years lived with 
disability (YLD). In previous years, the global burden of depressive disorders was 
estimated as a sub-category of all mental and substance use disorders (Whiteford et 
al, 2013). Depressive disorders were further split into two distinct categories: MDD 
and dysthymia. In order to be captured within the study, cases had to meet the clinical 
definition according to the ICD or DSM criteria. Mental and substance use disorders 
were the fifth leading disorder category worldwide and the leading global cause of 
all non-fatal burden of disease in 2010 (Whiteford et al, 2013). Depressive disorders 
had the highest proportion of all mental and substance use disorder burden across all 
regions of the world. Whilst depressive disorders were the fourth leading cause of all 
YLD in 1990 and 2005, it has risen to the third leading cause of all YLD after lower 
back and neck pain and sense organ diseases in 2015 (GBD 2015 Disease and Injury 
Incidence and Prevalence Collaborators, 2016).  
The latest estimates of the global burden of depressive disorders were published in 
2017 (Table 2.1). In 2017 the global burden of depressive disorders was estimated as 
a subcategory of all mental disorders. Substance use disorders were treated as a 
separate category. 4.9% (95% CI: 3.9% – 5.9%) of all DALYs were due to mental 
disorders of which 26.5% and 8.2% were due to MDD and dysthymia, respectively 
(Global Burden of Disease Collaborative Network, 2018). All of the DALYs attributed 
to depressive disorders were due to YLD since neither MDD nor dysthymia were 
regarded as potential direct causes of deaths. The only mental disorders that were 
treated as potential direct causes of deaths were anorexia nervosa and bulimia 
nervosa. The burden of depressive disorders was higher among women than men 






Table 2.1: Global burden of mental & depressive disorders in 2017 (Global Burden of Disease 
Collaborative Network, 2018)* 
  Depressive disorders 
Mental disorders  
(estimate and % of total) 
Major depressive disorder 
(estimate and % of total) 
Dysthymia 
(estimate and % of total) 
DALYs 
122.8 million (91.6 – 157.9) 
4.9% (3.9% – 5.9%) 
32.8 million (23.1 – 44.3) 
1.3% (1.0% – 1.7%) 
10.3 million (6.9 – 15.0) 
0.4% (0.3% – 0.6%) 
YLD 
122.7 million (91.6 – 157.9) 
14.4% (12.3% – 16.3%) 
32.8 million (23.1 – 44.3) 
3.9% (3.0% – 4.8%) 
10.3 million (6.9 – 15.0) 
1.2% (1.0% – 1.5%) 
YLL 
17.5 thousand (15.7 – 19.2) 
0.0% (0.0% – 0.0%) 
--- --- 
* Data are presented as n (95% confidence interval) 
DALYs: Disability-adjusted life years, YLD: Years lived with disability, YLL: Years of life lost 
 
Of note, these disability estimates capture short- or long-term health losses of the 
individual suffering from depression but do not capture losses due to effects on 
families or social and economic consequences (Whiteford et al, 2013). Furthermore, 
despite evidence of excess mortality attributable to multiple mental and substance 
use disorders (Liu et al, 2017), most of them were not recognised as underlying causes 
of death. Furthermore, suicides were captured under injuries (as self-harm). Since this 
might lead to an underestimation of the actual disease burden, Ferrari et al (2014) 
estimated suicide DALYs attributable to mental and substance use disorders. Mental 
and substance use disorders were responsible for 62.1% (95% CI: 43.8 – 75.3%) of all 
DALYs allocated to suicide in 2010. With 46.1% (95% CI: 28.0 – 60.8%) depression was 
responsible for the largest proportion. The inclusion of attributable suicide DALYs 
would have increased the YLL and, as a result, the global ranking of mental and 
substance use disorders would have changed from the fifth to third leading cause of 
burden in 2010. Even after consideration of the burden of suicide attributable to 
mental and substance use disorder the estimates might be underestimated “due to 
inadequate appreciation of the links between depression and other health conditions” 





2.2 Cardiovascular diseases 
2.2.1 Introduction to cardiovascular diseases 
CVD and cerebrovascular diseases (hereafter referred to as CVD) are two subgroups 
of circulatory diseases involving heart and blood vessels, as defined by the National 
Health Service (NHS) in the United Kingdom (UK) (National Health Service, 2018). 
Usually, the underlying disease of the blood vessel does not cause any symptoms. 
However, depending on the location of the vessels involved it can cause 
cardiovascular events such as myocardial infarctions (MI) or cerebrovascular events 
such as strokes (World Health Organisation, 2017). These events in turn cause 
symptoms such as pain or discomfort in the chest, arms, or shoulders, numbness of 
the face, difficulties walking, speaking, unconsciousness, or headaches. Major 
behavioural risk factors of CVD are smoking, physical inactivity, and an unhealthy 
diet, which in turn cause obesity, hypertension, and hyperlipidaemia. Both the 
behavioural risk factors as well as their consequences are recognised risk factors of 
CVD. CVD are largely preventable through primary prevention of the 
aforementioned behaviours or secondary prevention in those with established 
diseases (e.g. treatment with beta-blockers or statins) (National Health Service, 2018). 
2.2.2 Assessment of cardiovascular diseases 
In routine health records CVD diagnoses are often recorded based on the ICD. The 
current ICD-10 version differentiates between 100 diseases of the circulatory system 
(I00 to I99) which are grouped into the following ten categories (World Health 
Organisation, 2016b): 
- Acute rheumatic fever 
- Chronic rheumatic heart diseases 
- Hypertensive diseases 
- Ischaemic heart diseases 
- Pulmonary heart disease and diseases of pulmonary circulation 
- Other forms of heart disease 





- Diseases of arteries, arterioles and capillaries 
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere 
classified 
- Other and unspecified disorders of the circulatory system. 
Due to the focus of this thesis, the assessment of cerebrovascular diseases (CBVD) and 
ischaemic heart diseases (IHD) will be described in more detail below. 
CBVD are circulatory diseases involving blood vessels that supply the brain. CBVD 
are further divided into subarachnoid, intracerebral, and other non-traumatic 
intracranial haemorrhage, cerebral infarction, unspecified stroke, occlusion and 
stenosis of cerebral arteries not resulting in cerebral infarction, other CBVD such as 
cerebral aneurysm and sequelae of CBVD (World Health Organisation, 2016b). A 
differentiation between these disorders is usually made by a clinician based on the 
patient’s symptoms and clinical signs, often accompanied by brain imaging findings. 
In 1970, the WHO defined stroke as “rapidly developing clinical signs of focal (at 
times global) disturbance of cerebral function, lasting more than 24h or leading to 
death with no apparent cause other than that of vascular origin” (Hatano, 1976, p541). 
It has been criticised that this definition has never been updated although major 
advances have been made in the understanding of aetiology, clinical recognition and 
diagnosis since the definition was formulated (Sacco et al, 2013). Although the term 
CBVD is meant to describe all of the aforementioned disorders, the terms stroke and 
CBVD are often used interchangeably. For example, although the American Heart 
Association called for an updated definition of stroke taking advances in science into 
account in 2013 (Sacco et al, 2013), they used the terms CBVD and stroke 
interchangeably in their publication of stroke statistics in 2019 (Benjamin et al, 2019). 
As a result, prevalence, incidence and mortality estimates may be less comparable 
between sources, and researchers need to pay particular attention to the definition 
used in existing literature. 
IHD, also known as coronary heart diseases (CHD), are CVD involving blood vessels 





MI, subsequent MI, certain current complications following MI, other acute IHD, and 
chronic IHD. In 2012, the third universal definition of MI was published by members 
of the European Society of Cardiology, the American College of Cardiology 
Foundation, the American Heart Association, and the World Heart Federation 
(Thygesen et al, 2012). MI is defined as “myocardial cell death due to prolonged 
ischaemia” (Thygesen et al, 2012, p2023). Ischaemia is most commonly caused by 
atherosclerosis of arteries but in some cases it is caused by spasms of plaque free 
arteries or endothelial dysfunctions. The WHO adopted the same definition in high 
resource settings but incorporated more flexibility in diagnostic criteria in settings 
with resource constraints (Mendis et al, 2010). 
2.2.3 The global burden of cardiovascular diseases 
CVD are recognised as the leading causes of death worldwide (GBD 2015 Mortality 
and Causes of Death Collaborators, 2016). In 2017, CVD accounted for 31.8% (95% CI: 
31.4% – 32.2%) of all deaths and 14.7% (95% CI: 13.6% – 15.6%) of all DALYs globally 
(Table 2.2). Although the age-standardised death rate has fallen over the past two 
decades, the absolute number of CVD deaths has risen due to ageing and growth of 
the world’s population (Roth et al, 2015a). The majority of the CVD burden was 
attributable to both CBVD and IHD (Roth et al, 2015a).  
The burden of CBVD was calculated as the sum of disease burdens due to ischaemic, 
haemorrhagic and other non-ischaemic strokes (Roth et al, 2015b). Stroke morbidity 
was calculated in accordance with the WHO definition of stroke, thus not counting 
transient ischaemic attacks (TIAs), epidural and subdural haemorrhage towards the 
stroke burden. In contrast, the burden due to stroke mortality was calculated after re-
distributing all causes of death due to CBVD (ICD-10: I60 – 69) between ischaemic 
and haemorrhagic or other non-ischaemic strokes. Deaths due to TIA (ICD-10: G45) 
were coded as ischaemic strokes and deaths due to non-ruptured aneurysms (ICD-
10: I67.0) were coded as haemorrhagic stroke. Nonspecific codes, including ICD-10 
codes I64, I67.9, I68.8 and I69.4 – I69.9, were redistributed to ischaemic and 





2015b). Presumably, this was done under the assumption that causes of deaths were 
misclassified since disease classifications such as TIA or non-ruptured aneurysms 
should not have led to death. However, the paper describing the methodology for 
estimating the global burden of CBVD did not specifically state the rationale behind 
this approach (Roth et al, 2015b). CBVD were responsible for 36.1% of all CVD DALYs 
(Table 2.2). A large proportion of CBVD DALYs was due to YLL and a much smaller 
proportion was due to years lived with CBVD (85.8% and 14.2%, respectively). The 
CBVD burden was slightly larger in men than women (54.7% and 45.3% of all CBVD 
DALYs, respectively) (Global Burden of Disease Collaborative Network, 2018). 
The burden of IHD was estimated as the sum of all YLL due to acute MI and IHD and 
all YLD with non-fatal acute MI, angina pectoris, and ischaemic heart failure (Moran 
et al, 2014). IHD were responsible for 46.5% of all CVD DALYs. As with CBVD, the 
contribution of YLL towards the overall burden of IHD was much higher than the 
contribution of YLD (96.9% and 3.1%, respectively). The burden of IHD was higher 
among men than women (61.7 and 38.3% of all IHD DALYs, respectively) (Global 
Burden of Disease Collaborative Network, 2018).  
Table 2.2: Global burden of cardiovascular diseases, ischaemic heart disease, and cerebrovascular 
diseases in 2017 (Global Burden of Disease Collaborative Network, 2018)* 
 Cardiovascular diseases 
(reported estimate and % of 
total) 
Cerebrovascular Diseases 
(reported estimate and % of 
CVD) 
Ischaemic Heart Disease 
(reported estimate and % of 
CVD) 
DALYs 
365.9 million (355.2 – 376.7) 
14.7% (13.6% – 15.6%) 
132.1 million (126.5 – 137.4) 
5.3% (4.9% – 5.7%) 
170.3 million (167.1 – 174.0) 
6.8% (6.3% – 7.4%) 
YLD 
35.7 million (26.4 – 45.5) 
4.2% (3.7% – 4.6%) 
18.7 million (13.6 – 23.7) 
2.2% (1.7% – 2.6%) 
5.3 million (3.7 – 7.2) 
0.6% (0.5% – 0.7%) 
YLL 
330.2 million (324.9 – 335.2) 
20.1% (19.7% – 20.4%) 
113.4 million (111.0 – 116.2) 
6.9% (6.7% – 7.1%) 
165.0 million (162.3 – 168.6) 
10.0% (9.8% – 10.2%) 
Deaths 
17.8 million (17.5 – 18.0) 
31.8% (31.4% – 32.2%) 
6.2 million (6.0 – 6.3) 
11.0% (10.8% – 11.3%) 
8.9 million (8.8 – 9.1) 
16.0% (15.7% – 16.3%) 
* Data are presented as n (95% CI) 
CVD: cardiovascular diseases, DALYs: Disability-adjusted life years, YLD: Years lived with disability, 






2.3 Mental-physical comorbidity 
2.3.1 The relationship between major mental disorders and physical 
disorders 
The co-existence of at least one mental and one physical health condition (hereafter 
referred to as mental-physical comorbidity) is a public health concern. In Scotland, 
prevalence of multimorbidity was estimated at 23.2% (95% CI: 23.1 – 23.2%) (Barnett 
et al, 2012), and mental-physical comorbidity accounted for 40% of all multimorbidity 
among primary care patients (McLean et al, 2014). McLean et al (2014) further 
highlighted that the prevalence of mental-physical comorbidity in the most deprived 
decile of the Scottish population was almost twice that of the least deprived decile 
(5.9%, 95% CI: 5.8 – 6.0%, and 11.0%, 95% CI: 10.9 – 11.2%, respectively). Furthermore, 
the onset of multimorbidity was ten years earlier among people living in the most 
deprived area than among people living in the least deprived area (Barnett et al, 2012). 
In the United States (US), the prevalence of mental-physical comorbidity was 
estimated at 9.5% among women and 6.0% among men (Bobo et al, 2016). Whilst this 
appears to be much lower than in Scotland, a comparison of estimates across 
populations is complicated due to the use of different data sources and the inclusion 
of different disorders in their analyses. Whilst Bobo et al (2016) took 15 conditions, 
including five mental health conditions into account, Barnett et al (2012) and McLean 
et al (2014) used information on 40 conditions including eight mental health 
conditions. 
Individuals with major mental disorders die prematurely. Reisinger Walker et al 
(2015) performed a systematic review on the risk of all-cause mortality among people 
with a diagnosed mental disorder relative to people with no diagnosed mental 
disorder. Out of 148 included cohort studies 135 studies showed increased risks of 
all-cause mortality. The pooled risk ratio (RR) was estimated at 2.22 (95% CI: 2.12 – 
2.33) and individuals with mental disorders had a median loss of ten years of 
potential life. Furthermore, there was some indication that the gaps between 





al, 2007). An exception thereof is the study by Wahlbeck et al (2011) that shows a 
modest decrease in the life expectancy gap in Finland and Denmark and among 
women in Sweden. One potential reason for the excess mortality is lack of effective 
interventions that target risk factors of excess mortality in people with severe mental 
disorder such as behavioural risk factors, or screening and management of physical 
health conditions (Liu et al, 2017). Other potential reasons for the excess mortality are 
differences in treatment and/ or under-treatment of physical disorders in people with 
mental disorders (Newcomer & Hennekens, 2007; Reisinger Walker et al, 2015), and 
higher prevalence of adverse lifestyle factors such as smoking, physical inactivity, 
high caloric intake or poor diet quality (Liu et al, 2017; Newcomer & Hennekens, 2007; 
Reisinger Walker et al, 2015; World Health Organisation, 2015). Whilst potential 
reasons for the excess mortality have been proposed, the relative importance of 
different potential reasons remains to be established. Since the reasons are likely to 
be multifactorial, a multilevel model of interventions has been proposed to reduce 
excess mortality among people with severe mental disorders (Liu et al, 2017). This 
model combines individual-focused interventions, health-system focussed 
interventions, and community level and policy-focused interventions. Individual-
focused interventions include but are not limited to smoking cessation programmes, 
behavioural weight management programmes aiming to improve diet and increase 
physical activity, and interventions addressing alcohol and substance abuse. Health-
system focussed interventions address factors related to service delivery. Community 
level and policy-focused interventions include programmes addressing social 
support, stigma, employment, housing, and social welfare. Importantly, while 
suicides and accidents accounted for some of the excess mortality risk, 67.3% of all 
deaths among mental disorder patients were due to natural causes (Reisinger Walker 
et al, 2015). Furthermore, it has been emphasised that the main causes of deaths were 
similar to the general population, with CVD being the leading cause of death (Crump 
et al, 2013; Gatov et al, 2017; Nordentoft et al, 2013). 
There is evidence that major mental disorders, defined as schizophrenia, bipolar 





Correll et al (2017) estimated the incidence and mortality from CVD among people 
with severe mental disorders. Individuals with severe mental disorders were at 
increased hazard of CVD incidence (pooled HR: 1.78, 95% CI: 1.60 – 1.98), 
cardiovascular related death (pooled HR: 1.85, 95% CI: 1.53 – 2.24), CHD (pooled HR: 
1.54, 95% CI: 1.30 – 1.82), CBVD (pooled HR: 1.64, 95% CI: 1.26 – 2.14), and congestive 
heart failure (pooled HR: 2.10, 95% CI: 1.64 – 2.70), relative to individuals without any 
major mental disorder. Due to the focus of this thesis, the evidence on the association 
between depression and CVD will be discussed in detail in section 2.3.2 The 
relationship between depression and cardiovascular diseases. For both bipolar 
disorder and schizophrenia a scoping review was performed to identify existing 
meta-analyses on their association with subsequent CVD. In this review, three meta-
analyses on the association between bipolar disorder and subsequent CVD and four 
meta-analyses on the association between schizophrenia and subsequent CVD were 
identified (Table 2.3). Both bipolar disorder and schizophrenia were associated with 
increased risks of CVD, CVD-related mortality, CBVD, stroke, and coronary heart 
failure (Correll et al, 2017; Fan et al, 2013; Li et al, 2014; Prieto et al, 2014). Whilst 
bipolar disorder was associated with increased risk of hypertension but not CHD 
(Ayerbe et al, 2018; Correll et al, 2017), schizophrenia was associated with increased 
risk of CHD but not hypertension (Ayerbe et al, 2018; Correll et al, 2017). Furthermore, 
individuals with bipolar disorder were at increased risk of MI but the confidence 
interval (CI) overlapped with the null value (Prieto et al, 2014). No meta-analysis on 
the association between schizophrenia and MI was identified. Meta-analyses on the 
association between antidepressant and antipsychotic drug use and risk of CVD are 







Table 2.3: Existing meta-analyses on the association between bipolar disorder or schizophrenia and 
subsequent cardiovascular diseases (reverse chronological order)* 












Ayerbe et al (2018) Hypertension IRR 1.27 (1.15 – 1.40) 
Correll et al (2017) 
Cardiovascular diseases 
HR 
1.57 (1.28 – 1.93) 
Coronary heart disease 1.16 (0.76 – 1.78) 
Cerebrovascular diseases 1.60 (0.99 – 2.57) 
Coronary heart failure* 2.27 (1.49 – 3.45) 
Cardiovascular disease-related death 1.65 (1.10 – 2.47) 
Prieto et al (2014) 
Myocardial infarction 
RR 
1.09 (0.96 – 1.24) 












Ayerbe et al (2018) Hypertension IRR 0.94 (0.75 – 1.14) 
Correll et al (2017) 
Cardiovascular diseases 
HR 
1.95 (1.41 – 2.70) 
Coronary heart disease 1.59 (1.08 – 2.35) 
Cerebrovascular diseases 1.57 (1.09 – 2.25) 
Cardiovascular disease-related death 2.45 (1.64 – 3.65) 
Li et al (2014) 
Stroke (fatal or non-fatal) 
RR 
1.50 (1.25 – 1.80) 
Stroke (fatal) 1.65 (1.31 – 2.08) 
Fan et al (2013) 
Cardiovascular diseases 
RR 
1.53 (1.27 – 1.86) 
Coronary heart disease 1.53 (1.27 – 1.86) 
Stroke 1.71 (1.19 – 2.46) 
Coronary heart failure 1.81 (1.42 – 2.29) 
* Results are based on one study 
CI: Confidence interval, HR: Hazard ratio, IRR: Incidence rate ratio, RR: Risk ratio 
 
2.3.2 The relationship between depression and cardiovascular diseases 
2.3.2.1 The comorbidity of depression and CVD  
Depression is more common among people suffering from CVD than among the 
general population. The global prevalence of depressive disorders was estimated at 
3.6% (95% CI: 3.3 – 3.9) in the general population in 2017, with a higher prevalence 
among women than men (4.4%, 95% CI: 4.1 – 4.7 and 2.8%, 95% CI: 2.6 – 3.1, 
respectively) (Global Burden of Disease Collaborative Network, 2018). Air et al (2016) 
investigated data on the prevalence of depression among cardiac disease patients and 
found that depression disproportionally affected people suffering from CVD with 
little variation between CVD subtypes. The authors concluded that at least one in five 
patients with CVD met the criteria for major depression (Air et al, 2016). Combining 
data from four diagnostic interview studies, Doyle et al (2015) reported that 20% of 





questionnaire studies, this estimate increased to 36% of women and 29% of men 
reporting elevated depressive symptoms or major depression. Bobo et al (2016) 
investigated the coexistence of chronic mental and somatic disorders. Due to its high 
prevalence depression was the condition most commonly involved in mental-
physical comorbidity. Hyperlipidaemia, hypertension, diabetes, cardiac arrhythmia, 
and arthritis were the most common somatic conditions co-occurring with 
depression. 
2.3.2.2 Longitudinal studies 
2.3.2.2.1 Depression among individuals with existing cardiovascular disease 
Depression is associated with increased risks of mortality and recurrent non-fatal 
events among individuals with existing CVD. In a systematic review and individual 
patient data meta-analysis, Doyle et al (2015) reported an increased hazard of all-
cause mortality among depressed MI patients relative to non-depressed MI patients. 
The association was stronger in men than women (pooled HR: 1.38, 95% CI: 1.30 – 
1.47, and pooled HR: 1.22, 95% CI: 1.14 – 1.31, respectively), which partly might have 
been explained by disease severity. Nicholson et al (2006) performed a meta-analysis 
assessing depression as a prognostic factor among CHD patients. Twenty-four of the 
included primary studies defined a worse prognosis by assessing the risk of all-cause 
mortality among depressed CHD patients relative to non-depressed CHD patients. 
The pooled relative risk of dying from any cause was 1.80 (95% CI: 1.46 – 2.22) times 
higher in those with depression than in those without depression. Furthermore, the 
pooled relative risk of cardiovascular or cardiac mortality among depressed 
participants with CHD relative to non-depressed participants was estimated at 2.29 
(95% CI: 1.33 – 3.94) using information from six primary studies. In addition, 
depression has been shown to be associated with a negative effect on functional 
outcomes. For example, poststroke depression is associated with worse quality of life 
(QOL), poor life satisfaction, and less efficient use of rehabilitation services 
(Kutlubaev & Hackett, 2014; Towfighi et al, 2017). Although the results of the 





participants included, measurement of depression, and covariates included, an expert 
group recommended “that the American Health Association should elevate 
depression to the status of a risk factor for adverse medical outcomes in patients with 
acute coronary syndrome” in 2014 (Lichtman et al, 2014, p1350). This was based on 
strong, consistent associations between depression and acute coronary syndrome and 
plausible biological mechanisms. However, it was emphasised that this 
recommendation was given despite a lack of evidence that treatment of depression 
lowers the risk of acute coronary syndrome.  
2.3.2.2.2 Depression among individuals with no history of cardiovascular 
disease 
Depression is associated with increased risk of CVD among individuals with no 
history of CVD. Thirteen meta-analyses on the association between clinical 
depression and/ or depressive symptoms and subsequent CVD were identified in a 
scoping review (Figure 2.1). These meta-analyses provided 37 pooled effect estimates 
on the association between different measures of depression and subsequent CVD, 
IHD, CBVD, stroke, ischaemic stroke, haemorrhagic stroke, MI, congestive heart 
disease, CVD-related mortality, and hypertension. Three meta-analyses reported 
estimates assessing depression based on depressive symptom rating scales (Charlson 
et al, 2013; Gan et al, 2014; Rugulies, 2002), five meta-analyses reported estimates 
using a measure of clinical depression (Barlinn et al, 2014; Charlson et al, 2013; Correll 
et al, 2017; Gan et al, 2014; Rugulies, 2002), and twelve meta-analyses reported 
estimates combining information obtained through rating scales and measures of 
clinical depression (Barlinn et al, 2014; Charlson et al, 2013; Dong et al, 2012; Gan et 
al, 2014; Leung et al, 2012; Li et al, 2015; Meng et al, 2012; Nicholson et al, 2006; Pan 
et al, 2011b; Rugulies, 2002; Wu & Kling, 2016; Wulsin & Singal, 2003). All meta-
analyses indicated that depression is associated with increased risk of CVD but two 
CIs of smaller meta-analyses overlapped with the null value (Charlson et al, 2013; 
Gan et al, 2014). The pooled effect estimates were broadly consistent across studies 
with the exception of two studies on the risk of IHD among individuals with clinical 





estimates (Rugulies, 2002; Wu & Kling, 2016). Among the three studies that provided 
estimates on both depressive symptoms alone and clinical depression alone two 
studies provided higher effect estimates among individuals with clinical depression 
(Charlson et al, 2013; Rugulies, 2002), whereas the effect estimate among individuals 
with depressive symptoms was higher in the study by Gan et al (2014). 
 
Figure 2.1: Existing meta-analyses on the association between clinical depression and/ or depressive 
symptoms and subsequent cardiovascular diseases 
 
2.3.2.2.3 Limitations of existing observational studies 
These associations suggest a close relationship between depression and CVD but they 
do not necessarily indicate a causal relationship. There is an ongoing debate about 
whether or not there is sufficient evidence to classify depression as independent risk 
factor for CVD. Whilst some argue that there is sufficient evidence to consider 





(Charlson et al, 2011; Goldston & Baillie, 2008), others argue that depression is yet to 
be confirmed as independent risk factor for CVD (Baxter et al, 2011) and CHD 
(Nicholson et al, 2006). Those that argue that depression is not yet established as 
independent risk factor for CVD point towards shortcomings of existing reviews and 
primary studies. First, existing reviews have struggled to explain the high 
heterogeneity between studies and methodological shortcomings of included studies 
have likely influenced the conclusions of existing reviews. For example, there is no 
agreement on how depression and CVD should be assessed. As a result, there are 
differences in exposure and outcome assessments across primary studies, which 
partly explains the high heterogeneity. In addition, most primary studies included in 
the systematic reviews have assessed depression once at baseline. Since depressive 
disorders are episodic and fluctuating, assessing the presence of clinical depression 
or severity of depressive symptoms at one point in time might not capture the 
longitudinal trajectory of the disorder (Colman & Ataullahjan, 2010). Additionally, 
longitudinal observational studies are needed that provide valuable insights into 
sequence of events and changes over time among participants enrolled in the study. 
Third, many primary studies inadequately adjusted for potential confounding or 
effect-modifying factors (Nicholson et al, 2006). Lastly, publication bias has been 
detected (Wu & Kling, 2016) with an indication that studies with negative results have 
not been published. In contrast, other researchers, who argue in favour of sufficient 
evidence to assess depression as an independent risk factor of CVD, emphasise that a 
number of the Bradford-Hill criteria for causality are met (Hill, 1965). First, the 
association between depression and CVD has been consistent and strong in existing 
primary studies (Charlson et al, 2011; Goldston & Baillie, 2008). Moreover, it was 
stated that there is sufficient evidence for a temporal relationship between depression 
and CVD since multiple well-conducted prospective studies have excluded people 
with a known history of CVD at baseline, and evidence for a dose-response 
relationship between depression and CVD was observed (Charlson et al, 2011; 
Goldston & Baillie, 2008). In contrast to the opposing view, these researchers argued 





could be argued that some covariates might be on the causal pathway. Additionally, 
an association has been observed across multiple somatic and mental health 
conditions suggesting that there is biological plausibility for a causal relationship. 
Lastly, it was argued that possible biological and behavioural pathways have been 
identified in the relationship between depression and CVD. 
2.3.2.3 Proposed mechanisms 
Several pathways might explain the increased risk of CVD among people suffering 
from depression. Potential mediating factors, such as biological dysregulations, 
behavioural factors, and worse medical care causally relate depression to CVD, 
whereas the residual confounding hypothesis, the vascular depression hypothesis, 
the common soil hypothesis, and iatrogenic effects of medication could contribute to 
a non-causal relationship between depression and CVD. It should be noted that all of 
these explanations potentially play a role, which adds to the complexity of the topic.  
The main candidate pathways for biological dysregulations are dysregulations of the 
autonomic nervous system, hypothalamus-pituitary-axis hyperactivity, 
inflammatory processes, endothelial dysfunctions, and alterations of the platelet-
clotting cascade. The autonomic nervous system has two divisions, one of which 
regulates the fight or flight response (sympathetic nervous systems) whereas the 
other maintains bodily functions such as digesting and resting (parasympathetic 
nervous system). In stressful situations the sympathetic nervous system is more 
active than the parasympathetic nervous system. Due to chronic stress, it has been 
hypothesised that the sympathetic nervous system is over-active among depressed 
patients. For example, it has been observed that heart-rate variability, an indirect 
measure of autonomic nervous system functioning, is decreased among depressed 
patients (Kemp et al, 2010). Since autonomic dysregulations are associated with 
increased CVD risk (Licht et al, 2013), it was proposed as a possible mediator of the 
relationship between depression and CVD. Since the hypothalamus-pituitary-
adrenal-axis (HPA axis), a neuroendocrine system consisting of the hypothalamus, 





been proposed as a second potential mediator of the relationship between depression 
and CVD (Fiedorowicz, 2014). A hyperactive HPA axis leads to increased cortisol and 
catecholamine levels, both of which have been observed in depressed patients (Stetler 
& Miller, 2011). Highly increased cortisol levels influence platelet activation and 
aggregation, and alterations in these processes have been observed among depressed 
patients (Nemeroff & Goldschmidt-Clermont, 2012). Since platelet activation and 
aggregation are involved in arterial repair, it has been hypothesised that the alteration 
of these processes might be responsible for the failure to repair arteries which has 
been observed among people with depression (Nemeroff & Goldschmidt-Clermont, 
2012). Additionally, inflammatory processes, which limit the function of the arterial 
wall, have been observed more often among people with depression than in the 
general population (Beatriz Currier & B Nemeroff, 2010). Through the combination 
of impaired arterial function and failure to repair arteries, depression might lead to 
arteriosclerotic processes, which in turn lead to CVD. However, Nemeroff & 
Goldschmidt-Clermont (2012) and Fiedorowicz (2014) criticise that the mechanisms 
are mostly speculative and the precise nature of this relationship is yet to be 
established. Whooley & Wong (2013) argue that the previously described biological 
changes may result from poor health behaviours, which have been observed among 
depressed patients.  
Behavioural factors that might act as mediators of the relationship between 
depression and CVD include physical inactivity, CVD medication non-adherence, 
excessive alcohol use, and smoking. Win et al (2011) investigated the influence of 
adding physical activity variables to a Cox proportional hazards model investigating 
the influence of depressive symptoms on cardiovascular mortality. They observed a 
reduction of the log hazard ratio (HR) by 26% and concluded that physical activity 
acts as a partial mediator of the depression–CVD mortality association. Another 
study investigated the potential synergistic association between depression and 
smoking with heart disease and found the strongest association among depressed 
adults with greater smoking exposure compared with less smoking exposure (Carroll 





between depression and cardiovascular events among patients with CHD and 
investigated the change in the strength of the age-adjusted log HRs after adjustment 
for potential confounding and mediating factors. They concluded that the association 
between depression and cardiovascular events was largely explained by behavioural 
factors since adjustment for alcohol use, medication non-adherence, smoking, and 
physical activity resulted in 5%, 10.9%, 5.3%, and 31.7% reduction of the age-adjusted 
log HR, respectively. However, it was not described clearly whether these 
adjustments were done individually or incrementally. 
Depression might be associated but not causally related to CVD due to residual 
confounding in existing research, shared risk factors, reverse causation, or iatrogenic 
effects of antidepressants. The residual confounding hypothesis originated from 
findings that depressed patients are markedly different from non-depressed patients 
in terms of their sociodemographic characteristics as well as lifestyle and biological 
factors (Penninx, 2016a). Consequently, these factors should ideally be taken into 
account in statistical analyses. Although most primary studies have presented 
adjusted results, some studies have not adjusted their results for main confounding 
factors. Due to the strength and consistency of the association some argue that it is 
unlikely due to residual confounding alone (Penninx, 2016a). Others emphasise the 
lack of adjustments in primary research (Nicholson et al, 2006) and argue that 
variation of estimates might be due to variation in statistical adjustment (Stapelberg 
et al, 2013). A second hypothesis is that depression and CVD share common roots 
(common soil hypothesis), but the effect of these common roots manifests earlier on 
one disease than the other, thus leading to a spurious longitudinal association 
between depression and CVD. Examples of potential shared risk factors are shared 
genetic variants (genetic pleiotropy) (de Geus, 2006), early-life factors or low 
socioeconomic status (SES) (Mortimer et al, 2016). Furthermore, underlying 
cerebrovascular disease itself might “predispose, precipitate, or perpetuate some 
geriatric depressive symptoms” (Alexopoulos et al, 1997, p915). This hypothesis is 





individuals with geriatric depressive symptoms and individuals with vascular 
dysregulations show greater severity of white matter lesions (ischaemic lesions in the 
brain), identified as white matter hyperintensities on MRIs (Taylor et al, 2013). If 
depressive symptoms are indeed related to worsening of underlying vascular disease, 
depression may not be causally related with subsequent cardiovascular events but 
instead reflect a prodromal feature of worsening vascular disease itself. A third 
hypothesis is that psychotropic medications and not depression itself are responsible 
for the increased CVD risk among people with depression. However, it has been 
challenging to disentangle the effects of depressive disorders and antidepressants 
since antidepressant use is likely to act as an identifier of disease severity at the same 
time (see section 7.3.4.1 The need to disentangle the role of depression and 
psychotropic medications for a more detailed discussion). Also, in the literature on 
the association between antidepressants and CVD risk methodological shortcomings 
similar to those observed in the literature between depression and CVD have been 
reported (Shin et al, 2014). 
It remains to be established to what extent each proposed mechanism contributes to 
the increased risk of CVD among people with depression. Due to the complexity of 
the relationship between depression and CVD, the likely interplay of different 
mechanisms, and challenges in using causal inference methods in research on 
psychological disorders (see section 7.3.3.3 Causal inference in research on 
psychological disorders for further discussion), quantifying the mediating effect of 
one or all of the mechanisms has proven challenging. Therefore, whilst potential 
mechanisms have been proposed, the importance of different mechanisms has yet to 
be established.  
2.3.2.4 Intervention studies 
2.3.2.4.1 Existing randomised controlled trials 
Existing meta-analyses aimed at investigating the effectiveness of psychological 
interventions on risk of all-cause mortality, CVD-specific mortality, and recurrent 





et al, 2019; Linden et al, 2007; Reavell et al, 2018; Richards et al, 2017; Welton et al, 
2009; Whalley et al, 2014). The most recently published systematic review and meta-
analysis investigated the additional impact of psychological lifestyle change or 
distress management interventions on depression, anxiety, QOL, cardiac morbidity, 
and cardiovascular or total mortality compared to usual care among patients with 
coronary artery disease or congestive heart failure (Albus et al, 2019). Whilst pooled 
effect estimates indicated a trend towards decreased depressive symptoms and 
reduced cardiac morbidity among those allocated to the intervention group, there 
was no evidence for changes in anxiety, QOL, and cardiovascular or all-cause 
mortality. These results are only partially consistent with another meta-analysis 
aimed at assessing the effectiveness of psychological interventions compared to usual 
care among CHD patients (Richards et al, 2017). Whilst neither the risk of all-cause 
mortality nor the risk of non-fatal MI was significantly different between the 
intervention and control group, there was a 21% (95% CI: 2% – 37%) reduced risk of 
cardiac mortality among the intervention group. Importantly, the authors of the meta-
analyses highlighted the low quality of evidence and emphasised significant 
heterogeneity between studies due to differences in study populations and 
characteristics of interventions. Furthermore, it was highlighted that only 12 of 35 
included RCTs used the existence of psychopathology at baseline as eligibility 
criterion. Goldston & Baillie (2008) emphasised that this has likely led to floor effects 
since participants had little need for psychological intervention thereby not 
benefitting from it. In addition, it was highlighted that a further potential explanation 
for the null findings might be that participants in these trials had already developed 
CVD (Stewart et al, 2014).  
There is a lack of trials on the effect of depression treatment on first-ever CVD events. 
I have only identified one RCT that investigated the effectiveness of a psychological 
intervention among patients free from CVD at baseline. Stewart et al (2014) conducted 
an analysis using data from the Improving Mood- Promoting Access to Collaborative 





compared to usual care among participants with major depression or dysthymia with 
and without established CVD at baseline. They observed a significantly decreased 
hazard of CVD, defined as fatal or non-fatal MI or stroke, among participants without 
baseline CVD (HR: 0.52, 95% CI: 0.31 – 0.86) but not among participants with baseline 
CVD (HR: 1.19, 95% CI: 0.70 – 2.03). However, the authors acknowledged limitations 
such as a post-hoc nature, low statistical power, and a non-effective psychological 
intervention among participants with baseline CVD. As a result, they concluded that 
there is a need for well-powered RCTs to replicate their findings and to elucidate 
mechanisms underlying the effect of depression on CVD.  
2.3.2.4.2 Limitations of existing randomised controlled trials 
There are major shortcomings in existing RCTs. First, the findings of existing studies 
might have been influenced by chance. The sample sizes of studies included in the 
systematic review by Albus et al (2019) ranged from 70 to 1,127 participants. Likely 
explanations of small sample sizes were high costs involved in running a trial and 
resource intensive treatments in trials involving psychological interventions. 
Furthermore, it has been highlighted that power calculations might have been based 
on existing studies that were too small to observe an effect or existing studies that 
were not comparable methodologically (Pedersen & Doyle, 2019). Due to small 
sample sizes true differences between groups might have remained undetected.  
Second, selection bias is likely to have influenced the results of existing RCTs on the 
effect of psychological interventions on risk of cardiovascular events. Participants of 
RCTs underlay strict inclusion and exclusion criteria in order to increase homogeneity 
among trial participants. As a result, the limited number of potentially eligible 
participants were highly selected which affected the generalisability of findings. 
Furthermore, selection bias is likely to have influenced results due to self-selected 
samples. Participants of trials are usually highly motivated individuals who tend to 
have less serious medical conditions. In keeping with that it has been shown that 
individuals with mental health conditions are less likely to enrol in RCTs (Pogosova 





participants might have had little need for psychological interventions thereby not 
benefitting from it (Goldston & Baillie, 2008).  
A further limitation of existing RCTs is that psychological interventions were not 
well-defined. A major shortcoming was that usual care tended to include advice on 
lifestyle and psychological advice. Whilst it might be unethical not to give this advice 
to the control group, the levels of treatment might not be sufficiently different 
between the intervention and control groups. Also, if usual care is effective, an 
additional psychological intervention might not have an additional effect (Albus et 
al, 2019; Pedersen & Doyle, 2019). Moreover, the use of different versions of 
treatments and comparators across studies complicated the comparison of findings 
of different RCTs. Observed differences across trials might have been due to varying 
effects of different psychological interventions or due to methodological differences 
across studies. To improve the quality and completeness of descriptions of 
interventions and enhance interpretation of observed differences across trials, it is 
recommended that future studies follow the template for intervention description 
and replication (TIDieR) checklist and guide (Hoffmann et al, 2014). 
2.4 Summary of justification for this project 
Depression and CVD both substantially contribute to the global burden of diseases. 
An association between depression and CVD onset and progression has been 
observed in numerous primary studies and existing reviews but there is an ongoing 
debate whether or not the evidence base is sufficient to acknowledge depression as 
an independent risk factor for CVD. Multiple plausible mechanisms have been 
proposed but the exact nature of the association between depression and CVD 
remains poorly understood. If depression is indeed a causal risk factor for CVD, this 
will have important implications on resource allocation, depression and CVD 
treatment, and it offers possibilities for new preventive treatments for CVD if the 
pathophysiological effect of depression on arteries can be identified. Therefore, the 
overall aim of this project is to further our understanding of the relationship between 





Chapter 3: The association between clinical 
depression or depressive symptoms and major 
cardiovascular events – A systematic review and 
meta-analysis 
3.1 Background 
Existing systematic reviews and meta-analyses have provided pooled effect estimates 
of the association between depression and subsequent CVD. However, they did not 
provide sufficient information to gain a detailed understanding of the literature and 
its methodological shortcomings. Whilst pooled effect estimates will be provided in 
this chapter to synthesise the results of existing studies, this review’s primary aim 
was to provide a detailed assessment of the current evidence base. A particular focus 
of this review was to assess the strengths and weaknesses of existing studies and to 
identify whether studies have previously explored mechanisms and mediating 
pathways of the depression-CVD association. After completion of the review, I 
investigated the extent to which shortcomings of existing studies can be overcome as 
part of this project. Studies that have previously explored mechanisms and mediating 
pathways were identified because at the outset of this PhD one of the objectives was 
to explore mechanisms and mediating pathways between depression and CVD. 
However, due to methodological considerations and time restrictions this then was 
not taken further. A more detailed discussion of this methodological consideration is 
given in section 7.3.2 The need for an accurate definition of depression. 
A preliminary search highlighted that a large number of primary studies on the 
association between depression and different CVD subtypes have been published. 
Given the vast amount of literature in this area a systematic review of all primary 
studies on the association between depression and any CVD subtypes was not 
deemed feasible within the time restrictions of this project. Therefore, it was decided 
to restrict this review to studies on the risk of first-ever fatal or non-fatal stroke or MI. 
Stroke and MI were chosen as outcomes because they are two common and severely 





hospital records which was an important consideration because it had already been 
decided that linkage to hospital records would be used as a part of at least one project 
of this thesis. The implications of this decision will be further discussed below (see 
section 3.5.3 Strengths and limitations of this systematic review).  
3.2 Objectives 
1. To systematically identify studies on the association between depression and risk 
of first-ever fatal or non-fatal stroke and/ or MI 
2. To investigate to what extent studies have previously explored mechanisms and 
mediating pathways of the depression-CVD association 
3. To assess strength and weaknesses of the current evidence base 
3.3 Methods 
3.3.1 Search strategy 
Primary studies assessing the relationship between depression and risk of first-ever 
fatal or non-fatal stroke or MI were identified through a comprehensive search of 
electronic literature databases. Based on the database’s focus, EMBASE, Medline, 
PsycINFO, CINAHL, and Web of Science were identified as relevant databases. The 
search strategy was based on three search clusters: depression, stroke or MI, and 
association or causality. For each of the clusters, synonyms were identified through 
screening of relevant studies and previous published systematic reviews. A 
preliminary search was performed and the search strategy was discussed with a 
librarian. No language restrictions were made. An adapted version of the search 
strategy was developed for each database (Appendix 1 to Appendix 5). Since the 
preliminary search highlighted a large number of hits, it was decided to screen all 
search results backwards until 01 January 2010. This date was chosen because it was 
deemed likely that relevant primary studies published before January 2010 could be 
identified through screening of reference lists of eligible primary studies published 
after January 2010 and through screening of reference lists of well-conducted 
published systematic reviews and meta-analyses. The first search was run on all 





during the course of this project, an update of the systematic review was performed 
on 24 January 2019.  
3.3.2 Study selection 
3.3.2.1 Selection procedure 
All retrieved articles were imported into EndNote X8 (Clarivate Analytics, 2016). 
Titles and abstracts were screened for potentially relevant studies. Full texts of all 
potentially relevant studies were read to compare the articles against a priori stated 
inclusion and exclusion criteria. If articles did not meet all inclusion criteria, the 
reason for exclusion was noted. Authors were contacted if eligibility could not be 
definitely determined after reading the full-text of articles. If authors did not respond 
or could not provide necessary information, the article was excluded. I tried to 
identify published articles of potentially eligible conference abstracts. If I could not 
identify a published article, I contacted the authors. If the authors did not respond or 
no article was published, the conference abstract was excluded. 
3.3.2.2 Inclusion and exclusion criteria 
Eligible participants were adults (≥ 18 years), free from stroke (when interested in 
stroke as outcome) or MI (when interested in MI as outcome). Participants in the 
exposure group either had to have a clinical diagnosis of depression or depressive 
symptoms. In contrast, the comparison group had to be free of clinically diagnosed 
depression or depressive symptoms. Additionally, studies were eligible if they 
reported the risk of stroke and/ or MI per unit increase on a depressive symptom 
rating scale. To decrease heterogeneity between studies, it was decided not to include 
studies that used measures of general psychological distress, some of which focus 
more on depression and anxiety and others capture a broader spectrum of mental 
health symptoms. However, since one of the projects of this thesis uses a measure of 
psychological distress, these studies will be discussed in the background section of 
the other project (see section 6.1 Background). Studies solely focusing on the effect of 
antidepressant or antipsychotic medication on stroke or MI risk were not eligible. The 
outcomes of interest were first-ever fatal or non-fatal stroke and first-ever fatal or non-





recorded diagnosis in medical records. Studies were not eligible if they defined 
strokes according to all CBVD ICD codes (e.g. ICD-10: I60 – 69, ICD-9: 430 – 438) or 
all IHD (e.g. ICD-10: I20 – I25, ICD-9: 410 – 414), except for studies in which these 
events were adjudicated by a medical committee. Equally, TIAs as well as coronary 
artery bypass grafting or percutaneous coronary interventions were not eligible as 
assessment of stroke and MI. Studies with participants that were selected on a 
condition other than depression were excluded.  
3.3.3 Quality assessment 
Since previous reviews pointed towards limitations in the exposure and outcome 
assessment and in the way potential confounding factors were considered, it was of 
interest to identify a quality assessment tool that allowed a detailed assessment of 
these factors. The Critical Appraisal Skills Programme (CASP) cohort study checklist 
was selected since it fulfilled the criteria mentioned above and was user friendly. The 
three sections of the CASP checklist allowed for an assessment of the validity of 
results, the results itself, and the implications and usefulness of the study (Critical 
Appraisal Skills Programme, 2019). One additional category was added to the 
checklist because the CASP checklist did not cover to what extent mediating factors/ 
mechanisms were discussed and taken into account in the analysis. 
3.3.4 Data extraction 
Data from eligible studies were extracted into pre-tested Microsoft Access tables. This 
form contained information on the study (e.g. author, year, country, data source), its 
characteristics (e.g. total sample size and size of each group, number of events, mean 
age, sex distribution, years of follow-up, loss to follow-up), methodology (e.g. 
exposure and outcome assessment, statistical method of analysis, adjustments, 
mediation discussed/ examined, interaction analyses, stratified analyses) and results 
(e.g. effect estimates for the total sample and subgroups with 95% CIs). If numbers 
differed between text and tables, the information of the table was extracted. If a 
specific value, such as number of events or individuals in the exposure group, was 





number was calculated by the author of this dissertation. If a study compared three 
or more exposure groups, information of the most and least exposed groups was 
extracted. 
3.3.5 Data synthesis 
Studies which were deemed comparable were included in a random effects meta-
analysis. Separate meta-analyses were performed for each of total stroke, ischaemic 
stroke, haemorrhagic stroke, and MI. Since the use of dichotomised and continuous 
exposure scales has implications on the interpretation of effect estimates, separate 
meta-analyses were performed for studies depending on the exposure assessment. 
Heterogeneity was assessed using the chi-squared test and the I² statistic. The I² 
statistic quantifies the proportion of variance between studies that is not explained 
by random variation (Higgins & Green, 2011). Subgroup analyses were conducted to 
investigate to what extent there were differences in the risk of stroke or MI between 
men and women and between studies using a measure of clinical depression and 
depressive symptoms. To avoid double-counting information of the same participant, 
only one effect estimate of each study was included in the meta-analysis. The effect 
estimate that was deemed most comparable to the other included studies with regard 
to the methodological approach was chosen. Furthermore, if more than one study 
used the same data source, only one of the studies was included in the meta-analysis. 
Studies were chosen based on the number of participants and/ or length of follow-up. 
The results of studies excluded from the quantitative data synthesis will be discussed 
and compared to the results of included studies. Meta-analyses were performed using 
the metagen function of the meta package in R (Schwarzer, 2007).  
3.4 Results 
3.4.1 Study selection 
Fifty-one studies met the inclusion criteria, 36 of which investigated the relationship 
between depression or depressive symptoms and risk of stroke and 24 of which 







Figure 3.1: Flow-chart of study selection (adapted version of the PRISMA Flow Diagram (Moher et al, 
2009)) 
 
3.4.2 Study characteristics 
3.4.2.1 Eligible studies 
Included studies were published from 1996 (Barefoot & Schroll, 1996; Pratt et al, 1996) 
to 2018 (Niles & O'Donovan, 2018). The length of follow-up ranged from 2 years (Kim 
et al, 2011) to 37 years (Janszky et al, 2010) and the sample sizes ranged from 574 
(Gafarov et al, 2017) to 1,937,360 participants (Daskalopoulou et al, 2016). The 
included studies were based on 35 different data sources. Fifteen of these were based 
on data from the US, three from the UK, two each from Australia, Germany and the 
Netherlands, and one each from Denmark, Finland, Sweden, Norway, Spain, France, 
Russia, China, Japan, and Taiwan. One study combined data from France and 
Northern Ireland. Four of these data sources solely relied on routinely collected 
medical records (Daskalopoulou et al, 2016; Janszky et al, 2010; Mathur et al, 2016; 





Lin et al, 2014), and the remaining data sources obtained their data through 
questionnaires, interviews, and medical examinations. 
3.4.2.2 Participants 
Whilst the selection procedure of the exposure and comparison groups was the same 
within studies, the selection procedure of participants markedly differed across 
studies. For example, whilst all studies included participants free from stroke and/ or 
MI at baseline, many studies additionally excluded participants with a history of 
other CVD (Ariyo et al, 2000; Brown et al, 2011; Cummings et al, 2016; Daskalopoulou 
et al, 2016; Everson-Rose et al, 2014; Gafarov et al, 2017; Gustad et al, 2014; Joyce, 2015; 
Langvik & Hjemdal, 2015; Majed et al, 2012; Moise et al, 2016; Ohira et al, 2001; 
Péquignot et al, 2016; Péquignot et al, 2013; Pössel et al, 2015; Pratt et al, 1996; Scherrer 
et al, 2010; Scherrer et al, 2011; Stürmer et al, 2006; Sun et al, 2016; Wassertheil-Smoller 
et al, 2004), a history of other CVD or cardiac procedures (Stewart et al, 2016), or any 
known medical conditions at baseline (Kubzansky et al, 2006; Sesso et al, 1998) 
thereby creating samples of healthy participants at baseline. Four studies compared 
results after exclusion of participants with a history of cardiovascular events other 
than stroke and/ or MI at baseline to results with exclusion of participants with a 
history of stroke and/ or MI only (Barefoot & Schroll, 1996; Everson et al, 1998; 
Marijnissen et al, 2014; Wouts et al, 2008). One study excluded participants with any 
CVD at baseline (Mejía-Lancheros et al, 2014) but selected participants with an above 
average risk of developing events during follow-up by selecting participants with 
known cardiovascular risk factors at baseline. Another notable selection criterion was 
observed in the study by Arbelaez et al (2007) in which participants with a 
haemorrhagic stroke during follow-up were excluded. The authors justified this by 
the lack of association between depression and haemorrhagic stroke in the sample.  
There were differences in the age and sex distribution of participants across studies. 
Forty-two studies enrolled both male and female participants, five studies enrolled 
men only (Janszky et al, 2010; Kubzansky et al, 2006; Majed et al, 2012; Pössel et al, 





2013; Pan et al, 2011a; Wassertheil-Smoller et al, 2004). Of the 39 studies that reported 
their participant’s mean age at baseline, one study reported a mean age below 39 
years, four studies reported a mean age from 40 – 49 years, eight studies reported a 
mean age from 50 – 59 years, 19 studies reported a mean age from 60 – 69 years, and 
seven studies reported a mean age over 70 years. Of the twelve studies that did not 
report their participants’ mean age, four studies reported a median age of 
participants. One study reported a median age from 40 – 49 years, one study reported 
a median age from 50 – 59 years, and two studies reported a median age over 70 years. 
Eight studies reported the range of their participants at baseline, of which one study 
each included participants aged 18 – 20 years, aged 50 – 60 years, aged at least 65 
years, and aged at least 75 years. Furthermore, three studies included participants 
aged at least 18 years at baseline. 
Participant characteristics of individuals in the exposure group were compared to 
characteristics of those in the comparison group in 23 studies (Brown et al, 2011; 
Cummings et al, 2016; Daskalopoulou et al, 2016; Everson et al, 1998; Glymour et al, 
2010; Jackson & Mishra, 2013; Janszky et al, 2010; Joyce, 2015; Köhler et al, 2013; 
Larson et al, 2001; Lin et al, 2014; Majed et al, 2012; Mathur et al, 2016; Mejía-
Lancheros et al, 2014; Moise et al, 2016; O'Brien et al, 2015; Pan et al, 2011a; Péquignot 
et al, 2013; Pratt et al, 1996; Scherrer et al, 2010; Sesso et al, 1998; Stürmer et al, 2006; 
Sun et al, 2016). All of these studies reported higher proportions of women among 
the exposure group than among the comparison group. In ten of the studies 
participants in the exposure group were younger, in six studies participants in both 
groups were of similar age, in six studies they were older, and two studies did not 
report differences in age. Fifteen studies reported a lower SES among the exposed 
group, three studies reported higher educational attainment, one study reported no 
differences between the SES of the groups, and one study reported higher 
unemployment despite higher educational attainment among the exposure group. 
Furthermore, participants in the exposure group were less likely to be married, and 





A notable exception is the difference in alcohol intake. Whilst seven studies reported 
a higher alcohol intake or more alcohol abuse/ dependence among the group with 
depression, eight studies reported a lower intake of alcohol among the exposure 
group. 
3.4.2.3 Exposure assessment 
The included studies varied in their way of assessing the exposure. Thirty-four 
studies assessed depression based on depressive symptom rating scales, 11 studies 
used a measure of clinical depression, three studies combined information obtained 
through rating scales and diagnostic interviews, two studies combined information 
on clinical depression and antidepressant use, and one study combined information 
obtained from a rating scale and/ or clinical depression and/ or antidepressant use 
(Table 3.1).  
Differences were not only present in the use of different rating scales but also in the 
way different studies used the same rating scale. Nine different depressive symptom 
rating scales were used, of which the CES-D was the scale that was used most often 
(22 studies). Whilst some studies used the recommended cut-off score of at least 16 to 
define the presence of depressive symptoms, other studies formed quartiles, used the 
CES-D scale as continuous exposure scale, or used two exposure waves to define 
constant low, recent onset, recently remitted, and stable high depressive symptoms. 
Similarly, different data sources were used to define clinical depression. Whilst some 
studies defined clinical depression based on ICD codes (versions 8 or 9), others used 
Read codes, the Diagnostic Interview Schedule (DIS), or self-report of (doctor) 
diagnoses. 
Whilst most studies assessed depressive symptoms or clinical depression at baseline 
only, twelve studies investigated the influence of symptom severity, timing of 
symptoms, and symptom recurrence on effect estimates. Five of these studies 
assessed the risk of stroke and/ or MI using time-updated information on depressive 
symptom in statistical models (Everson et al, 1998; Glymour et al, 2010; Jackson & 





estimates of the risk of stroke and/ or MI among individuals with current depression 
and individuals with a history of depression (Daskalopoulou et al, 2016; Pan et al, 
2011a). Two studies assessed depressive symptom scores at multiple waves and 
calculated a mean score (Ariyo et al, 2000; Wouts et al, 2008). Wouts et al (2008) 
additionally investigated the risk of stroke/MI dependent on the proportion of 
observations with clinical depression or depressive symptoms. Péquignot et al (2016) 
assessed depressive symptoms at multiple waves and modelled the risk of stroke as 
a function of the count of occasions with high depressive symptoms. Gilsanz et al 
(2017); Gilsanz et al (2015) investigated the risk of stroke dependent on changes in 
depressive symptoms. Changes in depressive symptoms were defined according to 
two exposure waves preceding the outcome wave. Participants were allocated to a 
group with stable high depressive symptoms, recent onset depressive symptoms, 
recently remitted depressive symptoms, and stable low depressive symptoms 
depending on whether they had depressive symptoms (CES-D score of at least 16) in 
both, neither, the first exposure wave only or the second exposure wave only. 
3.4.2.4 Outcome assessment 
Thirty-six studies reported the association between depression or depressive 
symptoms and subsequent stroke. Thirty-two of these studies investigated the 
association between depression or depressive symptoms and total stroke, ten studies 
explored the relationship with ischaemic stroke, six studies assessed the risk of 
haemorrhagic stroke, and one study looked at the relationship between depression or 
depressive symptoms and risk of uncertain type of stroke. Twenty-four studies 
reported the association between depression or depressive symptoms and 
subsequent MI.  
Studies varied greatly with regard to what data sources were used to determine 
events during follow-up (Appendix Table A 1). Thirty-eight studies had access to at 
least one source of routinely collected medical records including death records. 
Twenty-four studies had access to hospital records of participants. Furthermore, 16 





on confirmation through the participant’s GP whereas five studies had access to 
routinely collected primary care records. Thirty studies used death records to 
determine the date and cause of death. Eight studies additionally used coroner 
reports, autopsy reports or obituaries to identify stroke and/ or MI events. Seven 
studies solely relied on self-report of participants or proxies, six of which were based 
on data from the Health and Retirement study. Two studies relied on national health 
insurance records but did not further specify what type of records were collected. 
One study did not give any information on data sources used to establish events 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
   
 
56 
3.4.2.5 Conditioning on covariates 
All studies addressed potential confounding and/ or mediating factors to some extent, 
either by adjusting for covariates in statistical models, by restricting the sample, by 
reporting stratified results, or by applying inverse probability weights (Table 3.2). All 
studies reported effect estimates after conditioning on age and all but one study 
conditioned on sex. Thirty-one studies conditioned on SES. Whilst most studies used 
a measure of educational attainment to condition on SES, others used a measure of 
occupation, employment status, income, wealth, area-based deprivation, and 
homeownership. Other sociodemographic factors that were taken into account by 
some but not all studies were race/ ethnicity, marital status, region/ urbanisation, and 
social support. Forty studies conditioned on at least one lifestyle factor with smoking 
being the most common factor conditioned on (40 studies), followed by at least one 
measure of body weight (32 studies). However, only eleven studies conditioned on 
each of smoking, physical activity, alcohol intake, and a measure of weight (e.g. body 
mass index (BMI)) of which two studies additionally conditioned on at least one 
dietary factor. Forty-seven studies conditioned on at least one comorbidity at 
baseline. Of these, 42 studies conditioned on blood pressure/ hypertension, 40 studies 
on diabetes mellitus, 24 studies on cholesterol levels, and 41 studies on CVD (other 
than stroke or MI at baseline). Thirteen studies conditioned on psychopathology other 
than depression at baseline. Fourteen studies conditioned on at least one medication, 
ten studies on at least one biological factor, nine studies on at least one factor related 
to the family of participants, and seven studies on at least one study-design related 
factor. 
Whilst the majority of studies conditioned on covariates at baseline only, six studies 
conditioned on time-updated information of covariates during follow-up. Three of 
these studies adjusted for time-varying covariate information in Cox proportional 
hazards models (Everson et al, 1998; Pan et al, 2011a; Wouts et al, 2008), one study 
included time-updated information in a generalised estimating equation (GEE) 
regression model (Jackson & Mishra, 2013), and two studies applied stabilised inverse 





in such a way that depressive symptoms were no longer associated with time-
updated covariates, survival, and study dropout. 
Whilst most studies discussed the role of different pathways or mediating factors in 
the relationship between depression and cardiovascular events in the background 
and discussion sections, only 12 studies took the role of mediating factors into account 
in their analysis. Four of these studies hypothesised that some of the covariates might 
be on the causal pathways but adjusted for these factors using the same approach as 
for hypothesised confounding factors (Majed et al, 2012; Moise et al, 2016; O'Brien et 
al, 2015; Péquignot et al, 2016). Janszky et al (2010), Glymour et al (2010), Glymour et 
al (2012) and Gustad et al (2014) hypothesised that some of the covariates were on the 
causal pathway and reported effect estimates with and without inclusion of these 
covariates. Furthermore, Glymour et al (2010; 2012) highlighted that the effect 
estimates after inclusion of potential mediating factors should not be interpreted 
causally. Wassertheil-Smoller et al (2004) identified some of the covariates as 
mediators and stated that these variables were not included in the multivariate model 
since they were assumed to be on the causal pathway. Gilsanz et al (2015; 2017) 
considered the timing of exposure, covariates, and outcome and stated that inverse 
probability weights were applied to control for time-updated covariates since they 
might act as confounders as well as mediators. Arbelaez et al (2007) aimed to 
investigate the potential role of inflammation as a mediator. For that, the authors 
investigated to what extent the effect estimate was altered when results were first 









































































































































































BMI/obesity/weight/ waist circumference 
Diet/ dietary supplements 
CVD (other than stroke/MI) 
Blood pressure/ hypertension 
Diabetes (mellitus) 
Cholesterol/ lipid levels 
Cancer 
Psychopathology (other than depression) 
Physical impairment 
Cognitive impairment/ function 
Height 
C-reactive protein 




Lipid-/ cholesterols-lowering drugs 
Aspirin/ antithrombotic drugs 
Study site 
Year of enrolment 
Mother's/ father's SES 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mother's/ father's SES 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mother's/ father's SES 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mother's/ father's SES 
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3.4.3 Quality assessment 
The assessment of the included studies’ focus, recruitment strategy, accuracy of 
exposure and outcome, method of conditioning on confounding and mediating 
factors, length and loss of follow-up, precision and generalisability of results allowed 
for an assessment of the strengths and weaknesses of included studies (see section 
3.5.2 Strengths and limitations of included studies for detailed assessment). Overall, 
the included studies were rated to have a clear focus but there were important 
shortcomings in the exposure assessments, precision of results, and method of 
conditioning on confounding and mediating factors. An example of a completed 
CASP Cohort Study Checklist is included in Appendix 6. 
3.4.4 Data synthesis 
3.4.4.1 Stroke 
3.4.4.1.1 Assessing eligibility of studies for inclusion in meta-analysis 
Among 36 studies on the association between depression and risk of stroke, 32 studies 
explored the risk of total stroke. Twenty-four of these studies were eligible for 
inclusion in the meta-analysis. Reasons for exclusion were overlapping populations 
(Gilsanz et al, 2015; Glymour et al, 2012; Marijnissen et al, 2014; Péquignot et al, 2013) 
and non-comparable effect estimates (Jackson & Mishra, 2013; Kim et al, 2011; Kim et 
al, 2013; Larson et al, 2001). Twenty-three eligible studies reported effect estimates on 
the hazard of total stroke among individuals with depression or depressive 
symptoms relative to non-exposed individuals. Additionally, seven studies reported 
the hazard of total stroke per unit increase on a depressive symptom rating scale. Ten 
studies investigated the hazard of ischaemic stroke of which eight studies were 
eligible for inclusion whereas two studies were excluded due to overlapping 
populations (Gilsanz et al, 2017; Yan et al, 2013). Out of six studies that examined the 
hazard of haemorrhagic stroke five studies were eligible for inclusion in the meta-
analysis. One study was excluded because authors did not provide CIs (Henderson 
et al, 2013). Four of the included studies reported the hazard of all types of 
haemorrhagic stroke whereas Daskalopoulou et al (2016) reported results separately 




based on the same individuals and the number of people who had an intracerebral 
haemorrhage was higher, the decision was made to only include the effect estimate 
on the hazard of intracerebral haemorrhage in the meta-analysis. The estimate of the 
association between depression and hazard of unknown stroke type reported by Pan 
et al (2011a) was extracted but was not included in any of the meta-analyses.  
3.4.4.1.2 Total stroke - dichotomous exposure 
Twenty-three studies reported effect estimates of the hazard of total stroke among 
individuals with depression or depressive symptoms relative to non-exposed 
individuals (Appendix Table A 2). The reported HRs ranged from 0.44 (95% CI: 0.06 
– 3.22) to 8.50 (95% CI: 1.05 – 68.73) with these extreme values based on sub-groups 
of people in each study (Gafarov et al, 2017; Wouts et al, 2008). Nine studies reported 
effect estimates that did not overlap with the null value, all of which indicated 
increased hazards of total stroke among individuals with depression or depressive 
symptoms relative to non-exposed individuals. The pooled random effects meta-
analysis indicated a 30% (95% CI: 19 – 43%) increased hazard of stroke among 
individuals with depression or depressive symptoms, relative to non-exposed 
individuals (Figure 3.2). There were statistically significant differences between 
studies and the estimate of between-study heterogeneity that remained unexplained 





Figure 3.2: Meta-analysis of the hazard of total stroke among individuals with depression or depressive 
symptoms, relative to non-exposed individuals 
 
Among studies that provided sex-specific estimates, depression or depressive 
symptoms were associated with increased hazards of stroke among both men and 
women (pooled HR: 1.26, 95% CI: 1.01 – 1.57, and 1.23, 95% CI: 1.06 – 1.44, 
respectively) (Figure 3.3). There was moderate between-study heterogeneity that 
remained unexplained among studies with male and female participants (I2: 45.1% 





Figure 3.3: Meta-analysis of the hazard of total stroke among individuals with depression or depressive 
symptoms, relative to non-exposed individuals, separately for men and women 
 
The pooled effect estimates were slightly higher among studies using a measure of 
depressive symptoms than among studies using a measure of clinical depression 
(Figure 3.4). The pooled HR indicated a possible 20% increased hazard of stroke 
among individuals with clinical depression, relative to individuals without clinical 
depression (pooled HR: 1.20, 95% CI: 0.99 – 1.45). There were no statistically 
significant differences among studies using a measure of clinical depression (p = 0.06). 
However, the p-value of the chi2 test of differences between studies was close to the 
cut-off value of statistical significance. The estimated proportion of heterogeneity that 
remained unexplained was moderate at 52.5%. The increased hazard of stroke among 
individuals with depressive symptoms was estimated to be 35% (95% CI: 21 – 50%), 
relative to individuals without depressive symptoms. Heterogeneity among studies 





Figure 3.4: Meta-analysis of the hazard of total stroke among individuals with clinical depression or 
depressive symptoms, relative to non-exposed individuals, separately for studies using a measure of 
clinical depression and depressive symptoms 
 
3.4.4.1.3 Total stroke - continuous exposure 
Six studies investigated the hazard of total stroke assessing depressive symptoms on 
a continuous scale (Appendix Table A 3). Three studies investigated the hazard of 
stroke per one point increase on depressive symptom scales (Everson et al, 1998; 
Glymour et al, 2010; Wouts et al, 2008) and three studies reported the increased 
hazard per one standard deviation increase (O'Brien et al, 2015; Ohira et al, 2001; 
Stürmer et al, 2006). Ohira et al (2001) provided sufficient information to convert the 
effect size from per standard deviation to per unit increase whereas O'Brien et al 
(2015) and Stürmer et al (2006) did not provide sufficient information. The pooled HR 




1.01 – 1.08) (Figure 3.5). Substantial between-study heterogeneity remained 
unexplained (I²: 83.4%) which was unlikely to be due to chance alone (p < 0.01). The 
pooled HR per standard deviation increase on depressive symptom scales was 
estimated as 1.22 (95% CI: 1.02 – 1.45) (Figure 3.5). There was no between-study 
heterogeneity that remained unexplained (0.0%). 
  
Figure 3.5: Meta-analysis of the hazard of total stroke per unit increase on depressive symptom scales 
 
3.4.4.1.4 Ischaemic stroke 
All eight included studies reported increased hazards of ischaemic stroke among 
exposed individuals relative to unexposed individuals with effect estimates ranging 
from 1.13 (95% CI: 0.96 – 1.34) to 2.70 (95% CI: 1.21 – 6.04) (Ohira et al, 2001; Sun et al, 
2016) (Appendix Table A 4). The pooled HR was estimated at 1.27 (95% CI: 1.13 – 1.34) 
(Figure 3.6). There were no statistically significant differences between studies (p = 





Figure 3.6: Meta-analysis of the hazard of ischaemic stroke among individuals with depression or 
depressive symptoms, relative to non-exposed individuals, separately for studies using a measure of 
clinical depression and depressive symptoms 
 
3.4.4.1.5 Haemorrhagic stroke 
Whilst four of the five HRs indicated a possible increased hazard of haemorrhagic 
stroke among individuals with the exposure relative to individuals without 
depression or depressive symptoms, the estimates of included studies were imprecise 
and all reported CIs included the null value (Appendix Table A 5). The pooled HR 
was estimated at 1.17 (95% CI: 0.97 – 1.42) (Figure 3.7). There were no statistically 
significant differences between studies and no between-study heterogeneity 
remained unexplained (I²: 0.0%). 
 
Figure 3.7: Meta-analysis of the hazard of haemorrhagic stroke among individuals with depression or 
depressive symptoms, relative to non-exposed individuals, separately for studies using a measure of 
clinical depression and depressive symptoms 
 
3.4.4.1.6 Summary of main findings of studies not included in the meta-analysis 
3.4.4.1.6.1 Total stroke 
The results of excluded studies generally followed the same pattern as the overall 




increased risks of individuals with depression or depressive symptoms, relative to 
unexposed individuals. 
Eight excluded studies reported estimates on the risk of total stroke among 
individuals with depression or depressive symptoms relative to individuals without 
depression or depressive symptoms (Figure 3.8). All studies that were excluded due 
to the provision of non-comparable effect estimates reported increased risks of total 
stroke among exposed individuals relative to unexposed individuals (Jackson & 
Mishra, 2013; Kim et al, 2011; Kim et al, 2013; Larson et al, 2001). Whilst the magnitude 
of the effects was not directly comparable between excluded studies and the meta-
analysis, the direction of the effects were the same. Three of the four studies that were 
excluded due to overlapping populations showed increased hazards of total stroke 
among exposed individuals relative to those without depression or depressive 
symptoms (Gilsanz et al, 2015; Marijnissen et al, 2014; Péquignot et al, 2013). The CIs 
of the estimates by Gilsanz et al (2015) and Marijnissen et al (2014) did not overlap 
with the CI of the pooled HR indicating that the observed effect estimates were more 
different than would be expected due chance alone. One potential reason for the 
differences between the pooled effect estimate and the estimate of the study by 
Gilsanz et al (2015) was the difference in the exposure assessment. The reported effect 
estimate reflected the hazard of total stroke among individuals with stable high 
depressive symptoms relative to those with stable low depressive symptoms. The 
effect estimates were lower among individuals with recent onset depressive 
symptoms (1.08, 95% CI: 0.81 – 1.44) and recently remitted depressive symptoms 
(1.66, 95% CI: 1.22 – 2.26), relative to those with stable low depressive symptoms. 
However, these estimates were not included in the meta-analysis due to overlap in 
participants in the comparison groups. Another potential explanation is 
methodological differences in dealing with time-updated covariates and loss to 
follow-up. The estimate provided by Marijnissen et al (2014) was imprecise and the 
number of events was low indicating that the results might be influenced by random 
error. One study showed an increased hazard of total stroke among White adults but 




However, the estimates of the latter two groups were imprecise and CIs overlapped 
with the null value.  
 
Figure 3.8: Results of studies not included in the meta-analyses on the risk of stroke 
 
The direction of the effect of both excluded studies on the risk of total stroke per unit 
increase on a depressive symptom rating scale is in keeping with studies included in 
the meta-analysis (Marijnissen et al, 2014; Niles & O'Donovan, 2018). Marijnissen et 
al (2014) reported a 12% (95% CI: 3 – 22%) increased hazard of fatal or non-fatal stroke 
per unit increase on the depressive symptom scale. Similarly, Niles & O'Donovan 
(2018) found higher odds of fatal stroke per unit increase on the depressive symptom 
scale (OR: 1.12, 95% CI: 1.01 – 1.24). However, the authors did not report what unit of 
increase was used.  
3.4.4.1.6.2 Ischaemic stroke 
The studies by Gilsanz et al (2017) and Yan et al (2013) were excluded from the meta-
analysis on the risk of ischaemic stroke because they were based on the same data 
source as the study by Arbelaez et al (2007). Whilst Gilsanz et al (2017) reported 
higher estimates than Arbelaez et al (2007) (1.64, 95% CI: 1.04 – 2.60 and 1.25, 95% CI: 
1.02 – 1.53, respectively), Yan et al (2013) reported slightly lower effect estimates for 
both White and African American adults (1.20, 95% CI: 0.97 – 1.48, and 1.21, 95% CI: 
0.97 – 1.84, respectively). However, the CIs of all estimates overlapped. As discussed 




and the methods of conditioning on covariates. Of note, the highest risk of ischaemic 
stroke was observed among individuals with stable high depressive symptoms, 
relative to those with stable low depressive symptoms. The corresponding estimates 
for recent onset depressive symptoms and recently remitted depressive symptoms 
were 1.49 (95% CI: 0.97 – 2.30) and 1.08 (95% CI: 0.69 – 1.70), respectively (Gilsanz et 
al, 2017). 
3.4.4.1.6.3 Haemorrhagic stroke 
The study by Henderson et al (2013) was excluded from the meta-analysis on the risk 
of haemorrhagic stroke since authors did not provide CIs. The reported HR was 
higher than the effect estimates of any included studies (HR: 1.63, p < 0.01). It is likely 
that one reason for the high hazard ratio is that a different unit of measurement was 
used. Whilst all included studies dichotomised the exposure, Henderson et al (2013) 
assessed the risk of haemorrhagic stroke per standard deviation increase on the 
depressive symptom scale.  
3.4.4.2 Myocardial infarction 
3.4.4.2.1 Assessing eligibility of studies for inclusion in meta-analysis 
Nineteen of the 24 studies that estimated the risk of MI were eligible for inclusion in 
the meta-analysis. The reasons for exclusion were non-comparable effect estimates 
(Kubzansky et al, 2006; Langvik & Hjemdal, 2015; Pratt et al, 1996) and overlapping 
populations (Lin et al, 2014; Scherrer et al, 2011). Sixteen of the eligible studies 
reported the hazard of MI among individuals with depression or depressive 
symptoms relative to individuals without depression or depressive symptoms. Four 
studies estimated the hazard of MI using continuous depressive symptoms scales. 
3.4.4.2.2 Dichotomous exposure 
The reported hazards of MI among individuals with depression or depressive 
symptoms relative to those not exposed ranged from 0.80 (95% CI: 0.44 – 1.44) to 3.47 
(95% CI: 0.51 – 23.64) (Gafarov et al, 2017; Stürmer et al, 2006) (Appendix Table A 6). 
Four of the studies reported CIs that did not overlap with the null value. Of these, all 




exposed individuals. The pooled random effects HR of developing MI among 
individuals with depression or depressive symptoms to non-exposed individuals was 
1.19 (95% CI: 1.08 – 1.31) (Figure 3.9). The chi² test showed statistically significant 
differences between studies that were unlikely due to chance alone (p < 0.01). 
Furthermore, the I² statistic suggested that a moderate to substantial part of the 
heterogeneity between studies remained unexplained (I² = 65.9%).  
 
Figure 3.9: Meta-analysis of the hazard of myocardial infarction among individuals with depression or 
depressive symptoms, relative to non-exposed individuals 
 
Depression or depressive symptoms were associated with increased hazards of MI 
among men and women (pooled HR, 95% CI: 1.12, 1.01 – 1.24, and 1.14, 1.04 – 1.26, 
respectively) (Figure 3.10). Both I² statistics indicated low heterogeneity between 
seven studies among men and six studies among women (I²: 0.0%, and I²: 0.0%, 
respectively). Furthermore, the chi² test suggested that differences between studies 
might be due to chance alone (men: p = 0.68, women: p = 0.91). This might indicate 
that sex is a potential source of heterogeneity. However, it should be noted that some 
studies were excluded from this subgroup analysis because they did not provide 





Figure 3.10: Meta-analysis of the hazard of myocardial infarction among individuals with depression or 
depressive symptoms, relative to non-exposed individuals, separately for men and women 
 
There were increased hazards among individuals with clinical depression (pooled 
HR: 1.15, 95% CI: 1.00 – 1.32) as well as among individuals with depressive symptoms 
(pooled HR: 1.24, 95% CI: 1.09 – 1.41) relative to non-exposed individuals (Figure 
3.11). Chi² tests indicated that statistically significant differences between studies 
remained among studies using a measure of clinical depression (p < 0.01), whereas 
differences between studies using a measure of depressive symptoms might be due 
to chance alone (p = 0.22). The proportion of heterogeneity that remained unexplained 
was substantial among studies using a clinical depression measure (I²: 82.0%) but low 





Figure 3.11: Meta-analysis of the hazard of myocardial infarction among individuals with depression or 
depressive symptoms, relative to non-exposed individuals, separately for studies using a measure of 
clinical depression and depressive symptoms 
 
3.4.4.2.3 Continuous exposure 
Four studies reported the hazard of MI per unit increase on depressive symptom 
scales (Appendix Table A 7). Whilst Pössel et al (2015) investigated the hazard of MI 
per one score increase on the depressive symptom scale, Ariyo et al (2000) 
investigated the hazard of MI per five unit increase on the depressive symptom scale, 
and Stürmer et al (2006) and Barefoot & Schroll (1996) investigated the hazard per one 
and two standard deviation increase on the depressive symptom scale, respectively. 
Ariyo et al (2000) and Barefoot & Schroll (1996) provided sufficient information to 
convert the reported effect size to the effect per one point increase on depressive 
symptom scales. Stürmer et al (2006) did not provide sufficient information. The 
pooled HR of MI per one point increase on depressive symptom scales was estimated 




(I²: 0.0%, p = 0.45). Stürmer et al (2006) reported an increased hazard of 1.09 (95% CI: 
0.84 – 1.41) per standard deviation increase on the depressive symptom scale.  
 
 
Figure 3.12: Meta-analysis of the hazard of myocardial infarction per unit increase on depressive 
symptom scales 
 
3.4.4.2.4 Summary of main findings of studies not included in the meta-analysis 
Overall, the results of excluded studies followed the same pattern as results of 
included studies, but the majority of excluded studies were small with low precision 
of estimates. Four of the five excluded studies reported effect estimates of the risk of 
MI among individuals with depression or depressive symptoms relative to non-
exposed individuals (Figure 3.13). The point estimates of all excluded studies were 
higher than the point estimate of the pooled HR. Two studies were excluded due to 
non-comparable effect estimates. Pratt et al (1996) reported increased odds of MI 
among individuals with depressive symptoms relative to individuals without 
depressive symptoms. However, the number of events in the exposure and 
comparison groups were low (n = 6 and 37, respectively) and, as a result, the estimate 
was very imprecise. Kubzansky et al (2005) reported an increased hazard of MI 
among individuals with depression in the highest tertile relative to individuals in the 
middle tertile but the estimate was imprecise and CIs overlapped with the null value. 
Two studies were excluded because they were based on the same data source as one 
included study. Both studies reported increased hazards of MI among individuals 
with depressive symptoms relative to individuals without depressive symptoms 




the effect was higher. Whilst CIs of the study by Scherrer et al (2011) overlapped with 
those of the pooled HR, there was no overlap of the CIs among the study by Lin et al 
(2014). The study that was based on the same data source used the same exposure 
and outcome assessment but reported a lower effect estimate (1.03, 95% CI: 0.93 – 
1.15) (Chi et al, 2014). One potential reason might be differences between the study 
populations. However, the age and sex distribution and selection procedure of the 
two studies were very similar. Another potential reason is differences in length of 
follow-up. Whilst Lin et al (2014) followed participants for ten years, the length of 
follow-up in the study by Chi et al (2014) was six years. 
 
Figure 3.13: Results of studies not included in the meta-analyses on the risk of myocardial infarction 
 
One of the excluded studies estimated the odds of non-fatal MI per unit increase on 
the depressive symptom scale (OR: 1.04, 95% CI: 1.01 – 1.04) (Langvik & Hjemdal, 
2015). Whilst the direction of the effect is the same as the effect observed in the meta-
analysis, the magnitude of the effect is not directly comparable to the pooled effect 
estimate of the meta-analysis due to the use of odds ratios (ORs) instead of HRs. 
3.5 Discussion 
3.5.1 Summary of key findings 
The meta-analysis of 51 studies suggested that the hazard of stroke and MI was higher 
among individuals with depression or depressive symptoms relative to non-exposed 
individuals. The association was slightly stronger for stroke than for MI, although CIs 
overlapped. For both outcomes, the results were similar for men and women. 
Furthermore, there were increased hazards of total stroke, ischaemic stroke, and 




relative to non-exposed individuals. However, the effect estimate for the association 
between depression and haemorrhagic stroke was imprecise and overlapped with the 
null value. There might be a dose-dependent effect of depressive symptoms on 
hazard of MCVE since there were increased hazards of stroke and MI per unit 
increase on depressive symptom rating scales. In contrast, the point estimates for 
hazards of stroke and MI were higher among studies using a measure of depressive 
symptoms than among studies using a measure of clinical depression. Again, CIs 
largely overlapped. The results of studies excluded from the meta-analysis were 
consistent with results of included studies in that the majority of studies showed 
increased risks of MCVE among individuals with depression or depressive 
symptoms. There were some differences in the effect sizes which might have been 
explained by differences between samples, methodology, or the effect measure used. 
Since the results of meta-analyses are directly influenced by the strengths and 
weaknesses of included studies, the following will discuss to what extent chance, bias, 
and confounding might explain the increased risk of stroke or MI among individuals 
with depression and depressive symptoms. After that, strengths and weaknesses of 
this systematic review and meta-analysis are presented, the findings are put in the 
context of existing literature, and implications for research are given. Implications for 
practice are presented at the end of this thesis, taking into account the results of all 
projects (see section 7.5 Implications for practice).  
3.5.2 Strengths and limitations of included studies 
3.5.2.1 Chance 
Some included studies are very likely influenced by chance. All but one of the studies 
considered the possibility of chance by providing CIs. Wide CIs indicated imprecise 
estimates in a number of included studies. This could either be explained by small 
sample sizes or by small numbers of events in either the exposure or comparison 
groups. For example, even though the overall sample size (N) and number of events 
(n) of the study by Janszky et al (2010) was fairly largely (n/ N: 1,295 / 49,321), the 
number of events and the size of the group with clinical depression were small (n/ N: 




with certainty whether there truly was no association between depression and MI or 
whether the findings were explained by limited power. Also, some studies provided 
estimates separately for subgroups. For example, Wouts et al (2008) provided results 
separately for individuals with and without cardiac diseases and Cummings et al 
(2016) provided results separately for individuals with and without diabetes. Whilst 
the point estimates between these subgroups differed, the CIs of the estimates largely 
overlapped indicating that differences between groups might be due to chance alone. 
Henderson et al (2013) provided a p-value as measure of statistical significance but 
did not provide a CI. Whilst, the authors showed that there is a statistically significant 
association between depression and haemorrhagic stroke, it was not possible to assess 
the precision of the estimate.  
3.5.2.2 Bias 
3.5.2.1 Selection bias 
The selection of participants might have biased the results of included studies. First, 
results might be biased if the sample did not represent the population of interest. The 
population of interest were adults free from stroke and/ or MI at baseline. The 
exclusion of participants with prior stroke or MI was important since a history of 
stroke or MI would raise questions of reverse causation in that a prior history of stroke 
or MI might increase the risk of depression as well as the risk of future cardiovascular 
events. Included studies aimed to exclude adults with a history of stroke or MI relying 
on self-report and/ or medical records. Some studies might have missed participants 
with a history of stroke and/ or MI, particularly if they relied on self-report. Also, 
studies differed in their extent of excluding participants with prior CVD other than 
stroke or MI. Therefore, the results of some studies might partly reflect reverse 
causation.  
Second, results might be biased if the exposure group differs from the comparison 
group in factors other than the exposure of interest. All studies sampled both groups 
from the same source population. However, twenty-three studies reported baseline 




the exposure of interest. These differences were considered in analyses of studies 
through restriction, stratification, adjustment and inverse probability weighting. The 
impact of applying these different methods will be further discussed in section 3.5.2.3 
Confounding and mediation. 
Third, selection bias might have influenced findings due to differential loss to follow-
up among the exposure and comparison groups. Since information of participants 
lost to follow-up was unknown, studies inevitably conditioned on loss to follow-up 
by restricting their analysis to those not lost to follow-up. As a result, the effect 
estimates represented the association between depression or depressive symptoms 
and risk of stroke or MI among those not lost to follow-up whilst effect estimates 
among those lost to follow-up remained unknown. Since individuals who were lost 
to follow-up often differ from those not lost to follow-up, this might introduce 
selection bias. However, whilst loss to follow-up is often a concern in prospective 
studies, it was not a major concern in the included studies, at least for those conducted 
among stable populations, because linkage to hospital and death records was used to 
follow participants over time. 
Fourth, competing risks during follow-up might have introduced selection bias since 
the occurrence of the competing event (death from causes other than stroke or MI) 
made it impossible for the event of interest to occur and it was likely related to the 
exposure of interest. Therefore, it is important to take competing risks into account at 
the analysis stage. However, the potential impact of competing events were taken into 
account in three studies only (Gilsanz et al, 2017; Gilsanz et al, 2015; Köhler et al, 
2013). Two of these studies applied stabilised inverse probability weights because of 
which the exposure was no longer associated with the competing risk, therefore 
preventing an open backdoor path that might bias the results (Gilsanz et al, 2017; 
Gilsanz et al, 2015). One study calculated a subdistribution hazard ratio (SHR) on the 
association between depression and stroke whilst considering death as competing 
event (Köhler et al, 2013). This analysis indicated a possible 20% decreased hazard of 




0.80, 95% CI: 0.47 – 1.36). However, it should be noted that the study by Köhler et al 
(2013) was one of only a few studies that did not observe an increased hazard of stroke 
among individuals with depressive symptoms in analyses not considering competing 
risks. 
3.5.2.2 Information bias 
3.5.2.2.1 Exposure assessment 
Inaccurate measurement of the exposure has very likely introduced information bias. 
First, some studies assessed depressive symptoms based on rating scales whilst others 
used measures of clinical depression based on medical records or self-report. Whilst 
self-reported information was prone to recall and response bias, studies using 
information from medical records were only able to define participants as depressed 
if participants had access to and used health care services. Considering that a large 
proportion of studies were conducted in the US where health services are not free of 
charge, this might have introduced bias. If depression is indeed associated with 
increased risk of cardiovascular events, this would have biased the estimate towards 
null. This bias might also explain why the pooled effect estimates of studies using a 
measure of clinical depression were lower than those of studies using a measure of 
depressive symptoms. However, there were other potential explanations of this 
finding. For example, the comparison groups of studies using a measure of clinical 
depression included participants with depressive symptoms. If depressive symptoms 
indeed increased the risk of stroke and MI, this would have biased the effect measure 
of these studies towards null. Another potential explanation is that observed 
differences were due to chance alone since the CIs of both estimates largely 
overlapped. It seems likely that a non-causal explanation is responsible for the higher 
effect estimate among studies using a measure of depressive symptoms instead of 
clinical depression since it appears counterintuitive that less exposure is associated 
with more harm.  
Second, most but not all of the studies used rating scales that have been validated and 




participants to the exposure and comparison groups. Examples of well-validated 
scales are the CES-D (Orme et al, 1986; Radloff, 1977) and the Hospital and Anxiety 
Depression Scale (HADS) (Bjelland et al, 2002; Snaith, 2002). In contrast, to the best of 
my knowledge, the HPL Depression scale and the MONICA psychosocial depression 
scale have not been validated. The use of scales that have not been validated is 
problematic since it remained unknown how well these scales were able to 
differentiate between individuals with high and low measures of depressive 
symptoms. The use of different cut-points of the same scale hampered the comparison 
of findings across studies since it remained unknown to what extent differences were 
due to differences in chosen cut-points, sample variation, or true differences in 
findings. Also, some studies used cut-points that were data-driven. For example, 
Everson-Rose et al (2014) created groups based on quartiles of the CES-D score, the 
top group was further split into two groups, and the group with the highest scores 
was compared to the group with the lowest scores. Since the cut-points were data-
driven, the distribution of depressive symptoms in the sample greatly influenced to 
what extent the exposure and comparison group differed in the exposure of interest. 
For example, if there was great variation in depressive symptom scores, then this 
method would compare two groups with very high and low depressive symptom 
scores. In contrast, if there was less variation in depressive symptom scores, then the 
exposure of interest would be similar among the two groups. Furthermore, the use of 
data-driven cut-points reduced the generalisability of results. Moreover, some studies 
used continuous scales. Whilst this was beneficial in terms of increased statistical 
power compared to categorical definitions of exposure, it might have been 
problematic if the scale was not validated to assess symptom severity. 
Third, most studies allocated participants to the exposure and comparison groups 
based on information collected at baseline only. Whilst this approach was likely 
chosen due to inherent limitations of data sources, it did not consider the nature of 
depressive symptoms and clinical depression. Depressive symptom levels are known 
to fluctuate over time and whilst some individuals are diagnosed with clinical 




Ataullahjan, 2010). It is likely that the risk of cardiovascular events differs between 
individuals with different depressive symptom trajectories over time and between 
individuals with one or multiple episodes of clinical depression. It should be noted 
that studies using repeat assessments of the exposure differed in their methodological 
approach, each of which had different strengths and limitations. For example, studies 
defining their exposure based on the proportion of observations with depression or 
depressive symptoms considered that participants who were depressed once might 
not be depressed at other points in time. However, they also assumed an 
accumulation of risk that was independent of the timing of depressive symptoms. For 
example, a participant that was depressed at the first and second wave of data 
collection had the same exposure level as a participant that was exposed at the fifth 
and sixth exposure wave. Another approach was to define the exposure based on 
changes in depressive symptoms at two successive waves. The authors argued that 
an investigation of changes of depressive symptoms is more meaningful than an 
assessment of depressive symptoms at one point in time since it more closely mimics 
the effect a potential intervention in RCTs (Glymour & Kubzansky, 2017). 
Furthermore, the author emphasised that time-constant confounders were controlled 
for due to the use of within-person change in exposure levels. However, the approach 
only assessed the impact of changes in depressive symptoms in two exposure waves 
on the risk of outcome in the next exposure wave which might have introduced bias 
if the latency period linking the exposure and outcome was longer.  
Fourth, assessments of depression might be influenced by other constructs such as 
anxiety. Depression and anxiety are highly comorbid across the life course which 
might be unsurprising considering the overlap in diagnostic symptoms (Zbozinek et 
al, 2012). Although studies using measures of general psychological distress were 
excluded, due to overlap in symptoms it is very likely that the exposure of included 
studies captured symptoms of depression as well as anxiety. The effect estimates 
might therefore not solely reflect the association between depression and hazards of 
stroke or MI but partly reflect increased hazards of stroke and MI among individuals 




individuals with depression or depressive symptoms relative to non-exposed 
individuals was due to unique symptoms of depression or shared symptoms of 
depression and anxiety. Some included studies adjusted their effect estimates for 
anxiety to prevent anxiety from acting as a confounder. However, this might have 
had unintended effects if the adjustment for anxiety simultaneously adjusted for the 
effect of shared symptoms of depression and anxiety.  
Fifth, individuals with subclinical CVD might have been misclassified as depressed 
due to the overlap of somatic symptoms in both disorders such as chest tightness, 
fatigue, shortness of breath, and sleep disturbance (Kapfhammer, 2006). Barefoot & 
Schroll (1996) conducted a sensitivity analysis in which they excluded somatic 
symptoms from the depressive symptom rating scale. Whilst effect estimates were 
slightly lower after exclusion of somatic symptoms, CIs largely overlapped and 
Barefoot & Schroll (1996) concluded that results were unchanged. Other studies used 
the Hospital Anxiety and Depression Scale (HADS) (Gustad et al, 2014; Langvik & 
Hjemdal, 2015) and the Geriatric Depression Scale (GDS) (Köhler et al, 2013), two 
depressive symptom rating scales that do not contain questions on somatic 
symptoms. Gustad et al (2014) and Langvik & Hjemdal (2015) observed increased 
risks of MI among individuals with depression relative to non-exposed individuals. 
Köhler et al (2013) observed an increased risk of stroke in unadjusted but not fully 
adjusted model. However, effect estimates were imprecise. If individuals with 
subclinical CVD were indeed more likely to be misclassified as being depressed than 
people without subclinical CVD, this would have biased the estimates away from the 
null value. 
3.5.2.2.2 Outcome assessment 
Inaccurate measurement of the outcome might also have introduced bias. Whilst 
some studies solely relied on hospital and cause of death records to identify events 
during follow-up, others additionally used self-reported information to identify non-
fatal events. Whilst the inclusion of self-reported events might have led to the 




MI and stroke events that were not treated in the hospital setting. In addition, recall 
and response bias might have influenced studies that relied on self-reported events. 
In a systematic review assessing the accuracy of electronic health records for 
identifying stroke events, Woodfield et al (2015) concluded that positive predictive 
values of more than 90% can be achieved when stroke-specific codes were chosen. 
This was true for stroke and each pathological subtype. McCormick et al (2014) 
performed a systematic review to assess the validity of electronic health records for 
identifying individuals with MI. Whilst equally high positive predictive values were 
seen for MI using hospital records (92% in more than half of all included studies), the 
highest positive predictive value for MI in cause of death records was 59%. Therefore, 
McCormick et al (2014) concluded that hospital records appear to provide valid data 
on MI whilst the accuracy of cause of death records was lower. 
3.5.2.3 Confounding and mediation 
It is important to consider the timing of covariates when differentiating between 
confounders and mediators. Confounders are common sources of both the exposure 
and outcome that preceded the exposure and outcome. Mediators are covariates that 
lie on the causal pathway and occur after the exposure but precede the outcome. 
Whilst some studies might have failed to condition on common sources of depression 
and cardiovascular events because of which estimates are influenced by confounding 
(Figure 3.14a), other studies might have conditioned on factors that lie on the causal 
pathway, thereby blocking causal effects and introducing bias.  
Different methods of conditioning on covariates were used in included studies. Most 
studies used adjustment in statistical models, restriction and/ or stratification to 
condition on covariates. Adjustment, restriction, and stratification are different 
methods to condition on common sources of both the exposure and outcome, all of 
which are aimed at closing an open backdoor path and thereby preventing 
confounding (Figure 3.14b). Whilst these methods prevent confounding in situations 
with common sources of both the exposure and outcome, it introduces bias if 




probability weights. The aim of inverse probability weighting is to create a pseudo 
population in which exposed and unexposed individuals are unconditionally 
exchangeable (i.e. no confounding) (Hernán et al, 2000). If inverse probability weights 
are estimated correctly, the exposure is no longer related to measured confounders 
(missing arrow in Figure 3.14c). As a result it is assumed that the risk of CVD among 
the unexposed group would have been the same as the risk of CVD among the 
exposed group had individuals in the unexposed group been exposed. In contrast to 
adjustment, restriction, and stratification, inverse probability weighting does not 
block the effects of variables that lie on the causal pathway (missing arrow from 
covariate to exposure instead of square border in Figure 3.14c). It is important to note 
that covariates might act as confounding and mediating factor at the same time when 
time-varying exposure and covariate assessments are present (see section 7.3.2 The 
need for an accurate definition of depression for a detailed discussion). 
 
Figure 3.14: Directed acyclic graphs of confounding (a) and methods of preventing confounding: 
conditioning on common sources (b) and inverse probability weighting (c) 
NB: Presence of arrow; causal effect is assumed or unwilling to assume that causal effect does not exist; 
absence of arrow: willing to assume that causal effect does not exist; direction of arrow: direction of 
causal effect; arrow with question mark: causal path of interest; square border: conditioning on variable 
through adjustment, stratification or restriction 
 
Residual confounding has likely influenced the results of some existing studies. 
Residual confounding occurred when studies failed to condition on common sources 
of both depression and stroke or MI. Whilst most studies conditioned on 
sociodemographic factors, only 11 studies conditioned on smoking, physical activity, 
alcohol intake, and a measure of weight (e.g. BMI). Assuming that all of these risk 
factors preceded the onset of depression and stroke or MI, these factors would be 
potentially important confounding factors. Furthermore, comorbidities at baseline 




the onset of the exposure and outcome. Another potential reason for residual 
confounding was measurement error of covariates. This has likely influenced the 
estimates of some included studies due to recall and response bias.  
Effect estimates were likely to be biased due to conditioning on mediating factors. 
Some authors argued that some covariates were on the causal pathway but adjusted 
for these covariates in the analysis (Majed et al, 2012; Moise et al, 2016; O'Brien et al, 
2015; Péquignot et al, 2016). This introduced bias since a causal pathway between 
depression and stroke/ MI was blocked. Furthermore, many studies mentioned 
mediating factors in the background and discussion section but did not consider the 
implications of this assumption in their analysis. The exception to that are six studies 
that either reported that they did not condition on specific covariates since they were 
assumed to be on the causal pathway (Glymour et al, 2010; Glymour et al, 2012; 
Gustad et al, 2014; Wassertheil-Smoller et al, 2004) or that applied inverse probability 
weights to control for time-updated confounding without conditioning on potential 
mediating pathways. (Gilsanz et al, 2017; Gilsanz et al, 2015). 
Overall, studies did not sufficiently justify their chosen analytical approach. For 
example, most studies did not discuss the importance of the timing of covariates in 
order to differentiate between confounders and mediators. Furthermore, studies 
discussed mechanisms in their discussion section but did not take these mechanisms 
into account in their own analysis. Also, the implications of using adjustments instead 
of inverse probability weighting in the presence of time-updated exposures and 
covariates were neither discussed nor taken into account in the majority of studies.  
3.5.3 Strengths and limitations of this systematic review 
This systematic review has major strengths. After screening 10,476 primary studies 
that have been published since January 2010 and 49 articles that were identified 
through screening of reference lists of existing reviews and published primary 
studies, this systematic review identified 51 studies that were eligible for inclusion. 
The large number of screened studies reflects the comprehensive search of multiple 




lowered the risk of missing potentially relevant studies. Furthermore, this systematic 
review provided an update of existing reviews on the risk of stroke or MI among 
individuals with depression or depressive symptoms, relative to unexposed 
individuals. Twelve additional primary studies were included in this meta-analysis 
that have not been identified in existing meta-analyses on the risk of total stroke, 
ischaemic stroke or haemorrhagic stroke (Cummings et al, 2016; Daskalopoulou et al, 
2016; Everson-Rose et al, 2014; Gafarov et al, 2017; Gilsanz et al, 2017; Mathur et al, 
2016; Mejía-Lancheros et al, 2014; Moise et al, 2016; O'Brien et al, 2015; Péquignot et 
al, 2016; Stewart et al, 2016; Sun et al, 2016). Moreover, 11 studies were included in 
this systematic review and meta-analysis that have not been included in either of the 
two existing meta-analyses on the risk of MI (Chi et al, 2014; Cummings et al, 2016; 
Daskalopoulou et al, 2016; Gafarov et al, 2017; Joyce, 2015; Mathur et al, 2016; Mejía-
Lancheros et al, 2014; Péquignot et al, 2013; Stewart et al, 2016; Stürmer et al, 2006; 
Wassertheil-Smoller et al, 2004). Also, this is the first systematic review that 
considered studies which assessed depressive symptoms on continuous scales. The 
identification of eligible studies was thorough and transparent. A quality assessment 
of included studies was conducted to ensure a detailed assessment of the strengths 
and weaknesses of studies and identify potential sources of errors. The identification 
of a large number of eligible studies allowed a detailed analysis of the current 
evidence base. Furthermore, through pooling results of multiple primary studies in a 
meta-analysis, more weight was given to more robust studies with bigger sample 
sizes. 
Some limitations of this systematic review should be noted. First, whilst the decision 
to look at risk of stroke and MI increased comparability between methods applied in 
different parts of this project, it has narrowed the picture of the literature and studies 
of potential interest to the overall aim of this project might have been missed. Second, 
the systematic review and meta-analysis was conducted by only one person. Ideally, 
there would have been an independent review of all search results by a second 
reviewer. However, due to the large number of search hits this was not deemed 




influenced findings since decisions were not challenged by a second reviewer. Third, 
although there was a protocol for the systematic review, the protocol was not 
published on a database of systematic reviews such as PROSPERO (Page et al, 2018). 
Ideally, the protocol would have been registered to ensure that researchers can 
compare planned and reported methods and to avoid unwanted duplication of work 
(Stewart et al, 2012). Fourth, the findings of this systematic review and meta-analysis 
were directly influenced by strengths and weaknesses of included studies. Clinical 
and/ or methodological differences between studies led to moderate to substantial 
between-study heterogeneity in the analysis on the hazard of MI among individuals 
with depression or depressive symptoms relative to non-exposed individuals. 
Subgroup analyses were performed, and sex was identified as a potential source of 
heterogeneity. However, as described above the lower between-study heterogeneity 
in the subgroup analysis of studies that provided sex-specific results might also be 
explained by the exclusion of studies that did not provide results separately for men 
and women. Between-study heterogeneity was low to moderate in the meta-analysis 
on the hazard of stroke. In addition, publication bias might have influenced findings. 
Publication bias is a source of error that results from the failure to publish studies 
with small effect sizes or negative findings (Dickersin & Min, 1993). If studies with 
negative findings or small effects have not been published, this would have biased 
the estimates of the meta-analysis away from null. A formal investigation of 
publication bias, for example using funnel plots and Egger test, was not performed 
as part of this systematic review since the aim of this project was to identify gaps in 
the research that potentially could be overcome as part of this project. There was 
evidence for publication bias in existing systematic reviews and meta-analyses on the 
risk of stroke or MI (Barlinn et al, 2014; Dong et al, 2012; Gan et al, 2014; Pan et al, 
2011b; Wu & Kling, 2016). Correction for publication bias using trim-and-fill methods 
slightly attenuated results of existing reviews but risks of stroke and MI among 
individuals with depression or depressive symptoms remained higher than among 
unexposed individuals. Moreover, it should be noted that it is uncommon to publish 




findings of included studies might be the result of fishing for discoveries in datasets, 
and null findings might not get published. If fishing was present, this would have 
biased the estimates away from the null value. 
3.5.4 Comparison of findings with previous systematic reviews 
3.5.4.1 Stroke 
The results of four existing systematic reviews and meta-analyses on the association 
between depression or depressive symptoms and risk of different types of stroke 
were consistent with the results of this systematic review and meta-analysis (Barlinn 
et al, 2014; Dong et al, 2012; Li et al, 2015; Pan et al, 2011b). All existing meta-analyses 
reported pooled effect estimates on the risk of total stroke among individuals with 
depression or depressive symptoms relative to non-exposed individuals (see section 
2.3.2.2.2 Depression among individuals with no history of cardiovascular disease for 
pooled estimates). The reported associations were stronger than the associations in 
this meta-analysis but CIs overlapped. None of the existing meta-analyses reported 
the risk of total stroke per unit increase in depressive symptom scales. Studies 
included in existing reviews but excluded from this review were screened but used 
outcome definitions that were not in keeping with inclusion criteria of this review or 
included participants with a history of stroke. Two existing meta-analyses reported 
the risk of ischaemic and haemorrhagic stroke among individuals with depression or 
depressive symptoms relative to non-exposed individuals (Li et al, 2015; Pan et al, 
2011b). In contrast to this meta-analysis, both of the existing reviews included studies 
in which participants with a history of stroke were not excluded. The strength of 
associations was very similar to the one reported in this meta-analysis (see section 
2.3.2.2.2 Depression among individuals with no history of cardiovascular disease for 
pooled estimates). 
3.5.4.2 Myocardial infarction 
The results of the two existing systematic reviews and meta-analyses on the 
association between depression and risk of MI are consistent with the results of this 
systematic review and meta-analysis (Gan et al, 2014; Wu & Kling, 2016). The reported 




section 2.3.2.2.2 Depression among individuals with no history of cardiovascular 
disease for pooled estimates). However, differences might be due to chance alone. 
Neither of the existing meta-analyses reported the risk of MI per unit increase on 
depressive symptom scales. Some of the studies included in existing reviews were 
excluded in this review since they included participants with CVD at baseline (Gump 
et al, 2005), reported non-comparable effect estimates (Pratt et al, 1996), were based 
on a selected population (Cohen et al, 2015), used a measure of psychological distress 
(Whang et al, 2009), or used an outcome definition that was not consistent with the 
inclusion criteria of this review (Capistrant et al, 2013; Hawkins et al, 2014; Huang et 
al, 2013; Surtees et al, 2008).  
3.5.5 Implications for research 
This systematic review and meta-analysis suggests an association between 
depression or depressive symptoms and hazards of stroke or MI. However, it also 
highlights shortcomings of the current evidence base which suggests that more 
research is needed. First, more studies with repeat assessments of the exposure are 
needed. It is of interest to investigate to what extent the cardiovascular risk differs 
between individuals with different depressive symptom trajectories and between 
individuals with single or recurrent episodes of clinical depression. Second, although 
a large number of primary studies was identified, it is not clear whether associations 
were similar in population subgroups. In this review, sex differences and differences 
between studies using different assessments of the exposure were investigated. 
However, there might be differences between individuals from different ethnic 
groups, SES, and with and without comorbidities. Only a limited number of studies 
performed subgroup and interaction analyses, possibly due to small sample sizes 
and/ or number of events. Such analyses might help in further defining the population 
at particularly high risk of stroke and MI. Third, the role of covariates needs to be 
investigated further. Specifically, the timing of exposure, covariates and outcomes 
needs to be assessed and considered in more detail. Future studies should justify the 
methodological approach taken in the analysis. For example, were covariates 




considered to be on the causal pathway? If covariates were assumed to be on the 
causal pathway, mediation analyses might be able to further our understanding of 
the pathways between depression and risk of stroke and MI. However, benefits and 
limitations of conducting mediation analyses in the context of depression should be 
carefully considered (see section 7.3.3 The challenge of establishing causality between 
depression and CVD). 
3.6 Conclusion 
This review aimed to identify and critically appraise existing research and identify 
shortcomings of existing studies that could potentially be addressed as part of this 
project. The meta-analysis of 51 studies suggests that the hazard of stroke and MI is 
higher among individuals with depression or depressive symptoms relative to non-
exposed individuals. However, findings were influenced by shortcomings of existing 
studies. The next chapters of this thesis present data analyses of the UK Biobank 
(Chapter 4), the ALSWH (Chapter 5), and the Whitehall II study (Chapter 6). The 
analyses benefitted from strengths of each of the datasets and addressed different 





Chapter 4: The association between different 
measures of depression and subsequent major 
cardiovascular events 
4.1 Background 
The observed association between depression or depressive symptoms and 
subsequent CVD might be partly explained by residual confounding. The residual 
confounding hypothesis originated from findings that depressed patients are 
markedly different from non-depressed patients in terms of their sociodemographic 
characteristics as well as lifestyle and biological factors (Penninx, 2016a). 
Consequently, these factors should be taken into account in epidemiological studies 
of the association between depression and CVD. Due to the strength and consistency 
of the association some researchers argue that the observed associations are unlikely 
explained by residual confounding alone (Penninx, 2016a), others emphasise the lack 
of adjustments in primary research (Nicholson et al, 2006) and argue that variation of 
estimates might be due to variation in statistical adjustment (Stapelberg et al, 2013).  
Due to the large amount of data collected the UK Biobank offers a unique opportunity 
to control for a wide range of potentially important confounding factors. The UK 
Biobank is a prospective study of 500,000 participants aged between 40 and 69 years, 
recruited in 22 assessment centres in England, Scotland, and Wales from 2006 to 2010 
(Sudlow et al, 2015). During the baseline assessment, participants completed a 
touchscreen questionnaire, which included questions on sociodemographic details 
(such as age, sex, education, income, and area-based deprivation), medical history 
(such as self-reported doctor diagnoses), lifestyle factors (such as smoking habit and 
physical activity), and medication use. In addition, participants were asked to 
participate in a computer-assisted verbal interview with a nurse and to undergo 
physical measurements such as body weight, height, and blood pressure. Health 
outcomes of UK Biobank participants are captured through data linkage to routine 
health records including primary and secondary care health records, cancer registries 




A further unique advantage of the UK Biobank is its large sample size. This offers an 
opportunity to identify potential effect modifying factors of the risk of CVD among 
individuals with depression or depressive symptoms. Identifying characteristics of 
individuals with depression or depressive symptoms that put them at particularly 
high or low risk of adverse health events is important since it might allow tailoring of 
resources and preventive measures. Furthermore, the identification of effect-
modifying factors might help inform our understanding of the association between 
depression and CVD from a mechanism perspective. Since depression is highly 
comorbid with physical disorders (Air et al, 2016), it was of particular interest to 
assess to what extent the association between depression and CVD differs between 
individuals with and without comorbidities (see section 2.3.1 The relationship 
between major mental disorders and physical disorders for more detailed discussion 
of mental-physical comorbidity). Depression has been shown to be associated with 
worse self-management strategies and treatment adherence among individuals with 
physical comorbidities (DiMatteo et al, 2000; Gonzalez et al, 2008; Sjösten et al, 2013). 
Therefore, individuals with depression who additionally have a diagnosis of physical 
health conditions might be at particularly high risk of adverse health outcomes, such 
as MCVE. In addition, mental-physical comorbidity was shown to be more prevalent 
among individuals with lower socioeconomic background (Barnett et al, 2012; 
McLean et al, 2014). It is of interest to assess to what extent individuals with lower 
socioeconomic background not only have higher absolute risks of mental-physical 
comorbidity but also have a more pronounced relative risk of cardiovascular events 
associated with depression or depressive symptoms than individuals from a higher 
socioeconomic background. 
This analysis aimed to explore the association between different measures of 
depression and MCVE in the UK Biobank whilst taking account of a wide range of 
potential confounding factors. Furthermore, the role of comorbidities (hypertension, 
diabetes, cholesterol levels) and socioeconomic factors (education, area-based 





1. To explore the association between different measures of depression and MCVE, 
defined as first-ever fatal or non-fatal stroke and first-ever fatal or non-fatal MI, 
as well as stroke and MI separately 
2. To investigate the role of comorbidities (hypertension, diabetes, cholesterol 
levels) and socioeconomic factors (education, area-based deprivation) as 
potential effect-modifying factors 
4.3 Methods 
4.3.1 Sample 
The study population included UK Biobank participants without a history of CVD 
and major mental disorders other than depression. History of CVD and major mental 
disorders other than depression were defined as present if a participant reported a 
history of any of the disorders in the touchscreen questionnaire or nurse interview, 
or if an event was identified through linkage to hospital inpatient records in England, 
Scotland, and Wales (Table 4.1). History of CVD was defined as history of stroke, MI, 
angina or TIA before baseline. In accordance with UK Biobank recommendations, 
stroke was defined as subarachnoid haemorrhage, intracerebral haemorrhage, 
cerebral infarction, or unspecified stroke (ICD-10: I60.X, I62.X, I64.X, I64.X) and MI 
was defined as acute or subsequent MI, Dressler syndrome, and old MI (ICD-10: 
I21.X, I22.X, I24.1, I25.2) (Schnier et al, 2017a; Schnier et al, 2017b). TIA was defined 
using ICD-10 codes G45.0, G45.1, G45.8 and G45.9 and angina using I20.0, I20.1, I20.8, 
and I20.9. History of major mental disorders other than depression was defined as 
history of bipolar disorder or schizophrenia (ICD-10: F20.X, F21, F22.X, F23.X, F24, 
F25.X, F28, F29, F30.X, F31.X). In contrast to UK Biobank recommendations, prevalent 
events were not identified using ICD-9 codes in order to improve the consistency of 
look-back periods for events in Scotland, Wales and England. Participants whose 
records could not be linked with hospital inpatient or cause of death data, with 
missing or conflicting information in the cause of death dataset, with unreasonable 
death dates (date prior to attending the assessment centre), and individuals who have 




Table 4.1: Overview of available information on hospital inpatient data (UK Biobank, 2018) 
Data source Data provider ICD-9 ICD-10 


















1997 onwards 31 October 2015 
Patient Episode 
Database for Wales 
SAIL, Wales --- 
1999 
onwards 
1998 onwards 29 February 2016 
ISD: Information and Statistics Division, NHS: National Health Services, SAIL: Secure Anonymised 
Information Linkage 
 
The analyses of UK Biobank data were conducted under generic approval from the 
NHS National Research Ethics Service (Ref 11/NW/0382, approval letter dated 17 June 
2011). Full written informed consent was gained from participants at the point of data 
collection. This research has been conducted using the UK Biobank Resource under 
application number 13797. 
4.3.2 Definition of variables 
4.3.2.1 Exposure 
The exposures of interest were different measures of depression (Table 4.2). 
Antidepressant use and self-reported doctor diagnosis of depression were identified 
in a nurse interview at baseline. Antidepressant use was defined as self-reported use 
of at least one selective serotonin reuptake inhibitor (SSRI) or ‘other’ antidepressant 
in accordance with the list described by Martin et al (2016). Hospital diagnosis with 
depression was defined as a hospital inpatient record with depressive episode or 
recurrent depressive episode (ICD-10: F32.X, F33.X) before baseline. Depression was 
defined as at least one of antidepressant use, self-reported depression, or hospital 
diagnosis with depression at baseline. In the following, the term depression is used 





Table 4.2: Overview of the definition of different measures of depression 
Exposure Definition 
Depression 
At least one of antidepressant use, hospital diagnosis with depression or 
self-reported doctor diagnosis of depression 
Antidepressant use 
Self-reported use of at least one of the following antidepressants:  
Prozac 20mg capsule, sertraline, lustral 50mg tablet, paroxetine, fluoxetine, 
fluvoxamine, seroxat 20mg tablet, citalopram, cipramil 10mg tablet, 
escitalopram, cipralex 5mg tablet, Limbitrol 10 capsule, prothiaden 25mg 
capsule, elavil 10mg tablet, lentizol 25mg m/r capsule, tryptizol 10mg tablet, 
anafranil 10mg capsule, tofranil 10mg tablet, lofepramine, trimipramine, 
surmontil 10mg tablet, bolvidon 10mg tablet, norval 10mg tablet, 
phenelzine, nardil 15mg tablet, moclobemide, manerix 150mg tablet, 
limbitrol-5 capsule, triptafen tablet, amitriptyline+chlordiazepoxide 
12.5mg/5mg capsule, amitriptyline, hydrochloride+perphenazine 10mg/2mg 
tablet, mianserin, amitriptyline, clomipramine, dothiepin, imipramine, 
gamanil 70mg tablet, dosulepin, maoi- phenelzine, venlafaxine, efexor 
37.5mg tablet, lomont 70mg/5ml s/f suspension, mirtazapine, zispin 30mg 
tablet, thaden 25mg capsule, duloxetine, yentreve 20mg gastro-resistant 
capsule, cymbalta 30mg gastro-resistant capsule 
Self-reported 
depression 
Self-reported doctor diagnosis of depression in nurse interview at baseline 
Hospital diagnosis 
with depression 
Records on depressive episode or recurrent depressive episode (ICD-10: 
F32.X, F33.X) in the hospital episode statistics before baseline 
 
4.3.2.2 Outcome 
MCVEs were defined as first-ever fatal or non-fatal stroke or MI, whichever occurred 
first. Non-fatal stroke and MI during follow-up were identified through linkage to 
hospital inpatient data (Table 4.1). The ICD codes used to identify events during 
follow-up were consistent with the definition used to identify prevalent events (see 
section 4.3.1 Sample). In order to increase comparability between participants from 
England, Scotland, and Wales, the same censoring date was used for all participants 
(31 March 2015). Fatal stroke and MI were identified through linkage to cause of death 
registers (Table 4.3). Cause and date of death were provided by NHS Digital for 
participants from England and Wales, and by Information Services Division for 
participants from Scotland. Again, the same censoring date was chosen for all 
participants (30 November 2015). Survival times were calculated from the date of 
attending the baseline assessment centre to the date of first-ever MCVEs, date of 




Table 4.3: Overview of available information on date and cause of death (UK Biobank, 2018) 
Data source Data provider ICD-9 ICD-10 
Period of data currently available 
              Start                            End 
Death register 
England & Wales 
NHS Digital --- 2006 onwards April 2006 onwards 31 January 2016 
Death register 
Scotland 
ISD --- 2006 onwards April 2006 onwards 30 November 2015 
ISD: Information and Statistics Division, NHS: National Health Services 
 
4.3.2.3 Covariates 
The following covariates were ascertained through self-report on the touchscreen 
questionnaire at baseline. Income was defined as average household income before 
tax and categorised into five groups (less than £18,000, £18,000 to 30,999, £31,000 to 
51,999, £52,000 to 100,000, greater than £100,000). Education was defined as highest 
educational attainment and categorised into three groups (College or university 
degree; A levels, O levels, Certificate of Secondary Education (CSE) or National 
Vocational Qualification (NVQ), or equivalent; and none of the above). Area-based 
deprivation was assessed through the Townsend Deprivation Index (Townsend, 
2009), and divided into fifths within the study population. The Townsend index was 
recalculated for all UK Biobank participants using the 2001 UK Census (UK Biobank 
Data Management Team, 2017). Due to small numbers of participants with a non-
white ethnicity, ethnicity was categorised as white or other ethnicity. Smoking was 
categorised as never, previous, or current smoker. Alcohol was defined as safe 
drinking if men or women had ≤ 14 units of alcohol per week and as risky drinking if 
alcohol intake exceeded 14 units per week which is in accordance with the weekly 
intake guideline of the UK Department of Health (UK Chief Medical Officer, 2016). 
Physical activity was categorised as low, moderate or high level of physical activity 
in accordance with the International Physical Activity Questionnaire (IPAQ Group, 
2010). BMI was calculated based on height and weight measurements ascertained at 
the assessment centre at baseline. Due to small numbers of participants with 
underweight BMI was categorised as under- or normal weight (< 18.5 – 24.9 kg/m2), 
overweight (25 – 29.9 kg/m2), obese (30 – 34.9 kg/m2), severely obese (35 – 39.9 kg/m2), 




least once a week, less than once per week, never). Following a recommended intake 
approach, total fruit and vegetable intake was treated as binary variable assessing 
whether or not participants consumed at least five fruits or vegetables a day (World 
Health Organisation and Food and Agriculture Organisation of the United Nations, 
2004). Family history of stroke, heart disease, high blood pressure, and severe 
depression, was defined as self-reported illness of mother or father. Diabetes, 
hypertension, and high cholesterol were defined as diagnosis and/ or treatment, 
ascertained through self-report in the touchscreen questionnaire or nurse interview. 
Hypertension was additionally ascertained through blood pressure measurements of 
≥140/90mm Hg at the assessment centre at baseline. 
4.3.3 Statistical analyses 
4.3.3.1 Association between depression and subsequent MCVE, stroke, and MI 
Baseline characteristics were assessed separately for participants with and without 
the exposures and outcomes of interest. Due to the large sample size no formal tests 
for differences between groups were performed. Cox proportional hazards models 
were performed to estimate HRs and 95% CI of the hazard of MCVE among 
participants with depression, antidepressant use, hospital admission with 
depression, and self-reported depression relative to participants without the 
exposure of interest. In accordance with the residual confounding hypothesis, 
measured covariates were treated as potential confounding factors of both depression 
and MCVE. Implicitly the assumption was made that all covariates measured at 
baseline preceded depression and CVD onset. The first Cox proportional hazards 
model represented the unadjusted association between different measures of 
depression and MCVE. The second model was adjusted for age, sex, ethnicity, and all 
socioeconomic factors (education, income, and area-based deprivation). The third 
model additionally controlled for BMI, alcohol intake, physical activity, smoking, 
fruit and vegetable consumption, oily fish intake, family history of CVD, and family 
history of depression. Since age did not fulfil the assumption of a linear contribution 
to the Cox proportional hazards model, it was split into four equally sized groups 




was checked visually using log-minus-log survival plots and by testing the 
proportional hazard assumption (cox.zph function). There was no evidence of a 
violation of the proportional hazard assumption in any of the fully adjusted models. 
The results of the global tests of the proportional hazard assumption of each fully 
adjusted model are presented in Appendix Table A 9. Furthermore, the results of the 
checks for proportionality for all covariates of one of the models are presented as an 
example (Appendix Table A 10). In secondary analysis, the association between 
depression and first-ever fatal or non-fatal stroke and first-ever fatal or non-fatal MI 
were analysed separately. Since participants were censored if they died from causes 
other than stroke or MI, it was of interest to investigate to what extent deaths from 
causes other than stroke and MI might affect associations between depression and 
MCVE by running a competing risk analysis. Therefore, cumulative incidence 
functions of fatal or non-fatal stroke or MI and death from causes other than stroke 
or MI among participants with and without any indication of depression at baseline 
were described. In addition, cause-specific HRs (95% CI) of the association between 
depression and deaths from causes other than stroke or MI were calculated.  
4.3.3.2 Multiplicative and/ or additive interaction 
Evidence of multiplicative and/ or additive interaction between depression and 
socioeconomic factors or comorbidities was investigated in order to determine to 
what extent these factors modify the effect of depression on MCVE. The presence of 
multiplicative interaction was tested by adding a product term of the two variables 
of interest to the fully adjusted Cox proportional hazards model. The null hypothesis 
of no multiplicative interaction between depression and the second variable of 
interest was rejected at the 5% significance level (p < 0.05). The presence of additive 
interaction was investigated by calculating the relative excess risk due to interaction 
(RERI), the attributable proportion due to interaction (AP), and the synergy index. All 
measures of additive interaction and their corresponding 95% CIs were derived in 
keeping with Andersson et al (2005). A RERI estimate close to zero indicates that there 
is little excess risk due to interaction. Similarly, an AP close to zero indicates that the 




risk from the exposure to both factors when interaction is present relative to the risk 
from being exposed to both factors when interaction is absent. Therefore, a synergy 
index of one indicates that interaction is absent. Educational attainment and area-
based deprivation were treated as binary variables in the interaction analyses 
between depression and socioeconomic factors. Educational attainment was defined 
as high for participants with a university or college degree and as low for participants 
with no university or college degree. Area-based deprivation was defined as high if 
the Townsend score had a positive value, whereas it was defined as low if the 
Townsend score had a negative value. A Townsend score of 0 indicated an area in the 
UK with mean values. A score of 0 did not occur in the sample. 
4.3.3.3 Multiple imputation 
The patterns of missing data as well as the plausibility of different mechanisms of 
missingness were investigated. The pattern of missing data was investigated by 
describing the number and proportion of missing data for each variable and 
participant. Baseline characteristics of participants with and without any missing data 
were compared in order to explore to what extent missing data are missing 
completely at random (MCAR). Differences between participants with and without 
complete data were indicative of a violation of the MCAR assumption. Since a MCAR 
mechanism was deemed unlikely, univariate and multivariate logistic regressions 
were performed in order to determine predictors of missingness. A missing data 
indicator variable was used as dependent variable in these models. The multivariate 
logistic regressions were adjusted for age, sex, ethnicity, education, income, and area-
based deprivation. Since a missing at random (MAR) mechanism was deemed likely, 
multiple imputation of missing data was performed using the MICE package in R 
(van Buuren & Groothuis-Oudshoorn, 2011). One imputation for each percent of 
incomplete cases in the dataset is recommended (van Buuren, 2012). In keeping with 
that, 40 imputations with ten iterations were performed. Since it is essential that the 
imputation model is in keeping with the substantive model of the analysis, 
imputations were performed separately for each exposure-outcome combination. In 




interaction terms were interactions between two binary variables, one of which was 
fully observed (depression), the imputations were run separately for participants 
with and without depression. Thus, the association between the second variable of 
the interaction term and cardiovascular events could differ by depression status (van 
Buuren, 2012). Since a complete case analysis is biased when missing data are not 
MCAR, the analyses presented in this chapter are based on imputed data. The latter 
were compared to results obtained through complete-case analyses. 
4.4 Results 
4.4.1 Study population 
Out of 502,655 UK Biobank participants, 465,215 participants were included in the 
analysis (Figure 4.1). 
 
Figure 4.1: Flow chart of UK Biobank participants included in analyses 
  
4.4.2 Investigation of missing data mechanism 
4.4.2.1 Missingness pattern 
The average number of variables with missing information was low (0.6 variables per 
participant) but overall missingness was high due to the large number of variables of 
interest (Table 4.4). Out of all participants 39.3% had at least one missing value in any 
of the variables. Among participants with at least one variable with missing 
information, the largest proportion had missing information on one variable (25.9%). 




frequency of missingness was below 5.0% for all variables except income (15.1%), 
alcohol intake (14.8%), family history of depression (13.0%), and family history of 
CVD (7.6%). 
Table 4.4: Number (%) of missing 







0 282,190 (60.7) 
1 120,659 (25.9) 
2 43,410 (9.3) 
3 13,757 (2.0) 
4 3,324 (0.7) 
5 725 (0.2) 
6 158 (< 0.1) 
7 49 (< 0.1) 
8 37 (< 0.1) 
9 31 (< 0.1) 
10 538 (< 0.2) 
11 335 (< 0.1) 
12 2 (< 0.01) 
 





Income 70,079 (15.1) 
Alcohol intake 68,817 (14.8) 
Family history of depression 60,595 (13.0) 
Family history of cardiovascular 
disease 
35,497 (7.6) 
Physical activity 18,961 (4.1) 
Highest educational attainment 9,144 (2.0) 
Oily fish intake 3,641 (0.8) 
Body mass index 2,661 (0.6) 
Smoking 2,599 (0.6) 
Ethnicity 2,523 (0.5) 
Fruit and vegetable intake 1,534 (0.3) 
Area-based deprivation 575 (0.1) 
Depression, age, sex, hypertension, 
diabetes, cholesterol, major 





4.4.2.2 Plausibility of different missingness mechanisms 
The plausibility of a MCAR mechanism was investigated by comparing baseline 
characteristics of participants with and without complete data available (Table 4.6). 
Differences in baseline characteristics were observed for all variables. However, 
differences in self-reported depression, smoking, fruit and vegetable intake, oily fish 
intake, and family history of depression were less pronounced than differences 
among the other variables of interest. The proportion of participants with any 
measure of depression, obesity, low physical activity levels, hypertension, diabetes, 
or high cholesterol levels was lower among participants with complete data available 
than among participants with at least one missing variable. In contrast, the proportion 
of male participants and participants with a college or university degree and high 




Table 4.6: Baseline characteristics separately for participants with and without complete data available 
(page 1 of 2)* 
 
Incomplete case 
(n = 183,025, 39.3%) 
Complete case 
(n = 282,190, 60.7%) 
Depression (%) 17,969 (9.8) 22,384 (7.9) 
Antidepressant use (%) 13,997 (7.6) 17,133 (6.1) 
Self-reported depression (%) 10,785 (5.9) 14,354 (5.1) 
Hospital diagnosis with depression (%) 1,574 (0.9) 1,657 (0.6) 
Male (%) 72,453 (39.6) 132,925 (47.1) 
Age (median [IQR]) 58.0 [50.0, 64.0] 57.0 [49.0, 62.0] 
Ethnicity = Other ethnic groups (%) 13,565 (7.5) 11,222 (4.0) 
Income (%) 
   Greater than 100,000 3,142 (2.8) 19,115 (6.8) 
   52,000 to 100,000 16,728 (14.8) 66,534 (23.6) 
   31,000 to 51,999 27,501 (24.3) 77,839 (27.6) 
   18,000 to 30,999 31,339 (27.7) 68,623 (24.3) 
   Less than 18,000 34,236 (30.3) 50,079 (17.7) 
Highest educational attainment (%) 
   College or university degree 42,290 (24.3) 110,852 (39.3) 
   A levels, O levels, CSE, NVQ, or equivalent 89,565 (51.5) 139,488 (49.4) 
   None of the above 42,026 (24.2) 31,850 (11.3) 
Area-based deprivation (%) 
   1 (Least deprived) 33,826 (18.5) 61,125 (21.7) 
   2 34,394 (18.9) 59,334 (21.0) 
   3 35,670 (19.6) 57,943 (20.5) 
   4 36,086 (19.8) 56,752 (20.1) 
   5 (Most deprived) 42,474 (23.3) 47,036 (16.7) 
Body mass index (%) 
   Under- or normal weight 56,840 (31.5) 100,932 (35.8) 
   Overweight 74,823 (41.5) 121,549 (43.1) 
   Obese 33,706 (18.7) 44,443 (15.7) 
   Severely obese 10,512 (5.8) 11,354 (4.0) 
   Morbidly obese 4,483 (2.5) 3,912 (1.4) 
Physical activity (%) 
   High 13,675 (8.3) 28,652 (10.2) 
   Moderate 109,883 (67.0) 194,877 (69.1) 
   Low 40,506 (24.7) 58,661 (20.8) 
Alcohol intake = Risky drinking (%) 48,255 (42.3) 139,654 (49.5) 
Smoking status (%) 
   Never 101,991 (56.5) 156,822 (55.6) 
   Previous 57,396 (31.8) 98,755 (35.0) 





Table 4.6 continued: Baseline characteristics separately for participants with and without complete 
data available (page 2 of 2)* 
 
Incomplete case 
(n = 183,025, 39.3%) 
Complete case 
(n = 282,190, 60.7%) 
Fruit and vegetable intake per day = Less than 
five a day (%) 
124,832 (68.8) 198,211 (70.2) 
Oily fish intake (%) 
   At least once a week 96,833 (54.0) 159,652 (56.6) 
   Less than once per week 59,279 (33.0) 95,226 (33.7) 
   Never 23,272 (13.0) 27,312 (9.7) 
Hypertension (%) 104,016 (56.8) 148,647 (52.7) 
Diabetes (%) 9,936 (5.4) 10,158 (3.6) 
High cholesterol levels (%) 29,967 (16.4) 38,823 (13.8) 
Family history of cardiovascular disease (%) 113,503 (76.9) 206,631 (73.2) 
Family history of depression (%) 12,706 (10.4) 28,398 (10.1) 
* Data are given as n (%) unless specified 
CSE: Certificate of secondary education, IQR: Interquartile range, NVQ: National vocational 
qualification 
 
In addition, differences in the proportion of individuals with a MCVE, stroke, and MI 
and the time of follow-up were investigated among complete and incomplete cases 
(Table 4.7). The proportion of individuals with a MCVE, stroke and MI was lower 
among cases with complete data than among cases with incomplete data. Also, the 
median follow-up time was 0.3 years shorter among cases with complete data than 
among individuals with at least one missing variable for all outcomes of interest.  
Table 4.7: Differences in events and follow-up times by complete case status* 
 
Incomplete case 
(n = 183,025, 39.3%) 
Complete case 
(n = 282,190, 60.7%) 
Major cardiovascular events (%) 3,648 (2.0) 4,201 (1.5) 
   Years of follow-up (median [IQR]) 7.0 [6.3, 7.6] 6.7 [6.0, 7.4] 
Stroke (%) 1,452 (0.8) 1,673 (0.6) 
   Years of follow-up (median [IQR]) 7.0 [6.3, 7.6] 6.7 [6.0, 7.4] 
Myocardial infarction (%) 2,269 (1.2) 2,616 (0.9) 
   Years of follow-up (median [IQR]) 7.0 [6.3, 7.6] 6.7 [6.0, 7.4] 
* Data are given as n (%) unless specified 
 
Since the observed differences between cases with complete and incomplete data 
indicate a violation of the MCAR assumption, the plausibility of a MAR mechanism 




analyses with a missing data indicator as dependent variable (Table 4.8). All variables 
of interest were predictors of missingness in univariate and multivariate logistic 
regression models. The odds of having at least one variable with missing data was 
higher among participants with depression, females, an ethnic background other than 
white, lower SES, higher BMI, lower physical activity level, less oily fish intake, 
hypertension, diabetes, high cholesterol, and a family history of CVD or depression. 
The odds of having at least one variable with missing values was lower among 
individuals in the second, third and fourth quartiles relative to the youngest quartile, 
and among participants with risky drinking behaviour. 
Table 4.8: Odds ratios (95% CI) of univariate and multivariate logistic regression analyses with a missing 






Depression (Any vs. none) 1.26 (1.24 – 1.29) 1.15 (1.12 – 1.18) 
Antidepressant use (Yes vs. no) 1.28 (1.25 – 1.31) 1.14 (1.10 – 1.17) 
Self–reported depression (Yes vs. no) 1.17 (1.14 – 1.20) 1.12 (1.09 – 1.16) 
Hospital diagnosis with depression (Yes vs. no) 1.47 (1.37 – 1.57) 1.13 (1.04 – 1.23) 
Sex (Female vs. Male) 1.36 (1.34 – 1.38) 1.12 (1.11 – 1.14) 
Ethnicity (Other vs. white ethnic group) 1.96 (1.91 – 2.01) 1.51 (1.46 – 1.56) 
Age, quartiles 
   1 (youngest) ref. ref. 
   2 0.97 (0.96 – 0.99) 0.86 (0.84 – 0.88) 
   3 1.15 (1.14 – 1.17) 0.79 (0.78 – 0.81) 
   4 (oldest) 1.51 (1.48 – 1.53) 0.83 (0.81 – 0.85) 
Income 
   Greater than 100,000 ref. ref. 
   52,000 to 100,000 1.53 (1.47 – 1.59) 1.48 (1.42 – 1.54) 
   31,000 to 51,999 2.15 (2.07 – 2.24) 1.96 (1.88 – 2.04) 
   18,000 to 30,999 2.78 (2.67 – 2.89) 2.38 (2.28 – 2.48) 
   Less than 18,000    4.16 (4.00 – 4.33) 3.07 (2.94 – 3.21) 
Highest educational attainment 
   College or university degree ref. ref. 
   A levels, O levels, CSE, NVQ, or equivalent 1.68 (1.66 – 1.71) 1.32 (1.30 – 1.34) 
   None of the above 3.46 (3.40 – 3.52) 1.95 (1.90 – 2.00) 
Area–based deprivation, fifths 
   1 (Least deprived) ref. ref. 
   2 1.05 (1.03 – 1.07) 1.00 (0.98 – 1.02) 
   3 1.11 (1.09 – 1.13) 1.04 (1.01 – 1.06) 
   4 1.15 (1.13 – 1.17) 1.05 (1.02 – 1.07) 





Table 4.8 continued: Odds ratios (95% CI) of univariate and multivariate logistic regression analyses 






Body mass index 
   Under– or normal weight ref. ref. 
   Overweight 1.09 (1.08 – 1.11) 1.11 (1.10 – 1.13) 
   Obese 1.35 (1.32 – 1.37) 1.31 (1.29 – 1.34) 
   Severely obese 1.64 (1.60 – 1.69) 1.56 (1.51 – 1.62) 
   Morbidly obese 2.03 (1.95 – 2.13) 1.91 (1.81 – 2.01) 
Physical activity 
   High ref. ref. 
   Moderate 1.18 (1.16 – 1.21) 1.03 (1.01 – 1.06) 
   Low 1.45 (1.41 – 1.48) 1.23 (1.19 – 1.26) 
Alcohol intake (Risky vs. safe drinking) 0.75 (0.74 – 0.76) 0.95 (0.93 – 0.97) 
Smoking 
   Never ref. ref. 
   Previous 0.89 (0.88 – 0.91) 0.87 (0.86 – 0.88) 
   Current 1.22 (1.19 – 1.24) 1.08 (1.05 – 1.10) 
Fruit and vegetable intake per day (Less than five a 
day vs. at least five a day) 
0.93 (0.92 – 0.95) 0.98 (0.96 – 0.99) 
Oily fish intake 
   At least once a week ref. ref. 
   Less than once per week 1.03 (1.01 – 1.04) 1.13 (1.12 – 1.15) 
   Never 1.40 (1.38 – 1.43) 1.33 (1.30 – 1.36) 
Hypertension (Yes vs. no) 1.18 (1.17 – 1.20) 1.04 (1.03 – 1.06) 
Diabetes (Yes vs. no) 1.54 (1.49 – 1.58) 1.35 (1.30 – 1.39) 
High cholesterol levels (Yes vs. no) 1.23 (1.21 – 1.25) 1.08 (1.05 – 1.10) 
Family history of cardiovascular disease (Yes vs. no) 1.22 (1.20 – 1.24) 1.33 (1.31 – 1.36) 
Family history of depression (Yes vs. no) 1.03 (1.01 – 1.06) 1.12 (1.09 – 1.15) 
* adjusted for age, sex, ethnicity, education, income, and area–based deprivation 
ref.: reference, CSE: Certificate of secondary education, NVQ: National vocational qualification 
 
All unadjusted and adjusted Cox proportional hazard models indicated increased 
hazards of MCVE, stroke, and MI among individuals with at least one variable with 
missing values relative to individuals with complete data (Table 4.9). 
Table 4.9: Hazard ratios (95% CI) of MCVE, stroke, and MI among individuals with at least one variable 
with missing information relative to complete cases* 
 Unadjusted hazard ratios 
(95% CI) 
Adjusted hazard ratios* 
(95% CI) 
Major cardiovascular events 1.30 (1.25 – 1.36) 1.20 (1.14 – 1.26) 
Stroke 1.30 (1.22 – 1.40) 1.13 (1.04 – 1.23) 
Myocardial infarction 1.30 (1.23 – 1.37) 1.23 (1.15 – 1.32) 




One cannot distinguish between MAR and missing not at random (MNAR) 
mechanisms since MNAR mechanisms depend on data that were not collected. 
However, a MAR mechanism was deemed likely given the large number of variables 
in the dataset and the numerous significant associations between observed variables 
and missingness. In the following, it is therefore assumed that data are independent 
of unobserved variables, given all observed variables. Multiple imputation was 
performed since a complete case analysis is likely biased when the MCAR assumption 
is violated. Therefore, the following results are based on imputed data. The results of 
a complete case analysis are presented in Appendix Table A 27 to Table A 34 and 
differences between the complete cases analysis and the analysis based on imputed 
data are discussed in section 4.4.5 Comparison of results based on complete cases and 
imputed data. The convergence of all multiple imputations was checked and deemed 
sufficient. The convergence plots of one exposure-outcome set are presented in 
Appendix Table A 11 as an example. 
4.4.3 To what extent are different measures of depression associated 
with subsequent major cardiovascular events, stroke, and myocardial 
infarction? 
4.4.3.1 Descriptive statistics 
Among 465,215 UK Biobank participants included in the analysis, 205,378 (44.1%) 
were male, and the median age was 57 (IQR: 50 – 63) years. The vast majority of 
participants had a white ethnic background (94.1%). A total of 40,353 (8.7%) 
participants were defined as depressed at baseline, of whom 25,139 (62.3%) had a self-
reported depression diagnosis, 3,231 (8.0%) had a hospital admission with 
depression, and 31,130 (77.1%) reported using antidepressants (Figure 4.2). 17,766 
(44.0%) of all participants with depression were identified through more than one 
data source, whereas 13,692 (33.9%) were identified through antidepressant use 
alone, 7,765 (19.2%) through self-report alone, and 1,130 (2.8%) through hospital 





Figure 4.2: Venn diagram representing the relationship between each measure of depression 
 
There were differences between participants with and without depression at baseline 
(Table 4.10). The proportion of male participants was lower among participants with 
versus without depression (30.4% and 45.5%, respectively). Furthermore, the 
proportion of participants with an average household income of more than £31,000, 
with a college or university degree, and in the three least deprived fifths was lower 
among participants with versus without depression. The proportion of individuals 
with obesity, who were previous or current smokers, physically inactive, or reported 
having diabetes or high cholesterol levels was higher whereas risky drinking 
behaviour was lower among participants with depression compared to those without 
depression. The proportion of participants with hypertension was almost identical 
among participants with and without depression at baseline (54.4% and 54.2%, 
respectively). Baseline characteristics separately for participants with and without 
antidepressant use, hospital diagnosis with depression, self-reported depression, and 
participants with and without MCVE, MI, and stroke during-follow-up are presented 




Table 4.10: Baseline characteristics separately for participants with and without one or more of self-
reported depression, antidepressant use, or hospital admission with depression (page 1 of 2)*
 
No depression 
(n = 424,862, 91.3%) 
Depression 
(n = 40,353, 8.7%) 
Male (%) 193,121 (45.5) 12,257 (30.4) 
Age (median [IQR]) 57.0 [50.0, 63.0] 57.0 [50.0, 62.0] 
Ethnicity (%) 
   White 399,138 (93.9) 38,767 (96.1) 
   Other ethnic groups 23,398 (5.5) 1,389 (3.4) 
Income (%) 
   Greater than 100,000 21,308 (5.0) 949 (2.4) 
   52,000 to 100,000 78,691 (18.5) 4,571 (11.3) 
   31,000 to 51,999 97,593 (23.0) 7,747 (19.2) 
   18,000 to 30,999 90,983 (21.4) 8,979 (22.3) 
   Less than 18,000 72,522 (17.1) 11,793 (29.2) 
Highest educational attainment (%) 
   College or university degree 141,857 (33.4) 11,285 (28.0) 
   A levels, O levels, CSE, NVQ, or equivalent 208,854 (49.2) 20,199 (50.1) 
   None of the above 65,732 (15.5) 8,144 (20.2) 
Area-based deprivation (%) 
   1 (Least deprived) 87,999 (20.7) 6,952 (17.2) 
   2 86,466 (20.4) 7,262 (18.0) 
   3 85,983 (20.2) 7,630 (18.9) 
   4 84,549 (19.9) 8,289 (20.5) 
   5 (Most deprived) 79,362 (18.7) 10,148 (25.1) 
Body mass index (%) 
   Under- or normal weight 146,201 (34.4) 11,571 (28.7) 
   Overweight 180,520 (42.5) 15,852 (39.3) 
   Obese 69,968 (16.5) 8,181 (20.3) 
   Severely obese 18,882 (4.4) 2,984 (7.4) 
   Morbidly obese 6,908 (1.6) 1,487 (3.7) 
Physical activity (%) 
   High 39,596 (9.3) 2,731 (6.8) 
   Moderate 280,569 (66.0) 24,191 (59.9) 
   Low 87,724 (20.6) 11,443 (28.4) 
Alcohol intake = Risky drinking (%) 174,947 (41.2) 12,962 (32.1) 
Smoking status (%) 
   Never 238,884 (56.2) 19,929 (49.4) 
   Previous 142,258 (33.5) 13,893 (34.4) 
   Current 41,337 (9.7) 6,315 (15.6) 
Fruit and vegetable intake per day = Less than five 
a day (%) 
295,180 (69.5) 27,863 (69.0) 
Oily fish intake (%) 
   At least once a week 235,774 (55.5) 20,711 (51.3) 
   Less than once per week 140,871 (33.2) 13,634 (33.8) 




Table 4.10 continued: Baseline characteristics separately for participants with and without one or 




(n = 424,862, 91.3%) 
Depression 
(n = 40,353, 8.7%) 
Hypertension (%) 230,315 (54.2) 22,348 (55.4) 
Diabetes (%) 17,609 (4.1) 2,485 (6.2) 
High cholesterol levels (%) 61,055 (14.4) 7,735 (19.2) 
Family history of cardiovascular disease (%) 291,388 (68.6) 28,746 (71.2) 
Family history of depression (%) 33,709 (7.9) 7,395 (18.3) 
* This table does not show the number and percentage of missing values. For more information on 
the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. Data 
are given as n (%) unless specified 
CSE: Certificate of secondary education, IQR: Interquartile range, NVQ: National vocational 
qualification 
 
4.4.3.2 The association between different measure of depression and major 
cardiovascular events, stroke, and myocardial infarction 
During a median of 6.8 (IQR: 6.1 – 7.5) years of follow-up, 7,849 MCVE occurred. 
There were increased hazards of MCVE among individuals with versus without 
depression in all models, irrespective of the different measures of depression (Figure 
4.3, Appendix Table A 18). The strength of the association between depression, 
antidepressant use, and self-reported depression and MCVE increased after 
adjustment for age, sex, ethnicity, and socioeconomic factors and attenuated after 
adjustment for comorbidities, lifestyle factors, and family history of CVD and 
depression. The strength of the association between hospital diagnosis with 
depression and MCVE attenuated with each adjustment. There was a 21% increased 
hazard of MCVE among individuals with depression relative to participants without 
depression in the fully adjusted model (HR: 1.21, 95% CI: 1.12 – 1.30). The association 
was strongest among individuals with a hospital admission with depression, 
followed by participants with antidepressant use, and individuals with self-reported 





Figure 4.3: Hazard ratios (95% CI) of the association between different measures of depression and 
MCVE in unadjusted, partially adjusted and fully adjusted models (imputed data) 
 
Similar patterns were observed when stroke and MI were used separately as 
outcomes. In total, there were 4,885 MI and 3,125 strokes during follow-up. There was 
an 18% increased hazard of stroke and 24% increased hazard of MI among 
individuals with depression, relative to unexposed individuals, in fully adjusted 
models (HR, 95% CI: 1.18, 1.05 – 1.33, and 1.24, 1.12 – 1.36, respectively). Whilst point 
estimates of the association between depression and MI were slightly higher than the 
point estimate of the association between depression and stroke, the pattern of the 
associations was similar for both outcomes and CIs overlapped (Appendix Table A 
19).  
Depression was associated with increased hazards of MCVE among both men and 
women (fully adjusted HR, 95% CI: 1.12, 1.00 – 1.24 and 1.31, 1.17 – 1.45, respectively), 
but the association was significantly stronger among women (p for multiplicative 
interaction: 0.01). The observed sex difference was largely driven by a statistically 
significant interaction between depression and sex in the analyses on MI but not 
stroke risk (p for multiplicative interaction: <0.01 and 0.55, respectively). On an 
additive scale, the hazards of MCVE were higher among women with depression, 
men without depression, and men with depression relative to women without 
depression (fully adjusted HR, 95% CI: 1.33, 1.20 – 1.47; 2.35, 2.23 – 2.49, and 2.60, 2.33 




was approximately equivalent to the sum of the hazards due to male gender and 
depression alone.  
 
Figure 4.4: Hazard ratio (95% CI) of major cardiovascular events, stroke, and myocardial infarction 
among women with depression, men without depression and men with depression, relative to women 
without depression (imputed data) 
 
4.4.3.3 Competing risk analysis 
The probability of dying from causes other than stroke or MI was higher among 
participants with depression than among participants without depression 
throughout follow-up (Figure 4.5). Furthermore, the cause-specific Cox proportional 
hazards model indicated increased hazards of deaths from causes other than MVCE 
among participants with depression, relative to participants without depression in 
unadjusted, partially adjusted and fully adjusted models (HR, 95% CI: 1.40, 1.32 – 
1.49; 1.40, 1.32 – 1.49, and 1.30, 1.22 – 1.39, respectively).  
 
Figure 4.5: Cumulative incidence function of fatal or non-fatal stroke or MI and death from causes other 




4.4.4 Do comorbidities or socioeconomic factors modify the association 
between depression and major cardiovascular events? 
4.4.4.1 Comorbidities 
Information on depression, hypertension, diabetes, and cholesterol levels was used 
to create three four-level predictor variables indicating whether a participant had 
neither depression nor the comorbidity of interest, depression alone, the comorbidity 
of interest alone, or both depression and the comorbidity of interest at baseline (Table 
4.11). In the analyses on depression and/ or diabetes, and depression and/ or high 
cholesterol levels, the largest proportion of participants was allocated to the group 
with neither depression nor the comorbidity of interest at baseline (87.5% and 78.2%, 
respectively). In contrast, in the depression and/ or hypertension analysis, the 
hypertension alone category was most common (49.5%), followed by the group with 
neither depression nor hypertension at baseline (41.8%). Similarly, whilst the neither 
depression nor the comorbidity of interest category was least common in the analyses 
on depression and/ or diabetes and depression and/ or high cholesterol analyses (0.5% 
and 1.7%, respectively), the depression alone category was least common in the 
analyses on depression and/ or hypertension (3.8%). 
Table 4.11: Distribution of the four level predictor variables depression and/ or hypertension, depression 
and/ or diabetes, and depression and/ or high cholesterol levels* 
 No hypertension Hypertension 
No depression 194,547 (41.8%) 230,315 (49.5%) 
Depression 18,005 (3.9%) 22,348 (4.8%) 
 
 No diabetes Diabetes 
No depression 407,253 (87.5%) 17,609 (3.9%) 
Depression 37,868 (8.1%) 2,485 (0.5%) 
 
 Low cholesterol levels High cholesterol levels 
No depression 363,807 (78.2%) 61,055 (13.1%) 
Depression 32,618 (7.0%) 7,735 (1.7%) 
* Data are given as n(%) 
 
There were differences between the groups with depression and/ or hypertension, 
depression and/ or diabetes, and depression and/ or high cholesterol levels at baseline 




among the groups with hypertension alone, high cholesterol levels alone, and 
diabetes alone and lowest among the groups with depression alone. The median age 
was higher among the groups with hypertension, diabetes, or high cholesterol levels 
than among the groups without the comorbidity of interest, irrespective of whether 
or not depression was present. The groups with comorbid depression and 
hypertension, diabetes, or high cholesterol levels were most likely to live in the most 
deprived area, to report less than £18,000 of income, and were least likely to have a 
college or university degree. The groups with both depression and at least one of the 
comorbidities had worse cardiovascular risk profiles at baseline in terms of the 
proportion of individuals with severe or morbid obesity, low physical activity, 
current smoking, oily fish intake, and were more likely to report a family history of 
CVD and depression. The groups with depression alone showed similar 
characteristics with regard to current smoking and oily fish intake. No clear pattern 
was observed for risky drinking behaviour. 
Individuals with depression and at least one of hypertension, diabetes, and high 
cholesterol levels were all at particularly high hazard of MCVE. However, the pattern 
of the association between the four level predictor variables and MCVE was different 
for each of the comorbidities of interest (Figure 4.6, Appendix Table A 23). 
Hypertension alone and comorbid depression and hypertension were associated with 
greater hazards of MCVE relative to participants with neither depression nor 
hypertension (1.78, 95% CI: 1.68 – 1.89, and 2.23, 95% CI: 2.03 – 2.45, respectively). In 
contrast, there was no increased hazard of MCVE among the group with depression 
alone relative to the group with neither depression nor hypertension (1.06, 95% CI: 
0.91 – 1.24). In the analysis on depression and/ or diabetes, there was a gradual 
increase in hazard of MCVE from individuals with depression alone (1.22, 95% CI: 
1.13 – 1.32) to participants with diabetes alone (1.47, 95% CI: 1.35 – 1.61), to 
participants with depression and diabetes (1.63, 95% CI: 1.33 – 2.00), relative to 
participants with neither depression nor diabetes. In the analysis on depression and/ 
or high cholesterol levels, depression alone and comorbid depression and high 




participants with neither depression nor high cholesterol levels in all models (1.17, 
95% CI: 1.07 – 1.28, and 1.24, 95% CI: 1.09 – 1.41, respectively). High cholesterol levels 
alone were associated with an increased hazard of MCVE in the unadjusted and 
partially adjusted models (1.90, 95% CI: 1.80 – 2.01, and 1.22, 95% CI: 1.15 – 1.29, 
respectively) but not in the fully adjusted model (0.97, 95% CI: 0.91 – 1.03). 
 
Figure 4.6: Hazard ratios (95% CI) of the association between depression and/ or hypertension, 
depression and/ or diabetes, and depression and/ or high cholesterol levels and MCVE in fully adjusted 
models (imputed data) 
 
Whilst there was formal evidence for additive interaction between depression and 
hypertension, evidence for interaction neither was found between depression and 
diabetes nor between depression and high cholesterol levels (Table 4.12). There was 
an excess risk due to interaction between depression and hypertension on the 
additive scale (RERI: 0.39, 95% CI: 0.16 – 0.63), with 17.5% (95% CI: 7.5 – 27.5%) of all 
MCVE events estimated to be due to the interaction between depression and 
hypertension (attributable proportion). In keeping with that, the excess risk from 
being exposed to depression and hypertension when interaction is present, relative 
to the risk when interaction is absent was 1.47 (95% CI: 1.14 – 1.89). There was no 
evidence for additive interaction between depression and diabetes and depression 
and high cholesterol levels. However, the CIs of all of the measures were wide 
indicating imprecise estimation. None of the product terms between depression and 
hypertension, depression and diabetes, and depression and high cholesterol levels 




should not reject the null hypothesis of no multiplicative interaction between 
depression and each of the comorbidities. 
Table 4.12: Results of formal tests for additive and multiplicative interaction between depression and 









0.39 (0.15 – 0.63) 17.5 (7.5 – 27.5) 1.47 (1.14 – 1.89) p = 0.06 
Depression and 
diabetes 
-0.06 (-0.41 – 0.29) 3.6 (-25.8 – 18.5) 0.91 (0.53 – 1.58) p = 0.40 
Depression and high 
cholesterol levels 
0.10 (-0.09 – 0.29) 8.1 (-6.2 – 22.3) 1.71 (0.62 – 4.76) p = 0.26 
* Data are presented as estimate (95% confidence interval) unless specified 
RERI: Relative excess risk for interaction 
 
4.4.4.2 Socioeconomic factors 
Two four level predictor variables were created indicating the presence of depression 
and/ or low educational attainment and depression and/ or high area-based 
deprivation (Table 4.13). Out of the four potential depression and educational 
attainment combinations, low educational attainment alone was most common 
(60.2%) and depression alone was least common (2.5%). Out of the four potential 
depression and area-based deprivation combinations, neither depression nor high 
area-based deprivation was most common (66.2%) and depression and high area-
based deprivation (3.0%) was least common. 
Table 4.13: Distribution of the four level predictor variables depression and/ or low educational attainment 
and depression and/ or high area-based deprivation* 
 High educational attainment Low educational attainment 
No depression 141,857 (31.1%) 274,586 (60.2%) 
Depression 11,285 (2.5%) 28,343 (6.2%) 
 
 Low area-based deprivation High area-based deprivation 
No depression 307,806 (66.2%) 116,553 (25.1%) 
Depression 26,318 (5.7%) 13,963 (3.0%) 
* Data are presented as n (%) 
 
There were differences between the groups with depression and/ or low education, 




24 and Table A 25). The proportion of male participants was higher among the groups 
without depression than among the groups with depression. The proportion of 
individuals with an income less than £18,000, severe and morbid obesity, diabetes, 
high cholesterol levels, and who were current smokers was highest among the groups 
with depression and low educational attainment and depression and high area-based 
deprivation. The proportion of individuals with low physical activity levels was 
highest among the groups with depression, irrespective of the socioeconomic factor. 
Risky drinking behaviour was most prevalent among individuals without depression 
and high educational attainment or low area-based deprivation. Whilst there was 
little difference in the proportion of individuals with hypertension between the 
groups with depression and/ or high area-based deprivation, the proportion of 
individuals with hypertension was about 10% higher among the groups with low 
educational attainment than among the groups with high educational attainment.  
Individuals with depression and low educational attainment and individuals with 
depression and high area-based deprivation showed the highest hazards of MCVE 
relative to the group with no depression and high educational attainment/ low area-
based deprivation (Figure 4.7, Appendix Table A 26). Depression alone, high area-
based deprivation alone, and combined depression and high area-based deprivation 
were associated with a higher hazard of MCVE relative to participants with no 
depression and low area-based deprivation (1.10, 95% CI: 1.00 – 1.22, 1.07, 95% CI: 
1.02 – 1.13, and 1.46, 95% CI: 1.31 – 1.63). Similarly, depression alone, low educational 
attainment alone, and combined depression and low educational attainment were 
associated with a higher hazard of MCVE relative to participants with no depression 
and high educational attainment (1.16, 95% CI: 0.99 – 1.37, 1.11, 95% CI: 1.05 – 1.18, 





Figure 4.7: Hazard ratios (95% CI) of the association between depression and/ or low educational 
attainment and depression and/or high area-based deprivation in fully adjusted models (imputed data) 
 
Although the pattern of the associations with MCVE looked similar for both four level 
predictor variables, evidence for additive and multiplicative interaction was found 
between depression and area-based deprivation but not between depression and 
educational attainment (Table 4.14). The product term between depression and high 
area-based deprivation reached the conventional threshold for statistical significance 
whereas the product term between depression and low educational attainment did 
not (p < 0.01, and p = 0.63, respectively). The RERI between depression and high area-
based deprivation was estimated at 0.28 (95% CI: 0.10 – 0.47), with an estimated 19.4% 
(95% CI: 8.0 – 30.8%) of MCVE that was due to interaction between depression and 
area-based deprivation. The excess risk from being exposed to depression and area-
based deprivation when interaction is present, relative to the risk when interaction is 
absent was 2.61 (95% CI: 1.22 – 5.60). The RERI between depression and low 
educational attainment was estimated at 0.08 (95% CI: -0.14 to 0.29). The proportion 
of MCVE that was due to interaction between depression and low educational 
attainment was estimated at 5.8% (95% CI: -10.0 to 21.5%). The excess risk from being 
exposed to depression and low educational attainment when interaction is present, 
relative to the risk when interaction is absent was 1.28 (95% CI: 0.60 – 2.72). The CIs 





Table 4.14: Results of formal tests for additive and multiplicative interaction between depression and 









0.08 (-0.14 – 0.29) 5.8 (-10.0 – 21.5) 1.28 (0.60 – 2.72) p = 0.63 
Depression and area-
based deprivation 
0.28 (0.10 – 0.47) 19.4 (8.0 – 30.8) 2.61 (1.22 –5.60) p < 0.01 
* Data are presented as estimate (95% confidence interval) unless specified 
RERI: Relative excess risk for interaction 
 
4.4.5 Comparison of results based on complete cases and imputed data 
The results of the complete cases analysis provided similar results as the analysis 
based on imputed data (Appendix Table A 27 to Table A 34). As expected, the CIs of 
all estimates based on imputed data were narrower than the CIs based on complete 
cases due to the larger sample size. Whilst the point estimates of the association 
between different measures of depression and MCVE were slightly higher in the 
analyses based on imputed data, the CIs overlapped with the estimates of the 
complete case analysis indicating that the observed differences might be due to 
chance alone. Whilst the association between depression and stroke was stronger than 
the association between depression and MI in all models based on complete cases, the 
association between depression and MI was stronger than the association between 
depression and stroke in all models based in imputed data. However, in both analyses 
CIs overlapped. The estimates of the competing risk analysis and the analyses on 
potential effect-modifying factors were similar in analyses based on complete cases 
and imputed data.  
4.5 Discussion 
4.5.1 Summary of key findings 
In a large prospective study, depression, antidepressant use, hospital diagnosis with 
depression, and self-reported depression were associated with increased hazards of 
MCVE, even after adjustment for a wide range of potential confounding factors. In 
the fully adjusted model, having at least one of antidepressant use, hospital diagnosis 




hazard of MCVE relative to the hazard among participants who did not have any of 
these indications of depression at baseline. There was a potential dose-response 
relationship since the association was more pronounced between a hospital diagnosis 
with depression and MCVE and slightly weaker between self-reported depression 
and MCVE. Depression was more strongly associated with hazard of MCVE among 
women but this was largely driven by sex differences in the association between 
depression and MI but not stroke risk. Furthermore, depression was associated with 
increased hazard of death from causes other than stroke or MI, indicating that the 
observed results were unlikely explained by competing risks.  
The observed association between depression and MCVE differed between 
individuals with and without comorbidities at baseline as well as between 
individuals from different socioeconomic backgrounds. Individuals with depression 
and hypertension, depression and diabetes, and depression and high cholesterol 
levels were all at particularly high hazard of MCVE although formal evidence of 
additive interaction was only present between depression and hypertension. No 
evidence of multiplicative interaction between depression and comorbidities was 
found in analyses based on imputed data. Similarly, individuals with depression and 
low educational attainment and individuals with depression and high area-based 
deprivation were at particularly high hazard of MCVE. Formal evidence of 
multiplicative and additive interaction was found between depression and area-
based deprivation only. The highest hazard of MCVE was observed among 
individuals with depression and hypertension at baseline, relative to individuals with 
no depression and no hypertension. 
4.5.2 Strengths and limitations of this analysis 
4.5.2.1 Chance 
It is reasonable to assume that the analysis was sufficiently powered where 
statistically significant findings that are clinically relevant were found. However, 
limited statistical power might have played a role in findings that were not 




it is unlikely that limited statistical power has influenced the results of the primary 
analyses whereas analyses on potential effect-modifying factors could have been 
affected by limited power. The sample size of this analysis was bigger than the sample 
sizes of 48 out of 51 existing studies on the relationship between depression and risk 
of MCVE (see Table 3.1). The sample size of the study by Sun et al (2016) was similar 
to the sample size of this analysis. A comparison of the sizes of effects that would be 
detectable in datasets of these sizes is complicated due to the use of different measures 
of depression.  However, the study by Sun et al (2016) was sufficiently powered to 
detect interactions between depression and age and between depression and smoking 
status which might indicate that studies with this sample size are sufficiently 
powered to detect interaction effects. Nonetheless, limited statistical power might 
have played a role in findings that were not statistically significant. 
First, the possibility that findings might be due to chance was considered by 
providing 95% CIs around all estimates. Due to the large sample size of the UK 
Biobank, the CIs around most estimates were narrow indicating precise estimation. 
Furthermore, the CIs did not overlap with the null value indicating that the increased 
hazards among individuals with depression were unlikely to be due to chance alone. 
Differences in the strength of the association between the different measures of 
depression and major CVD were observed which might reflect a dose-response 
relationship. Individuals with a hospital diagnosis with depression might suffer from 
more severe depression than individuals who were identified through self-reported 
depression alone. However, CIs overlapped suggesting that the observed differences 
might be due to chance alone. Due to smaller group sizes of the four exposure groups 
in analyses on potential effect-modifying factors, CIs were slightly wider indicating 
less precise estimation. Furthermore, in some of these analyses the CIs of the four 
exposure groups overlapped suggesting that the observed differences between the 
exposure groups might be due to chance alone.  
Second, in some analyses hypotheses tests were performed to detect statistically 




differences in baseline characteristics between groups instead of performing 
hypothesis tests to detect statistically significant differences. The reason for that was 
that hypothesis tests tend to show statistically significant differences between groups 
in very large studies that do not necessarily indicate meaningful differences in 
practice. P-values were provided in analyses assessing the presence of multiplicative 
interaction between depression and socioeconomic factors and depression and 
comorbidities. Some of the p-values did not reach the conventional threshold for 
statistical significance (p < 0.05). Therefore, the null hypothesis of no interaction 
between these factors was not rejected. A p-value greater than 0.05 could be an 
indication that there truly was no interaction between these factors, but it might also 
be that the analyses were not sufficiently powered to detect a true difference between 
the groups. Other p-values reached the conventional threshold for statistical 
significance (p < 0.05). Since multiple hypothesis tests have been performed, the 
chance of making any type I error is greater than 5%, and observed significant results 
could therefore also be due to chance. 
4.5.2.2 Bias 
4.5.2.2.1 Selection bias 
Selection bias might have influenced the results of the analyses. To avoid selection 
bias the study population should represent the population of interest. The population 
of interest were adults living in the UK, without a history of stroke, MI, angina, TIA, 
and mental disorders other than depression at baseline. The UK Biobank had a low 
response rate (5.5%) which resulted in a very healthy cohort from a high 
socioeconomic background (Allen et al, 2012). Allen et al (2012) acknowledged that 
this is problematic when estimating the prevalence or incidence of disorders. Some 
researchers have argued that it is less likely to influence estimates of associations 
between diseases given that there are large numbers of participants with different 
levels of risk factors in the sample (Allen et al, 2012). Nonetheless, selection bias might 
have influenced some results of this analysis. UK Biobank participants with a history 
of the previously mentioned cardiovascular disorders were excluded from the 




diagnosis at baseline. Whilst it is likely that most participants with a history of these 
CVDs were identified through this approach, individuals who did not self-report any 
of these disorders and who were treated in primary care might not have been 
identified and excluded. Since the health care system is free of charge for anyone 
living in the UK, it is unlikely that the identification of participants with a history of 
hospitalised CVD was differential between the exposure and comparison group. 
However, there might have been selection bias if individuals with depression do not 
report history of non-hospitalised CVD as accurately as people without depression. 
The comparison group should be comparable to the exposure group in all factors 
other than the exposure of interest. Baseline characteristics of participants were 
presented separately for individuals with and without the exposure of interest at 
baseline and observed differences between groups were discussed. Differences 
between groups were taken into account by restricting the analyses to participants 
free from CVD and by adjusting the analyses for all factors with differences between 
the exposure and comparison group at baseline. Multiple imputation of missing data 
was performed in order to overcome the potential bias of performing a complete case 
analysis when the MCAR assumption is violated. Missing data were assumed to be 
MAR, implicitly assuming that missing data did not depend on any unobserved 
variable, given the observed variables. Given the large range of variables collected, 
this assumption seemed sensible. However, it could not be formally tested. 
4.5.2.2.2 Information bias 
4.5.2.2.2.1 Exposure assessment  
It is likely that information bias has influenced findings due to inaccurate 
measurement of the exposure. First, a major limitation of the analyses is that 
depression was only assessed once at baseline. Since depression is known to fluctuate 
over time, participants allocated to the exposure group might be mistakenly assumed 
to be depressed over the whole period of follow-up, and individuals allocated to the 
comparison group may develop depression during follow-up. It would have been of 




not provide sufficient information to assess depression as time-varying exposure. 
There was some evidence that an assessment of depression on multiple occasions 
over time was warranted when looking at the proportion of people without 
depression at baseline who had a hospital diagnosis with depression during follow-
up. As expected, the proportion of individuals with a hospital diagnosis with 
depression during follow-up was larger among individuals with baseline depression 
(n = 4,587, 11.4%) than among individuals without baseline depression (n = 3,900, 
0.9%). Of the 3,900 individuals without baseline depression but with a hospital 
diagnosis with depression 249 individuals had a MCVE during follow-up. Whilst the 
diagnosis with depression among the 3,651 individuals without MCVE indicated a 
change in their exposure status throughout follow-up, the diagnosis with depression 
among the 249 individuals with MCVE during follow-up might have occurred after 
stroke or MI (reverse causation). In addition, it is possible that some individuals in 
the comparison group had depression at some point in time but neither reported 
depression at the baseline assessment nor had a hospital diagnosis with depression 
before baseline. If depression is indeed associated with an increased hazard of MCVE, 
then this will bias the estimates towards null.  
Second, an assessment of depression once at baseline might not accurately reflect the 
hazard of cardiovascular events among all individuals with depression but rather 
represent an average risk across disparate depression subgroups. The exposure group 
likely represented a heterogeneous group of participants, some of whom have 
suffered from depression for an extended time period whilst others have had a single 
episode of depression or depressive symptoms. It is likely that the strength of the 
association between depression and cardiovascular events differed between the 
different subgroups of individuals with depression. This further highlights the need 
to use repeat assessments of depression and assess depression trajectories over time.  
Third, underreporting and under-ascertainment likely introduced bias. Whilst 
hospital diagnosis with depression was identified through linkage to hospital 




Assessing depression based on self-report likely introduced recall and response bias. 
Recall bias will have occurred when participants did not recall whether or not they 
have been diagnosed with depression. Response bias will have occurred when 
participants chose not to provide accurate information on their exposure status. This 
might have happened due the stigma attached to depression or because individuals 
might not have considered an episode of depression in the past as important, for 
example because it happened long before baseline. Considering the stigma attached 
to a depression diagnosis, response bias likely had a bigger impact on the accuracy of 
the depression measure than recall bias. Ideally, primary care data would have been 
used to triangulate the assessment of depression. However, the UK Biobank did not 
offer the opportunity to link to primary care data at the time this project was 
undertaken. Furthermore, the use of a depressive symptom rating scale might have 
identified individuals with high depressive symptoms but undiagnosed or 
subthreshold depression. Since no measure of depressive symptoms was used in this 
analysis, the results might be influenced by under-ascertainment. If depressive 
symptoms are associated with increased hazard of MCVE, this would have biased the 
results towards null. 
A major strength of the analysis is that different measures of depression were used. 
The importance of using different data sources is highlighted in the fact that 56% of 
all participants were identified either through antidepressant use alone (33.9%), self-
reported depression alone (19.2%), or hospital diagnosis with depression alone 
(2.8%). If any of these measures had not been used, these individuals would not have 
been identified as being depressed. However, the group of participants with 
antidepressant use alone deserves special attention. The reason for that is that 
antidepressants are not only used to treat depression but also to treat medical 
conditions such as anxiety, insomnia, and irritable bowel syndrome (Wong et al, 
2017). Therefore, an unknown proportion of the group with antidepressant use might 
be misclassified as depressed due to the use of antidepressants to treat other medical 
conditions. Conducting an analysis based on electronic medical records and a 




antidepressants were prescribed off-label. Since the indication of the use of 
antidepressants was not recorded in the UK Biobank, it was not possible to 
differentiate between individuals who took antidepressants to treat depression and 
individuals who took antidepressants to treat other conditions. Misclassification of 
those using antidepressants for other reasons would have biased a true association 
between depression and MCVE towards null. 
4.5.2.2.2.2 Outcome assessment 
Inaccurate measurement of the outcome might have introduced bias. A major 
strength of the study is that participants were followed prospectively and that there 
was very limited loss to follow-up due to the assessment of the outcome through 
linked health records. Furthermore, relying on information of routinely collected 
health records prevented response and recall bias. Woodfield et al (2015) performed 
a systematic review to assess the accuracy of hospital and mortality records for 
identifying stroke cases. They concluded that positive predictive values were greater 
than 70% in most studies that used stroke-specific codes and greater than 90% in some 
studies. This was true for stroke and each pathological subtype. This study used ICD 
codes to detect stroke outcomes that were recommended by Woodfield et al (2015). 
However, these authors only used stroke codes in either the primary or secondary 
diagnostic position whereas this analysis allowed the stroke code to be in any 
diagnostic position. Whilst the use of any diagnostic position to identify stroke cases 
might have increased the number of false positive events, it is unlikely that this bias 
is differential between individuals with and without depression. McCormick et al 
(2014) performed a systematic review to assess the validity of electronic health 
records for identifying individuals with MI. Hospital records showed a positive 
predictive value of more than 92% in more than half of all included studies and the 
highest positive predictive value in cause of death records was 59%. Therefore, 
McCormick et al (2014) concluded that hospital records appear to provide valid data 
on MI whilst the accuracy of cause of death records was lower. A disadvantage of the 
existing review is that only three studies reported the accuracy of ICD-10 codes to 




needed to comment on the accuracy of the MI codes in this analysis. The number of 
false-negatives was lowered by using hospital and death records to identify stroke 
and MI during follow-up. Whilst record linkage to hospital and cause of death 
records offered many benefits, non-hospitalised events that were non-fatal were 
missed. However, it remains to be established to what extent the inclusion of primary 
care data will improve accuracy of outcome ascertainment (Woodfield et al, 2015). 
The outcome assessment might be biased since death censoring occurred eight 
months after hospitalisation censoring. This bias is non-differential since non-fatal 
events during this time period were missed for participants with and without the 
exposure of interest. If depression was indeed associated with increased hazards of 
fatal and non-fatal MCVE, this would have biased estimates towards null. 
4.5.2.3 Confounding 
Residual confounding due to unmeasured confounders or inaccurate measurement 
of measured confounders might have introduced bias. A major advantage of this 
analysis is that the UK Biobank provided information on a wide range of factors that 
have been discussed as potential confounding factors in the literature. The analyses 
controlled for confounding by demographic factors, socioeconomic factors, 
comorbidities, behavioural factors, and family history of CVD and depression by 
adjusting the analyses for these factors. In addition, the analyses were restricted to 
participants free from CVD at baseline. With the exception of blood pressure 
measurements, all measured covariates were assessed based on self-report in a 
touchscreen questionnaire and/ or nurse interview. Self-report of health behaviours 
might be inaccurate due to stigma attached to behaviours such as smoking or risky 
alcohol intake and due to recall bias of, for example, the amount of physical activity 
(Connor Gorber et al, 2009; Prince et al, 2008). Furthermore, unmeasured covariates, 
such as inflammatory markers or genetic factors, might have influenced findings. 
However, given the wide range of confounding factors considered, it is unlikely that 





Since the UK Biobank did not provide sufficient information to treat depression and 
covariates as time-varying factors, it was difficult to establish the temporal 
relationship. As a result, the assumption that all measured covariates were common 
sources rather than mediating factors in the relationship between depression and 
CVD might have been violated. In this analysis, the estimates of the fully adjusted 
model were adjusted for demographic, socioeconomic, and lifestyle factors, as well 
as comorbidities and family history of depression and CVD. If the assumption was 
valid that all of these covariates were common sources of both depression and 
cardiovascular events, then an open backdoor path was closed by conditioning on all 
of these factors (see section 3.4.2.5 Conditioning on covariates for more detail). Whilst 
it can be established with certainty that genetically determined factors such as sex or 
ethnicity preceded the onset of both depression and cardiovascular events, lifestyle 
factors and comorbidities might have occurred after the onset of depression. As a 
result, they might act as mediating factors rather than common sources in the 
relationship between depression and cardiovascular events. As shown in the directed 
acyclic graph (Figure 4.8), conditioning on a mediator closes a causal path between 
depression and cardiovascular events. If the covariates indeed acted as mediating 
factors in the relationship between depression and cardiovascular events, then the 
estimates of the fully adjusted models would represent an approximation of the direct 
effect rather than the total effect of depression on cardiovascular events. Since the 
direct effect of an exposure on an outcome is a representation of the effect of the 
exposure on the outcome through unknown or unmeasured mediators, an estimation 
of the direct effect is not meaningful in practice. Instead, an estimation of the total 
effect is more meaningful in practice. Under the assumption that lifestyle factors and 
comorbidities were mediating factors in the relationship between depression and 
cardiovascular events, the effect estimates of the partially adjusted models might be 
a closer approximation of the total effect of depression on cardiovascular events. Since 
the role of the covariates cannot be established with certainty in analyses without 




the association between depression and cardiovascular events in a dataset with 
multiple assessments of depression and covariates. 
 
Figure 4.8: Conditioning on mediator (violation of assumption that all covariates were common sources) 
NB: Presence of arrow; causal effect is assumed or unwilling to assume that causal effect does not exist; 
direction of arrow: direction of causal effect; square border: conditioning on variable through 
adjustment, stratification or restriction 
 
4.5.3 Comparisons of findings with previous research 
4.5.3.1 Existing Biobank publications 
Martin et al (2016) investigated the cross-sectional association between depression 
and cardiometabolic diseases in UK Biobank participants with complete data of 
lifetime features of mood disorders and self-reported cardiometabolic diseases (n = 
145,991). Depression was associated with increased risks of stroke, MI, diabetes, 
hypertension, and angina as well as a composite outcome of these outcomes. In a fully 
adjusted model adjusting for age, gender, deprivation, ethnicity, BMI, smoking 
status, alcohol consumption and psychotropic medication the OR was estimated at 
1.26 (95% CI: 1.13 – 1.40) for stroke and at 1.18 (95% CI: 1.08 – 1.30) for MI. The strength 
of the association between depression and each of the outcomes was very similar in 
the cross-sectional and prospective analyses. Whilst the association was slightly 
stronger between depression and stroke than between depression and MI in the 
analyses by Martin et al (2016), in the current analysis the association between 
depression and MI was slightly stronger than the association between depression and 
stroke. However, the CIs of the stroke and MI estimates overlapped in both analyses. 
The exposure measure used by Martin et al (2016) differed from the depression 
measures used in this analysis. Martin et al (2016) defined depression according to a 
set of criteria proposed by the UK Biobank’s mental health working group which was 
published by Smith et al (2013). A disadvantage of the criteria proposed by the UK 
Biobank mental health working-group is that they did not validate the criteria against 




et al (2016) is much smaller than the sample size of the current analysis because 
additional questions on depressive and manic symptoms were necessary to define 
their exposure measure. These questions were added to the UK Biobank assessment 
at a later point in time and among only a subset of the UK Biobank sample. Another 
difference is that Martin et al (2016) adjusted for psychotropic medication use in the 
fully adjusted model. This might be problematic since depression increases the risk 
of taking psychotropic medication. Therefore, psychotropic medication might be seen 
as a mediator in the relationship between depression and CVD or as a proxy measure 
of the exposure itself (see section 7.3.4.1 The need to disentangle the role of depression 
and psychotropic medications for more detailed discussion).  
The current analysis showed the same trend as an analysis investigating the 
prospective association between psychological distress and all-cause and cause-
specific mortality (Batty et al, 2016). Psychological distress, measured by the Patient 
Health Questionnaire (PHQ), was associated with greater hazards of all-cause 
mortality and deaths due to CVD, cancer, external causes and cause-specific mortality 
among 308,721 UK Biobank participants. In the fully adjusted model, each one SD 
increase on the PHQ was associated with an increased hazard of all-cause mortality 
of 1.16 (95% CI: 1.12 to 1.20) and an increased hazard of CVD mortality of 1.11 (95% 
CI: 1.03 to 1.20). Due to the use of a continuous scale it was not possible to compare 
the strength of the association to the current analysis. 
4.5.3.2 The association between depression and cardiovascular events 
The estimates of the current analysis were very similar to the pooled estimates of the 
systematic review that was performed as part of this project (see Chapter 3) and 
slightly lower than the pooled point estimates of the most recently published meta-
analyses (Li et al, 2015; Wu & Kling, 2016). However, CIs overlapped indicating that 
observed differences might be due to chance or variation in statistical adjustment. 
Only few existing studies reported results separately for men and women (see 
Chapter 3 for more detailed discussion). Among these studies, depression or 




both men and women with little difference in the strength of the association. In 
keeping with existing studies, depression was associated with increased risk of 
MCVE among both men and women. In contrast to existing studies, the association 
was significantly stronger among women than men, which was largely driven by a 
statistically significant interaction between depression and sex in the analyses on MI 
but not stroke risk. 
4.5.3.3 The role of socioeconomic factors 
In the current analysis, the association between depression and cardiovascular events 
was strongest among individuals from areas with high deprivation and among 
individuals with low educational attainment. However, formal evidence for 
multiplicative and additive interaction was present for depression and area-based 
deprivation only. Existing publications on the effect of socioeconomic factors on the 
association between depression and cardiovascular disorders are conflicting. Whilst 
some studies have shown that individuals from a lower socioeconomic background 
might be more vulnerable to the adverse effect of depression (Avendano et al, 2006; 
Lazzarino et al, 2013a; b), one study did not observe any effect modification by 
socioeconomic factors (Mittag & Meyer, 2012), and one study showed that individuals 
from a high socioeconomic background are more vulnerable to the adverse effect of 
depression (Sun et al, 2016). Psychological distress was more strongly associated with 
all-cause mortality (Lazzarino et al, 2013a) and stroke and CHD mortality (Lazzarino 
et al, 2013b) among individuals with lower SES. The product term between 
depression and SES was significant at the 5% significance level in both publications. 
In keeping with that, Avendano et al (2006) showed that the hazard of stroke was 
higher among participants with depression and 10 – 12 years of school, 8 – 10 years 
of school, and 0 – 7 years of school (HR: 1.55, 95% CI: 0.79 – 3.04, and 1.46, 95% CI: 
0.72 – 2.95, and 1.52, 95% CI: 0.73 – 3.15), relative to participants with at least 13 years 
of school. However, the CIs were wide and crossed the null value indicating that these 
results might be due to chance alone. Sun et al (2016) investigated to what extent the 
association between clinical depression and fatal or non-fatal stroke differed by 




Kadoorie Biobank. In contrast to the current analysis and the analyses by Lazzarino 
et al (2013a; 2013b) and Avendano et al (2006), Sun et al (2016) observed stronger 
associations between depression and stroke among individuals with high income, 
high educational attainment, and among participants from urban areas. Formal 
evidence of multiplicative interaction was present between depression and education 
(p = 0.05) but not depression and income (p = 0.49) or depression and area of residence 
(p = 0.54). Mittag & Meyer (2012) concluded that the association between depressive 
symptoms and IHD is not moderated by education. The author’s conclusion was 
based on a non-significant interaction term (p-value not reported). 
There are multiple possible explanations for the observed differences. First, the 
country of the study might have influenced the findings. Lazzarino et al (2013a; 
2013b) findings are based on a study from England, Avendano et al (2006) and Mittag 
& Meyer (2012) used data from US participants, and Sun et al (2016) used data from 
Chinese participants. It is possible that results of studies conducted in high income 
countries such as the UK and US are not generalisable to findings in low income 
countries or findings in middle-income countries with periods of rapid growth such 
as China. Second, the assessment of exposure, outcome and socioeconomic factors 
differed across studies. This likely introduced heterogeneity and decreased 
comparability between studies. Furthermore, there was evidence of additive and 
multiplicative interaction between depression and area-based deprivation but neither 
evidence of additive nor multiplicative interaction between depression and 
educational attainment in the current analysis. This highlights that there might be 
differences in the effect of different socioeconomic factors on the association between 
depression and cardiovascular events. Third, the observed differences between 
groups might be due to chance alone. The CIs of the analyses were all wide indicating 
imprecise estimation. Moreover, some p-value did not reach the threshold for 
statistical significance indicating that there might not be any differences between 
groups, or that the study was not sufficiently powered to detect true differences 




4.5.3.4 The role of comorbidities 
There was evidence for effect modification by hypertension in the current analysis 
which is in contrast to existing studies. Sun et al (2016) investigated to what extent 
the association between clinical depression and first ever fatal or non-fatal stroke was 
modified by hypertension in the China Kadoorie Biobank cohort. The estimates in the 
subgroups with and without hypertension were very similar (HR: 1.13, 95% CI: 0.95 
– 1.35, and 1.17, 95% CI: 0.90 – 1.53, respectively), and there was no evidence for 
multiplicative interaction between depression and hypertension (p = 0.83). Likewise, 
Pan et al (2011a) and Péquignot et al (2016) concluded that there was no effect 
modification by hypertension between depressive symptoms and stroke (p = 0.90) 
and depressive symptoms and combined CHD and stroke (p = 0.15), respectively. 
Again estimates of the association between depressive symptoms and stroke were 
very similar in participants with and without hypertension (HR: 1.29, 95% CI: 1.10 – 
1.51, and 1.28, 95% CI: 0.96 – 1.69, respectively) in the analysis by Pan et al (2011a). 
Péquignot et al (2016) did not report estimates separately for individuals with and 
without hypertension at baseline. One potential explanation for the observed 
differences between the current analysis and the existing studies is that different 
scales were used to investigate interaction between depression and hypertension. 
Whilst the current analysis found evidence for additive interaction between 
depression and hypertension, there was no evidence for multiplicative interaction 
between depression and hypertension in analyses based on imputed data. The 
existing studies investigated to what extent there was evidence for multiplicative 
interaction by adding a product term to Cox proportional hazard models. However, 
they did not investigate to what extent there was evidence for additive interaction 
thereby potentially failing to identify that biological interaction between depression 
and hypertension was present (Andersson et al, 2005). Another potential reason for 
the observed differences between the current analysis and existing studies might be 
differences in determining hypertension. However, Sun et al (2016) assessed the 
presence of hypertension based on blood pressure measurements, self-reported 




Similarly, Péquignot et al (2016) determined hypertension through blood pressure 
measurements and use of antihypertensive medication. Pan et al (2011a) determined 
hypertension solely based on a self-reported diagnosis of hypertension which might 
have been less accurate than the assessment methods of the other studies. 
The results of existing studies on the association between depression and/ or diabetes 
and CVD are consistent with the current analysis. Scherrer et al (2011) investigated 
the hazard of MI among individuals with depression and/ or diabetes using Veterans 
Administration electronic medical records of 345,949 participants without CVD at 
baseline. In keeping with the current analysis, Scherrer et al (2011) found both 
depression alone and diabetes alone to be associated with increased hazard of MI 
relative to the group with neither condition, and the HR was highest among the group 
with comorbid depression and diabetes (1.82, 95% CI: 1.69 – 1.97). These authors did 
not calculate the excess risk due to interaction. I calculated the RERI of the estimates 
provided by Scherrer et al (2011) to be 0.2 but insufficient information was available 
to calculate CIs. Therefore, in contrast to this analysis there might have been a small 
supra-additive interaction. However, this might have been due to differences in the 
adjustment sets. Scherrer et al (2011) adjusted for age, sex, race, marital status, and 
insurance type whilst the current analysis additionally adjusted for comorbidities 
other than diabetes at baseline, as well as lifestyle factors such as smoking and 
physical activity and family history of CVD and/ or depression. Cummings et al 
(2016) investigated the effect of depression or stress on stroke, acute CHD and 
cardiovascular death separately for participants with and without diabetes among 
participants free from stroke or heart disease at baseline. Among participants with 
diabetes, elevated stress or depressive symptoms were associated with stroke and 
cardiovascular death and there was a non-statistically significant association with 
acute CHD in participants with diabetes in the fully adjusted model. Among those 
without diabetes, elevated stress or depressive symptoms were not associated with 
any of the outcomes, indicating that diabetes might be an effect modifier. The findings 
of the current analysis cannot be directly compared to the study by Cummings et al 




comparison group that differed from the comparison group of the current analysis. 
However, the results indicated that there was an increased hazard of stroke among 
people with depression or stress and diabetes relative to the group with diabetes 
alone which is consistent with our findings. One study explored the individual and 
joint effect of antidepressant drugs and antidiabetic medication in a nationwide 
register study in Sweden (Rådholm et al, 2016). Although the exposure assessment 
differed from the current analysis, a combined treatment with antidepressant drugs 
and antidiabetic medication also showed a substantially increased hazard of first-ever 
fatal or non-fatal MI compared to individuals with treatment of neither or either 
condition alone. The corresponding HR for the combined effect of antidepressant 
drugs and antidiabetic medication compared to neither treatment for men and 
women aged 45 – 64 years were considerably higher than those of the current analysis 
(3.1, 95% CI 2.8 – 3.6, and 7.4, 95% CI: 6.3 – 8.6, respectively). 
To the best of my knowledge, only one study investigated to what extent high 
cholesterol levels modified the association between depressive symptoms and fatal 
or non-fatal stroke. In keeping with the results of this study, Pan et al (2011a) did not 
find any evidence for multiplicative interaction between depressive symptoms and 
high cholesterol levels (p = 0.93). Furthermore, the stratified analysis showed very 
similar estimates for participants with and without high cholesterol levels (HR: 1.27, 
95% CI: 1.08 – 1.48, and 1.36, 95% CI: 1.03 – 1.79, respectively), indicating little 
evidence for effect modification by high cholesterol levels.  
4.6 Conclusion 
This analysis made use of unique advantages of the UK Biobank, in particular its large 
sample size and the large amount of data collected. Depression, antidepressant use, 
hospital diagnosis with depression, and self-reported depression were associated 
with increased hazards of MCVE, even after adjustment for a wide range of potential 
confounding factors. Residual confounding due to measurement error of included 
covariates and due to unmeasured covariates might have introduced some bias. 




residual confounding alone explained the observed associations given the wide range 
of confounding factors considered. Furthermore, this analysis identified 
characteristics of individuals with depression which put them at particularly high 
hazard of MCVE. However, one limitation of this analysis was that, similar to what 
has been observed in the majority of existing studies, information on exposures and 










Chapter 5: Identification of depressive symptom 
trajectories and related cardiovascular risk factor 
profiles in young women 
5.1 Background 
In most existing studies on the association between clinical depression or depressive 
symptoms and subsequent cardiovascular events researchers relied on a 
measurement of the exposure at one point in time. Implicitly, these researchers 
assumed that a single measure of depression was a good approximation of the 
exposure status of participants throughout follow-up. However, this assumption may 
not be valid. For example, in a community-based sample Ames & Leadbeater (2018) 
identified four latent classes with different patterns of depressive symptoms among 
youth. Two subgroups were characterised by persistently high and low depressive 
symptoms (9% and 49%, respectively) but a considerable proportion of participants 
showed increasing and decreasing depressive symptoms (21% and 22%, respectively) 
from the age of 12 to 28 years. Whilst a single assessment of depressive symptoms 
would have accurately reflected the participant’s exposure status with persistently 
high and low depressive symptoms, it would not accurately reflect the pattern of 
depressive symptoms of the latter two groups. As a result, researchers have 
emphasised the importance of considering the course of depressive symptoms over 
the life course (Colman & Ataullahjan, 2010; Musliner et al, 2016).  
Unlike many other cohort studies, the ALSWH has assessed information on 
depressive symptoms, covariates and cardiovascular events at multiple occasions 
over several years. The ALSWH is an ongoing prospective cohort study of over 57,000 
women in three age-cohorts that were recruited in 1996 and one additional younger 
cohort that was recruited later (Lee et al, 2005; Loxton et al, 2017). Women in the 
young, middle-age, and oldest cohort were aged 18 – 23 years, 45 – 50 years, and 70 – 
75 years at baseline, respectively. Women were randomly selected from the national 
Medicare health insurance database, which includes all Australian citizens and 




oversampled. Self-administered questionnaires were first sent to women in 1996, four 
years later, and every three years thereafter until 2015 (Lee et al, 2005). In 2012/ 2013 
an additional age-cohort was recruited that consists of women born from 1989 to 1995. 
Due to its repeat assessments the ASLWH offered unique advantages with respect to 
assessing the patterns of depressive symptoms over time, exploring the risk of CVD 
that was associated with changes of depressive symptoms over time, and 
investigating the contribution of behavioural factors as potential mediating factors. 
A previous study based on the mid-aged ALSWH cohort showed that although time-
varying depressive symptoms were associated with increased risk of hypertension in 
the age-adjusted model, this association was no longer statistically significant in the 
fully adjusted model (Jackson et al, 2016). However, some of the factors adjusted for 
might have been on the causal pathway between depressive symptoms and 
hypertension. One of the candidate factors was BMI. Since many women were already 
overweight at baseline, the authors concluded that it was not appropriate to perform 
a mediation analysis between depressive symptoms, BMI and hypertension in this 
cohort. Therefore, it was of interest to investigate this further using data from women 
of the young cohort, where the temporality between depression and BMI could be 
more readily determined. Whilst using data from the young cohort of the ALSWH 
was advantageous with regard to the temporal relationship of variables, a 
disadvantage was that women of the young cohort were only aged 37 – 42 years at 
their last follow-up assessment. Thus, there were insufficient major CVD events to 
explore the relationship between repeated measures of depressive symptoms and 
CVD. As a result, I decided to use hypertension as outcome in this analysis because 
it develops at an earlier age and is a major risk factor for CVD events. 
Using data from the young cohort of the ALSWH, the original plan at the start of the 
PhD was to identify subgroups of women with similar patterns of depressive 
symptoms over time, to perform a marginal structural model on the risk of 
hypertension associated with different patterns of change of depressive symptoms 




the role of BMI as potential mediating factor in the relationship between depressive 
symptoms and hypertension. I intended to apply the counterfactual approach to 
causation to both the marginal structural model and the mediation analysis. I then 
explored this option in terms of feasibility and methodology in the context of 
psychological disorders and decided not to pursue these analyses within the PhD (see 
section 7.3.2 The need for an accurate definition of depression for more detailed 
discussion). As a result, this analysis focusses on identifying women with similar 
depressive symptoms trajectories over time and on exploring their profiles of key 
cardiovascular risk factors at the beginning and end of follow-up.  
Group-based trajectory modelling aims to identify subgroups of individuals with 
similar patterns of an exposure over time by simplifying heterogeneous populations 
into more homogenous subgroups (Lennon et al, 2018). Group-based trajectory 
modelling has multiple advantages over modelling patterns of change among groups 
that have been specified a priori. For example, since no assumption about the number 
of groups or shapes of trajectories are made prior to the analysis, it allows for a one-
class solution in which all individuals of the sample follow similar patterns of 
depressive symptoms over time. Another advantage in the presence of at least two 
subgroups is that it allows for an investigation of the certainty with which 
participants could be allocated to one of the identified classes (Nagin & Odgers, 2010). 
The identification of subgroups with similar trajectories over time might be 
particularly valuable in the context of depression (Schubert et al, 2017). Due to the 
substantial heterogeneity between participants with depressive symptoms, different 
patterns of depressive symptoms over time might be indicative of different causes 
and consequences. To investigate whether the identified subgroups were clinically 
meaningful, I investigated how the identified subgroups were related to key 
cardiovascular risk factors at the beginning and end of follow-up. Due to the 
potentially important role of BMI as mediating factor, I additionally investigated 
patterns of change of BMI over time for each of the identified subgroups and explored 





1. To identify subgroups of women with similar patterns of depressive 
symptoms over time using group-based trajectory modelling 
2. To investigate whether these subgroups had  
a) different profiles of key cardiovascular risk factors at the beginning and end 
of follow-up  
b) different patterns of change of BMI over time 
5.3 Methods 
5.3.1 Sample 
This analysis included women of the young cohort born from 1973 to 1978, who were 
aged 18 – 23 years at the start of the study and 37 – 42 years at the end of follow-up. 
Since depressive symptoms were first assessed in the second study phase, women 
were excluded from the analysis if they only participated in phase 1. Participants with 
no information on depressive symptoms in any of the study phases were excluded 
from the analyses. Women who had not responded to survey 2 were contacted and 
offered to complete a shorter version of the questionnaire that contained questions 
that were considered most important. Following recommendations from the ALSWH 
study team, participants who only completed the short survey at study phase 2 were 
excluded from this analysis. Observations of women were included until the end of 
follow-up, time of death, or date of withdrawal. Observations for which the date of 
withdrawal was the same as the date on which the survey was returned were 
included in the analysis.  
Secondary analyses of ALSWH data were conducted under generic approval from 
the University of Newcastle’s Human Research Ethics Committee, approval numbers 
H-076-0795 and H-2012-0256, and the University of Queensland’s Medical Research 
Ethics Committee, approval numbers 2004000224 and 2012000950 (all approved in 





Depressive symptoms were first assessed in the second study phase and in every 
survey thereafter using the 10-item version of the CES-D (Andresen et al, 1994; 
Radloff, 1977). Women were asked to rate the frequency of different depressive 
symptoms in the past week on a scale of: ‘0 = rarely or none of the time (less than 1 
day)’; ‘1 = some or a little of the time (1 – 2 days)’; ‘2 = occasionally or a moderate 
amount of the time (3 – 4 days)’; or ‘3 = most or all of the time (5 – 7 days)’. In keeping 
with recommendations by Andresen et al (1994), information on depressive 
symptoms was set to missing if fewer than nine CES-D items were completed. If 
women provided information on nine items, the value of the tenth item was 
considered to be the mean of the nine items provided. As a result, the final score 
ranges from 0 to 30 with higher scores indicating greater depressive symptoms. The 
CES-D score was treated as continuous variable when using group-based trajectory 
modelling. In addition, a binary variable was created to indicate the presence or 
absence of depressive symptoms in descriptive statistics. In keeping with 
recommendations (Andresen et al, 1994) and a previous ALSWH publication (Jackson 
et al, 2016), a score of at least 10 was classified as presence of depressive symptoms. 
Sociodemographic factors included age, area of residence, living arrangements, 
educational attainment, and ability to manage on income. Area of residence was 
categorised as metropolitan, rural and remote. Marital status was grouped into three 
categories of married/ de-facto, separated/ divorced/ widowed, and single. Women 
were asked who lived with them. That information was used to create a binary 
variable indicating whether or not women lived alone. SES was determined by two 
measures. First, women reported their highest educational attainment. Due to the 
large proportion of women reporting a university degree or higher university degree, 
educational attainment was treated as binary variable indicating whether or not 
women had a (higher) university degree. Second, women were asked how well they 
managed on their income. This information was grouped into three categories of 




Since women were not asked how well they managed on their income in study phase 
2, information provided in study phase 1 was carried forward to the next phase.  
Health behaviours included smoking, physical activity, and alcohol intake. Smoking 
was classified as never, ex-smoker, or current smoker. Physical activity was assessed 
using the metabolic equivalent (MET), a measure to define levels of physical activity 
as multiples of resting metabolic rate. Women were asked to report the time spent 
walking, in moderate leisure activity and vigorous leisure activity in the last week. A 
MET value of 3.33 has been assigned for walking and moderate leisure activity, a 
value of 6.66 has been assigned to vigorous physical activity. MET minutes per week 
were calculated as 3.33 * minutes walking + 3.33 * minutes moderate activities + 6.66 
* minutes vigorous activities (Brown & Pavey, 2016). Using that information women’s 
physical activity was defined as nil/ sedentary (0 to < 33 MET minutes/ week), low 
(33.3 to < 500 MET minutes/ week), moderate (500 to < 1000 MET minutes/ week), and 
high (≥ 1000 MET minutes/ week). Alcohol intake was defined in keeping with the 
Australian National Health and Medical Research Council guidelines (National 
Health and Medical Research Council, 2001). Due to the small proportion of risky 
drinkers (15 – 28 drinks/ week) and high-risk drinkers (> 28 drinks/ week), these 
groups were combined. Furthermore, women who reported that they drink less than 
once a month and non-drinkers were classified as non/ rarely drinkers. The remaining 
women were classified as low-risk drinkers (up to 14 drinks/ week). 
Variables related to the health status of participants included BMI, hypertension, 
diabetes, or heart disease. BMI (kg/m2) was calculated by the ALSWH study team 
based on women’s self-reported weight and height. The ALSWH study team set the 
BMI of pregnant women to missing from study phase 1 to 3 whereas it was set to the 
pre-pregnancy BMI from study phase 4 onwards. BMI was defined as continuous and 
categorical variable in keeping with WHO recommendations (underweight: < 18.5 
kg/m2, normal weight: 18.5 – 24.9 kg/m2, overweight: 25 – 29.9 kg/m2 or obese: ≥ 30 
kg/m2) (World Health Organisation, 2000). Women were asked to report a diagnosis 




survey. Once women first reported occurrence of either of these medical conditions, 
they were considered to have it at each subsequent survey.  
5.3.3 Statistical analyses 
5.3.3.1 Descriptive statistics 
Participant characteristics were described at each study phase and characteristics of 
included and excluded participants were compared. Since a large proportion of 
excluded women only participated in phase 1, the comparison of those included 
versus excluded was made with regard to participant characteristics at study phase 
1. Differences between those included versus excluded were assessed using t-tests for 
normally distributed continuous variables and chi-squared tests for proportions. A 
two-sided p-value < 0.05 was considered statistically significant. Using the binary 
variable for absence/ presence of depressive symptoms, patterns of depressive 
symptoms from study phases 2 to 7 were investigated. The number of unique 
response patterns was determined and the most common response patterns were 
reported. A random sample of 250 women was selected to illustrate individual 
depressive symptom trajectories plotted as a function of age using the continuous 
depressive symptom score.  
5.3.3.2 Group-based trajectory modelling of depressive symptoms (CES-D) 
5.3.3.2.1 Latent process mixed modelling 
Subgroups of participants with similar depressive symptoms trajectories were 
identified using the lcmm function of the R package Latent Class Mixed Modelling 
(LCMM) (Proust-Lima et al, 2017). Latent class mixed modelling assumes that the 
study population is heterogeneous and formed of a specific number of latent classes 
whose mean trajectory profiles can be estimated. The groups are referred to as latent 
classes because they are neither directly observed nor defined a priori. The 
heterogeneity between trajectories of participants is taken into account and 
subgroups with similar trajectories are identified. Latent process mixed models are 
an extension of standard linear mixed models that allow the study of non-Gaussian 
longitudinal markers over time. To estimate latent process linear mixed models, one 




effects (subset of covariates having a class-specific effect), and random effects (subset 
of covariates having a subject-specific effect in order to allow individual variation 
within classes and to take account of correlation between repeated measures of the 
same individual). Missing data are handled by fitting the model using maximum 
likelihood estimation (Nagin & Odgers, 2010). Subjects with missing data are 
included in the analysis but only available data for each subject are used. This 
generates unbiased parameter estimates under the assumption that data are MAR 
(Nagin & Odgers, 2010). Nagin (2005) highlighted that a sample of at least 300 to 500 
subjects is required to estimate trajectory models. Bigger samples are preferable to 
increase statistical power and ease identification of trajectory groups. The minimal 
number of data points depends on the complexity of the model. Whilst three data 
points might be sufficient to estimate linear and quadratic trajectories, preferably the 
dataset should have at least four or five data points to estimate more complex models 
(Curran & Muthén, 1999). 
5.3.3.2.2 Link function 
The optimal model to identify subgroups of participants with similar depressive 
symptom trajectories was chosen following a framework to construct latent class 
trajectory models developed by Lennon et al (2018); however, the first step of the 
framework was altered to take account of specific properties of the depressive 
symptom scale. As described previously, the depressive symptom score used in this 
analysis is a sum score of ten items. Proust-Lima et al (2011) emphasised that these 
discrete quantitative outcomes often suffer from floor and/ or ceiling effects due to 
the limited range of possible values, and they suffer from curvilinearity due to 
varying sensitivity to change at different levels of the scale. As a result, the 
relationship between depressive symptom scores and the underlying latent process 
of interest might not be accurately described through a linear link function (which is 
the default option in R software). Thus, the following method was developed based 
on recommendations by Proust-Lima et al (2011; 2017). Five latent process mixed 
models with depressive symptom scores as dependent variable were fitted using 




equidistant I-splines, five I-splines set at the quantiles of the distribution (Ramsay, 
1988), thresholds). The link function that provided the best model fit was determined 
using the discrete Akaike information criterion (AIC). In contrast to the AIC and 
Bayesian information criterion (BIC) for continuous outcomes, the discrete AIC takes 
into account that the measure of depressive symptoms is a discrete and bounded 
quantitative outcome by using the discrete log-likelihood instead of the continuous 
log-likelihood to estimate the information criterion. The fixed and random effects 
structures were kept constant in these models. Time was modelled using mean-
centred age divided by ten in order to ease the interpretation of the intercepts and 
reduce numerical problems due to very large numbers in quadratic models. Natural 
cubic splines of age were used to model time dependence for the fixed effects with 
the spline knots set at the quartiles of the distribution of age. A random intercept and 
slope was added to account for inter-subject variability. Due to the computational 
complexity of the models, the best link function was determined in models with one 
class. The model with the preferred link function was treated as scoping model. The 
R code for the model using a linear link function is presented below as an example. 
kn <- quantile(sample$age, probs = c(0.25,0.50,0.75))   #spline knots at the quartiles  
#of the distribution  
lcmm(fixed = CESD ~ ns(age, knots = kn),  
random = ~ time,  
subject = “ID”,  
link = “linear”,   #five different models using different link functions were fitted:  
#linear, beta, equidistant I-splines, I-splines set at quantiles  
#of distribution, threshold  





5.3.3.2.3 Number of classes 
After selecting the preferred link function, the optimal number of classes was 
identified. In this step, models with increasing numbers of groups were fitted whilst 
the link function and structure of the fixed and random effects were kept the same. 
To model time dependence for the mixture effects in models with more than one class 
natural cubic splines of age were used as before with spline knots set at the quartiles 
of the distribution. In the presence of at least two groups and mixture effects, it is 
recommended that the same model should be fitted several times using different sets 
of starting values. This is because the log-likelihood might have multiple maxima and 
convergence towards the global maximum is not ensured when running the model 
with only one set of starting values (Proust-Lima et al, 2017). Consequently, all 
models with at least two classes were run several times using different sets of starting 
values that were chosen at random from values of the asymptotic distribution of the 
maximum likelihood estimates of the one class model with the same model structure. 
Models with increasing number of classes were fitted until two models failed to reach 
convergence in 500 iterations. As recommended by van de Schoot et al (2017), the 
optimal number of classes to describe the dataset was determined by balancing 
statistical criteria (lowest discrete AIC) against criteria reflecting the clinical relevance 
and usefulness of the identified subgroups (e.g. group size).  
5.3.3.2.4 Model structure 
After selecting the optimal number of groups, the model structure was refined. The 
optimal model structure was determined by fitting models with increasingly complex 
model structures (Table 5.1). The link function and number of classes were kept 
constant in these models. The optimal model structure was determined based on the 





Table 5.1: Models with increasingly complex model structures 








splines of age 
Natural cubic 




splines of age 
Natural cubic 




splines of age 
Natural cubic 




Random quadratic - common 
variance structure 
Natural cubic 
splines of age 
Natural cubic 





Random quadratic - variance 




splines of age 
Natural cubic 







5.3.3.2.5 Model adequacy 
The favoured model was chosen based on the results of the assessment of the optimal 
structure and results of model adequacy tools. Model adequacy was investigated for 
each model of Table 5.1 that reached convergence in less than 500 iterations following 
guidance in the literature (Lennon et al, 2018). First, the number and proportion of 
women in each of the classes was described. In keeping with recommendations by 
Lennon et al (2018), models were regarded acceptable if at least 1% of the sample was 
allocated to each of the classes to ensure clinical plausibility and meaningfulness of 
the groups. Second, the average of the posterior probability of assignment (APPA) 
was estimated for each of the classes. For this measure the posterior probability of 
belonging to each of the classes was estimated for all women. Women were allocated 
to the class with the highest individual posterior class membership probability. The 
APPA is the average of all posterior class membership probabilities of women 
allocated to that class (Lennon et al, 2018). In keeping with Lennon et al (2018), a 
threshold of above 70% for all classes was regarded as acceptable. If this threshold 
was not reached, the average posterior probabilities of belonging to any of the other 
classes were investigated. Third, relative entropy was estimated as a measure of 




higher values indicating less classification uncertainty. In keeping with 
recommendations by Lennon et al (2018), relative entropy values greater than 0.5 
were considered acceptable. 
5.3.3.2.6 Clinical characterisation and plausibility 
The clinical characterisation and plausibility of the trajectory groups was assessed. 
First, the mean predicted trajectories of depressive symptoms over time and 95% 
prediction intervals were plotted for each identified class of the favoured model. 
Second, spaghetti plots of individual depressive symptom trajectories of 100 
randomly selected women allocated to each of the classes were plotted. Third, the 
extent to which the trajectory groups are distinguishable in terms of pre-existing 
characteristics and characteristics at the end of follow-up. For this purpose, 
participant characteristics at baseline (study phase 2) and end of follow-up (study 
phase 7) were investigated separately for each of the trajectory groups among women 
that had measures at both time points. To test for between-group differences chi-
squared tests with continuity correction were used for categorical variables, and t-
tests were used for normally distributed continuous variables (Yoshida et al, 2019). 
For non-normally distributed continuous variables, Kruskal-Wallis tests were used 
(Yoshida et al, 2019). 
5.3.3.3 Class-specific trajectories of BMI 
Among participants with at least one measure of BMI, the class-specific mean 
predicted trajectory of BMI was modelled. Using the Wald test, I investigated whether 
class membership was associated with different patterns of change of BMI over time. 
A two-sided p-value of <0.05 was considered statistically significant.  
5.3.3.4 Sensitivity analysis 
First, since some existing studies have excluded participants with less than two 
assessments of depressive symptoms throughout follow-up (Leigh et al, 2016; Nabi 
et al, 2008; Tran et al, 2019), the analysis was repeated after exclusion of 1,352 women 
with only one assessment of depressive symptoms. Second, to meaningfully interpret 




depressive symptom scale has to measure a single construct (unidimensionality) and 
has to measure that construct the same way across time (measurement invariance) 
(Fried et al, 2016; van de Schoot et al, 2017). It has been shown that these assumptions 
might not hold for depressive symptom rating scales (Fried et al, 2016). To overcome 
this problem, investigating specific depressive symptoms instead of investigating a 
sum score of multiple depressive symptoms has been recommended (Fried & Nesse, 
2015b). Therefore, the analysis was repeated using individual items of the CES-D 
scale. Due to time restrictions I decided to choose two out of the ten CES-D items for 
this analysis, as follows: “I felt depressed” and “I felt hopeful about the future”. These 
items were chosen because they have been shown to be among the specific symptoms 
of depression most commonly captured by depressive symptom scales (Fried, 2017a). 
“I felt hopeful about the future” is a positive mood item on the CES-D which was 
reversed for the analysis. 
5.4 Results 
5.4.1 Study population 
Out of 14,247 participants, 11,804 women were included in the analysis. Reasons for 
exclusion were participation only in study phase 1, withdrawal date earlier than date 
of participation, no depressive symptom measure in any of the study phases, and 
completion of the short survey at study phase 2 (Figure 5.1). 
  
Figure 5.1: Flow chart of Australian Longitudinal Study on Women’s Health participants included in 
analyses 
 
There were statistically significant differences between included and excluded 




of heart disease (Appendix Table A 35). The proportion of women with a university 
degree was lower and the proportion of women who reported that it was difficult to 
manage on their income was higher among women excluded from the analysis. 
Furthermore, those excluded were more likely to report that they were married or 
separated/ divorced/ widowed, current smokers, and to have risky alcohol intake, 
hypertension or diabetes than participants who were included in the analysis. The 
mean BMI was slightly lower among those excluded than among those included in 
the analysis; however, this might have been driven by the higher proportion of 
women with underweight among those excluded from the analysis. Although there 
were statistically significant age differences, the difference in the median was small. 
5.4.2 Descriptive statistics 
Out of 11,804 eligible women, 9,560 (81.0%) participated at study phase 2 (hereafter 
referred to as baseline) and 7,149 (60.6%) participated at study phase 7 (hereafter 
referred to as end of follow-up). At baseline, the median (IQR) age of women was 24.6 
(23.3, 25.8) years and 45.0% were married. Over half of the women lived in 
metropolitan areas (54.7%), 39.0% had a university degree, and 50.9% reported it was 
easy/ not too bad to manage on their income. The proportions of women with a 
university degree; who were married; found it easy/ not too bad to manage on their 
income; had risky/ high risk alcohol intake; sedentary physical activity levels; and 
who were overweight or obese increased over time. In contrast, the proportion of 
current smokers decreased over time. The proportion of women with diabetes and 
heart disease remained low throughout follow-up (3.0% and 1.0% at the end of 
follow-up, respectively). Whilst 251 (2.6%) women reported hypertension at baseline, 
































Marital status (%) 
   Married/ de-facto 4,301 (45.0) 5,519 (61.2) 6,550 (72.0) 6,283 (77.1) 6,195 (77.8) 5,406 (75.6) 
   Separated/ divorced/    
   widowed 
144 (1.5) 334 (3.7) 408 (4.5) 446 (5.5) 577 (7.2) 568 (7.9) 
   Single 5,071 (53.0) 3,133 (34.7) 2,095 (23.0) 1,394 (17.1) 1,098 (13.8) 813 (11.4) 
   Missing value 44 (0.5) 36 (0.4) 39 (0.4) 29 (0.4) 95 (1.2) 362 (5.1) 
Lives alone (%) 
   No 8,774 (91.8) 8,310 (92.1) 8,304 (91.3) 7,463 (91.5) 7,273 (91.3) 6,326 (88.5) 
   Yes 586 (6.1) 678 (7.5) 767 (8.4) 678 (8.3) 605 (7.6) 462 (6.5) 
   Missing value 200 (2.1) 34 (0.4) 21 (0.2) 11 (0.1) 87 (1.1) 361 (5.0) 
Area of residence (%) 
   Metropolitan 5,225 (54.7) 5,200 (57.6) 5,380 (59.2) 4,756 (58.3) 4,622 (58.0) 4,053 (56.7) 
   Rural 3,931 (41.1) 3,484 (38.6) 3,215 (35.4) 2,905 (35.6) 2,847 (35.7) 2,418 (33.8) 
   Remote 363 (3.8) 335 (3.7) 381 (4.2) 303 (3.7) 278 (3.5) 197 (2.8) 
   Missing value 41 (0.4) 3 (0.0) 116 (1.3) 188 (2.3) 218 (2.7) 481 (6.7) 
University degree (%) 
   No 5,484 (57.4) 4,906 (54.4) 4,791 (52.7) 3,834 (47.0) 3,579 (44.9) 2,899 (40.6) 
   Yes 3,733 (39.0) 3,906 (43.3) 4,268 (46.9) 4,144 (50.8) 4,243 (53.3) 3,870 (54.1) 
   Missing value 343 (3.6) 210 (2.3) 33 (0.4) 174 (2.1) 143 (1.8) 380 (5.3) 
Ability to manage on income (%) 
   Difficult/ impossible 1,603 (16.8) 1,074 (11.9) 1,141 (12.5) 992 (12.2) 1,038 (13.0) 982 (13.7) 
   Difficult some of the  
   time 
3,063 (32.0) 2,706 (30.0) 2,630 (28.9) 2,282 (28.0) 2,426 (30.5) 1,880 (26.3) 
   Easy/ not too bad 4,864 (50.9) 5,196 (57.6) 5,280 (58.1) 4,843 (59.4) 4,405 (55.3) 3,924 (54.9) 
   Missing value 30 (0.3) 46 (0.5) 41 (0.5) 35 (0.4) 96 (1.2) 363 (5.1) 
Alcohol intake (%) 
   Low risk 5,542 (58.0) 5,491 (60.9) 5,440 (59.8) 4,810 (59.0) 4,596 (57.7) 4,061 (56.8) 
   Non/ rarely 3,597 (37.6) 3,168 (35.1) 3,267 (35.9) 2,948 (36.2) 2,935 (36.8) 2,405 (33.6) 
   Risky/ high risk 359 (3.8) 327 (3.6) 340 (3.7) 361 (4.4) 363 (4.6) 464 (6.5) 
   Missing value 62 (0.6) 36 (0.4) 45 (0.5) 33 (0.4) 71 (0.9) 219 (3.1) 
Smoking status (%) 
   Never-smoker 5,443 (56.9) 5,139 (57.0) 5,254 (57.8) 4,852 (59.5) 4,828 (60.6) 4,270 (59.7) 
   Ex-smoker 1,376 (14.4) 1,664 (18.4) 2,008 (22.1) 2,092 (25.7) 2,157 (27.1) 1,932 (27.0) 
   Current smoker 2,664 (27.9) 2,187 (24.2) 1,784 (19.6) 1,190 (14.6) 923 (11.6) 720 (10.1) 
   Missing value 77 (0.8) 32 (0.4) 46 (0.5) 18 (0.2) 57 (0.7) 227 (3.2) 
Physical activity (%) 
   Nil/ sedentary 934 (9.8) 815 (9.0) 1,022 (11.2) 1,121 (13.8) 1,202 (15.1) 1,079 (15.1) 
   Low 3,057 (32.0) 2,919 (32.4) 3,130 (34.4) 2,913 (35.7) 2,687 (33.7) 1,911 (26.7) 
   Moderate 2,221 (23.2) 2,104 (23.3) 2,103 (23.1) 1,777 (21.8) 1,698 (21.3) 1,447 (20.2) 
   High 3,305 (34.6) 3,118 (34.6) 2,707 (29.8) 2,217 (27.2) 2,165 (27.2) 2,176 (30.4) 


















Body mass index (kg/m2) 
(mean (SD)) 
24.0 (5.0) 24.8 (5.5) 25.4 (5.9) 26.0 (6.0) 26.4 (6.3) 27.0 (6.6) 
Body mass index (WHO groups) (%) 
   Underweight 569 (6.0) 366 (4.1) 312 (3.4) 210 (2.6) 191 (2.4) 123 (1.7) 
   Acceptable weight 5,465 (57.2) 4,673 (51.8) 4,840 (53.2) 4,121 (50.6) 3,795 (47.6) 3,094 (43.3) 
   Overweight 1,743 (18.2) 1,791 (19.9) 2,143 (23.6) 2,051 (25.2) 2,025 (25.4) 1,875 (26.2) 
   Obese 969 (10.1) 1,223 (13.6) 1,581 (17.4) 1,629 (20.0) 1,798 (22.6) 1,790 (25.0) 
   Missing value 814 (8.5) 969 (10.7) 216 (2.4) 141 (1.7) 156 (2.0) 267 (3.7) 
Depressive symptom 













Depressive symptoms (binary) (%) 
   No 6,526 (68.3) 6,565 (72.8) 6,904 (75.9) 6,253 (76.7) 6,251 (78.5) 5,191 (72.6) 
   Yes 2,803 (29.3) 2,311 (25.6) 2,064 (22.7) 1,773 (21.7) 1,594 (20.0) 1,652 (23.1) 
   Missing value 231 (2.4) 146 (1.6) 124 (1.4) 126 (1.5) 120 (1.5) 306 (4.3) 
Diabetes (%) 
   No 9,429 (98.6) 8,914 (98.8) 8,924 (98.2) 7,968 (97.7) 7,754 (97.4) 6,935 (97.0) 
   Yes 29 (0.3) 77 (0.9) 117 (1.3) 160 (2.0) 206 (2.6) 214 (3.0) 
   Missing value 102 (1.1) 31 (0.3) 51 (0.6) 24 (0.3) 5 (0.1) 0 (0.0) 
Heart disease (%) 
   No 9,444 (98.8) 8,962 (99.3) 8,996 (98.9) 8,087 (99.2) 7,895 (99.1) 7,080 (99.0) 
   Yes 14 (0.1) 29 (0.3) 45 (0.5) 41 (0.5) 65 (0.8) 69 (1.0) 
   Missing value 102 (1.1) 31 (0.3) 51 (0.6) 24 (0.3) 5 (0.1) 0 (0.0) 
Hypertension (%) 
   No 9,207 (96.3) 8,658 (96.0) 8,638 (95.0) 7,566 (92.8) 7,289 (91.5) 6,439 (90.1) 
   Yes 251 (2.6) 333 (3.7) 403 (4.4) 562 (6.9) 671 (8.4) 710 (9.9) 
   Missing value 102 (1.1) 31 (0.3) 51 (0.6) 24 (0.3) 5 (0.1) 0 (0.0) 
* Data are given as n (%) unless specified 
 
Using the binary depressive symptoms variable, the proportion of women with 
depressive symptoms was 29.3% at baseline and 23.1% at the end of follow-up (Table 
5.2). There were 666 unique depressive symptom response patterns over time, with 
the 20 most common patterns presented in Table 5.3. The most common pattern was 
that women did not report depressive symptoms at any study phase (1,892 women, 
16.0%). The 18th most common pattern was that women reported depressive 





Table 5.3: The 20 most common depressive symptom response patterns using the binary depressive 
symptom variable 
Ranking 2nd wave 3rd wave 4th wave 5th wave 6th wave 7th wave Count 
1 No No No No No No 1892 
2 No Missing Missing Missing Missing Missing 460 
3 No No No No No Missing 291 
4 Yes Missing Missing Missing Missing Missing 282 
5 Yes No No No No No 256 
6 Missing No No No No No 252 
7 No No No Missing Missing Missing 248 
8 No No Missing Missing Missing Missing 211 
9 No No No No No Yes 165 
10 No Yes No No No No 165 
11 Missing No Missing Missing Missing Missing 161 
12 No No No No Missing Missing 158 
13 No Missing No No No No 148 
14 Missing Missing No Missing Missing Missing 128 
15 No No No Missing No No 125 
16 No No No Yes No No 120 
17 No No Yes No No No 109 
18 Yes Yes Yes Yes Yes Yes 109 
19 No Missing No Missing Missing Missing 99 
20 Yes Yes Missing Missing Missing Missing 93 
 
There was variation between depressive symptom scores reported by the same 
woman over time as well as variation between women (Figure 5.2). Throughout 
follow-up the majority of women reported depressive symptom scores below ten. 
There were more depressive symptom scores above ten among women aged 20 to 30 
years than among women over 30 years. However, it should be noted that some of 
these higher scores were reported by women with one only measure of depressive 
symptoms which might indicate that women with higher depressive symptom scores 





Figure 5.2: Depressive symptom trajectories of 250 randomly selected women as a function of age 
 
5.4.3 Identifying subgroups of women with similar depressive symptom 
trajectories 
5.4.3.1 Link function 
In the first step, five models with different link functions were fitted to identify the 
link function that provided the best model fit. The approximation of the linear link 
function was relatively far from the approximation of the non-linear link functions. 
In contrast, the approximations of the non-linear link functions were all close 
indicating that they might be good alternatives to each other (Figure 5.3). The model 
with a thresholds link function had the lowest discrete AIC (Table 5.4). The difference 
in discrete AIC values (Δ AIC) was greatest between the model using the thresholds 
link function and the linear link function (Δ AIC: 12,014), and smallest between the 
model using the thresholds link function and the I-splines link function with five 
equidistant knots (Δ AIC: 251). Proust-Lima et al (2011) recommend choosing the 
optimal link function based on the lowest discrete AIC but the estimation of the model 
using the thresholds link function was computationally intensive. For example, the 
computation of a two-class model took more than 24 hours. Since the difference 
between the approximations of all non-linear models were small, I decided to select 




Figure 5.3: Estimated link functions of 
depressive symptoms (CES-D, range 0 to 
30) in latent process mixed models 
Table 5.4: Model fit of five latent process mixed models 










Linear 13 9 286,272 12,014 
Beta 9 11 274,607 349 
Splines (5 
equidistant) 
26 14 274,509 251 
Splines (5 at 
quantiles) 
17 14 274,553 296 
Thresholds 15 37 274,257 --- 
* Difference in AIC between model using thresholds link 
function and models using other link functions 
 
  
5.4.3.2 Number of groups 
In the second step, the optimal number of groups was determined with the link 
function selected as I-splines with five equidistant knots. The lowest discrete AIC was 
observed in a model with five classes (Table 5.5); however, three of these classes 
contained less than 1% of the sample and the predicted mean trajectories of these 
groups largely overlapped (Appendix Figure A 1). The second lowest discrete AIC 
value was observed in a model with four groups. Again, two of the classes contained 
less than 1% of the sample and the predicted mean trajectories of the groups largely 
overlapped. The model with three groups had the third lowest discrete AIC value 
and lowest BIC value and whilst one of the groups was small, based on existing 
literature the small proportion of women with fluctuating depressive symptoms over 
time was considered plausible and potentially clinically relevant. Balancing the 
results of criteria reflecting clinical relevance/ usefulness and statistical criteria, the 
optimal number of classes was determined as three.  






















1 26 -138,030 14 274,509 276,191 100.0     
2 36 -137,972 20 274,437 276,132 27.4 72.6    
3 330 -137,940 26 274,392 276,125 71.1 28.1 0.7   
4 220 -137,891 32 274,312 276,083 0.9 0.7 70.9 27.6  
5 214 -137,859 38 274,263 276,075 0.2 70.3 0.7 0.9 27.9 
6 Model did not reach convergence in 500 iterations 




5.4.3.3 Model structure 
With the link function selected as I-splines with five equidistant knots and the 
number of groups selected as three, five models with increasingly complex model 
structures were fitted (Table 5.6). Four of the five models reached convergence in less 
than 500 iterations. The model with quadratic random effects that allowed the 
variance-covariance structure of random effects to vary across classes with a 
proportionality constraint failed to reach convergence. The model with random 
quadratic effects and a common variance structure of random effects across classed 
yielded the lowest discrete AIC; however, the discrete AIC values of all random effect 
models were close to each other. The model with no random effect was the model 
with the highest discrete AIC. 









probability of assignment 
per class (%) 
Relative 
entropy 
Fixed effect 275,768 277,317 51:22:28 80:84:86 0.64 
Random intercept 274,455 276,178 5:22:73 61:65:74 0.39 
Random slope 274,392 276,125 71:28:1 80:71:59 0.52 
Random quadratic (common 
var-cov* matrix across classes) 
274,369 276,109 1:30:69 62:72:80 0.52 
Random quadratic (var-cov* 
matrix with proportionality 
constraint) 
Model did not reach convergence in 500 iterations 
*var-cov: variance- covariance 
 
5.4.3.4 Model adequacy 
Model adequacy was assessed for all models of Table 5.6 that reached convergence. 
The proportion of women allocated to each of the classes was at least 1% in all of the 
models. The largest groups were made up of about 70% of all women in the random 
intercept, random slope and random quadratic model with a common variance-
covariance structure across classes and of about 50% in the fixed effects model. The 
average posterior probability of assignment per class is recommended to be above 
70% for each of the classes. This recommendation was met for the fixed effect model. 




models nor was it met for two classes of the random intercept model. Using the model 
with the lowest discrete AIC as an example, the posterior classification table of the 
random quadratic model indicated that women allocated to the first class of the model 
had an average posterior probability of 62% of belonging to that class, an average 
posterior probability of 17% of belonging to the second class, and an average posterior 
probability of 20% of belonging to the third class. Women allocated to the second class 
of the model had an average posterior probability of 72% of belonging to that class, 
an average posterior probability of 3% of belonging to the first class, and an average 
posterior probability of 25% of belonging to the third class. Women allocated to the 
third class had an average posterior probability of 80% of belonging to that class, an 
average posterior probability of 3% of belonging to the first class, and an average 
posterior probability of 18% of belonging to the second class. The relative entropy 
values of the models ranged from 0.39 to 0.64, with the fixed effects model reaching 
the highest relative entropy value. Whilst the fixed effects, random slope, and random 
quadratic model with a common variance-covariance structure across classes met the 
recommended relative entropy value of at least 0.5, the relative entropy value of the 
random intercept model was below that threshold.  
The favoured model was chosen balancing results of model adequacy tools and the 
assessment of the optimal structure. The fixed effect model was the only model that 
met all criteria of the model adequacy tools but was also the model with the highest 
discrete AIC value. The random quadratic model with a common variance-covariance 
structure across classes provided the lowest discrete AIC value; however, one of the 
classes had an APPA value below 70%. The optimal model was chosen to be the 
random quadratic model that had a common variance-covariance structure across 
classes because it met all other recommended model adequacy criteria and the 
posterior classification table of the model indicated that women allocated to the class 
with an APPA below 70% had a posterior probability of only 17% and 20% of 




5.4.4 Clinical characterisation and plausibility of identified depressive 
symptom trajectories 
5.4.4.1 Graphical presentation of trajectories 
The favoured model identified three groups with different patterns of depressive 
symptom over time (Figure 5.4). Most women were allocated to a class with stable 
low depressive symptoms (n = 8,118, 68.8%), followed by the class with stable 
moderate depressive symptoms (n = 3,558, 30.1%), and the class with fluctuating 
depressive symptoms (n = 128, 1.1%). 
 
Figure 5.4: Class-specific mean predicted depressive symptoms trajectories and 95% prediction intervals  
 
Whilst depressive symptom scores of women allocated to the stable low class were 
generally lower than the scores of women allocated to the stable moderate class, as 
expected there was some overlap in depressive symptom scores of these classes 
(Figure 5.5). Furthermore, there was variation between individuals allocated to the 
same class. The individual depressive symptom trajectories of those allocated to the 
fluctuating depressive symptoms class closely approximated the mean predicted 





Figure 5.5: Depressive symptom trajectories of 100 randomly selected women of each of the three 
identified latent classes 
 
5.4.4.2 Profiles of key cardiovascular risk factors among women with different 
depressive symptom trajectories 
5.4.4.2.1 Sociodemographic characteristics and health behaviours 
Using data from the subgroup of women that participated at baseline and end of 
follow-up (n = 7,149, 60.6%), there were statistically significant differences between 
groups in all sociodemographic characteristics and health behaviours except for area 
of residence (Table 5.7, Table 5.8). At baseline, women with stable low depressive 
symptoms were less likely to be separated, divorced or widowed, to live alone, and 
found it easier to manage on their income. Furthermore, the proportion of current 
smokers, risky/ high risk alcohol intake, and nil/ sedentary or low physical activity 
levels was lowest among this group. Women with stable moderate depressive 
symptoms reported lower educational attainment and found it harder to manage on 
their income than women allocated to the other two groups. Whilst women with 
stable moderate depressive symptoms reported higher smoking prevalence than 
women with fluctuating depressive symptoms, differences between these two groups 
were small with regard to risky/ high risk alcohol intake. The proportion of women 
with nil/ sedentary or low physical activity levels was highest among those with 




Table 5.7: Baseline characteristics, separately for women with stable low, stable moderate and 
fluctuating depressive symptoms over time*
 
Stable low 




(n = 100) 
p 
Age (median [IQR]) 24.6 [23.3, 25.8] 24.6 [23.4, 25.8] 24.1 [22.8, 25.3] 0.023 
Marital status (%) 0.001 
   Married/ de-facto 1,880 (44.2) 747 (43.9) 46 (46.0)  
   Separated/ divorced/   
   widowed 
36 (0.8) 36 (2.1) 1 (1.0)  
   Single 2,327 (54.7) 911 (53.6) 51 (51.0)  
Lives alone (%) 269 (6.3) 135 (7.9) 7 (7.0) 0.277 
Area of residence (%) 0.859 
   Metropolitan 2,414 (56.7) 978 (57.5) 63 (63.0)  
   Rural 1,675 (39.3) 659 (38.7) 35 (35.0)  
   Remote 150 (3.5) 56 (3.3) 2 (2.0)  
University degree (%) 2,131 (50.0) 627 (36.9) 44 (44.0) <0.001 
Ability to manage on income (%) <0.001 
   Difficult/ impossible 540 (12.7) 388 (22.8) 14 (14.0)  
   Difficult some of the time 1,266 (29.7) 586 (34.5) 33 (33.0)  
   Easy/ not too bad 2,438 (57.3) 721 (42.4) 53 (53.0)  
Alcohol intake (%) <0.001 
   Low risk 2,736 (64.3) 933 (54.9) 59 (59.0)  
   Non/ rarely 1,377 (32.3) 661 (38.9) 35 (35.0)  
   Risky/ high risk 126 (3.0) 92 (5.4) 6 (6.0)  
Smoking status (%) <0.001 
   Never-smoker 2,707 (63.6) 900 (52.9) 53 (53.0)  
   Ex-smoker 560 (13.2) 264 (15.5) 20 (20.0)  
   Current smoker 964 (22.6) 521 (30.6) 26 (26.0)  
Physical activity (%) <0.001 
   Nil/ sedentary 319 (7.5) 190 (11.2) 10 (10.0)  
   Low 1,280 (30.1) 566 (33.3) 41 (41.0)  
   Moderate 1,043 (24.5) 412 (24.2) 16 (16.0)  
   High 1,603 (37.6) 530 (31.2) 33 (33.0)  
* Data are given as n (%) unless specified; IQR: interquartile range 
 
In keeping with differences observed at baseline, the proportion of women who had 
a university degree and reported that it was easy/ not too bad to manage on their 
income was highest and the proportion of women who were separated, divorced, or 
widowed was lowest among those with stable low depressive symptoms (Table 5.8). 
Furthermore, the proportion of women with a university degree and who found it 
easy/ not too bad to manage on their income was lowest among those with stable 




women with stable low depressive symptoms at the end of follow-up. The proportion 
of women who were current smokers and physically less active was highest among 
those with stable moderate depressive symptoms. Risky/ high risk alcohol intake was 
most prevalent among those with fluctuating depressive symptoms.  
Table 5.8: Participant characteristics at study phase 7, separately for women with stable low, stable 
moderate, and fluctuating depressive symptoms over time* 
 Stable low 
(n = 4,285) 
Stable moderate 
(n = 1,701) 
Fluctuating 
(n = 100) 
p 
Age (median [IQR]) 39.6 [38.4, 40.9] 39.7 [38.5, 40.9] 39.2 [38.0, 40.3] 0.012 
Marital status (%) <0.001 
   Married/ de-facto 3,432 (80.6) 1,101 (64.7) 70 (70.0)  
   Separated/ divorced/   
   widowed 
263 (6.2) 195 (11.5) 12 (12.0)  
   Single 381 (8.9) 301 (17.7) 11 (11.0)  
Lives alone (%) 223 (5.2) 161 (9.5) 9 (9.0) <0.001 
Area of residence (%) 0.828 
   Metropolitan 2,410 (56.6) 947 (55.7) 59 (59.0)  
   Rural 1,465 (34.4) 586 (34.5) 32 (32.0)  
   Remote 125 (2.9) 49 (2.9) 4 (4.0)  
University degree (%) 2,506 (58.9) 756 (44.4) 55 (55.0) <0.001 
Ability to manage on income (%) <0.001 
   Difficult/ impossible 388 (9.1) 421 (24.8) 15 (15.0)  
   Difficult some of the time 1,040 (24.4) 530 (31.2) 28 (28.0)  
   Easy/ not too bad 2,649 (62.2) 645 (37.9) 50 (50.0)  
Alcohol intake (%) <0.001 
   Low risk 2,584 (60.7) 816 (48.0) 44 (44.0)  
   Non/ rarely 1,342 (31.5) 682 (40.1) 40 (40.0)  
   Risky/ high risk 225 (5.3) 139 (8.2) 14 (14.0)  
Smoking status (%) <0.001 
   Never-smoker 2,773 (65.1) 907 (53.3) 52 (52.0)  
   Ex-smoker 1,057 (24.8) 484 (28.5) 33 (33.0)  
   Current smoker 322 (7.6) 239 (14.1) 13 (13.0)  
Physical activity (%) <0.001 
   Nil/ sedentary 542 (12.7) 360 (21.2) 15 (15.0)  
   Low 1,132 (26.6) 478 (28.1) 28 (28.0)  
   Moderate 911 (21.4) 312 (18.3) 11 (11.0)  
   High 1,400 (32.9) 401 (23.6) 37 (37.0)  






Within each identified depressive symptom subgroups, the characteristics of women 
differed between baseline and end of follow-up. Among all groups the proportion of 
women who were separated, divorced or widowed; lived alone; with a university 
degree; and with risky/ high risk alcohol intake was higher at the end of follow-up 
than at baseline. In contrast, among all groups the proportion of current smokers was 
smaller at the end of follow-up. The proportion of women who reported that it was 
easy/ not too bad to manage on their income increased among those with stable low 
depressive symptoms whereas it decreased among those with stable moderate or 
fluctuating depressive symptoms from baseline to the end of follow-up. Whilst the 
proportion of women who report high physical activity increased among women 
with fluctuating depressive symptoms, it decreased among women with stable low 
and stable moderate depressive symptoms.  
5.4.4.2.2 Body mass index 
There were statistically significant differences between the three groups with regard 
to body mass index. Both at baseline and end of follow-up the proportion of women 
with overweight or obesity was lowest among the group with stable low depressive 
symptoms and highest among the group with stable moderate depressive symptoms 
(Table 5.9, Table 5.10). Among all groups, the mean BMI was higher and the 
proportion of women with overweight or obesity was greater at the end of follow-up 
than at baseline. 
Table 5.9: Body mass index of women with stable low, stable moderate and fluctuating depressive 
symptoms at baseline* 
 
Stable low 
(n = 4,285) 
Stable moderate 
(n = 1,701) 
Fluctuating 
(n = 100) 
p 
Body mass index (kg/m2) 
(mean (SD)) 
23.4 (4.4) 24.8 (5.7) 24.0 (4.8) <0.001 
BMI (WHO groups) (%) <0.001 
   Underweight 257 (6.0) 101 (5.9) 6 (6.0)  
   Acceptable weight 2,683 (63.0) 884 (52.0) 65 (65.0)  
   Overweight 745 (17.5) 357 (21.0) 13 (13.0)  
   Obese 340 (8.0) 251 (14.8) 11 (11.0)  





Table 5.10: Body mass index of women with stable low, stable moderate and fluctuating depressive 
symptoms at the end of follow-up* 
 
Stable low 
(n = 4,285) 
Stable moderate 
(n = 1,701) 
Fluctuating 
(n = 100) 
p 
Body mass index (kg/m2) 
(mean (SD)) 
26.3 (5.9) 28.9 (7.6) 28.1 (7.3) <0.001 
BMI (WHO groups) (%) <0.001 
   Underweight 67 (1.6) 33 (1.9) 0 (0.0)  
   Acceptable weight 2,025 (47.6) 561 (33.0) 39 (39.0)  
   Overweight 1,127 (26.5) 431 (25.3) 31 (31.0)  
   Obese 915 (21.5) 605 (35.6) 26 (26.0)  
* Data are given as n (%) unless specified; SD: standard deviation 
 
Among 11,355 women with at least one measure of BMI, there were differences in 
BMI trajectories among those with stable low, stable moderate, and fluctuating 
depressive symptoms (Figure 5.6). The mean BMI was consistently lower among 
women with stable low depressive symptoms but differences between groups were 
small at the age of 20 years. From the age of 20 to 40 years, the mean BMI increased 
among all depressive symptom groups. The change of BMI over time was 
significantly different between classes (Wald: 226.1, p < 0.0001). Whilst changes of 
BMI over time were similar for women with stable moderate and fluctuating 
depressive symptoms, the increase in mean BMI was less marked among those with 
stable low depressive symptoms. CIs were wide among those with fluctuating 
depressive symptoms. 
 
Figure 5.6: Class-specific mean predicted trajectory of body mass index for hypothetical woman with 





5.4.4.2.3 Medical conditions 
Among the subgroup of women that participated at baseline and end of follow-up (n 
= 7,149, 60.6%), the proportions of women with heart disease, diabetes, and 
hypertension were small among all of the groups (Table 5.11). There were no 
statistically significant differences between groups with regard to hypertension, 
diabetes and heart disease at baseline whereas there were statistically significant 
differences at the end of follow-up (Table 5.11). At the end of follow-up hypertension 
was most prevalent among those with fluctuating depressive symptoms and lowest 
among those with stable low depressive symptoms. The proportion of women with 
diabetes and heart disease was highest among those with stable moderate depressive 
symptoms. However, this should be interpreted with caution due to the small number 
of events, especially in the group with fluctuating depressive symptoms.  
Table 5.11: Numbers and proportion of women with hypertension, diabetes, and heart disease, 
separately for those with stable low, stable moderate, and fluctuating depressive symptoms over time* 
 
Stable low 
(n = 4,285) 
Stable moderate 
(n = 1,701) 
Fluctuating 
(n = 100) 
p 
 
 Baseline characteristics  
Hypertension (%) 94 (2.2) 59 (3.5) 2 (2.0) 0.064 
Diabetes (%) 9 (0.2) 6 (0.4) 0 (0.0) 0.691 
Heart disease (%) 2 (0.0) 4 (0.2) 0 (0.0) 0.244 
 
 Characteristics at end of follow-up  
Hypertension (%) 372 (8.7) 240 (14.1) 15 (15.0) <0.001 
Diabetes (%) 108 (2.5) 72 (4.2) 1 (1.0) 0.001 
Heart disease (%) 29 (0.7) 27 (1.6) 0 (0.0) 0.003 
* Data are given as n (%) unless specified 
 
The results were similar when the proportion of women with hypertension, diabetes, 
and heart disease was compared among women that were diagnosed with medical 




5.4.5 Sensitivity analyses 
5.4.5.1 Restriction of analysis to women with at least two measures of 
depressive symptoms 
When the analysis was restricted to 10,452 women with at least two measures of 
depressive symptoms, the favoured model was a random slope model with three 
latent classes. The depressive symptom trajectories of each of these classes were very 
similar to those identified in the main analysis (Figure 5.7). Of note, the four and five 
class models resulted in lower discrete AIC values than the three class model; 
however, these models resulted in one and two classes with less than 1% of all women 
allocated to the classes, respectively (Appendix Table A 37). Furthermore, the mean 
predicted trajectories of some classes largely overlapped (Appendix Figure A 2). As 
a result, three classes were chosen as preferred number of classes. 
 
Figure 5.7: Mean predicted depressive symptoms trajectories of three latent classes in analyses 
restricted to women with at least two assessments of depressive symptoms 
 
5.4.5.2 Unique CES-D items 
5.4.5.2.1 Item: I felt depressed 
Following the same steps as reported above, the favoured model to describe 
trajectories of the CES-D item “I felt depressed” was identified. Using the unique item 
“I felt depressed” as dependent variable, the favoured model was identified as a 
random slope model with one latent class (Figure 5.8). The predicted mean score of 
the item “I felt depressed” was low at the age of 20 years, and the mean predicted 
trajectory declined very slightly over time from 20 to 35 years of age. Although the 




symptom trajectories of the one and two class solution looked very similar to those of 
the main analysis (Appendix Figure A 3). The three and four class solution did not 
reach convergence in 500 iterations (Appendix Table A 38).  
 
Figure 5.8: Mean predicted trajectory of unique CES-D item "I felt depressed" 
 
5.4.5.2.2 Item: I felt hopeful about the future 
The favoured model to describe trajectories of the CES-D item “I felt hopeful” was 
identified as random quadratic model with one latent class (Figure 5.9). Similar to the 
trajectory of scores of the item “I felt depressed”, the mean predicted score of “I felt 
hopeful about the future” was low at 20 years of age and declined very slightly over 
time. Again, the three and four class solution did not reach convergence (Appendix 
Table A 39), and the one and two class solutions were similar to those observed in the 
main analysis (Appendix Figure A 4). 
 






5.5.1 Summary of main findings 
Among Australian women three subgroups of women with distinct depressive 
symptom trajectories were identified using group-based trajectory modelling. From 
the age of 20 to 40 years the majority of women had stable low depressive symptoms 
but there was a considerable proportion of women with stable moderate depressive 
symptoms and a small number of women with fluctuating depressive symptoms.  
There were differences between women with different patterns of depressive 
symptoms as well as differences between baseline and end of follow-up with regard 
to sociodemographic characteristics, health behaviours and proportions of women 
with medical conditions. At baseline and end of follow-up women with stable 
moderate or fluctuating depressive symptoms had lower educational attainment, 
found it harder to manage on their income, reported more adverse health behaviours, 
and had more medical conditions than women with stable low depressive symptoms. 
Among all groups, the proportion of current smokers decreased and proportion of 
women with risky/ high risk alcohol intake increased from baseline to the end of 
follow-up. There were differences in the patterns with regard to ability to manage on 
income and physical activity levels. Although the proportion of women with a 
university degree increased among all groups, the proportion of women who found 
it easy/ not too bad to manage on their income decreased among those with stable 
moderate and fluctuating depressive symptoms whereas it increased among those 
with stable low depressive symptoms. Furthermore, the proportion of women with 
high physical activity levels increased among women with fluctuating depressive 
symptoms but decreased among the other two groups between baseline and end of 
follow-up. Interestingly, the mean BMI of women with different patterns of 
depressive symptoms in young adulthood was similar at the age of 20 years. 
However, the patterns of change of BMI over time differed between women with 
stable low, stable moderate, and fluctuating depressive symptoms. Although the 
mean BMI of all groups increased over time, the increase was more gradual among 




considering that BMI is one of the potential mediators between depression and 
subsequent CVD (see sections 7.4 Implications for research and 7.5 Implications for 
practice for more detailed discussion). 
5.5.2 Strengths and limitations of this analysis 
5.5.2.1 Strengths 
This analysis has major strengths. First, it made use of repeat assessments of 
depressive symptoms using the CES-D rating scale, a well validated rating scale to 
assess depressive symptoms. The CES-D rating scale was validated against the 
revised Clinical Interview Schedule (CIS-R), a structured diagnostic interview for 
common mental disorders (Lewis et al, 1992), using a random sample of Whitehall II 
participants supplemented with Whitehall II participants with depression (Head et 
al, 2013). Sensitivity and specificity values for detecting any mental disorder were 
77% and 89%. Sensitivity and specificity for detecting depressive episode were 89% 
and 86% for the CES-D. Head et al (2013) concluded that the CES-D had good validity 
for detecting any mental disorder and depressive episodes. Furthermore, the 
shortened 10-item version of the CES-D that was used in this analysis was shown to 
have good validity and test-retest reliability (Carpenter et al, 1998; Furukawa et al, 
1997; Mohebbi et al, 2018). Existing studies often relied on a single measure of 
depressive symptoms, implicitly assuming that this measure approximates the 
participant’s exposure status throughout follow-up. In contrast to existing studies, 
this analysis did not assess the risk of CVD among those with and without depressive 
symptoms at one point in time. Instead, the trajectories of depressive symptoms over 
20 years of age were considered and profiles of key cardiovascular risk factors of 
women with similar depressive symptom trajectories were investigated. The 
identification of three groups with different patterns of depressive symptoms 
highlights the importance of using repeated measures of depressive symptoms, 
especially since there were differences in the profiles of key cardiovascular risk factors 




This is one of the first studies that investigated trajectories of BMI among women with 
different patterns of depressive symptoms over time. This analysis is of particular 
interest since BMI has been highlighted as the main potential confounding and/ or 
mediating factor in the relationship between depression and hypertension in an 
existing publication using the mid-aged cohort of the ALSWH (Jackson & Mishra, 
2013). It will be of interest to further investigate the relationship between depression 
or depressive symptoms, BMI, and CVD in future studies (see section 7.4 Implications 
for research for more detailed discussion). 
Further strengths of this analysis were that a framework to construct latent class 
trajectory models was followed, recommended model assessment tools were used to 
select the favoured model, and that all decisions were described transparently. This 
was particularly important since differences between existing studies using latent 
class trajectory modelling might have been due to different modelling assumptions 
rather than true differences between populations (Lennon et al, 2018). However, it 
should be noted that, although this analysis followed recommended steps of the 
framework to construct latent class trajectory models, the selection of the favoured 
model involved making a number of decisions that were largely subjective. For 
example, although the models with five and four number of groups had lower 
discrete AIC values than the model with three groups, the model with three groups 
was selected as the preferred model since it identified larger subgroups and showed 
non-overlapping depressive symptom trajectories. Other researchers might disagree 
with this decision. As a result, the favoured model of other researchers might have 
differed from the one identified in this analysis. However, all decisions were 
described transparently and an attempt was made to balance criteria of model fit and 
clinical usefulness. 
In contrast to existing studies, the model selection criterion that was chosen in this 
project allowed for specific properties of the depressive symptoms measure. As 
described previously (see section 5.3.3.2.2 Link function), the discrete AIC takes into 




quantitative outcome by using the discrete log-likelihood instead of the continuous 
log-likelihood. To the best of my knowledge, no discrete BIC has been described in 
the literature. In the context of latent class mixed modelling most studies have based 
their model selection on the BIC. Despite recommendations to use the BIC as model 
selection tool (Lennon et al, 2018; van de Schoot et al, 2017), I decided that taking into 
account specific properties of the depressive symptom measure outweighed the 
importance of a more general recommendation of an expert committee. A further 
model selection tool to choose the preferred number of classes is the Lo-Mendel-
Rubin-likelihood ratio test (Lo et al, 2001). This model selection tool is based on a 
hypothesis test. If p < 0.05, the model with fewer classes will be rejected in favour of 
a model with at least one more class. I decided not to use this model selection tool 
since van de Schoot et al (2017) reported that simulation studies suggested that the 
results may not be correct. Instead, I determined the optimal number of classes 
balancing the result of the chosen statistical tool (lowest discrete AIC) against criteria 
reflecting the clinical relevance and usefulness of the identified subgroups (e.g. group 
size). However, I acknowledge that there are several statistical criteria that could have 
been used to choose the preferred model and selecting the discrete AIC might have 
influenced the selection of the preferred model.  
5.5.2.2 Limitations 
5.5.2.2.1 Chance 
This analysis might be influenced by potential sources of error. A well-recognised 
disadvantage of group based trajectory modelling is the potential lack of statistical 
power due to differently sized subgroups and small numbers of individuals in each 
of the latent classes (Vistisen et al, 2014). Whilst the groups with stable low and stable 
moderate depressive symptoms were relatively large, the number of women with 
fluctuating depressive symptoms was small. As a result, there was limited power to 
detect statistically significant differences between this class and the other classes. 
Furthermore, the CIs of the mean predicted depressive symptom trajectory among 
those with fluctuating depressive symptoms were wide after the age of 37 years, 




in the mid to late thirties and a downward trend thereafter among women with 
fluctuating depressive symptoms. To the best of my knowledge, no other study has 
reported this pattern. This might be due to differences in model specifications, 
differences across samples, or differences across mental health measures. However, 
another explanation is that the apparent peak in the mid to late thirties and apparent 
downward trend in this sample was observed due to chance alone.  
The data requirements with regards to sample size and number of data points (see 
section 5.3.3.2.1 Latent process mixed modelling) were met in this analysis. 
Furthermore, the sample size of this analysis was bigger than 22 out of 25 existing 
studies that were identified in a systematic review of studies using group-based 
trajectory models (Musliner et al, 2016). Of the three studies with a similar or bigger 
sample size, one study was based on three data points (Costello et al, 2008), one study 
was based on five data points (Melchior et al, 2013), and one study was based on up 
to six data points (Liang et al, 2011). A comparison of the statistical power of this 
analysis with existing studies is complicated since statistical power is not only 
affected by the sample size and number of data points but also by the complexity of 
the model structure. Generally, there is a trade-off between statistical power and the 
complexity of the model structure. For example, the decision to select the model with 
three groups as preferred model had an impact on subsequent steps of the analysis. 
When five models with increasingly complex model structures were fitted, the model 
with quadratic random effects and a variance-covariance matrix that varied across 
classes with a proportionality constraint did not converge. This was likely driven by 
limited statistical power due to the small trajectory group of women with fluctuating 
depressive symptoms in combination with the complexity of the model structure. To 
investigate this further, I performed a post-hoc analysis in which I selected the 
preferred number of classes as two. I fitted models with increasingly complex model 
structures as described in Table 5.1. In this post-hoc analysis, all models reached 
convergence in 500 iterations. This highlights the need to carefully balance statistical 
criteria and criteria such as clinical plausibility and meaningfulness of trajectory 




Due to the young age of women at the end of follow-up (37 – 42 years), the number 
of medical conditions was small. As explained previously (see section 5.1 
Background), the young cohort of the ALSWH study was chosen because at the outset 
of this project one aim of the analysis was to investigate the potential mediating role 
of BMI in the relationship between depression and hypertension. Since an existing 
study based on the mid-aged cohort of the ALSWH concluded that the vast majority 
of women were already overweight at baseline, it was of interest to investigate the 
relationship further using the young cohort of the ALSWH. It will be of interest to 
further investigate the relationship between different patterns of change of depressive 
symptoms and risk of CVD in the young cohort of the ASLWH once women are older 
and more events have occurred (see section 7.4 Implications for research for more 
detailed discussion).  
5.5.2.2.2 Bias 
Women might have been classified to a depressive symptom trajectory group that did 
not accurately represent their course of depressive symptoms from the age of 20 to 40 
years. First, assessments of depressive symptoms were based on self-report which 
might be influenced by under- or over-reporting (Schubert et al, 2017). However, 
considering the large number of women enrolled in the ALSWH study and the 
number of follow-up assessments, interviews to ascertain clinical depression would 
not have been feasible. Also, potentially important differences in levels of 
subthreshold depression would remain undetected if a measure of clinical depression 
was used. Second, class membership was determined using the highest posterior 
group membership probability. Allocating women to the class with the highest 
posterior class membership probability assumes that class allocation was possible 
without classification error. However, it has been highlighted by other researchers 
that there might be uncertainty about class allocation (van de Schoot et al, 2017). 
Entropy values can guide an assessment of the extent of bias due to classification error 
in that higher entropy values indicate fewer classification errors and less bias in the 




threshold of 0.5 recommended by Lennon et al (2018), it only did so by a small margin 
in this analysis.  
Due to the use of a forward timescale, events during the course of the trajectory might 
have altered the trajectory itself. For example, if a women was diagnosed with 
hypertension at the age of 30 years, this might have altered her depressive symptom 
trajectory from the age of 30 to 40 years. The use of a forward timescale and age as a 
marker of time is useful if researchers are interested in the natural course of a marker 
over time. In contrast, the use of a backward timescale is warranted if researchers are 
interested in depressive symptom trajectories after a significant life event or before 
the diagnosis of medical conditions (Vistisen & Færch, 2014). Furthermore, a 
backward timescale is useful if one is interested in the aetiology of disease 
development (Vistisen & Færch, 2014) or for scenarios in which reverse causation 
might explain the observed relationship between the exposure and outcome of 
interest. Since the observed association between depression or depressive symptoms 
and subsequent CVD might be explained by reverse causation, group-based 
trajectory modelling using a backward timescale will be further explored in the next 
chapter (see Chapter 7). 
In contrast to existing studies, women with only one measurement of depressive 
symptoms were not excluded from the main analysis. Since women with only one 
assessment of depressive symptoms might be systematically different from women 
with more than one assessment of depressive symptoms, an exclusion of these 
women might introduce selection bias (Boucquemont et al, 2017). When investigating 
individual depressive symptom trajectories of a random subset of women included 
in the analysis, there was some indication that women with only one assessment of 
depressive symptoms had higher depressive symptom scores (see section 5.3.3.1 
Descriptive statistics). Exclusion of these women might therefore have led to an 
underestimation of the mean score of depressive symptoms in this population. Since 
existing studies have frequently excluded women with only one measurement of 




analysis was performed among women with at least two assessment of depressive 
symptoms during follow-up. In this analysis, the best model identified three latent 
classes that were very similar to those identified in the main analysis. Despite 
including women with only one assessment of depressive symptoms, there might 
have been some selection bias due to the exclusion of women who only participated 
in study phase 1 or who did not have any depressive symptom assessment. 
Unfortunately, differences between those included and excluded could not be 
assessed with regard to depressive symptoms since the CES-D scale was first 
introduced in study phase 2. Subjects with missing data on depressive symptoms 
were included in the analysis, but only available data for each subject were used in 
the analysis. This generated unbiased parameter estimates under the assumption that 
data were MAR (Nagin & Odgers, 2010). MAR means that missingness is conditional 
on observed variables but unconditional on unobserved variables. Variables that 
were observed and used in the trajectory analysis were depressive symptoms, age, 
sex (through restriction to women), and study wave. Neither age, sex, nor study wave 
had any missing data. At each wave of data collection the proportion of women with 
missing information on depressive symptoms was relatively low (see Table 5.2). 
Furthermore, missingness of depressive symptoms is assumed to be random given 
the observed measurements of depressive symptoms. Therefore, it seems likely that 
the MAR is valid. However, there might have been some bias due to the exclusion of 
women without any measurement of depressive symptoms throughout follow-up or 
due to women with few measurements of depressive symptoms. 
The sample included Australian women who were randomly selected from the 
national Medicare health insurance database. The response rate to the initial 
invitation letter was estimated at 41 – 42% for the young cohort with some uncertainty 
remaining due to unknown accuracy of the Medicare records (Brown et al, 1999). Due 
to data confidentiality, demographic characteristics of responders and non-
responders could not be compared. Based on aggregate data, there was some 
indication that non-responders made less use of health services (Brown et al, 1999). 




has been shown that the sample were reasonably representative of general Australian 
population, although well-educated women were overrepresented and immigrant 
women underrepresented (Brown et al, 1999). The extent to which the trajectories of 
depressive symptoms and their association with cardiovascular risk are generalisable 
to women from countries other than Australia, to older women, and to men has yet 
to be established in other datasets with multiple measures of depressive symptoms 
over time. As described previously, women from rural areas were intentionally 
oversampled. This would affect results of the analysis if the prevalence and pattern 
of trajectories of depressive symptoms over time was different among women from 
rural and urban areas. Whilst prior research showed evidence for rural-urban 
differences with regard to schizophrenia and suicides, evidence with regard to 
common mental health disorders such as depression and anxiety was inconclusive 
(Solmi et al, 2017). Thus, it remains to be determined to what extent the oversampling 
of women from rural areas affected the prevalence and/ or pattern of each of the 
depressive symptom trajectories.  
The use of a depressive symptom sum score might have biased the analysis due to a 
violation of the measurement invariance and unidimensionality assumptions. As 
discussed in section 5.3.3.4 Sensitivity analysis, previous research has shown that 
depressive symptom sum scores might not measure one underlying construct 
(unidimensionality) and might not measure that construct the same way across time 
(measurement invariance) (Fried et al, 2016; van Eeden et al, 2019). A violation of 
these assumptions changes the interpretations of the findings. Changes in the sum 
score would not reflect depressive symptom severity but rather have to be interpreted 
as a change in the sum of different underlying problems (Fried et al, 2016). Since the 
pattern of change of a sum of different underlying problems over time might not be 
meaningful, researchers have recommended to put more emphasis on the study of 
individual items (Fried et al, 2016; van Eeden et al, 2019). I followed this 
recommendation by modelling the pattern of change of two unique items of the 
depressive symptom scale over time. These unique items followed similar patterns 




preferred models identified a smaller number of classes. This might be explained a 
lack of statistical power since the unique items ranged from 0 to 4 whereas the sum 
score ranged from 0 to 30. The results of the sensitivity analysis should be interpreted 
with caution because the CES-D scale was not developed to analyse individual items. 
Fried et al (2016) recommended to increase the reliability of symptom measurement 
by using multiple items to measure the same unique symptoms. However, this was 
not possible using the CES-D scale because the scale assessed each unique symptom 
using one item. 
5.5.2.2.3 Confounding 
Unconditional latent process mixed models were fitted that explored patterns of 
depressive symptoms among Australian women from the age of 20 and 40 years. As 
such, the number of latent classes in this sample were explored without consideration 
of covariates. After allocation of women to the class with the highest posterior class 
membership probabilities, potential predictors of class membership and 
characteristics at the end of follow-up were explored. van de Schoot et al (2017) 
highlighted that researchers should not combine the step of finding the number of 
relevant classes with the step of selecting the main predictors of those classes. One of 
the reasons for this is that the inclusion of predictors overestimates the entropy value 
and thereby underestimates classification uncertainty. 
The comparison of participant characteristics of the three depressive symptom 
subgroups at baseline and end of follow-up should be interpreted with caution since 
they were not adjusted for potential confounding factors. I intended to perform 
logistic regression model to assess the association between class membership and 
sociodemographic characteristics, health behaviours, and variables related to the 
health status of participants. However, after identifying the favoured latent process 
mixed model, I decided to describe and discuss differences between groups rather 
than to run a regression model since the small number of women with fluctuating 




5.5.3 Comparison of findings with previous research 
Using data from the youngest and oldest cohort of the ALSWH, existing studies have 
investigated trajectories of mental health but not depressive symptoms. Using logistic 
group-based trajectory modelling, Holden et al (2016) identified four groups with 
different patterns of mental health in the young cohort of the ALSWH with complete 
data available. Most participants were allocated to a trajectory group that was 
characterised by stable high mental health (55%), whilst 24%, 12%, and 9% were 
allocated to groups with varying, improving, and stable low mental health over 16 
years of follow-up, respectively. In contrast to the analysis presented in this chapter, 
Holden et al (2016) did not use a measure of depressive symptoms but the 5-item 
Mental Health index which is a non-specific measure of mental health-related QOL. 
Furthermore, the authors dichotomised their measure to identify individuals with 
low versus high mental health throughout follow-up because of which potentially 
important information on variations in scores of mental health over time were missed. 
Another disadvantage of the study by Holden et al (2016) is that it was based on 
complete cases which might have introduced selection bias. In a recently published 
paper based on the young cohort of the ALSWH, Xu et al (2019) investigated if 
trajectories of mental health among women in their 20s predicted chronic physical 
conditions in their 30s. Chronic physical conditions were defined as diabetes, cancer, 
hypertension, CVD, asthma, and bronchitis. Using the 5-item Mental Health Index, 
the authors identified five mental health trajectories of high-stable (60%), improving 
(9.5%), declining then improving (19.2%), declining (4.8%), and low stable (6.4%) 
mental health-related QOL. Relative to women with high stable mental health, 
women allocated to the low stable, declining, declining then improving, and 
improving trajectory groups had higher odds of chronic physical condition. CIs 
overlapped with the null value in the latter two groups. Whilst the association 
between trajectories of mental health of women in their 20s with incidence of chronic 
physical diseases of women in their 30s is interesting, a disadvantage of the analysis 
is that about 3,000 women with chronic physical conditions in their 20s were 




separates the follow-up period into an exposure window (in which the trajectories are 
identified) and an outcome window (in which the odds of developing chronic 
physical conditions are estimated). Using data from the oldest cohort of the ALSWH 
(aged 70 – 75 years at baseline), two studies identified three different patterns of 
trajectories of mental health among women as they age (Leigh et al, 2016; Tran et al, 
2019). Whilst the number of groups was the same in both studies, the pattern of 
trajectories and proportion of women allocated to each trajectories differed between 
the two studies. Leigh et al (2016) used the 5-item Mental Health Index to allocate 
28%, 44% and 28% to groups characterised by excellent, good, and poor mental 
health, respectively. The trajectories were relatively flat with little change over time, 
although there was a slight decrease in mean mental health scores among those with 
poor mental health. Tran et al (2019) used the 4-item SF36 Vitality subscale which is 
a measure of positive mental health and identified a larger proportion of women with 
stable high mental health score (77%), a small group with declining mental health 
(4.8%), and 18.2% with stable low mental health. Differences between studies might 
be explained by the use of different mental health measures.  
Musliner et al (2016) published a systematic review on patterns, predictors and 
outcomes of long-term trajectories of depressive symptoms in studies using group-
based trajectory modelling. The authors identified 25 studies, seven of which were 
based on children or adolescents, four of which were of young adults (< 60 years), 
eight of older adults, and six studies were based on mothers. The identified number 
of latent classes ranged from three to six, with most studies identifying either three 
or four latent classes. The classes varied in their symptom severity and symptom 
stability over time. In most studies the largest class was characterised by stable low 
depressive symptoms. Other classes were characterised by persistently high 
depressive symptoms, stable moderate depressive symptoms, and unstable 
depressive symptoms, either increasing or decreasing. These findings were in 
keeping with another systematic review on depressive symptom trajectories in late 
adolescence and early adulthood (Schubert et al, 2017). In keeping with the majority 




depressive symptoms over time of which the group with stable low depressive 
symptoms was the largest. Musliner et al (2016) highlighted that patterns of 
trajectories were similar for men and women but the proportion of individuals with 
stable high depressive symptoms was larger among women than men. Furthermore, 
female gender was a strong predictor of belonging to the class that was characterised 
by stable high depressive symptoms. Other predictors of stable high depressive 
symptoms were low income, low education, non-white race, and stressful life events. 
This was in keeping with the current analysis showing differences between groups in 
terms of marital status, university degree and difficulty managing on their income. 
Despite the potentially important role of BMI as confounding and/ or mediating 
factor, only few existing studies have investigated BMI trajectories across different 
mental health subgroups. Gaysina et al (2011) investigated BMI trajectories among 
men and women with different patterns of affective disorders from adolescence to 
adulthood (15 to 53 years). Women with adolescent onset affective symptoms had a 
lower BMI at age 15, a faster increase of BMI over time, and a higher BMI at age 53 
years than those without symptoms. Men with adolescent onset affective symptoms 
had a lower BMI at all ages than men without such symptoms. There was no 
difference between trajectories of BMI among those with adult onset affective 
symptoms versus no symptoms. Mumford et al (2013) identified five concurrent 
trajectories of mental health (MHI-5) and BMI among individuals aged 15 to 27 years 
of age. Individuals were characterised as having stable good mental health and stable 
normal weight during follow-up (82.2%), stable good mental health and consistently 
obese (6.8%), declining mental health and overweight becoming obese (5.6%), 
improving mental health and stable normal weight (3.3%), and stable good mental 
health and morbid obesity (2.1%). In keeping with results of this analysis, existing 
studies reported that the average weight increases over time with differences in 
patterns of weight gain across groups. Gaysina et al (2011) and Mumford et al (2013) 
additionally observed differences in the starting point of weight gain whereas the 




explanations for this difference across studies are differences in the mean age and age 
range of the samples at baseline.  
5.6 Conclusion 
This analysis illustrated that group-based trajectory modelling is a useful tool to 
study patterns of changes of depressive symptoms over time. I identified potentially 
clinically meaningful subgroups of women with different patterns of depressive 
symptoms, characterised by differences in profiles of key cardiovascular risk factors 
across subgroups and differences between baseline and end of follow-up. 
Among Australian women three subgroups of women with distinct depressive 
symptom trajectories were identified from the age of 20 to 40 years. Whilst the 
majority of women had stable low depressive symptoms, there was a considerable 
proportion of women with stable moderate depressive symptoms and a small 
number of women with fluctuating depressive symptoms. Women with stable low, 
stable moderate, and fluctuating depressive symptoms differed in their profiles of 
key cardiovascular risk factors. Women with stable moderate or fluctuating 
depressive symptoms reported lower educational attainment, found it harder to 
manage on their income, reported more adverse health behaviours, had more medical 
conditions and gained weight more rapidly than women with stable low depressive 
symptoms. 
Using a forward timescale, this analysis identified women with similar patterns of 
depressive symptoms in early adulthood. As mentioned previously (see section 
5.5.2.2.2 Bias), a retrospective timescale, such as time before the diagnosis of CVD, is 
useful if one is interested in the aetiology of disease development (Vistisen & Færch, 
2014). It can also be valuable in scenarios in which reverse causation might explain 
the observed relationship between the exposure and outcome of interest. Thus, 
group-based trajectory modelling using a retrospective timescale will be further 





Chapter 6: Trajectories of psychological distress prior 
to diagnosis of coronary heart disease and stroke 
6.1 Background 
There are potential alternative explanations for the observed association between 
clinical depression, depressive symptoms and risk of cardiovascular events. First, as 
discussed in more detail previously (see section 2.3.2.3 Proposed mechanisms), 
underlying vascular disease may influence the development of depressive symptoms 
(vascular depression hypothesis) (Alexopoulos et al, 1997; Taylor et al, 2013). If 
depressive symptoms are indeed related to worsening vascular disease, depression 
might not be causally related with subsequent cardiovascular events but instead 
reflect a prodromal feature of worsening vascular disease itself. Second, researchers 
have highlighted that a potential explanation for the association between clinical 
depression, depressive symptoms and risk of cardiovascular events is that symptoms 
of subclinical CVD overlap with somatic symptoms of depression. If subclinical CVD 
increase the risk of being diagnosed with clinical depression or depressive symptoms, 
the apparent increased risk of cardiovascular events among those with clinical 
depression or depressive symptoms could be due reverse causation. If the association 
between clinical depression, depressive symptoms and risk of cardiovascular events 
was indeed due to worsening of underlying vascular disease or the overlap of 
symptoms, one would expect an increase in depressive symptoms prior to diagnosis 
of cardiovascular events. As a result, there would be differences between the 
trajectories of depressive symptoms among those with and without cardiovascular 
events in the years immediately prior to diagnosis with CVD. No difference between 
trajectories would be expected in the years prior to expected onset of subclinical CVD. 
The Whitehall II study offered unique advantages in investigating trajectories of 
depressive symptoms prior to diagnosis of cardiovascular events. First, participants 
of the Whitehall II study have been followed for 28 years. Due to the long subclinical 
phase of CVD, a long follow-up was needed to cover a time before likely onset of 




with repeat assessments of psychological distress and depressive symptoms using the 
same assessment tools throughout follow-up. A disadvantage of the Whitehall II 
study is that depressive symptoms were first assessed in study phase 7 whereas 
psychological distress was assessed in all study phases except for phase 4. It was 
decided that the benefits of using the more extensive repeated measures of 
psychological distress outweighed the disadvantages of using an exposure 
assessment that is less comparable to those used in other parts of this project. 
However, it should be noted that although the terms depressive symptoms and 
psychological distress are often used interchangeably in existing literature, 
psychological distress is a less specific measure of common mental health problems. 
Whilst some psychological distress scales have a stronger focus on symptoms of 
depression and anxiety (e.g. Kessler Psychological Distress scale), others capture a 
wider spectrum of mental health symptoms such as symptoms of social withdrawal 
(e.g. General Health Questionnaire (GHQ)) (Jackson, 2007). 
Existing research has not only shown an association between clinical depression, 
depressive symptoms and risk of cardiovascular events but also between 
psychological distress and risk of cardiovascular events. Four studies on the risk of 
stroke or myocardial infarction among individuals with psychological distress 
relative to those without psychological distress were identified in the systematic 
review and meta-analysis performed as part of this project (Brunner et al, 2014; 
Jackson et al, 2018; Pan et al, 2011a; Whang et al, 2009). One of the studies was 
performed in the Whitehall II cohort (Brunner et al, 2014). Whilst the search strategy 
of the systematic review did not include terms for psychological distress, studies 
using a measure of psychological distress were picked up in the search if they 
mentioned words starting with depressi* or dysthymi* anywhere in the article. Since 
it is very likely that studies on psychological distress mention terms such as 
depression, depressive, or dysthymia at least once, it is very likely that most eligible 
studies on psychological distress were identified in the literature search. Three of the 
identified studies assessed psychological distress using rating scales (Brunner et al, 




psychological distress using a rating scale, physician diagnosis of clinical depression 
or antidepressant use (Pan et al, 2011a). Using the same methodology as described in 
Chapter 3, I performed a random effects meta-analysis of these studies. Psychological 
distress was associated with increased hazards of total stroke, ischaemic stroke, 
haemorrhagic stroke, and MI (Figure 6.1). The pooled HRs ranged from a 22% 
increased hazard of MI to a 36% increased hazard of total stroke and haemorrhagic 
stroke among those with psychological distress, relative to those without 
psychological distress. There was some evidence of potential age and sex differences 
in the study by Jackson et al (2018). Furthermore, Brunner et al (2014) highlighted that 
an association between psychological distress and stroke was observed only over 0 – 
5 years but not over 5 – 10 years of follow-up of Whitehall II study participants 
suggesting that the relationship between psychological distress and stroke might be 
due to reverse causation.  
 
Figure 6.1: Meta-analysis of the risk of total stroke, ischaemic stroke, haemorrhagic stroke and 






As highlighted above, existing studies have repeatedly highlighted that the apparent 
increased risk of cardiovascular events among individuals with clinical depression, 
depressive symptoms, and psychological distress might be due to reverse causation 
or overlap in somatic symptoms. Therefore, the aim of the work presented in this 
chapter was to compare psychological distress trajectories of individuals prior to 
diagnosis of cardiovascular events to psychological distress trajectories of individuals 
free from cardiovascular events over the same time period using data from the 
Whitehall II study. A secondary objective was to investigate to what extent the group 
of people with cardiovascular events was composed of multiple latent classes that 
differed in their psychological distress trajectories before diagnosis of cardiovascular 
events. 
6.2 Objectives 
1. To compare trajectories of psychological distress of individuals prior to diagnosis 
of cardiovascular events to individuals free from cardiovascular events over the 
same period using group-based trajectory modelling 
2. To identify homogenous psychological distress subgroups within the 
heterogeneous group of individuals with a cardiovascular event 
6.3 Methods 
6.3.1 Study population 
The Whitehall II study is an ongoing prospective cohort study of non-industrial 
British civil servants in 20 London-based departments, aged 35 – 55 years at baseline 
(Marmot & Brunner, 2005). Individuals were invited by letter and 10,308 individuals 
(6,895 men and 3,413 women) of mainly white ethnicity were recruited between 1985 
and 1988 (73% of those invited). Participants were followed at ten subsequent study 
phases approximately 2.5 years apart. In all study phases individuals were asked to 
respond to a questionnaire, and every second phase included a clinical health 
examination. Participant consent was renewed at each contact and research ethics 





Whitehall II participants were excluded from this analysis if they did not have any 
assessment of psychological distress or if their record could not be linked with 
mortality records. Participants with missing data on psychological distress in some 
but not all study phases were included but only available data for each participant 
were used in the trajectory analysis. Furthermore, observations for participants were 
excluded after the occurrence of first-ever fatal CHD or non-fatal MI and fatal or non-
fatal stroke or if they contained missing information on person years at risk. 
Information of study phases with no validated information on outcomes were 
excluded from the analysis, since the Whitehall II study team advised me not to 
combine self-reported information on fatal CHD or non-fatal MI and fatal or non-fatal 
stroke with validated information on events of earlier study phases (see section 6.3.3.2 
Fatal CHD/ non-fatal MI and fatal or non-fatal stroke for more detail). 
6.3.3 Variables 
6.3.3.1 Psychological distress 
Psychological distress was self-reported at study phases 1 to 3 and 5 to 11 using the 
30-item General Health Questionnaire (GHQ), a screening questionnaire that was 
developed to identify individuals at high risk of non-psychotic psychiatric illness in 
the general population (Goldberg, 1972). Participants were asked to rate how their 
health has been in general over the past few weeks. There were four response options 
for each of the 30 questions. The overall GHQ score was calculated by the Whitehall 
II study team using a binary scoring method in which a score of 0 was allocated to the 
two least symptomatic response options and a score of 1 was allocated to the two 
most symptomatic response options (Jackson, 2007). As a result, the total score ranged 
from 0 to 30. The GHQ score was treated as continuous variable in the analyses. In 
addition, a binary variable indicating high versus low psychological distress was 
created. In keeping with recommendation, a cut-off of at least five was used to 
identify individuals with high psychological distress (Jackson, 2007). The binary 




6.3.3.2 Fatal CHD/ non-fatal MI and fatal or non-fatal stroke 
Outcomes were defined as first-ever fatal CHD or non-fatal MI and first-ever fatal or 
non-fatal stroke. The cause and date of death were ascertained using linkage to the 
national mortality register kept by the NHS Central Registry. In accordance with 
Whitehall II procedures, CHD mortality was defined by ICD-9 codes 410 – 414 or ICD-
10 codes I20 – I25 and stroke mortality by ICD-9 codes 430 – 438 or ICD-10 codes I60 
– 69 (Brunner et al, 2014). Non-fatal CHD and stroke events were validated using 
NHS Hospital Episode Statistics discharge diagnoses or General Practitioner’s (GP) 
confirmation. Two trained coders independently classified non-fatal events, with 
adjudication in case of disagreement. Validation of fatal CHD or non-fatal MI and 
fatal or non-fatal stroke events was available up to study phases 9 and 8, respectively. 
6.3.3.3 Covariates 
Sociodemographic factors included age, sex, ethnicity, marital status, and 
occupational position. Ethnicity was grouped into two categories of white and non-
white. In keeping with a previous Whitehall II publication, marital status was 
grouped into two categories of married/ cohabiting and other (Singh-Manoux et al, 
2017). Occupational position was ascertained as variable with three categories 
(administrative, professional/ executive, and clerical/ support workers) based on the 
participant’s salary, social status, and level of responsibility at work (Marmot et al, 
1991). Health behaviours included smoking status, alcohol consumption, physical 
activity, and frequency of fruit and vegetable consumption. Smoking status was 
grouped into three categories of current smoker, ex-smoker, and non-smoker. In 
keeping with weekly intake guidelines of the UK Department of Health, alcohol 
intake was defined as safe drinking if men or women reported ≤ 14 units of alcohol 
per week and as risky drinking if alcohol intake exceeded 14 units per week (UK Chief 
Medical Officer, 2016). Physical activity was defined as average hours per week of 
moderate and vigorous physical activity. In keeping with a previous Whitehall II 
publication, fruit and vegetable intake was grouped into three categories of less than 
once a day, daily, and more than once a day (Singh-Manoux et al, 2017). Variables 




and total cholesterol levels. BMI (kg/ m2) was calculated by the Whitehall II study 
team based on measured height and weight. A history of diabetes at baseline was 
defined based on self-reported information of a physician diagnosis or diabetes 
medication. Systolic and diastolic blood pressure were measured in a sitting position 
using Hawksley random-zero sphygmomanometer after five minutes of rest. Two 
measures of systolic and diastolic blood pressure were taken and their means were 
used in the analysis. Total cholesterol levels were measured using automated 
enzymatic colorimetric methods. 
6.3.4 Descriptive analysis 
Baseline characteristics were investigated separately for individuals with and without 
fatal CHD or non-fatal MI and with and without fatal or non-fatal stroke during 
follow-up. Furthermore, characteristics of excluded versus included participants 
were compared. Differences between groups were assessed using the t-test and chi-
squared test. A two-sided p-value <0.05 was considered statistically significant. To 
illustrate the variation of psychological distress scores within and across participants 
over time, individual psychological distress trajectories of 150 randomly selected 
participants with fatal CHD or non-fatal MI during follow-up were compared to 
individual psychological distress trajectories of 150 randomly selected individuals 
without events. This step was repeated for a random subset of 150 individuals each 
who did and did not have a fatal or non-fatal stroke by the end of follow-up. 
6.3.5 Retrospective analysis of psychological distress trajectories 
The aim of this analysis was to compare psychological distress trajectories of 
individuals prior to diagnosis of cardiovascular events to psychological distress 
trajectories of individuals free from cardiovascular events over the same time period. 
A latent process mixed model with psychological distress as dependent variable was 
fitted (see below). A mixed effects specification was used since repeated measures of 
the same participants are likely to be correlated. Time was modelled using a 
backward timescale starting at the date of diagnosis for individuals with events and 




dependence was modelled using natural cubic splines of time with knots set at the 
quartiles of the distribution. The event indicator was added to the model to allow for 
different intercepts among those with and without events, and an interaction term 
between time and the event indicator was added to allow for differences in the slope 
of the psychological distress trajectories. Furthermore, a random intercept and slope 
of time was added to the model to account for individual variation around the mean 
trajectory. In keeping with steps described in previous chapters (see section 5.3.3.2.2 
Link function), the optimal link function to describe the relationship between the 
dependent variable (scores of psychological distress) and the linear predictor was 
identified by running models using five different link functions.  
kn <- quantile(sample$time, probs = c(0.25, 0.50, 0.75))  #spline knots at the quartiles of the  
#distribution  
lcmm(fixed = GHQ ~ event*ns(time, knots = kn),  
random = ~ time,  
subject = “ID”,  
link = “linear”,   #five different models using different link functions were run: linear, 
beta,    #equidistant I-splines, I-splines set at quantiles of distribution,  
#threshold  
data = sample) 
Using the model with the preferred link function, mean predicted trajectories were 
plotted separately for those with and without events for each of the outcomes. Since 
differences between the trajectories of those with and without events might be due to 
differences in participant characteristics, analyses were subsequently adjusted for age 
at year 0 (year of diagnosis, death, or end-of follow-up), sex, and study phase. The 
Wald test was used to investigate if the addition of covariates and the interaction term 
between the event indicator and change of psychological distress over time improved 
model fit. A two-sided p-value <0.05 was considered statistically significant. The R 




6.3.6 Group-based trajectory modelling among those with an event 
Since the group of participants with cardiovascular events during follow-up might be 
composed of heterogeneous subgroups that differ in their trajectories of 
psychological distress over time, I investigated whether psychological distress 
subgroups (latent classes) could be identified. The steps involved in identifying 
potential latent classes were the same as those described as part of the group-based 
trajectory modelling of the ALSWH analysis (see section 5.3.3.2 Group-based 
trajectory modelling of depressive symptoms (CES-D)). In short, using the model 
with the preferred link function, the optimal number of classes was determined using 
statistical criteria with a prior requirement of at least 1% of all individuals in each of 
the latent classes. If the optimal number of classes exceeded one class, the optimal 
model structure would be determined by estimating models using model structures 
with increasing complexity (Table 5.1), and model adequacy and model 
discrimination would be investigated for each of the models that reached 
convergence in up to 500 iterations. The effect of confounders was assumed to be the 
same for all latent classes. The R code for a model with a two-class solution is 
presented below as an example. 
lcmm(fixed = GHQ ~ ns(time, knots = kn) + AGE0 + SEX + WAVE,  
mixture = ~ ns(time, knots = kn),  
random = ~ time,  
subject = “ID”,  
maxiter = 500,  
ng = 2,  
link = “linear”,   #determined based on comparison of different link functions  






6.4.1 Study population 
Out of 10,308 participants, 10,187 participants were included in the fatal CHD or non-
fatal MI analysis and 10,252 participants were included in the analysis on fatal or non-
fatal stroke (Figure 6.2). 
 
Figure 6.2: Flow chart of Whitehall II study participants included in analyses 
 
There were statistically significant differences between individuals included and 
excluded from the analyses (Appendix Table A 40). Participants excluded from the 
fatal CHD or non-fatal MI analysis were more likely to be male, older, non-white, and 
clerical or support worker, and generally had worse cardiovascular risk profiles. 
Characteristics were similar between those included and excluded from analyses on 
fatal or non-fatal stroke with the exception that the proportion of male participants 
was higher among those included in the analyses (Appendix Table A 41). 
6.4.2 Descriptive statistics 
The median age (IQR) of participants included in the analysis on fatal CHD or non-
fatal MI was 44.2 (39.6 – 50.3) years, the majority identified themselves as white 
(89.2%), and 6,803 (66.8%) were male (Table 6.1). The majority of participants were 
married (73.8%), and 48.1% were from professional or executive grades, whereas 




grades, respectively. The characteristics were similar for participants included in the 
analysis on fatal or non-fatal stroke (Table 6.1). There were 655 events of fatal CHD 
or non-fatal MI and 193 fatal or non-fatal stroke during follow-up. The median age 
(IQR) at fatal CHD or non-fatal MI was 59.8 (54.3 – 66.4) years and 63.6 (57.2 – 69.2) 
years at fatal or non-fatal stroke. 
Table 6.1: Characteristics of Whitehall II participants included in the analyses on fatal coronary heart 
disease or non-fatal myocardial infarction and fatal or non-fatal stroke at study phase 1 (page 1 of 2)*  
Population for 
CHD/ MI outcome 
(n = 10,187) 
Population for 
stroke outcome 
(n = 10,252) 
Male (%)  6,803 (66.8) 6,869 (67.0) 
Age (median [IQR])  44.2 [39.6, 50.3] 44.3 [39.6, 50.3] 
Ethnicity (%) 
   White  9,084 (89.2) 9,140 (89.2) 
   Non-white  1,011 (9.9) 1,020 (9.9) 
   Missing value 92 (0.9) 92 (0.9) 
Marital status (%) 
   Married/ cohabiting  7,523 (73.8) 7,571 (73.8) 
   Other  2,627 (25.8) 2,643 (25.8) 
   Missing value 37 (0.4) 38 (0.4) 
Occupational position (%) 
   Administrative  2,996 (29.4) 3,022 (29.5) 
   Professional/ executive  4,898 (48.1) 4,922 (48.0) 
   Clerical/ support  2,293 (22.5) 2,308 (22.5) 
Smoking status (%) 
   Never smoker  5,023 (49.3) 5,044 (49.2) 
   Ex-smoker  3,232 (31.7) 3,258 (31.8) 
   Current smoker  1,861 (18.3) 1,878 (18.3) 
   Missing value 71 (0.7) 72 (0.7) 
Alcohol intake (%) 
   Risky drinking  2,394 (23.5) 2,412 (23.5) 
   Safe drinking 7,701 (75.6) 7,747 (75.6) 
   Missing value 92 (0.9) 93 (0.9) 
Physical activity (median [IQR])  3.0 [1.0, 5.0] 3.0 [1.0, 5.0] 
Fruit and vegetable intake (%) 
   Less than once a day  4,240 (41.6) 4,267 (41.6) 
   Daily  4,231 (41.5) 4,255 (41.5) 
   More than daily  1,686 (16.6) 1,700 (16.6) 
   Missing value  30 (0.3) 30 (0.3) 
Body mass index (kg/ m2) (median [IQR])  24.2 [22.3, 26.3] 24.2 [22.3, 26.4] 
Diabetes (self-report or medication) (%)  95 (0.9) 98 (1.0) 




Table 6.1 continued: Characteristics of Whitehall II participants included in the analyses on fatal 
coronary heart disease or non-fatal myocardial infarction and fatal or non-fatal stroke at study 
phase 1 (page 2 of 2)* 
 
Population for 
CHD/ MI outcome 
(n = 10,187) 
Population for 
stroke outcome 
(n = 10,252) 
Diastolic blood pressure (median [IQR])  76.0 [70.0, 83.0] 76.0 [70.0, 83.0] 
Total cholesterol levels (median [IQR])  5.9 [5.2, 6.7] 5.9 [5.2, 6.7] 
Psychological distress (median [IQR])  1.0 [0.0, 5.0] 1.0 [0.0, 5.0] 
Psychological distress (binary) (%) 
   No  7,372 (72.4) 7,419 (72.4) 
   Yes  2,721 (26.7) 2,737 (26.7) 
   Missing value 94 (0.9) 96 (0.9) 
Time to event, death, or end of follow-up (mean 
(SD))  
21.3 (8.0) 19.1 (6.4) 
Event (whole follow-up) (%)  655 (6.4) 193 (1.9) 
Age at diagnosis/ end of follow-up (median [IQR])  66.8 [61.5, 72.8] 64.0 [59.5, 70.2] 
* Data are given as n (%) unless specified 
CHD: coronary heart disease, IQR: interquartile range, MI: myocardial infarction, SD: standard 
deviation 
 
There were statistically significant baseline differences between participants with and 
without events during follow-up (Table 6.2, Appendix Table A 42). Fatal CHD or non-
fatal MI and fatal or non-fatal stroke during follow-up was associated with older age, 
non-white ethnicity, current smoking status, higher BMI, and higher systolic and 
diastolic blood pressure at baseline. The proportion of male participants was higher 
among individuals with an event but the sex difference was not statistically 
significant between individuals with and without stroke during follow-up. 
Furthermore, there were statistically significant differences between individuals with 
and without fatal CHD or non-fatal MI with respect to marital status, fruit and 
vegetable intake, and total cholesterol levels but not between individuals with and 
without stroke during follow-up. No differences between median psychological 
distress scores were observed for each of the outcomes but the proportion of 






Table 6.2: Characteristics of Whitehall II participants at study phase 1, separately for those with and 
without fatal coronary heart disease or non-fatal myocardial infarction during follow-up* 
 No CHD/ MI 
(n = 9,532, 93.6%) 
CHD/ MI 
(n = 655, 6.4%) 
p 
Male (%) 6,285 (65.9) 518 (79.1) <0.001 
Age (median [IQR])  44.0 [39.5, 50.0] 48.4 [42.5, 52.8] <0.001 
Ethnicity (%)  <0.001 
   White  8,528 (89.5) 556 (84.9)  
   Non-white  916 (9.6) 95 (14.5)  
   Missing value 88 (0.9) 4 (0.6)  
Marital status (%)  0.031 
   Married/ cohabiting  7,031 (73.8) 492 (75.1)  
   Other  2,470 (25.9) 157 (24.0)  
   Missing value 31 (0.3) 6 (0.9)  
Occupational position (%)  0.432 
   Administrative  2,808 (29.5) 188 (28.7)  
   Professional/ executive  4,568 (47.9) 330 (50.4)  
   Clerical/ support  2,156 (22.6) 137 (20.9)  
Smoking status (%)  <0.001 
   Never smoker  4,744 (49.8) 279 (42.6)  
   Ex-smoker  3,028 (31.8) 204 (31.1)  
   Current smoker  1,694 (17.8) 167 (25.5)  
   Missing value 66 (0.7) 5 (0.8)  
Alcohol intake (%)  0.629 
   Risky drinking 2,230 (23.4) 164 (25.0)  
   Safe drinking 7,216 (75.7) 485 (74.0)  
   Missing value 86 (0.9) 6 (0.9)  
Physical activity (median [IQR])  3.0 [1.0, 5.0] 3.0 [1.0, 6.0] 0.271 
Fruit and vegetable intake (%)  0.022 
   Less than once a day  3,949 (41.4) 291 (44.4)  
   Daily  3,963 (41.6) 268 (40.9)  
   More than daily  1,595 (16.7) 91 (13.9)  
   Missing value 25 (0.3) 5 (0.8)  
Body mass index (kg/ m2) (median [IQR])  24.1 [22.3, 26.3] 25.2 [23.4, 27.2] <0.001 
Diabetes (self-report or medication) (%)  87 (0.9) 8 (1.2) 0.559 
Systolic blood pressure (median [IQR])  122.0 [113.0, 132.0] 127.0 [117.0, 139.0] <0.001 
Diastolic blood pressure (median [IQR])  76.0 [70.0, 83.0] 80.0 [74.0, 88.0] <0.001 
Total cholesterol levels (median [IQR])  5.8 [5.1, 6.6] 6.4 [5.7, 7.2] <0.001 
Psychological distress (median [IQR])  1.0 [0.0, 5.0] 1.0 [0.0, 6.0] 0.421 
Psychological distress (binary) (%)  0.027 
   No  6,903 (72.4) 469 (71.6)  
   Yes  2,535 (26.6) 186 (28.4)  
   Missing value 94 (1.0) 0 (0.0)  
Time to event, death, or end of follow-up 
(mean (SD))  
21.9 (7.8) 12.7 (6.9) <0.001 
Age at diagnosis/ end of follow-up (median 
[IQR])  
67.2 [62.2, 73.1] 59.8 [54.3, 66.4] <0.001 
* Data are given as n (%) unless specified, CHD: coronary heart disease, IQR: interquartile range, MI: 




Whilst there was variation between psychological distress trajectories of different 
participants and variation across measurements of the same individual over time, 
little difference was observed between psychological distress trajectories of those 
with and without events during follow-up (Figure 6.3 and Figure 6.4). Of note, the 
scarcity of data points at about 15 to 20 years before diagnosis or end of follow-up 
was data driven since psychological distress was not assessed in the fourth study 
phase. Also, there were no psychological distress measures exactly at year 0 (year of 
diagnosis, death, or end-of follow-up) since events were identified through linkage 
to medical records.  
 
Figure 6.3: Psychological distress trajectories of 150 participants prior to diagnosis of fatal CHD or non-
fatal myocardial infarction and 150 participants prior to death or end of follow-up 
 
Figure 6.4: Psychological distress trajectories of 150 participants prior to diagnosis of fatal or non-fatal 




6.4.3 Retrospective psychological distress trajectories of those with and 
without fatal CHD or non-fatal myocardial infarction 
Five models with the same model structure but different link functions were fitted to 
identify the link function that provided the best model fit (as defined by the lowest 
discrete AIC). The approximation of the linear link function was relatively far from 
the approximations of non-linear link functions (Figure 6.5). Whilst the thresholds 
link function provided the lowest discrete AIC value, the model was computationally 
very intensive. Balancing statistical criteria of model fit and computational 
complexity, the splines link function with knots set at the quantiles of the distribution 
was chosen as preferred link function since it had the second lowest discrete AIC 
value and was computationally much less intensive (Table 6.3). 
 
Figure 6.5: Estimated link functions of 
psychological distress (GHQ, range 0 to 30) 
in a latent process mixed model using 
natural cubic splines of time before fatal 
CHD, non-fatal myocardial infarction, or end 
of follow-up 
Table 6.3: Model fit of five latent process mixed models 
using different link functions and natural cubic splines of 
time before fatal CHD, non-fatal myocardial infarction, or 










Linear 42 14 252,629 25,785 
Beta 500 





25 17 243,135 16,290 
Splines (at 
quantiles) 
37 17 228,196 1,352 
Thresholds 14 42 226,844 --- 
* Difference in AIC between model using thresholds 
link function and models using other link functions 
 
 
In a model with the preferred link function, the unadjusted mean predicted 
psychological distress trajectories were estimated separately for individuals with and 
without fatal CHD or non-fatal MI (Figure 6.6). The mean predicted psychological 
distress trajectory of individuals with a fatal CHD or non-fatal MI event differed from 
the mean psychological distress trajectory of individuals without events. Throughout 
follow-up psychological distress scores were higher for people that had an event than 
those that did not. However, differences in mean scores were small and the CI of the 




people without events around year 0 and over 23 years before the end of follow-up. 
This was likely due to small numbers of individuals with measurements of 
psychological distress at these time points. The between-group difference in mean 
scores of psychological distress was relatively stable over time. 
 
Figure 6.6: Unadjusted mean predicted psychological distress trajectories, separately for those with 
and without fatal coronary heart disease or non-fatal myocardial infarction 
 
Since differences between psychological distress trajectories among those with and 
without events might be due to differences in participant characteristics, the analysis 
was subsequently adjusted for age at year 0 (year of diagnosis, death, or end-of 
follow-up), sex, and study phase. Whilst the addition of age at year 0 and sex 
improved model fit (p < 0.01, and p < 0.01, respectively), there was no statistically 
significant improvement of model fit due to the addition of study phase (p = 0.20). 
Furthermore, the interaction term between the event indicator and cubic splines of 
time did not improve model fit in either the unadjusted or adjusted model (p = 0.08 
and p = 0.14, respectively). This indicated that there was no statistically significant 
difference in change of psychological distress scores over time between individuals 
with and without events. As a result, mean predicted trajectories of psychological 
distress were modelled with an adjustment for the event indicator on the intercept 
only whilst additionally adjusting for age at year 0 and sex (Figure 6.7). The 
adjustment for the event indicator on the intercept provided statistically significant 
improvement of model fit (p < 0.01) indicating that there is a statistically significant 




exclusion of the interaction term this between-group difference had to be constant 
over time. Among both men and women, the mean predicted scores of psychological 
distress were slightly higher among those with a fatal CHD or non-fatal MI than 
among those without an event. Furthermore, the mean predicted score of 
psychological distress was very similar for women without events and men with 
events. A formal test of interaction between sex and change of psychological distress 
scores over time among those with and without events was not performed since 
numbers of events were considered too small to add a three-way interaction term. 
Figure 6.7: Mean predicted psychological distress trajectories of a hypothetical man aged 65 years at 
year 0 (left) and a hypothetical woman aged 65 years at year 0, separately for those with and without 
fatal coronary heart disease or non-fatal myocardial infarction 
 
6.4.4 Group-based trajectory modelling among those with fatal CHD/ non-
fatal MI 
There was no evidence that the group of individuals with fatal CHD or non-fatal MI 
was composed of multiple latent classes. Using the preferred link function identified 
in the previous analysis, models with increasing numbers of latent classes were fitted 
until two models did not reach convergence in up to 500 iterations (Table 6.4). The 
discrete AIC values of all models were very close. The lowest discrete AIC value was 
observed in the model with a one class solution. Interestingly, the model with a three 
class solution offered the second lowest discrete AIC value and lowest BIC value. An 
investigation of the mean predicted trajectories of all models that reached 
convergence showed that the three class solution closely approximated the three class 




since the one class solution had the lowest discrete AIC value, no further analysis was 
performed. 
Table 6.4: Model characteristics of models with increasing numbers of latent classes among those with 




















1 26 -5,192 14 11,013 10,475 100.0    
2 131 -5,161 20 11,027 10,451 19.1 80.9   
3 61 -5,140 26 11,022 10,448 25.3 4.0 70.7  
4 48 -5,140 32 11,034 10,487 28.1 4.6 67.3 0 
5 500 Model did not reach convergence 
6 500 Model did not reach convergence 
 
6.4.5 Retrospective psychological distress trajectories of those with and 
without fatal or non-fatal stroke 
The comparison of the approximations of five different link functions provided very 
similar results using cubic splines of time before fatal or non-fatal stroke or end of 
follow-up (Figure 6.8). Again, the threshold link function provided the lowest discrete 
AIC value. However, since it was computationally intensive the splines link function 
with knots set at the quantiles of the distribution was chosen balancing criteria of 
model fit and computational complexity (Table 6.5). 
 
Figure 6.8: Estimated link functions of 
psychological distress (GHQ, range 0 to 30) 
in a latent process mixed model using 
natural cubic splines of time before fatal or 
non-fatal stroke or end of follow-up 
Table 6.5: Model fit of five latent process mixed models 
using different link functions and natural cubic splines of 










Linear 17 14 235,988 23,161 
Beta 500 





76 17 227,323 14,496 
Splines (at 
quantiles) 
250 17 214,036 1,209 
Thresholds 56 42 212,827 --- 
* Difference in AIC between model using thresholds link 






There was little evidence for differences in mean predicted psychological distress 
scores among those with and without fatal or non-fatal stroke in unadjusted analysis 
(Figure 6.9). The mean predicted psychological distress scores of the group with 
events were slightly higher than those of the group without events from year 0 up to 
around 18 years prior to diagnosis, death or end of follow-up. In years 19 and 20 
before diagnosis, death or end of follow-up, the mean score of the group without 
events was slightly higher than that of individuals with events. Furthermore, there 
seemed to be slightly more variation in psychological distress scores among those 
with events over time. However, due to small numbers CIs of the group with events 
were wide, especially in the years 17 to 20 before diagnosis.  
 
Figure 6.9: Unadjusted mean predicted psychological distress trajectories, separately for those with and 
without fatal or non-fatal stroke 
 
There was some evidence for differences in mean predicted psychological distress 
scores among those with and without fatal or non-fatal stroke in adjusted analysis. 
Whilst adjustments for age at year 0 and sex improved model fit (p < 0.001, and p < 
0.001, respectively), adjustment for study phase and the interaction term between the 
event indicator and change of psychological distress scores over time did not (p = 
0.12, and p = 0.44, respectively). As described previously, this suggested that there 
was no statistically significant difference between those with and without events with 
regard to change of psychological distress scores over time. Therefore, models were 
subsequently fitted with an adjustment for the event indicator on the intercept of the 




year 0 and sex. The mean predicted psychological distress scores of a hypothetical 
man and woman aged 65 years at the time of diagnosis, death or end-of follow-up 
slightly decreased over time (Figure 6.10). As observed with the mean predicted 
scores of psychological distress prior to diagnosis with fatal CHD and non-fatal MI, 
the mean predicted scores of psychological distress were higher among women than 
men and higher among individuals with events than among those without events. In 
contrast to the analysis on psychological distress trajectories among those with or 
without fatal CHD or non-fatal MI, the CIs of the groups with and without fatal or 
non-fatal stroke overlapped. In keeping with that the adjustment for the event 
indicator on the intercept of the psychological distress trajectories did not provide 
statistically significant improvements of model fit (p = 0.17) suggesting that there is 
no statistically significant difference in mean predicted psychological distress scores 
between those with and without events. As described previously, the patterns of 
psychological distress over time had to be the same among those with and without 
events in this model since the interaction term between the event indicator and 
change of psychological distress over time was not included in the model. Following 
the same decision as described previously, it was not investigated if there was an 
interaction between sex and change of psychological distress over time among those 
with and without events.  
Figure 6.10: Mean predicted psychological distress trajectories of a hypothetical men aged 65 years at 
year 0 (left) and a hypothetical women aged 65 years at year 0 (right), separately for those with and 





6.4.6 Group-based trajectory modelling among those with fatal or non-
fatal stroke 
In keeping with results among those with fatal CHD or non-fatal MI, there was no 
evidence that the group of individuals with fatal or non-fatal stroke was composed of 
multiple latent classes. Models with one and two latent classes reached convergence 
in less than 500 iterations, whereas models with three and four classes did not reach 
convergence. The model with one latent class had the lowest discrete AIC indicating 
best model fit (Table 6.6). The mean predicted trajectories of psychological distress 
for a hypothetical man and women aged 65 years at year 0 are presented in Appendix 
Figure A 6. 
Table 6.6: Model characteristics of models with increasing number of latent classes among those with 











BIC  %  
class 1  
%  
class 2  
1 22 -1,634 14  3,548  3,341  100  
 
2 58 -1,621 20  3,557  3,347  13.0  87.0  
3 500 Model did not reach convergence 
4 500 Model did not reach convergence 
 
6.5 Discussion 
6.5.1 Summary of main findings 
There was some evidence of differences between mean predicted psychological 
distress scores among those with and without cardiovascular events in the time prior 
to diagnosis, death, or end-of follow-up but no clear evidence for differences in the 
patterns of psychological distress over time. The mean predicted scores of 
psychological distress were higher among those with fatal CHD or non-fatal MI than 
among those who did not have an event over the same time period. The difference in 
psychological distress scores between groups was constant over time. Although CIs 
did not overlap, the difference between groups was small and might not be clinically 
meaningful. A similar pattern was observed when psychological distress trajectories 
among those with fatal or non-fatal stroke were compared to those who remained 
free from stroke over the same time period. However, the difference between groups 




suggest a statistically significant difference between mean scores of psychological 
distress. For both outcomes, the intercepts of the psychological distress trajectories 
were higher among women than men. Differences in the shape of the trajectories 
among men and women with and without events were not investigated since 
numbers of events were considered too small to add a three-way interaction term. 
There was no evidence for latent classes with varying psychological distress 
trajectories among individuals with fatal CHD or non-fatal MI and those with fatal or 
non-fatal stroke during follow-up. Although trajectories of psychological distress 
differed between individuals in descriptive analyses, the one-class solution offered 
the lowest discrete AIC value for both outcomes. Of note, the discrete AIC values of 
models with varying number of classes were very close to each other indicating that 
they provide good alternatives to each other. Interestingly, the three class solution of 
psychological distress trajectories among those with a fatal CHD or non-fatal MI was 
very similar to the three psychological distress trajectories identified as part of the 
ALSWH analysis that suggested stable low, stable moderate and a fluctuating pattern 
of depressive symptoms over time. The model with a three class solution among those 
with fatal or non-fatal stroke did not reach convergence in less than 500 iterations, 
possibly due to lack of statistical power as a result of the lower number of individuals 
with fatal or non-fatal stroke during follow-up. 
6.5.2 Strength and weaknesses of study 
6.5.2.1 Chance 
The data requirements with regards to sample size and number of data points (see 
section 5.3.3.2.1 Latent process mixed modelling) were met in this analysis. However, 
lack of statistical power might have influenced findings, especially in the analysis on 
fatal or non-fatal stroke. First, p-values were used to identify the probability of 
finding the observed or more extreme baseline differences between those with and 
without events during follow-up given that the null hypothesis of no difference 
between groups was true. Baseline differences were considered statistically 




that there truly was no difference between groups or that the analysis lacked 
statistical power to identify differences between groups. This might have been 
particularly important among those with and without stroke during follow-up due to 
the low number of events. Furthermore, p-values were used to detect statistically 
significant improvements of model fit using the Wald test. For both outcomes neither 
the interaction term between change of psychological distress score over time and the 
event indicator nor the covariate study phase significantly improved the model fit at 
the 5% significance level. Again, this might be because there truly was no interaction 
and improvement of model fit. However, a different explanation could be lack of 
statistical power to detect an interaction. Second, the possibility of chance was 
considered by providing CIs. Generally, bigger sample sizes and larger number of 
events improve the precision of estimates and narrow CIs. CIs were relatively narrow 
in the retrospective trajectory analyses among those with and without fatal CHD or 
non-fatal MI and among those with and without fatal or non-fatal stroke. However, 
CIs of psychological distress trajectories did not overlap in the analysis on fatal CHD 
or non-fatal MI whereas they did overlap between those with and without stroke 
during follow-up. Overlapping CIs indicate that differences between groups might 
have been due to chance alone. As described above, one potential explanation for this 
finding was the smaller number of events in the analysis on fatal or non-fatal stroke. 
In order to investigate this further, it would be of interest to repeat the analysis once 
the information on events in study phases 9 and 11 were validated by the Whitehall 
II study team. In addition, CIs of trajectories of potential latent classes were wide and 
overlapped. The one class solution was the preferred solution in this analysis. 
However, it has been discussed that one disadvantage of latent class analysis is the 
potential lack of statistical power due to differently sized subgroups and small 
numbers among latent classes (Vistisen et al, 2014). Therefore, the one class solution 
might have been identified as the preferred option because there was insufficient 





This analysis has major advantages over existing studies. One major strength of the 
analytical approach is the use of repeated measures of psychological distress. The use 
of repeated measures over time allowed for fluctuating exposure levels across 
measurements of the same individual. This is a major advantage over existing studies 
since those frequently relied on the use of a baseline measure of the exposure (see 
section 3.4.2.3 Exposure assessment for more detail). Furthermore, due to the use of 
scores of psychological distress the creation of an arbitrary cut-off was avoided. 
Applying cut-offs to identify individuals with and without psychological distress 
might lead to misclassification of individuals, especially misclassification of those 
with scores close to the cut-off value. A further strength is the long follow-up that 
allowed an assessment of psychological distress trajectories over around 25 years. The 
long follow-up was particularly important since CVD are often preceded by a long 
subclinical phase of atherosclerosis development. For example, one study among 
individuals aged 65 years and older suggested that 62% of individuals without 
clinical CVD had subclinical CVD (Kuller et al, 2006). Since the prevalence of 
subclinical CVD increases with age, younger participants are less likely to have 
subclinical CVD at baseline. Participants of the Whitehall II study were aged between 
35 to 55 years at baseline. Ideally, participants would have been even younger at 
baseline but the advantages of the Whitehall II study with regards to the rich 
information on psychological distress over time outweighed its disadvantage of not 
having an even younger sample at baseline. 
One disadvantage of the analysis is that the GHQ scale is a non-specific measure of 
psychological distress rather than a measure of depressive symptoms. The GHQ and 
CES-D rating scales have been validated against the revised Clinical Interview 
Schedule (CIS-R), a structured diagnostic interview for common mental disorders 
(Lewis et al, 1992), using a random sample of Whitehall II participants supplemented 
with Whitehall II participants with depression (Head et al, 2013). Sensitivity and 
specificity values for detecting any mental disorder were 86% and 87% for the GHQ 




episode were 78% and 83% for the GHQ and 89% and 86% for the CES-D. Head et al 
(2013) concluded that both scales had good validity for detecting any mental 
disorders and depressive episodes. However, in the investigation of the validity of 
the GHQ scale for detecting depressive episodes a four-item subscale was identified 
from the 30-item GHQ scale which was not used in this analysis. Therefore, it was 
likely that the GHQ scores used in this analysis represented a measure of non-specific 
psychological distress rather than a measure of depressive symptoms. It would have 
been interesting to compare results using the psychological distress rating scale with 
results using the CES-D scale. Unfortunately, the CES-D scale was first introduced in 
study phase 7. Whilst there were repeat assessments of depressive symptoms in study 
phases 9 and 11, these study phases could not be used in this analysis due to the lack 
of validated outcomes. Once outcomes are validated for these waves and additional 
assessments of depressive symptoms are collected, it will be of interest to compare 
the findings based on psychological distress with findings based on depressive 
symptoms. However, it should be noted that this would not have influenced the 
internal validity of results but reduced the comparability of findings with other parts 
of this project. 
The Whitehall II study population is not representative of the general population. The 
characteristics of the study population reflect the composition of the Civil Service at 
study baseline (Marmot & Brunner, 2005). Most participants are white collar workers 
in stable employment, there are no manual worker in the sample, and two thirds of 
the sample are men. As a result, the prevalence of high psychological distress might 
be lower in the Whitehall II study population than in the general population. 
Furthermore, the target population only included civil servants in London offices 
thereby limiting the geographical generalisability.  
Loss to follow-up might have introduced selection bias. In study phase 8 (last phase 
used in analyses on fatal or non-fatal stroke) 75.2% of those alive participated whereas 
72.3% of those alive participated in study phase 9 (last phase of analyses on fatal 




lost to follow-up was missing, the analysis was inevitably restricted to those not lost 
to follow-up. Since those not lost to follow-up might have differed in their participant 
characteristics, the analysis might be influenced by selection bias. Additionally, the 
selection of participants might have influenced the generalisability of findings. 
Participants of the Whitehall II study were British civil servants of mainly white 
ethnicity. Whilst this would not have influenced the internal validity of findings, it 
might have influenced the external validity. 
Psychological distress might have been underreported due to the stigma attached to 
mental disorders. If there was reporting bias, the mean scores of psychological 
distress would likely be underestimated. This effect would have been non-differential 
between individuals with and without cardiovascular events since these events had 
not happened at the time of reporting psychological distress. Furthermore, it seems 
unlikely that the effect of underreporting differed over time. As a result, 
underreporting would have biased findings towards the null. In this analysis, men 
had consistently lower mean score of psychological distress than women. If men were 
more likely to underreport depressive symptoms, the lower mean scores of 
psychological distress might reflect reporting bias rather than true differences in 
mean scores among men and women.  
6.5.2.3 Confounding 
Confounding might have influenced findings. Results were adjusted for sex, age at 
year 0 and study phase, all of which were potential time-constant confounding 
factors. Whilst no adjustment is perfect, it is likely that it accounted for most of 
difference in age profiles in the groups with and without events. However, it should 
also be noted that there was longer follow-up of those without events than those with 
events. It is likely that this affected the precision of the estimation of trajectories of 
those with events at longer follow-up.  
An existing publication using the Whitehall II study that investigated the trajectories 
of psychological distress and depressive symptoms before diagnosis of dementia 




adjust for ethnicity in this analysis since the vast majority of Whitehall II participants 
were of white ethnicity. Furthermore, the analysis was not adjusted for education 
since that information was not available at baseline. Furthermore, there were no 
baseline differences in occupational position between those with and without events 
during follow-up. Additionally, it was decided not to adjust the analysis for time-
varying factors since events during follow-up might influence the trajectories as 
potential mediating factors. It would have been of interest to investigate if there were 
differences in the shape of psychological distress trajectories over time among men 
and women with and without events. This was not investigated since numbers of 
events were considered too small to add a three-way interaction term. 
6.5.3 Comparison of findings with previous research 
This is the first study that compared psychological distress trajectories prior to 
diagnosis with cardiovascular events to psychological distress trajectories among 
individuals free from cardiovascular events over the same time period. Thus, this 
study complements existing studies by investigating if reverse causation or overlap 
of somatic symptoms might explain the association between psychological distress 
and CVD. Due to the use of a retrospective timescale, an advantage over existing 
studies is that this study did not create a window in which the exposure was defined 
and assessed the risk of outcomes in the period after the exposure window but used 
information on the exposure in all waves prior to cardiovascular events, death, or end 
of follow-up. Also, the use of psychological distress as continuous measure allowed 
for an assessment of the change in psychological distress over time without creating 
an arbitrary cut-off. Whilst it might be argued that a comparison of those with high 
and low psychological distress scores is clinically more meaningful, the use of 
continuous scales is advantageous from a statistical power standpoint.  
Three existing studies have investigated the relationship between psychological 
distress, depressive symptoms and risk of CHD and stroke using data from the 
Whitehall II study (Brunner et al, 2014; Nabi et al, 2008; Stansfeld et al, 2002). Stansfeld 




were higher among men and women with high psychological distress, compared to 
those with low psychological distress at baseline. In keeping with that, Brunner et al 
(2014) reported higher hazards of fatal CHD or non-fatal MI among individuals with 
high psychological distress, relative to those with low psychological distress over five 
years and over ten years of follow-up. A five year lag period was used in the latter 
analysis to minimise the potential effect of reverse causation. Furthermore, high 
psychological distress was associated with higher hazards of fatal or non-fatal stroke 
over five years but not over ten years of follow-up using a five year lag period 
(Brunner et al, 2014). There was evidence of a dose-response relationship between 
number of study phases with high psychological distress and hazard of fatal CHD or 
non-fatal MI but not for risk of fatal or non-fatal stroke. However, estimates were 
imprecise due to low number of events. Additionally, there were higher hazards of 
fatal CHD or non-fatal MI and fatal or non-fatal stroke among those with high 
depressive symptoms, relative to those with low depressive symptoms over 2.5 years 
of follow-up. Brunner et al (2014) concluded that there was evidence of an association 
and dose-response relationship between psychological distress and fatal CHD or non-
fatal MI whereas the association between psychological distress and fatal or non-fatal 
stroke was explained by reverse causation. The observed dose-response effect was 
only partially seen in a different study using data from the Whitehall II study (Nabi 
et al, 2008). Using information from two study phases to identify individuals with 
high psychological distress in none, one, and two of the study phases, there were 
increased hazards of fatal CHD or non-fatal MI among individuals with high 
psychological distress in two study phases but not in one study phase, relative to 
those with low psychological distress in all study phases over a mean follow-up of 
11.1 years. Differences between the study results might be explained by differences 
in the categorisation of the cumulative effect of psychological distress. Whilst Nabi et 
al (2008) used three categories of none of the times, once, and two times to investigate 
the effect of cumulative phases of high psychological distress on fatal CHD or non-
fatal MI, Brunner et al (2014) used categories of none of the times, one to two times, 




The pattern of the trajectories of psychological distress prior to diagnosis of 
cardiovascular events was different from the pattern of psychological distress before 
diagnosis of dementia. Using data from the Whitehall II study, Singh-Manoux et al 
(2017) observed a steep increase in psychological distress scores a decade before 
diagnosis of dementia whilst scores of psychological distress remained low among 
those free from dementia over the same time period. In contrast, this analysis showed 
slightly higher mean scores among those with cardiovascular events than among 
those without cardiovascular events throughout follow-up but the difference 
between mean scores of psychological distress was constant over time. 
Whilst the results by Singh-Manoux et al (2017) seemed to support that high 
psychological distress prior to diagnosis of dementia was a prodromal feature of 
dementia itself, this was an unlikely explanation for observed differences between 
those with and without cardiovascular events in this analysis. One potential 
explanation why there might not have been clear evidence for differences between 
those with and without events in terms of the change of psychological distress over 
time might be lack of power to detect statistically significant interaction between the 
event indicator and change of psychological distress over time. However, this 
explanation seems unlikely, at least for the outcome of fatal CHD/ non-fatal MI, given 
that there was sufficient statistical power to detect interaction in the study by Singh-
Manoux et al (2017). Singh-Manoux et al (2017) used the same data source and the 
number of participants with dementia during follow-up was lower than the number 
of participants with fatal CHD/ non-fatal MI in this analysis (n = 322 and n = 655, 
respectively). Furthermore, findings are unlikely explained due to chance alone since 
results were consistent for both fatal CHD or non-fatal MI and fatal or non-fatal 
stroke. The common soil hypothesis might explain why participants with events had 
consistently higher mean psychological distress scores before time of diagnosis, death 
or end of follow-up. As described previously some researchers believe that 
depression and CVD share common roots (common soil hypothesis), but the effect of 
these common roots manifests earlier on one disease than the other (see section 2.3.2.3 




variants (genetic pleiotropy) (de Geus, 2006), early-life stressors or low SES (Mortimer 
et al, 2016). However, it seems unlikely that these common roots would have the same 
effect on psychological distress scores over 25 years of follow-up. A further potential 
explanation is that consistently higher mean scores of psychological distress are 
indeed a risk factor for cardiovascular events later in life. However, it should be noted 
that the difference between the trajectories of psychological distress were very small 
and CIs overlapped between those with and without fatal or non-fatal stroke which 
might suggest that the difference is not clinically meaningful. Therefore, a third 
potential explanation is that differences between mean scores of psychological 
distress were observed due to chance alone. 
6.6 Conclusion 
In a prospective study of British civil servants, there was some evidence of differences 
between mean psychological distress scores among those with and without 
cardiovascular events in the time prior to diagnosis, death, or end-of follow-up but 
no clear evidence for differences in the patterns of psychological distress over time. 
Thus, it is unlikely that reverse causation or overlap of symptoms between subclinical 
CVD and somatic symptoms of psychological distress explain the association 




Chapter 7: Discussion 
7.1 Introduction 
Depression and CVD both substantially contribute to the global burden of diseases. 
An association between depression and CVD onset and progression has been 
observed in numerous primary studies and existing reviews but depression has not 
been conclusively identified as independent risk factor for CVD. Several potential 
mechanisms have been proposed, some of which causally relate depression to CVD 
whereas others suggest that similar aetiological processes or methodological 
shortcomings of the previous studies were likely to be responsible for the observed 
association.  
This project aimed to improve our understanding of the relationship between 
depression and subsequent CVD. A systematic review and meta-analysis was 
performed to identify shortcomings of existing studies that could potentially be 
overcome in this project. Quantitative analyses of three cohort studies and linkage to 
administrative datasets were used to further our understanding of the relationship. 
The analyses benefitted from strengths of each of the datasets and were able to 
address some of the limitations of the prior evidence base.  
This discussion is subdivided into three parts. The first part outlines the contribution 
of this PhD to our understanding of the relationship between depression and 
subsequent CVD and relates them to methodological shortcomings identified in the 
systematic review. The second part of this discussion highlights strengths and 
limitations of this project as a whole. It also contains a discussion of potential 
alternative explanations for the observed association that were outside the scope of 
this project but that could be addressed in future research. This section will not repeat 
the discussion of strengths, limitations and potential sources of error of the systematic 
review and primary data analyses since these issues have been discussed in detail in 
the respective chapters. In the third part of this discussion potential implications for 




7.2 Contribution of this project to our understanding of the 
relationship between depression and subsequent CVD 
This project furthered our understanding of the relationship between depression and 
subsequent CVD by investigating the merit of potential non-causal explanations of 
the observed association. First, the residual confounding hypothesis was investigated 
using data from the UK Biobank. Depression, defined in different ways, was 
associated with increased hazards of MCVE in unadjusted, partially adjusted and 
fully adjusted models. Furthermore, there was the suggestion of a possible dose-
response relationship. The UK Biobank collected a great breadth of variables, 
allowing for adjustment for a wide range of potential confounding factors. Despite 
some potential remaining residual confounding, the strength and consistency of the 
association between depression and hazard of MCVE strongly suggests that the 
association between depression and CVD is unlikely to be due to residual 
confounding alone. It should also be noted that some of the covariates adjusted for in 
the analysis may have occurred after the onset of depression and therefore may be on 
the causal pathway. Due to their genetic determination and the age of our sample 
participants, it is likely that the covariates of the partially adjusted model occurred 
before the onset of depressive symptoms. In contrast, some covariates of the fully 
adjusted model, such as weight gain or the onset of comorbidities, may have occurred 
after the onset of depression. If so, the partially adjusted model, which provided 
stronger effect estimates than the fully adjusted model, may have offered better 
estimates of the total effect of depression on MCVE risk.  
Second, the hypothesis that the observed association was due to reverse causation or 
misclassification of individuals due to the overlap between somatic symptoms of 
depression and symptoms of subclinical CVD was investigated using data from the 
Whitehall II study. Previous studies tried to address the issue of reverse causation by 
excluding participants with events in the first months or years of follow-up (Brunner 
et al, 2014; Everson et al, 1998; Gustad et al, 2014; Scherrer et al, 2011; Stürmer et al, 
2006; Wouts et al, 2008), by using depressive rating scales that did not contain somatic 




Langvik & Hjemdal, 2015), or by conducting sensitivity analyses in which the authors 
excluded items from the depressive symptom rating scale that captured somatic 
symptoms (Barefoot & Schroll, 1996). The analysis based on data from the Whitehall 
II study was the first to address the reverse causation hypothesis in a more 
sophisticated way using repeat assessments of psychological distress before diagnosis 
of cardiovascular events. There was some evidence of higher mean psychological 
distress scores among those with cardiovascular events than among those without 
cardiovascular events prior to diagnosis, death, or end of follow-up. However, the 
difference in mean scores of psychological distress was small and constant over time. 
If higher psychological distress scores were indeed an indication of prodromal CVD 
itself, one would expect an increase in psychological distress scores in the years 
immediately prior to development of CVD. Therefore, reverse causation or 
misclassification of individuals due to an overlap in somatic symptoms did not seem 
to explain the observed association in this dataset. Instead the results suggest that 
psychological distress and CVD share common roots (common soil hypothesis) or 
that psychological distress is causally related to CVD.  
In addition to investigating these non-causal explanations, the review highlighted 
that the vast majority of existing studies relied on single measures of depression or 
depressive symptoms. Taking into account that depressive symptoms may not be 
static over time, I identified three latent classes with stable low, stable moderate, and 
fluctuating depressive symptoms in the young cohort of the ALSWH. Importantly, 
the three latent classes did not only differ in their pattern of depressive symptoms 
over time but also were characterised by differences in terms of their cardiovascular 
risk profiles at baseline and end of follow-up. It was particularly interesting that the 
patterns of change of BMI over time differed between women with stable low, stable 
moderate, and fluctuating depressive symptoms. Although the mean BMI of all 
groups increased over time, the increase was more rapid among those with stable 
moderate and fluctuating depressive symptoms than among those with stable low 
depressive symptoms. The difference in mean scores of BMI at 20 years of age was 




potential mediators between depression and subsequent CVD. Since this project was 
one of the first to investigate the change of BMI over time among women with 
different patterns of depressive symptoms, it is of interest to replicate this analysis 
using data from other cohort studies. As a next step, there is a need to investigate the 
relevance of different patterns of change of depressive symptoms in terms of risk of 
subsequent CVD and the role of BMI as mediating factor using more advanced 
statistical analyses (see section 7.4 Implications for research for more detailed 
discussion). Furthermore, these results may be important with regard to potential 
interventions aiming at the prevention of weight gain, especially among individuals 
with stable moderate and fluctuating depressive symptoms (see section 7.5 
Implications for practice). 
Moreover, this project highlighted that the association between depression and CVD 
was stronger among individuals from low socioeconomic backgrounds. The factors 
contributing to the increased risk of CVD among this group of participants are likely 
to be multifactorial. First, individual level factors such as behaviours, attitudes and 
habits might contribute to the observed association. For example, individuals with 
depression and a low socioeconomic status may be less likely to seek help than 
individuals with depression and a high socioeconomic status. This might be due to 
differences in the individual’s attitudes towards health services or the availability of 
resources such as transport to reach services (Magaard et al, 2017; Roberts et al, 2018). 
The proportion of individuals that seek help might not align with the proportion of 
individuals that need treatment for depression. Given that individuals from low 
socioeconomic backgrounds are more likely to suffer from multimorbidity from early 
adulthood onwards (McLean et al, 2014), one would expect a higher need for services 
and treatment among these individuals. Furthermore, there was a large proportion of 
individuals with adverse health behaviours in this group of participants in the UK 
Biobank analysis. If less help-seeking occurs despite higher needs for services and 
treatment, the increased risk of CVD among individuals with depression and a low 
socioeconomic status may reflect the association between more severe or untreated 




contribute to the observed pattern. For example, factors related to health care services 
such as availability of services, waiting times and quality of care might affect the 
observed association. Using routine data from 956 general practices in Scotland 
McLean et al (2015) have investigated the relationship between multimorbidity, 
general practice resources, workload and deprivation. They concluded that general 
practices in more deprived areas carried out more consultations but the gradient did 
not align with the social gradient in need due to higher levels of multimorbidity and 
mortality. Furthermore, general practices in more deprived areas did not receive 
additional funding to meet the higher need in more deprived areas. These findings 
are of particular interest with regard to implications for practice (see section 7.5 
Implications for practice). 
Similarly, this project highlighted that the association between depression and CVD 
was stronger among those with physical comorbidities. If the comorbidities indeed 
occurred before the onset of depression, potential reasons for this observed pattern 
might be that depression might make self-management strategies more difficult 
among individuals with existing diabetes, hypertension or high cholesterol levels. For 
example, depression has been shown to be a risk factor for medical noncompliance 
among individuals with diabetes (DiMatteo et al, 2000; Gonzalez et al, 2008) which 
might lead to adverse effects such as poor glycaemic control among individuals with 
comorbid depression and diabetes (Lustman et al, 2000). It is also possible that 
individuals with mental-physical comorbidity receive worse quality of care which in 
turn might increase their risk of adverse events such as cardiovascular events 
(Jørgensen et al, 2017; Kurdyak et al, 2017). If instead the onset of depressive 
symptoms or the diagnosis of depression preceded the onset of diabetes, 
hypertension and high cholesterol levels, these physical comorbidities may be on the 
causal pathway between depression and CVD. Interestingly, individuals with 
depression but no hypertension were not at increased risk of CVD, relative to those 
with neither depression nor hypertension. However, the risk of individuals with 
depression and hypertension exceeded the sum of the risks due to depression alone 




(see section 4.5.3.4 The role of comorbidities), there is a need to replicate this analysis 
in future studies. Also, further research is needed to improve our understanding of 
the role of comorbidities in the relationship between depression and CVD (see section 
7.4 Implications for research). 
7.3 Strengths and limitations 
7.3.1 The use of three cohort studies in this project 
The use of three different datasets in this project offered advantages but also had 
disadvantages. One advantage of using three cohort studies and different analytical 
approaches was that various aspects of the relationship between depression and 
subsequent CVD were investigated. Thus, a number of shortcomings of the existing 
evidence base could be addressed. More specifically, I addressed potential 
explanations of the observed association such as residual confounding, reverse 
causation, and potential overlap of somatic symptoms of individuals with worsening 
vascular disease and depressive symptoms. Furthermore, I improved upon one of the 
main methodological shortcomings of the evidence base by using repeat assessments 
of depressive symptoms instead of a single measure and I identified factors that 
modified the relationship between depression and CVD. A further advantage of using 
three cohort studies and different analytical approaches was that it provided me with 
experience of using different datasets and novel methods. A disadvantage of using 
three datasets was that I could not use the same measure of depression and CVD for 
all analyses since different information was collected in each of the cohort studies. For 
example, whilst various measures of depression were used in analyses based on the 
UK Biobank, measures of depressive symptoms and psychological distress were used 
in the analyses of the ALSWH and Whitehall II study, respectively. A further 
disadvantage of using three cohort studies was the considerable time spent on data 
management and data cleaning. Since this project did not aim to compare findings of 
similar analyses across studies, it was decided that the advantages of using three 
datasets outweighed its disadvantages. However, I acknowledge that findings of this 




7.3.2 The need for an accurate definition of depression 
A major challenge of this project was that depression was not well-defined. As 
highlighted in the background chapter and evident in the systematic review, there is 
a wide range of assessment tools for clinical depression and depressive symptoms 
(see sections 2.1.2 Assessment of depression and 3.4.2.3 Exposure assessment). Due 
to the large number of potential combinations of diagnostic criteria and the variety of 
information collected on different depressive symptoms, people who share related 
symptoms but with different aetiological and biological mechanisms might be 
grouped together under the term depression.  
The issue of defining depression created challenges in my PhD. First, the absence of 
a gold standard to measure depression or depressive symptoms was evident when I 
was trying to identify suitable cohort studies to investigate the relationship between 
depression and CVD. The identified cohort studies assessed depression or depressive 
symptoms using a wide variety of measurement tools. Furthermore, some of the 
identified studies changed their measurement of depression during follow-up. Under 
the assumption that all assessment tools measure the same construct of depression 
and that all tools identify the same group of participants as depressed, the 
heterogeneity of measurement tools used would not be problematic. However, as 
discussed previously (see section 2.1.2.2 Rating scales), it has been highlighted by 
researchers that different depressive symptom rating scales should not be used 
interchangeably due to the lack of content overlap. Ideally, I would have liked to use 
the same measure of depression or depressive symptoms in all of the projects. 
However, given the variation in measures used across the identified cohort studies, 
it was not possible to focus on just one depression or depressive symptom measure. 
As mentioned previously, the results of the projects might therefore be specific to each 
measure used. It remains to be determined how well the results of this thesis are 
generalisable to all patients with “depression”. As a next step, it will be of interest to 
determine a preferred measurement tool to assess depression in research. 
Considering the large input of human and financial resources to conduct interviews 




cohort studies. Instead, it is very likely that cohort studies will continue to use 
depressive symptom rating scales or linkage to routinely collected health records. In 
these cohort studies the use of existing validated instruments should be prioritised 
over creating new measurement tools. Furthermore, a justification for why a certain 
tool was used should be presented. 
Second, the issue of defining depression had an impact on the interpretation of my 
results. By relying on depressive symptoms and psychological distress sum scores in 
the ALSWH and Whitehall II projects, I implicitly made two assumptions (Fried, 
2015). First, I assumed that depression is a distinct disease category. Second, I 
assumed that all symptoms of depression are equally important. However, these 
assumptions might not be valid. As highlighted by Fried (2017b), certain symptoms 
of depression might be more important with regard to risk of CVD than others. Thus, 
my analytic approach simplified a potentially much more complex situation in which, 
for example, somatic symptoms of depression might be more important than affective 
symptoms with regard to risk of CVD. Whilst I might have lost potentially important 
information by not looking at individual items of rating scales, the use of individual 
items has remained challenging in practice since rating scales were neither developed 
nor validated to measure individual depressive symptoms (Fried et al, 2016). In future 
studies, it will be essential to acknowledge the assumptions that are made when 
relying on sum scores of depressive symptoms or psychological distress.  
7.3.3 The challenge of establishing causality between depression and 
CVD 
7.3.3.1 Methods of assessing causality 
One conventional way of assessing whether an epidemiologic association between an 
exposure and outcome of interest is causal is to assess whether is meets the Bradford-
Hill criteria of causality (Hill, 1965). The nine proposed criteria are: Strength, 
consistency, specificity, temporality, biological gradient (dose-response effect), 
plausibility, coherence, experiment, and analogy (Hill, 1965). Applying this concept 




risk of CVD, six of the criteria are met. The findings of this PhD support a strong and 
consistent association, temporality, and potentially support a biological gradient. 
Furthermore, previous research has reported plausible mechanisms for the observed 
association and the findings are not in conflict with the general knowledge of the 
history and biology of both depression and CVD (coherence). Three criteria might not 
be met. First, so far randomised controlled trials have not been able to show that a 
change in depressive symptoms results in a change of risk of CVD. Second, the 
specificity criterion might not be met. Hill (1965) suggested that associations are more 
likely to be causal when one exposure only causes one disease. In contrast, there are 
associations between clinical depression or depressive symptoms and a number of 
different health outcomes, such as all-cause mortality, CVD, and possibly cancer (lack 
of specificity). However, researcher have argued that the specificity criterion might 
be more relevant for infectious diseases or chemical exposures than for more complex 
exposures, such as mental illnesses (Fedak et al, 2015). Third, the analogy criteria 
specifies that the observed association should be similar to other known causal 
associations. To the best of my knowledge, no definite causal relationship has been 
established between severe mental illnesses and cardiovascular diseases yet. 
Another more direct way of assessing whether an observed association between an 
exposure and outcome of interest might be causal is to infer the cause-effect 
relationship from data. In most cases, data from randomised controlled trials are used 
to infer such relationship between an intervention and outcome of interest. Some 
researchers have argued that observational data could be used to infer cause-effect 
relationships using a counterfactual approach to causation (Hernán & Taubman, 
2019). In these situations, observational data are used to mimic randomised controlled 
trials that might not be feasible, for example due to high financial resources required, 
or might not be ethical. However, these causal inference methods provide valid 
estimates of the causal effect under strong assumptions. One such assumption is the 
consistency assumption. Of note, this consistency assumption (described in more 
detail below) is not equivalent to the consistency assumption of the Bradford-Hill 




7.3.3.2 The consistency assumption 
Covert heterogeneity of depression is particularly problematic if one is interested in 
causal inference since the term depression might “encompass a multitude of 
meanings” (Rehkopf et al, 2016, p2). The reason behind this is that exposures with 
multiple subcomponents and heterogeneous underlying experiences, often referred 
to as compound treatments, have been shown to violate the consistency assumption 
(Hernán & VanderWeele, 2011; Rehkopf et al, 2016). The consistency assumption is 
an important assumption for the application of causal inference methods using the 
counterfactual approach to causation. It requires that there are no two versions of 
treatments for which the potential outcome would be different had everyone been 
exposed to version A or version B (Rehkopf et al, 2016). For example, we might be 
interested in estimating the causal effect of changing the depressive symptom sum 
score on risk of CVD. Two potential treatments of depression might be the use of an 
antidepressant and the use of counselling. Assuming both interventions are equally 
efficient, they will result in the same change of the depressive symptom sum score. 
However, both interventions might have direct effects on the outcome of interest that 
are not mediated through depression. Therefore, the effect of the interventions on 
CVD might be different even though both interventions resulted in the same change 
of the depressive symptom sum score. Since the potential outcome would be different 
had everyone been exposed to the antidepressant or to counselling sessions, the 
exposure “changes in depressive symptom sum scores” violates the consistency 
assumption. Acknowledging that all treatments might be somewhat vague, Hernán 
& Taubman (2008) highlighted that there is a question of degree. It was argued that 
treatments should be specific enough so that variation between different versions of 
the treatment is irrelevant to the potential outcome (treatment-variation irrelevance) 
(Hernán & VanderWeele, 2011). In contrast, researchers should avoid estimating the 
average causal effect of treatments with multiple versions that differ in their effect on 





7.3.3.3 Causal inference in research on psychological disorders 
There is an ongoing discussion about whether or not causal inference methods should 
be used in research on psychological disorders. Due to its multiple subcomponents 
and considerable heterogeneity, a violation of the consistency assumption is plausible 
and likely for depression. Some researchers argue that causal inference methods 
should not be used in the absence of well-defined interventions (Hernán & Taubman, 
2008; Hernán & VanderWeele, 2011). Hernán & VanderWeele (2011) further 
encourage researchers to imagine a hypothetical RCT, even if it might not be ethical 
or feasible, to ensure relevant causal questions that fulfil the consistency assumption. 
Hernán & Taubman (2008) acknowledged that an investigation of the effect of 
compound exposures may generate interesting hypotheses but they additionally 
highlight that it remains unclear to what extent estimates can be translated into 
policies. Other researchers have more nuanced opinions on the application of causal 
inference methods for compound treatments (Glymour & Kubzansky, 2017; Rehkopf 
et al, 2016). Rehkopf et al (2016) and Glymour & Kubzansky (2017) stated that the 
importance of the consistency assumption might be higher once a research area 
matures whereas it might be less relevant in the early stages of research questions. 
Glymour & Kubzansky (2017) further highlighted the difficulty of imagining 
hypothetical interventions in psychosocial epidemiology and emphasised that 
progress towards a causal understanding might be possible even in the presence of a 
violation of the consistency assumption. To provide a complete picture, it should be 
noted that some authors disagree with the concept of consistency as an assumption 
that needs to be evaluated. Whilst the evaluation of the consistency assumption is an 
integral part of causal inference based on the counterfactual approach (Hernán & 
VanderWeele, 2011), other researchers argue that consistency will hold for 
individuals whether or not the exact version of an exposure is known (Van der Laan 
et al, 2005), or that it is a logical consequence when using nonparametric structural 
equation models (Pearl, 2010). 
There are additional methodological considerations that need to be taken into account 




of CVD. Since longitudinal studies assess the exposure and covariates repeatedly over 
time, exposure-covariate feedback (often referred to as treatment-confounder 
feedback) needs to be considered in the analytic approach (Hernán & Robins, 2019). 
Treatment-confounder feedback refers to a situation in which covariates affect the 
exposure and prior exposure status affects the covariate (Figure 7.1). In the presence 
of treatment-confounder feedback simply adjusting for time-varying covariates leads 
to biased results since time-varying covariates might act as confounders and 
mediators at the same time (Glymour et al, 2019). One analytical approach that 
accounts for potential treatment-confounder feedback is the use of marginal 
structural models in which the analysis is adjusted for time-invariant covariates 
whereas inverse probability weighting is used for time-variant confounders. As 
discussed in section 3.5.2.3 Confounding and mediation, this approach has been used 
in two published studies on the effect of depression on the risk of CVD (Gilsanz et al, 
2017; Gilsanz et al, 2015). Whilst this approach can deal with treatment-confounder 
feedback, it does not overcome the likely violation of the consistency assumption. One 
example of exposure-covariate feedback is the relationship between psychotropic 
medication, depression severity and risk of CVD. This example is further described 
in section 7.3.4.1 The need to disentangle the role of depression and psychotropic 
medications. 
 
Figure 7.1: Directed acyclic graph of treatment-confounder feedback, adapted from Glymour et al 
(2019) 
NB: Presence of arrow; causal effect is assumed or unwilling to assume that causal effect does not exist; 





7.3.4 Alternative explanations of the observed association outside the 
scope of this project 
7.3.4.1 The need to disentangle the role of depression and psychotropic 
medications 
Whilst a number of shortcomings of the existing evidence base could be addressed, 
some alternative explanations of the observed association between depression and 
CVD remain to be investigated. For example, as discussed in the background section 
of this thesis, iatrogenic effects of psychotropic medications might partly explain the 
observed association between depression and CVD. Whilst investigating this 
alternative explanation was outside the scope of this project, it might result in 
valuable insights into the relationship between depression and CVD.  
Antidepressant and antipsychotic drug use have been shown to be associated with 
increased risks of MCVE in systematic reviews and meta-analyses. Antidepressant 
use, defined either as use of any antidepressant, SSRI or tricyclic antidepressant 
(TCA) alone has been shown to be associated with increased risk of total stroke (Pan 
et al, 2011b; Shin et al, 2014; Trajkova et al, 2019), ischaemic stroke (Shin et al, 2014), 
intracranial (Shin et al, 2014) and intracerebral haemorrhage but not subarachnoid 
stroke (Hackam & Mrkobrada, 2012; Shin et al, 2014). Furthermore, SSRI but not TCA 
were associated with increased risk of CBVD (Biffi et al, 2017), and TCA but not SSRI 
were associated with increased risk of acute heart disease (Biffi et al, 2017) and MI 
(Undela et al, 2015). Antipsychotic drug use has been shown to be associated with 
increased risks of stroke in two existing meta-analyses (Hsu et al, 2017; Zivkovic et al, 
2019) whereas results on the risk of MI among individuals with antipsychotic drug 
use are conflicting (Brauer et al, 2011; Huang et al, 2017; Yu et al, 2016; Zivkovic et al, 
2019). However, most authors emphasised that a cautious interpretation of results is 
warranted due to high between-study heterogeneity (Biffi et al, 2017; Brauer et al, 
2011; Huang et al, 2017; Shin et al, 2014; Zivkovic et al, 2019). 
Two of the meta-analyses on the association between antidepressant use and 
subsequent stroke aimed to estimate the effect of antidepressant use on risk of stroke, 




risk remained after restricting their analyses to studies that accounted for potential 
confounding by depression, the researchers argued for an independent effect of 
antidepressants. Furthermore, Trajkova et al (2019) highlighted that there was an 
effect of antidepressant use on risk of stroke in a case-crossover study (Wu et al, 2011) 
which by design controls for time-invariant confounding. However, it should be 
noted that the effect of depression is unlikely to be time-invariant and not just 
depression but also severity of depression needs to be taken into account.  
It has been challenging to disentangle the effects of depression and psychotropic 
medication use since medication use likely acts as an identifier of disease severity at 
the same time. Therefore, the increased risk among individuals with medication use 
might reflect increased risk of more severe depression rather than an independent 
effect of the medication itself. Furthermore, due to treatment-confounder feedback 
between depression severity and medication use, disease severity is potentially both 
a confounder and mediator in the relationship between medication use and risk of 
CVD (see Figure 7.1 for directed acyclic graph). Glymour et al (2019) highlighted the 
importance of time-updated measures due to the feedback between depression 
severity and antidepressant use. Potential reasons for the lack of studies 
incorporating disease severity as potential confounder and mediating factor is the 
complexity of the analysis as well as the lack of datasets with detailed information on 
depression severity, medications and outcomes. One notable exception is a recently 
published study by Glymour et al (2019). Using data from 2,302 adult participants of 
the Changes In Thoughts cohort study, the authors estimated the effect of ever having 
initiated antidepressant medication on risk of first-ever stroke over 8.4 years of 
follow-up. In contrast to existing studies, Glymour et al (2019) adjusted for time-
constant confounders and applied inverse probability weights to take account of 
time-varying covariates, such as disease severity. As highlighted previously, inverse 
probability weighting is a method to condition on covariates without blocking 
potential mediating pathways (see section 3.4.2.5 Conditioning on covariates for 
detailed discussion). Glymour et al (2019) reported that individuals who used 




patients using TCA but not to patients using SSRI or other antidepressants. A 
disadvantage of this analysis was that the authors did not account for individuals 
stopping medication once they initiated it. The authors argued that they aimed to 
avoid bias due to individuals stopping medications because of side effects or health 
concerns. Nonetheless, the risk of stroke might differ between individuals who stop 
and continue taking medications. Therefore, it would be of interest to incorporate this 
aspect in future research.  
7.3.4.2 The need to investigate genetic pleiotropy in depression and CVD 
The observed association between depression and CVD might be explained through 
a genetic region that affects both depression and CVD. This concept is known as 
genetic pleiotropy (Amare et al, 2016). Genetic pleiotropy has been shown for 
depression and coronary artery disease (Hagenaars et al, 2019; Wray et al, 2018) and 
depression and stroke (Hagenaars et al, 2019; Wassertheil-Smoller et al, 2018) in some 
studies whereas other studies have not found evidence for genetic pleiotropy for 
depression and CHD (Khandaker et al, 2019) or depression and stroke (Anttila et al, 
2018). Although it was outside the scope of this project to investigate the potential 
common genetic aetiology of depression and CVD, an investigation of this alternative 
explanation for the observed associations might provide valuable insights into the 
relationship between depression and CVD. More research into potential shared 
genetic or biological mechanisms for depression and CVD is needed. However, the 
success of future studies might depend on a clear and specific definition of 
depression.  
Despite the modest heritability of depression, it has proven difficult to identify 
independent genetic loci for depression that replicate in other studies. Heritability is 
defined as the “proportion of total variance in a population for a particular 
measurement, taken at a particular time or age, that is attributable to variation in 
additive genetic or total genetic values” (Visscher et al, 2008, p255). By definition, the 
measure of heritability depends on the study population. The heritability of 




genome-wide single nucleotide polymorphism (SNP) based heritability of unrelated 
subjects was estimated to be 8.7% indicating that about one quarter of the heritability 
of depression is explained by common genetic variants (Wray et al, 2018). 
Furthermore, some studies suggested that the heritability of depression might differ 
between different depressive symptoms with somatic symptoms, such as fatigue, 
having a stronger heritable basis than non-somatic symptoms, such as suicidal 
ideation (Jang et al, 2004; Thorp et al, 2019). Thorp et al (2019) highlighted that 108 
independent genetic loci for schizophrenia had been identified whereas none had 
been identified for depression by 2014. There are several potential explanations for 
this null finding. First, the heritability estimates of depression are much lower than 
those of other severe mental illnesses suggesting that environmental factors might be 
much more important than genetic risk factors. Second, depression is much more 
prevalent than other severe mental illnesses (Thorp et al, 2019). Therefore, bigger 
sample sizes might be needed to identify genetic loci for depression. In keeping with 
that theory, more recent studies using much larger sample sizes were more successful 
in identifying genetic loci. For example, Wray et al (2018) identified 44 genetic loci, 30 
of which were new findings and 12 of which have been reported in prior studies. 
Another potential explanation for the lack of findings might be the considerable 
heterogeneity of depression. Whilst studies relying on bigger sample sizes assume 
that sample size can overcome clinical heterogeneity (Wray et al, 2018), other 
researchers have argued that there should be more emphasis on the genetic 
contribution of unique symptoms (Jang et al, 2004; Thorp et al, 2019). 
7.4 Implications for research 
The systematic review and meta-analysis convincingly shows that there is an 
association between a single measure of depression or depressive symptoms and risk 
of CVD. Furthermore, the results of the UK Biobank analysis suggest that residual 
confounding alone does not explain the observed association. Considering the results 
of the systematic review and meta-analysis and the results of the UK Biobank project, 
there is no need for additional studies on the association between a single measure of 




repeat assessments of depression, on investigating the inter-relationship of variables 
throughout follow-up, and on understanding potential mechanisms involved. 
Further research is needed that takes into account the inter-relationship of variables 
throughout follow-up. For example, a marginal structural model estimating the effect 
of changes of depressive symptoms on risk of CVD might provide valuable insights 
into the relationship between depression and CVD. In the ALSWH analysis I showed 
that there were differences in profiles of key cardiovascular risk factors across 
subgroups of women with different depressive symptom trajectories at baseline. 
Furthermore, there were differences in these cardiovascular risk factors over time. 
Whilst differences between groups at baseline might confound any relationship 
between depression and risk of CVD, changes in these characteristics during follow-
up might act as confounding and/ or mediating factors. Through the use of inverse 
probability weighting, marginal structural models account for time-varying 
confounding without blocking potential causal pathways. As explained in more 
detail previously (see section 7.3.3 The challenge of establishing causality between 
depression and CVD), the application of causal inference methods in the context of 
depression is controversial and the analyses are very complex and time-consuming. 
Furthermore, the likely violation of the consistency assumption should be 
acknowledged and discussed in future research. A potential approach might be to 
break down the exposure into more specific subcomponents when trying to evaluate 
causal effects of depression on risk of CVD. It has been highlighted that researchers 
should aim to identify specific subcomponents of depression for which, regardless of 
which component of depression is changed, the same effect would occur (treatment-
variation irrelevance) (Glymour & Kubzansky, 2017; Rehkopf et al, 2016). Potential 
subcomponents might be individual items of depressive symptom rating scales. 
However, it remains to be determined whether these subcomponents fulfil the 
consistency assumption.  
There is a need for research to now focus on understanding potential mechanisms 




of biological or lifestyle factors in the context of depression and CVD has been 
performed that accounted for treatment-confounder feedback and the likely violation 
of the consistency assumption. I agree with authors of a previous study that the 
relationship between depression or depressive symptoms, BMI and subsequent CVD 
deserves more attention (Jackson & Mishra, 2013). In contrast to findings of the study 
by Jackson & Mishra (2013) that was based on the mid-aged ALSWH cohort, the 
majority of women of the young cohort were not overweight or obese at baseline. 
Interestingly, the mean BMI was similar among women with stable low, stable 
moderate and fluctuating depressive symptoms at the age of 20 years but the patterns 
of change of BMI differed from the age of 20 to 40 years. Since the time from the age 
of 20 to 40 years seems to be important in terms of changes of BMI over time, future 
studies on the potential mediating effect of BMI should be based on participants that 
are not older than 20 years at baseline. Since depressive symptoms and BMI are time-
varying, there might be feedback between change of BMI and change of depressive 
symptoms over time. It will be important to acknowledge this feedback in future 
research and choose an analytic approach, such as inverse probability weighting, that 
can deal with time-varying confounding without blocking potential mediating 
pathways.  
An additional relationship that deserves more attention is the relationship between 
depression, physical comorbidities and risk of CVD. It remains to be determined 
whether physical comorbidities act as common sources and/ or mediators in the 
relationship between depression and subsequent CVD. In contrast to existing 
publications, the UK Biobank analysis suggests that individuals with depression but 
no hypertension are not at increased risk of CVD, relative to those with neither 
depression nor hypertension, but the risk of individuals with depression and 
hypertension exceeds the sum of the risks of depression and hypertension alone. The 
mechanisms explaining this pattern will depend on whether depression or 
hypertension occurred first (see section 7.2 Contribution of this project to our 
understanding of the relationship between depression and subsequent CVD). 




physical illnesses accrual over time relate to risk of CVD in future studies. Cohort 
studies with repeat assessments or access to routinely collected health records will be 
essential in determining what conditions develop first and what conditions follow. In 
time, one potential cohort study to investigate this relationship further is the young 
cohort of the ALSWH study as women of this cohort age. 
The analysis of data from the Whitehall II study provided an interesting and 
innovative new perspective on the relationship between psychological distress and 
cardiovascular events. The next obvious step would be to make use of study phases 
9 and 11 for which outcomes have not yet been validated. This would offer 
advantages in terms of statistical power by increasing the number of events and in 
terms of follow-up by providing 2.5 years additional years of follow-up in the analysis 
on fatal CHD or non-fatal MI and five years of additional follow-up in the analysis on 
fatal or non-fatal stroke. Second, it would be interesting to repeat the analysis using 
different outcomes such as diagnosis of any CVD or any CHD. Again, the use of a 
broader outcome definition would increase the number of events in the analysis and 
thereby increase statistical power to detect differences between trajectories of 
psychological distress among those with and without events. Third, it remains to be 
established if results are similar if a measure of depressive symptoms is used instead 
of a measure of psychological distress. Unfortunately, the current dataset did not 
allow for a replication of findings using a measure of depressive symptoms due to 
lack of validated cardiovascular events in study phases 9 and 11. Once outcomes are 
validated for these waves and additional assessments of depressive symptoms are 
collected, it will be of interest to compare the findings based on psychological distress 
with findings based on depressive symptoms. Fourth, given that this was the first 
study that compared psychological distress trajectories prior to diagnosis with 
cardiovascular events to psychological distress trajectories among individuals free 
from cardiovascular events over the same time period, it would be of interest to 
replicate the analysis using a different dataset. Ideally, this dataset would have 
equally extensive information on the exposure before diagnosis of cardiovascular 




cohort study that offers similar advantages is the ALSHW. Since the number of 
women that had a stroke and myocardial infarction was very small due to the young 
age of the young cohort of the ALSWH at their last follow-up assessment, depressive 
symptom trajectories prior to diagnosis with hypertension could be compared to 
depressive symptom trajectories among individuals free from hypertension over the 
same time period. Once women of the young cohort of the ALSWH were followed up 
for a longer time and more cardiovascular events have occurred, the analysis could 
be repeated using a diagnosis of stroke and/ or MI as outcome. Alternatively, data 
from the mid-aged ALSWH cohort could be used to replicate the Whitehall II 
analysis. 
Lastly, further research is needed to investigate other alternative explanations of the 
observed associations that were beyond the scope of this project. As described in more 
detail previously (see sections 7.3.4.1 The need to disentangle the role of depression 
and psychotropic medications and 7.3.4.2 The need to investigate genetic pleiotropy 
in depression and CVD), two potential alternative explanations that warrant further 
research are iatrogenic effects of psychotropic medications and genetic pleiotropy in 
depression and CVD.  
7.5 Implications for practice 
This project furthered our understanding of the relationship between depression and 
CVD. Yet, it remains to be established to what extent clinical depression and 
depressive symptoms are indeed causally related with increased risk of CVD. Whilst 
further research is clearly needed, this section proposes possible implications for 
practice based on the findings of this PhD. 
Targeted screening or preventive programmes for CVD and its risk factors may be 
needed, if successful treatment strategies are available to those that are identified as 
being at high risk of CVD. Since findings of this thesis suggest that individuals with 
depression and physical comorbidities and/ or individuals with depression from low 
socioeconomic backgrounds are at particularly high risk of CVD, screening strategies 




for CVD and its risk factors delivered in primary care in England and Scotland 
(National Health Service, 2016b; NHS Health Scotland, no date). The NHS health 
check programme in England is a universal programme targeted at all adults aged 40 
– 74 years without pre-existing diabetes or CVD. In contrast to the English health 
check programme, the Scottish programme Keep Well uses a targeted approach to 
identify adults aged 40 – 64 years at particularly high risk of CVD. Furthermore, there 
was a particular emphasis on reducing health inequalities and targeting individuals 
living in areas of Scotland with high deprivation. Both health check programmes were 
evaluated four years after implementation. The overall coverage of the English 
programme was low (Chang et al, 2015; Robson et al, 2016), there was no significant 
difference in coverage by deprivation (Chang et al, 2015), a small effect on early 
identification of CVD and risk factor management (Chang et al, 2019) but this effect 
did not differ by deprivation (Chang et al, 2019). Thus, the English health check 
programme was not successful in reducing health inequalities. The Keep Well 
programme successfully targeted individuals in the most deprived areas (NHS 
Health Scotland, 2014). However, the effects of the Keep Well programme on incident 
hospitalisations, prescription rates, and CHD and stroke mortality were small (Geue 
et al, 2016). To increase the effect of future preventive programmes at a population 
level, these programmes should incorporate recommendations of NHS Health 
Scotland (2014). For example, both the English and Scottish programmes offered brief 
advice on changes of health behaviours or prescription of relevant medication for 
individuals at high risk of CVD. Instead, future programme should offer continuous 
support to individuals and, more importantly, should incorporate changes to the 
living environment which takes away the responsibility from individuals. 
To decrease health inequalities between individuals with depression from low and 
high socioeconomic backgrounds with regard to risk of CVD, an alignment of general 
practice funding with the social gradient in clinical need is urgently needed (McLean 
et al, 2015; Mercer & Watt, 2007). In the UK, the majority of health care services are 
provided free of charge to all UK residents. Whilst this ensures access to care, McLean 




general practice is aligned with the high clinical need in deprived areas. In keeping 
with that Mercer & Watt (2007) showed that the increased need in areas with high 
area-based deprivation was associated with “poorer access to care, less time spent 
with the doctor, higher GP stress, and lower patient enablement in encounters for 
psychosocial problems” (Mercer & Watt, 2007, p507). To overcome this problem, the 
funding allocation formula for general practice may need to be altered. McLean et al 
(2015) suggested that the allocation of funding for general practice should consider 
that individuals living in areas of high deprivation are at higher risk of 
multimorbidity from early adulthood onwards. The authors emphasised that general 
practices in more deprived areas will be disadvantaged if the allocation of funding is 
based on the age of the practice population.  
The results of the ALSWH analysis suggest that more effective primary and 
secondary prevention strategies are needed for risky alcohol intake and weight gain 
whereas smoking prevention was effective among women with stable low, stable 
moderate and fluctuating depressive symptoms. Since the proportion of current 
smokers among individuals with stable low, stable moderate and fluctuating 
depressive symptoms decreased over time, the results of the ALSWH analysis 
suggest that primary and/ or secondary prevention programmes are effective with 
regards to smoking. In contrast, the proportion of individuals with risky/ high risk 
alcohol intake increased over time. Furthermore, women with stable moderate and 
fluctuating depressive symptoms gained weight more rapidly than women with 
stable low depressive symptoms. Thus, these results suggest that there is a need to 
develop more effective strategies to prevent risky alcohol intake and weight gain. 
Based on results of the ASLWH analysis it seems particularly important to monitor 
and prevent weight gain among individuals with stable moderate and fluctuating 
depressive symptoms in their 20s. Potential explanations for weight gain among 
women with stable moderate and fluctuating depressive symptoms are an unhealthy 
diet or low levels of physical activity. However, a further explanation may be that 
these women are more likely to use antidepressants which in turn may promote 




Irrespective of the potential independent effect of depression on CVD onset and 
progression, efforts towards better recognition and treatment of depression are 
warranted. Despite its high prevalence and considerable contribution to the global 
burden of diseases, it has been shown that the majority of people with MDD do not 
receive adequate treatment (Thornicroft et al, 2017). The reasons behind this are 
multifactorial. First, individuals with depression might not recognise their need for 
treatment. Using data from the WHO World Mental Health Surveys from 21 
countries, Thornicroft et al (2017) reported that only 56.7% of all individuals who met 
the DSM-IV criteria of MDD in the past 12 months recognised their need for 
treatment. Therefore, there is a need to encourage individuals with depressive 
symptoms to seek medical help and to increase awareness that depression is a 
treatable condition. However, there is also a need to improve the supply of timely 
and effective services since it has been shown that individuals who recognise their 
need for treatment might not receive treatment. Thornicroft et al (2017) reported that 
71.1% of all participants who recognised their need for treatment made at least one 
visit to a service provider but only 41.0% received treatment meeting minimal 
standards. Since it has been shown that recovery rates of individuals with mental 
health problems are associated with shorter waiting times between referral and 
treatment, higher numbers of treatment sessions, and better ability of service 
providers to identify the problem they are treating, service level factors should 
additionally be taken into account to achieve better treatment of individuals with 










Chapter 8: Conclusion 
Although an association between depression and CVD onset and progression has 
been observed in numerous primary studies and existing reviews, there was an 
ongoing debate whether or not the evidence base was sufficient to acknowledge 
depression as an independent risk factor of CVD. This was due to potential non-
causal explanations of the observed association and methodological shortcomings of 
existing studies. 
This PhD furthered our understanding of the relationship between depression and 
CVD by exploring the merit of two potential non-causal explanation of the observed 
association. The results of the UK Biobank analysis suggest that it is unlikely that 
residual confounding due to unmeasured covariates alone explains the observed 
associations between different measure of depression and MCVE. The results of the 
Whitehall II analysis suggest that it is unlikely that reverse causation or overlap of 
symptoms between subclinical CVD and somatic symptoms of depression explains 
the observed association. In addition, this project highlights the importance of using 
repeat assessments of depressive symptoms and identifies individuals with 
depression who are at particularly high risk of CVD. 
Considering the substantial contribution of both depression and CVD to the global 
burden of disease, it should remain a public health priority to further investigate the 
relationship between depression and CVD. Whilst this PhD furthered our 
understanding of the relationship between depression and subsequent CVD, more 
research is clearly needed to establish depression as an independent risk factor of 
CVD. Instead of investigating the relationship between a single measure of 
depression and risk of CVD, research should now focus on using repeat assessments 
of depression, on investigating the inter-relationship of variables throughout follow-
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A.I. Systematic review 
Appendix 1: Search strategy - EMBASE 




5. 1 or 2 or 3 or 4  
6. cerebrovascular disease/  
7. exp basal ganglion haemorrhage/  
8. exp brain haemorrhage/  
9. brain infarction/  
10. exp brain ischemia/  
11. carotid artery disease/  
12. cerebral artery disease/  
13. exp cerebrovascular accident/  
14. occlusive cerebrovascular disease/  
15. brain embolism/  
16. stroke.mp.  
17. ((brain$ or cerebr$ or intracerebr$ or intracran$ or subarachnoid) adj5 (haemorrhag$ or 
haemorrhag$ or haematoma$ or hematoma$ or bleed$)).mp.  
18. ((brain$ or cerebr$ or intracerebr$ or intracran$) adj5 (ischemi$ or ischaemi$ or infarct$ 
or thrombo$ or embol$ or occclus$)).mp. 
19. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18  
20. exp heart infarction/  
21. ((heart or myocardial or cardiac) adj5 (infarct$ or attack)).mp. 
22. 20 or 21  
23. 19 or 22  
24. longitudinal study/  
25. prospective study/  
26. follow up/  





28. cohort analysis/  
29. etiology/  
30. pathogenesis/  
31. path analysis/  
32. structural equation modeling/  
33. epidemiology/  
34. comorbidity/  
35. (causal$ or causat$).mp.  
36. ((direct or indirect) adj3 effect).mp.  
37. (pathway$ or mechanism$).mp.  
38. (structural equation model$ or "path analys$").mp. 
39. mental-physical comorbidit*.mp.  
40. physical-mental comorbidit*.mp.  
41. cohort.mp.  
42. prospective.mp.  
43. longitudinal.mp.  
44. followup.mp.  
45. follow-up.mp. 
46. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 
40 or 41 or 42 or 43 or 44 or 45  
47. 5 and 23 and 46  
48. limit 47 to embase 
 
Appendix 2: Search strategy - Medline 
1. Depression/  
2. exp Depressive Disorder/  
3. depressi*.mp.  
4. dysthymi*.mp.  
5. MDD.mp.  
6. 1 or 2 or 3 or 4 or 5  
7. Cerebrovascular Disorders/  
8. exp Basal Ganglia Cerebrovascular Disease/  




10. Carotid Artery Diseases/  
11. Intracranial Arterial Diseases/  
12. exp "Intracranial Embolism and Thrombosis"/  
13. exp Intracranial Haemorrhages/  
14. exp Stroke/  
15. Vasospasm, Intracranial/  
16. (stroke or apoplex*).mp.  
17. ((brain$ or cerebr$ or intracerebr$ or intracran$ or subarachnoid) adj5 (haemorrhag$ or 
haemorrhag$ or haematoma$ or hematoma$ or bleed$)).mp.  
18. ((brain$ or cerebr$ or intracerebr$ or intracran$) adj5 (ischemi$ or ischaemi$ or infarct$ 
or thrombo$ or embol$ or occclus$)).mp.  
19. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18  
20. exp Myocardial Infarction/  
21. ((heart or myocardial or cardiac) adj5 (infarct$ or attack)).mp.  
22. 20 or 21  
23. 19 or 22 
24. exp Cohort Studies/  
25. incidence/  
26. Epidemiology/  
27. exp causality/  
28. Comorbidity/  
29. (causal$ or causat$).mp.  
30. ((direct or indirect) adj3 effect).mp.  
31. (pathway$ or mechanism$).mp.  
32. (structural equation model$ or "path analys$").mp.  
33. mental-physical comorbidit*.mp.  
34. physical-mental comorbidit*.mp.  
35. cohort.mp.  
36. prospective.mp.  
37. longitudinal.mp.  
38. followup.mp.  
39. follow-up.mp.  





41. 6 and 23 and 40 
 
Appendix 3: Search strategy - PsycINFO 
1. exp Major Depression/  
2. "Depression (Emotion)"/  
3. depressi*.mp.  
4. dysthymi*.mp.  
5. MDD.mp.  
6. 1 or 2 or 3 or 4 or 5  
7. cerebrovascular accidents/  
8. exp cerebrovascular disorders/  
9. (stroke or apoplex*).mp. 
10. ((brain$ or cerebr$ or intracerebr$ or intracran$) adj5 (ischemi$ or ischaemi$ or infarct$ 
or thrombo$ or embol$ or occclus$)).mp.  
11. ((brain$ or cerebr$ or intracerebr$ or intracran$ or subarachnoid) adj5 (haemorrhag$ or 
haemorrhag$ or haematoma$ or hematoma$ or bleed$)).mp.  
12. 7 or 8 or 9 or 10 or 11  
13. exp myocardial infarctions/  
14. heart disorders/  
15. ((heart or myocardial or cardiac) adj5 (infarct$ or attack)).mp.  
16. 13 or 14 or 15  
17. 12 or 16  
18. exp longitudinal studies/  
19. followup studies/  
20. epidemiology/  
21. exp causality/  
22. causal analysis/  
23. path analysis/  
24. structural equation modeling/  
25. risk factors/  
26. cohort analysis/  
27. etiology/  




29. (causal$ or causat$).mp.  
30. ((direct or indirect) adj3 effect).mp.  
31. (pathway$ or mechanism$).mp.  
32. (structural equation model$ or "path analys$").mp.  
33. mental-physical comorbidit*.mp.  
34. physical-mental comorbidit*.mp.  
35. cohort.mp.  
36. prospective.mp.  
37. longitudinal.mp.  
38. followup.mp.  
39. follow-up.mp.  
40. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 
34 or 35 or 36 or 37 or 38 or 39  
41. 6 and 17 and 40 
 
Appendix 4: Search strategy - Web of Science 
1. #11 AND #8 AND #1 
2. TS=(longitudinal OR "follow up" OR follow-up OR followup OR prospective OR cohort) 
3. TS=(stroke) 
4. TS=((brain$ or cerebr$ or intracerebr$ or intracran$ or subarachnoid) NEAR/5 
(haemorrhag$ or haemorrhag$ or haematoma$ or hematoma$ or bleed$)) 
5. TS=((brain$ or cerebr$ or intracerebr$ or intracran$) NEAR/5 (isch*mi$ or infarct$ or 
thrombo$ or embol$ or occclus$)) 
6. #5 OR #4 OR #3 
7. #6 AND #2 AND #1 
8. TS=(longitudinal OR "follow up" OR follow-up OR followup OR prospective OR cohort 
OR mediat* OR "structural equation model*" OR causal* OR "mental-physical comorbidit*" 
OR "physical-mental comorbidity" OR mechanism* OR pathway*) 
9. #8 AND #6 AND #1 
10. TS=((heart or myocardial or cardiac) NEAR/5 (infarct$ or attack)) 
11. #10 OR #6 






Appendix 5: Search strategy – CINAHL 
S1. (MH "Depression") OR (MH "Dysthymic Disorder") 
S2. (TX "MDD") OR (TX "depressi*") OR (TX "dysthymi*") 
S3. (MH "Cerebrovascular Disorders") OR (MH "Basal Ganglia Cerebrovascular Disease+") 
OR (MH "Hypoxia-Ischemia, Brain") OR (MH "Cerebral Ischemia+") OR (MH "Cerebral 
Small Vessel Diseases") OR (MH "Intracranial Arterial Diseases") OR (MH "Intracranial 
Embolism and Thrombosis+") OR (MH "Carotid Artery Diseases") OR (MH "Stroke+") OR 
(MH "Intracranial Haemorrhage+") OR (MH "Cerebral Vasospasm") 
S4. TX stroke 
S5. TX ((brain* or cerebr* or intracerebr* or intracran* or subarachnoid) N5 (haemorrhag* 
or haemorrhag* or haematoma* or hematoma* or bleed*)) 
S6. TX ((brain* or cerebr* or intracerebr* or intracran*) N5 (ischemi* or ischaemi* or infarct* 
or thrombo* or embol* or occclus*)) 
S7. (MH "Myocardial Infarction+") 
S8. TX ((heart or myocardial or cardiac) N5 (infarct* or attack)) 
S9. (MH "Causal Modeling+") OR (MH "Comorbidity") OR (MH "Incidence") OR (MH 
"Postexposure Follow-Up") OR (MH "Prospective Studies+") 
S10. (TX "prospective") OR (TX "longitudinal") OR (TX "cohort") OR (TX "follow-up") OR 
(TX "follow up") OR (TX "followup") OR (TX "mediat*") OR (TX "structural equation 
model*") OR (TX "causal*") OR (TX "mental-physical comorbidit*") OR (TX "physical-
mental comorbidit*") OR (TX "mechanism*") OR (TX "pathway*" OR (TX "causal*) OR (TX 
"causat*) OR (TX "pathway*) OR (TX "mechanism*") OR (TX "structural equation model*") 
OR (TX "path analys*) OR (TX ((direct or indirect) N3 effect)) 
S11. S1 OR S2 
S12. S3 OR S4 OR S5 OR S6 OR S7 OR S8 
S13. S9 OR S10 






Appendix 6: Example of completed CASP Cohort Study Checklist 
(A) Are the results of the study valid? 
1. Did the study address a clearly focussed issue? 
Yes – to examine the relationship between depressive symptoms and subsequent 
ischaemic stroke & to assess the potential mediating role of inflammation 
2. Was the cohort recruited in an acceptable way? 
Mostly – Random sample of Medicare-eligible, non-institutionalised adults, aged 
≥65 years, residing in one of four US counties, recruited 1989 – 1991. A second 
enrolment of African-Americans completed 1992 – 1993. Participants being 
wheelchair bound in the home, undergoing radiation or chemotherapy for cancer 
and with a haemorrhagic stroke during follow-up were excluded. 
Exclusion of individuals with haemorrhagic stroke might be problematic. 
3. Was the exposure accurately measured to minimise bias? 
No – Validated scale but only assessed at baseline. 
Depressive symptoms at baseline, using the 10 item CES-D rating scale, collected 
by trained interviewers, no time-updated information 
4. Was the outcome accurately measured to minimise bias? 
Can’t tell – Self-report led to review of medical records, without self-report no 
diagnosis: 
Self-report of events every 6 months, then confirmation of events or deaths through 
review of medical records (death records and hospital records), raters were blinded 
to exposure status. 
5. A) Have the authors identified all important confounding factors? 
Mostly, did not identify physical inactivity, alcohol use, and medications 
B) Have they taken account of the confounding factors in the design and/ or 
analysis? 
Yes – Adjustment in statistical analyses, stratification by c-reactive protein tertiles 
C) Have the authors discussed mechanisms/ mediating factors? 
Yes – inflammation (c-reactive protein) 
D) Have they taken account of the mediating factors in the design and/ or analysis? 
Yes – taken into account by stratifying the analysis 
6. A) Was the follow-up of subjects complete enough? 





B) Was the follow-up of subjects long enough? 
Yes – Median follow-up: 11 years but no range reported 
 
(B) What are the results of this study? 
7. What are the results of this study?  
No association between depressive symptoms and haemorrhagic stroke 
(participants with haemorrhagic stroke were excluded due to this), positive 
association between depressive symptoms and ischaemic stroke, j-shaped 
relationship with c-reactive protein tertiles, authors concluded that it did not act as 
mediator (investigated by adjusting for it in cox model), results were similar for 
men and women 
8. How precise are the results? 
Relatively precise (HR: 1.25, 95% CI: 1.02 – 1.53 in fully adjusted model) 
9. Do you believe the results? 
+ Stroke at baseline excluded 
+ Attempted to investigate mediation but… 
- Used adjustment in cox model to investigate mediation 
- Participants with haemorrhagic stroke excluded (potential selection bias) 
- Small sample size within tertiles 
 
(C) Will the results help locally? 
10. Can the results be applied to the local population? 
Applicable to Medicare-insured adults but selection bias might explain some of the 
risk. Difficult to know to what extent sample sufficiently differs from local 
population to cause concern 
11. Do the results of this study fit with other available evidence? 
Yes – all included studies on the association between depressive symptoms and 
risk of ischaemic stroke showed an increased risk among individuals with high 
depressive symptoms, relative to non-exposed individuals 
12. What are the implications of this study for practice? 
Results of one observational study not sufficiently robust to recommend changes 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




























































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   














































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





Table A 8: Additional information on other covariates in included studies 
Author Other covariates 
Arbelaez et al (2007) Haemorrhagic stroke during follow-up† 
Barefoot & Schroll (1996) (Possible ischaemia†) 
Bos et al (2008) Intima-media thickness 
Chi et al (2014) Charlson comorbidity index 
Cummings et al (2016) Health insurance 
Daskalopoulou et al 
(2016) 
GP practice 
Gilsanz et al (2015) Baseline depressive symptoms††, participation††, sampling††, survival†† 
Gilsanz et al (2017) Cumulative exposure to depression††, participation††, survival†† 
Glymour et al (2010) Southern birth 
Glymour et al (2012) Southern birth 
Henderson et al (2013) Hip fractures 
Joyce (2015) 
K10***, other languages***, depression/anxiety treatment last month***, 
QOL*** 
Kim et al (2011) Optimism, lung disease and arthritis†††, self-rated health 
Kim et al (2013) Purpose in life 
Köhler et al (2013) ApoE status 
Kubzansky et al (2006) Any known medical conditions† 
Majed et al (2012) Treatment for diabetes 
Marijnissen et al (2014) Neuroticism 
Mejía-Lancheros et al 
(2014) 
Intervention group, major endocrine or neurological disorders† 
Moise et al Moise et al 
(2016) 
Albumin to creatinine ratio, QT interval corrected for HR, health 
insurance 
O'Brien et al (2015) Coping skills, dialysis§§§ 
Pössel et al (2015) Hopelessness 
Scherrer et al (2010) Hypothyroidism† 
Scherrer et al (2011) Health insurance 
Sesso et al (1998) Any known medical condition† 
Sun et al (2016) (Neurasthenia) 
† Restriction  
†† Variable was taken into account by applying inverse probability weights 
*** Added in stepwise but did not end up in final model 
††† Added as index of chronic illness (self-reported doctor diagnosis of high blood pressure, cancer, 
lung disease, psychiatric problems, and arthritis) 
§§§ These variables were taken into account by fitting a separate model to obtain a stroke risk score 
which in turn was included in the regression model 







A.II. UK Biobank 
Table A 9: Results of the global cox.zph test* of all fully adjusted models (complete cases) 
Outcome Exposure p-value 
Major cardiovascular events 
Depression 0.33 
Antidepressant use 0.33 
Hospital diagnosis with depression 0.31 
Self-reported depression 0.32 
Myocardial infarction 
Depression 0.45 
Antidepressant use 0.47 
Hospital diagnosis with depression 0.48 
Self-reported depression 0.49 
Stroke 
Depression 0.09 
Antidepressant use 0.10 
Hospital diagnosis with depression 0.07 
Self-reported depression 0.10 
Major cardiovascular events 
Depression and/ or hypertension 0.38 
Depression and/ or diabetes 0.37 
Depression and/ or high cholesterol levels 0.25 
Depression and/ or low educational attainment 0.38 
Depression and/ or high area-based deprivation 0.26 
* The null hypothesis of the cox.zph function is that there are constant regression coefficients 
of the covariates over time. Therefore, a p-value <0.05 indicates a likely violation of the 





Table A 10: Results of the cox.zph test* of the fully adjusted model investigating the association between 
depression and MCVE (complete cases) 
Variable rho chisq p-value 
Depression -0.003 2.87E-02 0.87 
Sex 0.001 1.75E-03 0.97 
Age (2nd quartile) -0.026 2.86E+00 0.09 
Age (3rd quartile) -0.013 7.69E-01 0.38 
Age (4th quartile) -0.031 4.14E+00 0.04 
Ethnicity (Other ethnic groups) -0.010 4.12E-01 0.52 
Educational attainment (A levels, O levels, CSE, NVQ, 
or equivalent 
-0.010 4.00E-01 0.53 
Educational attainment (None of the above) -0.025 2.68E+00 0.10 
Area-based deprivation (2) -0.017 1.28E+00 0.26 
Area-based deprivation (3) <0.001 1.84E-04 0.99 
Area-based deprivation (4) -0.020 1.60E+00 0.21 
Area-based deprivation (5 - Most deprived) 0.005 8.75E-02 0.77 
Income (52,000 to 100,000) 0.009 3.26E-01 0.57 
Income (31,000 to 51,999) 0.001 3.24E-03 0.95 
Income (18,000 to 30,999) 0.011 4.95E-01 0.48 
Income (less than 18,000) 0.008 2.81E-01 0.60 
Body mass index (overweight) -0.016 1.05E+00 0.30 
Body mass index (obese) -0.025 2.63E+00 0.11 
Body mass index (severely obese) 0.008 3.05E-01 0.58 
Body mass index (morbidly obese) -0.025 2.58E+00 0.11 
Physical activity (moderate) -0.023 2.15E+00 0.14 
Physical activity (low) -0.002 2.28E-02 0.88 
Alcohol intake (risky drinking) 0.027 3.14E+00 0.08 
Smoking status (previous) -0.018 1.34E+00 0.25 
Smoking status (current) -0.021 1.82E+00 0.18 
Fruit and vegetable intake (less than five a day) -0.022 1.99E+00 0.16 
Oily fish intake (less than once per week) -0.001 1.03E-03 0.97 
Oily fish intake (never) -0.002 2.11E-02 0.88 
Hypertension 0.007 2.19E-01 0.64 
Diabetes -0.002 1.57E-02 0.90 
Cholesterol 0.010 3.96E-01 0.53 
Family history of cardiovascular disease 0.012 6.19E-01 0.43 
Family history of depression 0.006 1.34E-01 0.71 
GLOBAL NA 3.59E+01 0.33 
CSE: Certificate of secondary education, NVQ: National vocational qualification 
* The null hypothesis of the cox.zph function is that there are constant regression coefficients 
of the covariates over time. Therefore, a p-value <0.05 indicates a likely violation of the 







Table A 11: Convergence plots of multiple imputations in keeping with analyses on depression and 
MCVE 
Exposure status: Depression 
Outcome: Major cardiovascular events 
Interaction: Comorbidities 
Exposure status: No depression 









Table A 12: Baseline characteristics separately for participants with and without antidepressant use at 
baseline (page 1 of 2)* 
 
No antidepressant use  
(n = 434,085, 93.3%) 
Antidepressant use 
(n = 31,130, 6.7%) 
Male (%) 196,653 (45.3) 8,725 (28.0) 
Age (median [IQR]) 57.0 [50.0, 63.0] 57.0 [50.0, 62.0] 
Ethnicity (%) 
   White 407,929 (94.0) 29,976 (96.3) 
   Other ethnic groups 23,768 (5.5) 1,019 (3.3) 
Income (%) 
   Greater than 100,000 21,557 (5.0) 700 (2.2) 
   52,000 to 100,000 79,895 (18.4) 3,367 (10.8) 
   31,000 to 51,999 99,510 (22.9) 5,830 (18.7) 
   18,000 to 30,999 93,026 (21.4) 6,936 (22.3) 
   Less than 18,000 75,030 (17.3) 9,285 (29.8) 
Highest educational attainment (%) 
   College or university degree 145,073 (33.4) 8,069 (25.9) 
   A levels, O levels, NVQ, or equivalent 213,253 (49.1) 15,800 (50.8) 
   None of the above 67,193 (15.5) 6,683 (21.5) 
Area-based deprivation (%) 
   1 (Least deprived) 89,533 (20.6) 5,418 (17.4) 
   2 88,102 (20.3) 5,626 (18.1) 
   3 87,657 (20.2) 5,956 (19.1) 
   4 86,450 (19.9) 6,388 (20.5) 
   5 (Most deprived) 81,825 (18.8) 7,685 (24.7) 
Body mass index (%) 
   Under- or normal weight 149,242 (34.4) 8,530 (27.4) 
   Overweight 184,207 (42.4) 12,165 (39.1) 
   Obese 71,647 (16.5) 6,502 (20.9) 
   Severely obese 19,403 (4.5) 2,463 (7.9) 
   Morbidly obese 7,134 (1.6) 1,261 (4.1) 
Physical activity (%) 
   High 40,313 (9.3) 2,014 (6.5) 
   Moderate 286,428 (66.0) 18,332 (58.9) 
   Low 89,944 (20.7) 9,223 (29.6) 
Alcohol intake (%) 
   Safe drinking 193,210 (44.5) 15,279 (49.1) 
   Risky drinking 178,299 (41.1) 9,610 (30.9) 
Smoking status (%) 
   Never 243,507 (56.1) 15,306 (49.2) 
   Previous 145,379 (33.5) 10,772 (34.6) 
   Current 42,761 (9.9) 4,891 (15.7) 
Fruit and vegetable intake per day (%) 
   At least five a day 130,907 (30.2) 9,731 (31.3) 






Table A 12 continued: Baseline characteristics separately for participants with and without 
antidepressant use at baseline (page 2 of 2)* 
 
No antidepressant use  
(n = 434,085, 93.3%) 
Antidepressant use 
(n = 31,130, 6.7%) 
Oily fish intake (%) 
   At least once a week 240,638 (55.4) 15,847 (50.9) 
   Less than once per week 143,957 (33.2) 10,548 (33.9) 
   Never 46,109 (10.6) 4,475 (14.4) 
Hypertension (%) 235,034 (54.1) 17,629 (56.6) 
Diabetes (%) 17,993 (4.1) 2,101 (6.7) 
High cholesterol levels (%) 62,311 (14.4) 6,479 (20.8) 
Family history of cardiovascular disease (%) 
   No 103,170 (23.8) 6,414 (20.6) 
   Yes 297,832 (68.6) 22,302 (71.6) 
Family history of depression (%) 
   No 342,343 (78.9) 21,173 (68.0) 
   Yes 35,588 (8.2) 5,516 (17.7) 
* This table does not show the number and percentage with missing values. For more 
information on the distribution of missing values see section 4.4.2 Investigation of missing data 
mechanism. Data are given as n (%) unless specified 







Table A 13: Baseline characteristics separately for participants with and without hospital diagnosis with 
depression at baseline (page 1 of 2)* 
 
No hospital diagnosis 
with depression 
(n = 461,984, 99.3%) 
Hospital diagnosis with 
depression 
(n = 3,231, 0.7%) 
Male (%) 204,190 (44.2) 1,188 (36.8) 
Age (median [IQR]) 57.0 [50.0, 63.0] 55.0 [48.0, 62.0] 
Ethnicity (%) 
   White 434,843 (94.1) 3,062 (94.8) 
   Other ethnic groups 24,641 (5.3) 146 (4.5) 
Income (%) 
   Greater than 100,000 22,225 (4.8) 32 (1.0) 
   52,000 to 100,000 83,040 (18.0) 222 (6.9) 
   31,000 to 51,999 104,885 (22.7) 455 (14.1) 
   18,000 to 30,999 99,305 (21.5) 657 (20.3) 
   Less than 18,000 83,036 (18.0) 1,279 (39.6) 
Highest educational attainment (%) 
   College or university degree 152,402 (33.0) 740 (22.9) 
   A levels, O levels, NVQ, or equivalent 227,416 (49.2) 1,637 (50.7) 
   None of the above 73,095 (15.8) 781 (24.2) 
Area-based deprivation (%) 
   1 (Least deprived) 94,558 (20.5) 393 (12.2) 
   2 93,268 (20.2) 460 (14.2) 
   3 93,104 (20.2) 509 (15.8) 
   4 92,154 (19.9) 684 (21.2) 
   5 (Most deprived) 88,332 (19.1) 1,178 (36.5) 
Body mass index (%) 
   Under- or normal weight 156,949 (34.0) 823 (25.5) 
   Overweight 195,180 (42.2) 1,192 (36.9) 
   Obese 77,441 (16.8) 708 (21.9) 
   Severely obese 21,581 (4.7) 285 (8.8) 
   Morbidly obese 8,225 (1.8) 170 (5.3) 
Physical activity (%) 
   High 42,127 (9.1) 200 (6.2) 
   Moderate 302,862 (65.6) 1,898 (58.7) 
   Low 98,217 (21.3) 950 (29.4) 
Alcohol intake (%) 
   Safe drinking 206,855 (44.8) 1,634 (50.6) 
   Risky drinking 186,922 (40.5) 987 (30.5) 
Smoking status (%) 
   Never 257,376 (55.7) 1,437 (44.5) 
   Previous 155,123 (33.6) 1,028 (31.8) 
   Current 46,912 (10.2) 740 (22.9) 
Fruit and vegetable intake per day (%) 
   At least five a day 139,714 (30.2) 924 (28.6) 





Table A 13 continued: Baseline characteristics separately for participants with and without 
hospital diagnosis with depression at baseline (page 2 of 2)* 
 
No hospital diagnosis 
with depression 
(n = 461,984, 99.3%) 
Hospital diagnosis with 
depression 
(n = 3,231, 0.7%) 
Oily fish intake (%) 
   At least once a week 254,907 (55.2) 1,578 (48.8) 
   Less than once per week 153,461 (33.2) 1,044 (32.3) 
   Never 50,024 (10.8) 560 (17.3) 
Hypertension (%) 250,766 (54.3) 1,897 (58.7) 
Diabetes (%) 19,828 (4.3) 266 (8.2) 
High cholesterol levels (%) 68,107 (14.7) 683 (21.1) 
Family history of cardiovascular disease (%) 
   No 108,935 (23.6) 649 (20.1) 
   Yes 317,876 (68.8) 2,258 (69.9) 
Family history of depression (%) 
   No 361,498 (78.2) 2,018 (62.5) 
   Yes 40,464 (8.8) 640 (19.8) 
* This table does not show the number and percentage with missing values. For more 
information on the distribution of missing values see section 4.4.2 Investigation of missing data 
mechanism. Data are given as n (%) unless specified. 







Table A 14: Baseline characteristics separately for participants with and without self-reported depression 
at baseline (page 1 of 2)* 
 
No self-reported depression 
(n = 440,076, 94.6%) 
Self-reported depression 
(n = 25,139, 5.4%) 
Male (%) 197,281 (44.8) 8,097 (32.2) 
Age (median [IQR]) 57.0 [50.0, 63.0] 56.0 [49.0, 61.0] 
Ethnicity (%) 
   White 413,798 (94.0) 24,107 (95.9) 
   Other ethnic groups 23,888 (5.4) 899 (3.6) 
Income (%) 
   Greater than 100,000 21,613 (4.9) 644 (2.6) 
   52,000 to 100,000 80,305 (18.2) 2,957 (11.8) 
   31,000 to 51,999 100,291 (22.8) 5,049 (20.1) 
   18,000 to 30,999 94,329 (21.4) 5,633 (22.4) 
   Less than 18,000 76,993 (17.5) 7,322 (29.1) 
Highest educational attainment (%) 
   College or university degree 145,377 (33.0) 7,765 (30.9) 
   A levels, O levels, NVQ, or equivalent 216,457 (49.2) 12,596 (50.1) 
   None of the above 69,385 (15.8) 4,491 (17.9) 
Area-based deprivation (%) 
   1 (Least deprived) 90,766 (20.6) 4,185 (16.6) 
   2 89,240 (20.3) 4,488 (17.9) 
   3 88,915 (20.2) 4,698 (18.7) 
   4 87,609 (19.9) 5,229 (20.8) 
   5 (Most deprived) 83,016 (18.9) 6,494 (25.8) 
Body mass index (%) 
   Under- or normal weight 150,433 (34.2) 7,339 (29.2) 
   Overweight 186,455 (42.4) 9,917 (39.4) 
   Obese 73,135 (16.6) 5,014 (19.9) 
   Severely obese 20,055 (4.6) 1,811 (7.2) 
   Morbidly obese 7,467 (1.7) 928 (3.7) 
Physical activity (%) 
   High 40,535 (9.2) 1,792 (7.1) 
   Moderate 289,435 (65.8) 15,325 (61.0) 
   Low 92,276 (21.0) 6,891 (27.4) 
Alcohol intake (%) 
   Safe drinking 196,730 (44.7) 11,759 (46.8) 
   Risky drinking 179,285 (40.7) 8,624 (34.3) 
Smoking status (%) 
   Never 246,398 (56.0) 12,415 (49.4) 
   Previous 147,647 (33.6) 8,504 (33.8) 
   Current 43,543 (9.9) 4,109 (16.3) 
Fruit and vegetable intake per day (%) 
   At least five a day 133,414 (30.3) 7,224 (28.7) 






Table A 14 continued: Baseline characteristics separately for participants with and without self-
reported depression at baseline (page 2 of 2)* 
 
No self-reported depression 
(n = 440,076, 94.6%) 
Self-reported depression 
(n = 25,139, 5.4%) 
Oily fish intake (%) 
   At least once a week 243,841 (55.4) 12,644 (50.3) 
   Less than once per week 145,836 (33.1) 8,669 (34.5) 
   Never 46,962 (10.7) 3,622 (14.4) 
Hypertension (%) 239,578 (54.4) 13,085 (52.1) 
Diabetes (%) 18,804 (4.3) 1,290 (5.1) 
High cholesterol levels (%) 64,549 (14.7) 4,241 (16.9) 
Family history of cardiovascular disease (%) 
   No 104,359 (23.7) 5,225 (20.8) 
   Yes 302,198 (68.7) 17,936 (71.3) 
Family history of depression (%) 
   No 347,293 (78.9) 16,223 (64.5) 
   Yes 35,754 (8.1) 5,350 (21.3) 
* This table does not show the number and percentage with missing values. For more 
information on the distribution of missing values see section 4.4.2 Investigation of missing data 
mechanism. Data are given as n (%) unless specified. 







Table A 15: Baseline characteristics separately for participants with and without MCVE during follow-up 
(page 1 of 2)* 
 
No major cardiovascular 
event (n = 457,366, 98.3%) 
Major cardiovascular 
event (n = 7,849, 1.7%) 
Male (%) 200,250 (43.8) 5,128 (65.3) 
Age (median [IQR]) 57.0 [50.0, 63.0] 62.0 [56.0, 66.0] 
Ethnicity (%) 
   White 430,474 (94.1) 7,431 (94.7) 
   Other ethnic groups 24,430 (5.3) 357 (4.5) 
Income (%) 
   Greater than 100,000 22,071 (4.8) 186 (2.4) 
   52,000 to 100,000 82,408 (18.0) 854 (10.9) 
   31,000 to 51,999 103,853 (22.7) 1,487 (18.9) 
   18,000 to 30,999 98,089 (21.4) 1,873 (23.9) 
   Less than 18,000 82,236 (18.0) 2,079 (26.5) 
Highest educational attainment (%) 
   College or university degree 151,255 (33.1) 1,887 (24.0) 
   A levels, O levels, NVQ, or equivalent 225,405 (49.3) 3,648 (46.5) 
   None of the above 71,814 (15.7) 2,062 (26.3) 
Area-based deprivation (%) 
   1 (Least deprived) 93,488 (20.4) 1,463 (18.6) 
   2 92,270 (20.2) 1,458 (18.6) 
   3 92,020 (20.1) 1,593 (20.3) 
   4 91,326 (20.0) 1,512 (19.3) 
   5 (Most deprived) 87,695 (19.2) 1,815 (23.1) 
Body mass index (%) 
   Under- or normal weight 155,833 (34.1) 1,939 (24.7) 
   Overweight 192,883 (42.2) 3,489 (44.5) 
   Obese 76,470 (16.7) 1,679 (21.4) 
   Severely obese 21,407 (4.7) 459 (5.8) 
   Morbidly obese 8,198 (1.8) 197 (2.5) 
Physical activity (%) 
   High 41,785 (9.1) 542 (6.9) 
   Moderate 299,741 (65.5) 5,019 (63.9) 
   Low 97,292 (21.3) 1,875 (23.9) 
Alcohol intake (%) 
   Safe drinking 205,285 (44.9) 3,204 (40.8) 
   Risky drinking 184,607 (40.4) 3,302 (42.1) 
Smoking status (%) 
   Never 255,480 (55.9) 3,333 (42.5) 
   Previous 153,229 (33.5) 2,922 (37.2) 
   Current 46,120 (10.1) 1,532 (19.5) 
Fruit and vegetable intake per day (%) 
   At least five a day 138,525 (30.3) 2,113 (26.9) 






Table A 15 continued: Baseline characteristics separately for participants with and without MCVE 
during follow-up (page 2 of 2)* 
 
No major cardiovascular 
event (n = 457,366, 98.3%) 
Major cardiovascular 
event (n = 7,849, 1.7%) 
Oily fish intake (%) 
   At least once a week 252,271 (55.2) 4,214 (53.7) 
   Less than once per week 151,955 (33.2) 2,550 (32.5) 
   Never 49,590 (10.8) 994 (12.7) 
Hypertension (%) 246,658 (53.9) 6,005 (76.5) 
Diabetes (%) 19,326 (4.2) 768 (9.8) 
High cholesterol levels (%) 66,853 (14.6) 1,937 (24.7) 
Family history of cardiovascular disease (%) 
   No 107,917 (23.6) 1,667 (21.2) 
   Yes 314,722 (68.8) 5,412 (69.0) 
Family history of depression (%) 
   No 357,737 (78.2) 5,779 (73.6) 
   Yes 40,471 (8.8) 633 (8.1) 
Depression (%) 39530 (8.6) 823 (10.5) 
Antidepressant use (%) 30475 (6.7) 655 (8.3) 
Self-reported depression (%) 24666 (5.4) 473 (6.0) 
Hospital diagnosis with depression (%) 3136 (0.7) 95 (1.2) 
* This table does not show the number and percentage with missing values. For more information 
on the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. Data 
are given as n (%) unless specified. 







Table A 16: Baseline characteristics separately for participants with and without stroke during follow-up 
(page 1 of 2)* 
 
No stroke 
(n = 462,090, 99.3%) 
Stroke 
(n = 3,125, 0.7%) 
Male (%) 203,624 (44.1) 1,754 (56.1) 
Age (median [IQR]) 57.0 [50.0, 63.0] 63.0 [57.0, 66.0] 
Ethnicity (%) 
   White 434,933 (94.1) 2,972 (95.1) 
   Other ethnic groups 24,652 (5.3) 135 (4.3) 
Income (%) 
   Greater than 100,000 22,185 (4.8) 72 (2.3) 
   52,000 to 100,000 82,956 (18.0) 306 (9.8) 
   31,000 to 51,999 104,787 (22.7) 553 (17.7) 
   18,000 to 30,999 99,216 (21.5) 746 (23.9) 
   Less than 18,000 83,441 (18.1) 874 (28.0) 
Highest educational attainment (%) 
   College or university degree 152,363 (33.0) 779 (24.9) 
   A levels, O levels, NVQ, or equivalent 227,617 (49.3) 1,436 (46.0) 
   None of the above 73,061 (15.8) 815 (26.1) 
Area-based deprivation (%) 
   1 (Least deprived) 94,398 (20.4) 553 (17.7) 
   2 93,162 (20.2) 566 (18.1) 
   3 92,982 (20.1) 631 (20.2) 
   4 92,221 (20.0) 617 (19.7) 
   5 (Most deprived) 88,759 (19.2) 751 (24.0) 
Body mass index (%) 
   Under- or normal weight 156,907 (34.0) 865 (27.7) 
   Overweight 195,045 (42.2) 1,327 (42.5) 
   Obese 77,529 (16.8) 620 (19.8) 
   Severely obese 21,681 (4.7) 185 (5.9) 
   Morbidly obese 8,307 (1.8) 88 (2.8) 
Physical activity (%) 
   High 42,099 (9.1) 228 (7.3) 
   Moderate 302,739 (65.5) 2,021 (64.7) 
   Low 98,447 (21.3) 720 (23.0) 
Alcohol intake (%) 
   Safe drinking 207,207 (44.8) 1,282 (41.0) 
   Risky drinking 186,580 (40.4) 1,329 (42.5) 
Smoking status (%) 
   Never 257,387 (55.7) 1,426 (45.6) 
   Previous 155,014 (33.5) 1,137 (36.4) 
   Current 47,114 (10.2) 538 (17.2) 
Fruit and vegetable intake per day (%) 
   At least five a day 139,763 (30.2) 875 (28.0) 






Table A 16 continued: Baseline characteristics separately for participants with and without 
stroke during follow-up (page 2 of 2)* 
 
No stroke 
(n = 462,090, 99.3%) 
Stroke 
(n = 3,125, 0.7%) 
Oily fish intake (%) 
   At least once a week 254,760 (55.1) 1,725 (55.2) 
   Less than once per week 153,493 (33.2) 1,012 (32.4) 
   Never 50,222 (10.9) 362 (11.6) 
Hypertension (%) 250,293 (54.2) 2,370 (75.8) 
Diabetes (%) 19,776 (4.3) 318 (10.2) 
High cholesterol levels (%) 68,015 (14.7) 775 (24.8) 
Family history of cardiovascular disease (%) 
   No 108,906 (23.6) 678 (21.7) 
   Yes 318,018 (68.8) 2,116 (67.7) 
Family history of depression (%) 
   No 361,186 (78.2) 2,330 (74.6) 
   Yes 40,860 (8.8) 244 (7.8) 
Depression (%) 40,025 (8.7) 328 (10.5) 
Antidepressant use (%) 30,858 (6.7) 272 (8.7) 
Self-reported depression (%) 24,951 (5.4) 188 (6.0) 
Hospital diagnosis with depression (%) 3,199 (0.7) 32 (1.0) 
* This table does not show the number and percentage with missing values. For more 
information on the distribution of missing values see section 4.4.2 Investigation of missing 
data mechanism. Data are given as n (%) unless specified. 







Table A 17: Baseline characteristics separately for participants with and without MI during follow-up (page 
1 of 2)* 
 
No myocardial infarction 
(n = 460,330, 98.9%) 
Myocardial infarction  
(n = 4,885, 1.1%) 
Male (%) 201,888 (43.9) 3,490 (71.4) 
Age (median [IQR]) 57.0 [50.0, 63.0] 61.0 [56.0, 65.0] 
Ethnicity (%) 
   White 433,291 (94.1) 4,614 (94.5) 
   Other ethnic groups 24,559 (5.3) 228 (4.7) 
Income (%) 
   Greater than 100,000 22,142 (4.8) 115 (2.4) 
   52,000 to 100,000 82,703 (18.0) 559 (11.4) 
   31,000 to 51,999 104,380 (22.7) 960 (19.7) 
   18,000 to 30,999 98,795 (21.5) 1,167 (23.9) 
   Less than 18,000 83,057 (18.0) 1,258 (25.8) 
Highest educational attainment (%) 
   College or university degree 151,998 (33.0) 1,144 (23.4) 
   A levels, O levels, NVQ, or equivalent 226,765 (49.3) 2,288 (46.8) 
   None of the above 72,582 (15.8) 1,294 (26.5) 
Area-based deprivation (%) 
   1 (Least deprived) 94,017 (20.4) 934 (19.1) 
   2 92,807 (20.2) 921 (18.9) 
   3 92,615 (20.1) 998 (20.4) 
   4 91,910 (20.0) 928 (19.0) 
   5 (Most deprived) 88,408 (19.2) 1,102 (22.6) 
Body mass index (%) 
   Under- or normal weight 156,658 (34.0) 1,114 (22.8) 
   Overweight 194,144 (42.2) 2,228 (45.6) 
   Obese 77,056 (16.7) 1,093 (22.4) 
   Severely obese 21,582 (4.7) 284 (5.8) 
   Morbidly obese 8,278 (1.8) 117 (2.4) 
Physical activity (%) 
   High 42,005 (9.1) 322 (6.6) 
   Moderate 301,659 (65.5) 3,101 (63.5) 
   Low 97,969 (21.3) 1,198 (24.5) 
Alcohol intake (%) 
   Safe drinking 206,501 (44.9) 1,988 (40.7) 
   Risky drinking 185,863 (40.4) 2,046 (41.9) 
Smoking status (%) 
   Never 256,838 (55.8) 1,975 (40.4) 
   Previous 154,303 (33.5) 1,848 (37.8) 
   Current 46,631 (10.1) 1,021 (20.9) 
Fruit and vegetable intake per day (%) 
   At least five a day 139,354 (30.3) 1,284 (26.3) 






Table A 17 continued: Baseline characteristics separately for participants with and without MI 
during follow-up (page 2 of 2)* 
 
No myocardial infarction 
(n = 460,330, 98.9%) 
Myocardial infarction  
(n = 4,885, 1.1%) 
Oily fish intake (%) 
   At least once a week 253,914 (55.2) 2,571 (52.6) 
   Less than once per week 152,915 (33.2) 1,590 (32.5) 
   Never 49,928 (10.8) 656 (13.4) 
Hypertension (%) 248,889 (54.1) 3,774 (77.3) 
Diabetes (%) 19,611 (4.3) 483 (9.9) 
High cholesterol levels (%) 67,570 (14.7) 1,220 (25.0) 
Family history of cardiovascular disease (%) 
   No 108,560 (23.6) 1,024 (21.0) 
   Yes 316,731 (68.8) 3,403 (69.7) 
Family history of depression (%) 
   No 359,949 (78.2) 3,567 (73.0) 
   Yes 40,704 (8.8) 400 (8.2) 
Depression (%) 39,838 (8.7) 515 (10.5) 
Antidepressant use (%) 30,731 (6.7) 399 (8.2) 
Self-reported depression (%) 24,841 (5.4) 298 (6.1) 
Hospital diagnosis with depression (%) 3,166 (0.7) 65 (1.3) 
* This table does not show the number and percentage with missing values. For more information 
on the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. 
Data are given as n (%) unless specified. 







Table A 18: Hazard ratios (95% CI) of the association between depression and MCVE (imputed data) 
 Unadjusted HR  
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
Depression 1.24 (1.15 – 1.33) 1.35 (1.25 – 1.45) 1.21 (1.12 – 1.30) 
Antidepressant use 1.27 (1.18 – 1.38) 1.38 (1.28 – 1.50) 1.22 (1.12 – 1.32) 
Hospital diagnosis 
with depression 
1.81 (1.48 – 2.22) 1.78 (1.45 – 2.18) 1.52 (1.24 – 1.86) 
Self-reported 
depression 
1.12 (1.02 – 1.23) 1.27 (1.16 – 1.40) 1.16 (1.05 – 1.27) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 
HR: Hazard ratio 
 
Table A 19: Hazard ratios (95% CI) of the association between depression and stroke and MI (imputed 
data) 
 Unadjusted HR  
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
Stroke 1.24 (1.10 – 1.39) 1.28 (1.14 – 1.43) 1.18 (1.05 – 1.33) 
Myocardial infarction 1.24 (1.13 – 1.36) 1.41 (1.29 – 1.55) 1.24 (1.12 – 1.36) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 







Table A 20: Baseline characteristics for participants with depression and/ or hypertension at baseline 
(page 1 of 2)* 
 












Male (%) 75,002 (38.6) 4,399 (24.4) 118,119 (51.3) 7,858 (35.2) 
Age (median [IQR]) 53.0 [47.0, 60.0] 53.0 [47.0, 60.0] 60.0 [53.0, 64.0] 59.0 [52.0, 64.0] 
Ethnicity (%) 
   White 181,945 (93.5) 17,275 (95.9) 217,193 (94.3) 21,492 (96.2) 
   Other ethnic groups 11,358 (5.8) 644 (3.6) 12,040 (5.2) 745 (3.3) 
Income (%)     
   Greater than 100,000 12,767 (6.6) 573 (3.2) 8,541 (3.7) 376 (1.7) 
   52,000 to 100,000 43,169 (22.2) 2,521 (14.0) 35,522 (15.4) 2,050 (9.2) 
   31,000 to 51,999 47,555 (24.4) 3,902 (21.7) 50,038 (21.7) 3,845 (17.2) 
   18,000 to 30,999 37,737 (19.4) 3,887 (21.6) 53,246 (23.1) 5,092 (22.8) 
   Less than 18,000 26,931 (13.8) 4,672 (25.9) 45,591 (19.8) 7,121 (31.9) 
Highest educational attainment (%) 
   College or university  
   degree 
75,325 (38.7) 5,816 (32.3) 66,532 (28.9) 5,469 (24.5) 
   A levels, O levels, CSE,  
   NVQ, or equivalent 
94,716 (48.7) 9,227 (51.2) 114,138 (49.6) 10,972 (49.1) 
   None of the above 20,625 (10.6) 2,691 (14.9) 45,107 (19.6) 5,453 (24.4) 
Area-based deprivation (%) 
   1 (Least deprived) 40,340 (20.7) 3,199 (17.8) 47,659 (20.7) 3,753 (16.8) 
   2 39,051 (20.1) 3,279 (18.2) 47,415 (20.6) 3,983 (17.8) 
   3 38,996 (20.0) 3,404 (18.9) 46,987 (20.4) 4,226 (18.9) 
   4 39,316 (20.2) 3,692 (20.5) 45,233 (19.6) 4,597 (20.6) 
   5 (Most deprived) 36,607 (18.8) 4,398 (24.4) 42,755 (18.6) 5,750 (25.7) 
Body mass index (%) 
   Under- or normal weight 88,846 (45.7) 7,076 (39.3) 57,355 (24.9) 4,495 (20.1) 
   Overweight 77,379 (39.8) 7,127 (39.6) 103,141 (44.8) 8,725 (39.0) 
   Obese 21,435 (11.0) 2,670 (14.8) 48,533 (21.1) 5,511 (24.7) 
   Severely obese 4,453 (2.3) 757 (4.2) 14,429 (6.3) 2,227 (10.0) 
   Morbidly obese 1,152 (0.6) 275 (1.5) 5,756 (2.5) 1,212 (5.4) 
Physical activity (%) 
   High 19,933 (10.2) 1,333 (7.4) 19,663 (8.5) 1,398 (6.3) 
   Moderate 128,772 (66.2) 11,116 (61.7) 151,797 (65.9) 13,075 (58.5) 
   Low 38,799 (19.9) 4,816 (26.7) 48,925 (21.2) 6,627 (29.7) 
Alcohol intake (%) 
   Safe drinking 92,211 (47.4) 9,006 (50.0) 96,745 (42.0) 10,527 (47.1) 
   Risky drinking 73,307 (37.7) 5,474 (30.4) 101,640 (44.1) 7,488 (33.5) 
Smoking status (%)     
   Never 113,686 (58.4) 9,035 (50.2) 125,198 (54.4) 10,894 (48.7) 
   Previous 58,847 (30.2) 5,758 (32.0) 83,411 (36.2) 8,135 (36.4) 





Table A 20 continued: Baseline characteristics for participants with depression and/ or hypertension at 
baseline (page 2 of 2)* 
 












Fruit and vegetable intake per day (%) 
   At least five a day 58,203 (29.9) 5,383 (29.9) 70,082 (30.4) 6,970 (31.2) 
   Less than five a day 135,520 (69.7) 12,566 (69.8) 159,660 (69.3) 15,297 (68.4) 
Oily fish intake (%) 
   At least once a week 103,772 (53.3) 8,933 (49.6) 132,002 (57.3) 11,778 (52.7) 
   Less than once per week 67,526 (34.7) 6,336 (35.2) 73,345 (31.8) 7,298 (32.7) 
   Never 21,616 (11.1) 2,596 (14.4) 23,311 (10.1) 3,061 (13.7) 
Diabetes (%) 3,098 (1.6) 418 (2.3) 14,511 (6.3) 2,067 (9.2) 
High cholesterol levels (%) 11,671 (6.0) 1,582 (8.8) 49,384 (21.4) 6,153 (27.5) 
Family history of cardiovascular disease (%) 
   No 54,369 (27.9) 4,414 (24.5) 46,825 (20.3) 3,976 (17.8) 
   Yes 126,326 (64.9) 12,237 (68.0) 165,062 (71.7) 16,509 (73.9) 
Family history of depression (%) 
   No 155,584 (80.0) 12,238 (68.0) 180,827 (78.5) 14,867 (66.5) 
   Yes 16,860 (8.7) 3,488 (19.4) 16,849 (7.3) 3,907 (17.5) 
* This table does not show the number and percentage with missing values. For more information on 
the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. Data are 
given as n (%) unless specified. 








Table A 21: Baseline characteristics for participants with depression and/ or diabetes (page 1 of 2)* 
 












Male (%) 182,209 (44.7) 11,106 (29.3) 10,912 (62.0) 1,151 (46.3) 
Age (median [IQR]) 57.0 [49.0, 63.0] 56.0 [49.0, 62.0] 61.0 [55.0, 65.0] 59.0 [53.0, 64.0] 
Ethnicity (%) 
   White 384,078 (94.3) 36,480 (96.3) 15,060 (85.5) 2,287 (92.0) 
   Other ethnic groups 21,002 (5.2) 1,208 (3.2) 2,396 (13.6) 181 (7.3) 
Income (%) 
   Greater than 100,000 20,868 (5.1) 925 (2.4) 440 (2.5) 24 (1.0) 
   52,000 to 100,000 76,672 (18.8) 4,408 (11.6) 2,019 (11.5) 163 (6.6) 
   31,000 to 51,999 94,433 (23.2) 7,405 (19.6) 3,160 (17.9) 342 (13.8) 
   18,000 to 30,999 86,867 (21.3) 8,437 (22.3) 4,116 (23.4) 542 (21.8) 
   Less than 18,000 67,885 (16.7) 10,824 (28.6) 4,637 (26.3) 969 (39.0) 
Highest educational attainment (%) 
   College or university  
   degree 
137,367 (33.7) 10,750 (28.4) 4,490 (25.5) 535 (21.5) 
   A levels, O levels, NVQ,  
   or equivalent 
200,545 (49.2) 19,024 (50.2) 8,309 (47.2) 1,175 (47.3) 
   None of the above 61,434 (15.1) 7,444 (19.7) 4,298 (24.4) 700 (28.2) 
Area-based deprivation (%) 
   1 (Least deprived) 85,280 (20.9) 6,637 (17.5) 2,719 (15.4) 315 (12.7) 
   2 83,501 (20.5) 6,886 (18.2) 2,965 (16.8) 376 (15.1) 
   3 82,677 (20.3) 7,240 (19.1) 3,306 (18.8) 390 (15.7) 
   4 80,832 (19.8) 7,758 (20.5) 3,717 (21.1) 531 (21.4) 
   5 (Most deprived) 74,488 (18.3) 9,278 (24.5) 4,874 (27.7) 870 (35.0) 
Body mass index (%) 
   Under- or normal weight 143,978 (35.4) 11,338 (29.9) 2,223 (12.6) 233 (9.4) 
   Overweight 174,288 (42.8) 15,178 (40.1) 6,232 (35.4) 674 (27.1) 
   Obese 64,723 (15.9) 7,447 (19.7) 5,245 (29.8) 734 (29.5) 
   Severely obese 16,507 (4.1) 2,523 (6.7) 2,375 (13.5) 461 (18.6) 
   Morbidly obese 5,556 (1.4) 1,146 (3.0) 1,352 (7.7) 341 (13.7) 
Physical activity (%) 
   High 38,301 (9.4) 2,612 (6.9) 1,295 (7.4) 119 (4.8) 
   Moderate 270,033 (66.3) 22,912 (60.5) 10,536 (59.8) 1,279 (51.5) 
   Low 82,874 (20.3) 10,520 (27.8) 4,850 (27.5) 923 (37.1) 
Alcohol intake (%) 
   Safe drinking 180,454 (44.3) 18,246 (48.2) 8,502 (48.3) 1,287 (51.8) 
   Risky drinking 169,090 (41.5) 12,389 (32.7) 5,857 (33.3) 573 (23.1) 
Smoking status (%) 
   Never 230,323 (56.6) 18,850 (49.8) 8,561 (48.6) 1,079 (43.4) 
   Previous 135,135 (33.2) 12,870 (34.0) 7,123 (40.5) 1,023 (41.2) 





Table A 21 continued: Baseline characteristics for participants with depression and/ or diabetes (page 
2 of 2)* 
 












Fruit and vegetable intake per day (%) 
   At least five a day 122,116 (30.0) 11,481 (30.3) 6,169 (35.0) 872 (35.1) 
   Less than five a day 283,847 (69.7) 26,263 (69.4) 11,333 (64.4) 1,600 (64.4) 
Oily fish intake (%) 
   At least once a week 225,934 (55.5) 19,442 (51.3) 9,840 (55.9) 1,269 (51.1) 
   Less than once per week 135,507 (33.3) 12,821 (33.9) 5,364 (30.5) 813 (32.7) 
   Never 42,746 (10.5) 5,287 (14.0) 2,181 (12.4) 370 (14.9) 
Hypertension (%) 215,804 (53.0) 20,281 (53.6) 14,511 (82.4) 2,067 (83.2) 
High cholesterol levels (%) 47,758 (11.7) 5,762 (15.2) 13,297 (75.5) 1,973 (79.4) 
Family history of cardiovascular disease (%) 
   No 97,524 (23.9) 7,921 (20.9) 3,670 (20.8) 469 (18.9) 
   Yes 279,346 (68.6) 26,970 (71.2) 12,042 (68.4) 1,776 (71.5) 
Family history of depression (%) 
   No 323,354 (79.4) 25,453 (67.2) 13,057 (74.1) 1,652 (66.5) 
   Yes 32,583 (8.0) 7,022 (18.5) 1,126 (6.4) 373 (15.0) 
* This table does not show the number and percentage with missing values. For more information on 
the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. Data are 
given as n (%) unless specified 








Table A 22: Baseline characteristics for participants with depression and/ or high cholesterol levels (page 














Male (%) 158,012 (43.4) 9,099 (27.9) 35,109 (57.5) 3,158 (40.8) 
Age (median [IQR]) 56.0 [49.0, 62.0] 55.0 [49.0, 61.0] 62.0 [57.0, 66.0] 61.0 [56.0, 65.0] 
Ethnicity (%) 
   White 342,657 (94.2) 31,414 (96.3) 56,481 (92.5) 7,353 (95.1) 
   Other ethnic groups 19,152 (5.3) 1,057 (3.2) 4,246 (7.0) 0,332 (4.3) 
Income (%) 
   Greater than 100,000 19,162 (5.3) 840 (2.6) 2,146 (3.5) 109 (1.4) 
   52,000 to 100,000 71,161 (19.6) 4,023 (12.3) 7,530 (12.3) 548 (7.1) 
   31,000 to 51,999 86,039 (23.6) 6,621 (20.3) 11,554 (18.9) 1,126 (14.6) 
   18,000 to 30,999 76,465 (21.0) 7,266 (22.3) 14,518 (23.8) 1,713 (22.1) 
   Less than 18,000 57,696 (15.9) 8,968 (27.5) 14,826 (24.3) 2,825 (36.5) 
Highest educational attainment (%) 
   College or university    
   degree 
125,810 (34.6) 9,580 (29.4) 16,047 (26.3) 1,705 (22.0) 
   A levels, O levels, NVQ,  
   or equivalent 
180,014 (49.5) 16,639 (51.0) 28,840 (47.2) 3,560 (46.0) 
   None of the above 50,921 (14.0) 5,850 (17.9) 14,811 (24.3) 2,294 (29.7) 
Area-based deprivation (%) 
   1 (Least deprived) 76,428 (21.0) 5,771 (17.7) 11,571 (19.0) 1,181 (15.3) 
   2 74,558 (20.5) 5,998 (18.4) 11,908 (19.5) 1,264 (16.3) 
   3 73,818 (20.3) 6,217 (19.1) 12,165 (19.9) 1,413 (18.3) 
   4 72,321 (19.9) 6,700 (20.5) 12,228 (20.0) 1,589 (20.5) 
   5 (Most deprived) 66,254 (18.2) 7,866 (24.1) 13,108 (21.5) 2,282 (29.5) 
Body mass index (%) 
   Under- or normal weight 134,544 (37.0) 10,395 (31.9) 11,657 (19.1) 1,176 (15.2) 
   Overweight 153,068 (42.1) 12,894 (39.5) 27,452 (45.0) 2,958 (38.2) 
   Obese 55,010 (15.1) 6,066 (18.6) 14,958 (24.5) 2,115 (27.3) 
   Severely obese 14,231 (3.9) 2,056 (6.3) 4,651 (7.6) 928 (12.0) 
   Morbidly obese 4,943 (1.4) 999 (3.1) 1,965 (3.2) 488 (6.3) 
Physical activity (%) 
   High 34,826 (9.6) 2,304 (7.1) 4,770 (7.8) 427 (5.5) 
   Moderate 241,287 (66.3) 19,854 (60.9) 39,282 (64.3) 4,337 (56.1) 
   Low 73,375 (20.2) 8,939 (27.4) 14,349 (23.5) 2,504 (32.4) 
Alcohol intake (%) 
   Safe drinking 162,633 (44.7) 15,728 (48.2) 26,323 (43.1) 3,805 (49.2) 
   Risky drinking 148,878 (40.9) 10,630 (32.6) 26,069 (42.7) 2,332 (30.1) 
Smoking status (%) 
   Never 209,162 (57.5) 16,565 (50.8) 29,722 (48.7) 3,364 (43.5) 
   Previous 117,318 (32.2) 10,820 (33.2) 24,940 (40.8) 3,073 (39.7) 





Table A 22 continued: Baseline characteristics for participants with depression and/ or high cholesterol 














Fruit and vegetable intake per day (%) 
   At least five a day 108,653 (29.9) 9,769 (29.9) 19,632 (32.2) 2,584 (33.4) 
   Less than five a day 253,945 (69.8) 22,754 (69.8) 41,235 (67.5) 5,109 (66.1) 
Oily fish intake (%) 
   At least once a week 198,717 (54.6) 16,459 (50.5) 37,057 (60.7) 4,252 (55.0) 
   Less than once per week 122,914 (33.8) 11,251 (34.5) 17,957 (29.4) 2,383 (30.8) 
   Never 39,379 (10.8) 4,645 (14.2) 5,548 (9.1) 1,012 (13.1) 
Hypertension (%) 180,931 (49.7) 16,195 (49.7) 49,384 (80.9) 6,153 (79.5) 
Diabetes (%) 4,312 (1.2) 512 (1.6) 13,297 (21.8) 1,973 (25.5) 
Family history of cardiovascular disease (%) 
   No 90,476 (24.9) 7,096 (21.8) 10,718 (17.6) 1,294 (16.7) 
   Yes 246,201 (67.7) 22,965 (70.4) 45,187 (74.0) 5,781 (74.7) 
Family history of depression (%) 
   No 289,392 (79.5) 21,947 (67.3) 47,019 (77.0) 5,158 (66.7) 
   Yes 29,426 (8.1) 6,170 (18.9) 4,283 (7.0) 1,225 (15.8) 
* This table does not show the number and percentage with missing values. For more information on 
the distribution of missing values see section 4.4.2 Investigation of missing data mechanism. Data are 
given as n (%) unless specified 








Table A 23: Hazard ratios (95% CI) of the association between depression and/ or different comorbidities 




Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
No depression, no 
hypertension 
ref. ref. ref. 
Depression alone 1.12 (0.96 – 1.31) 1.17 (1.00 – 1.37) 1.06 (0.91 – 1.24) 
Hypertension alone 2.74 (2.59 – 2.89) 1.84 (1.74 – 1.94) 1.78 (1.68 – 1.89) 
Depression and 
hypertension 
3.43 (3.14 – 3.76) 2.55 (2.32 – 2.79) 2.23 (2.03 – 2.45) 
 
No diabetes, no 
depression 
ref. ref. ref. 
Depression alone 1.22 (1.13 – 1.32) 1.34 (1.24 – 1.45) 1.22 (1.13 – 1.32) 
Diabetes alone 2.50 (2.31 – 2.71) 1.69 (1.55 – 1.83) 1.47 (1.35 – 1.61) 
Depression and diabetes 2.68 (2.20 – 3.26) 2.05 (1.69 – 2.50) 1.63 (1.33 – 2.00) 
 
No depression, low 
cholesterol levels 
ref. ref. ref. 
Depression alone 1.16 (1.06 – 1.26) 1.28 (1.18 – 1.40) 1.17 (1.07 – 1.28) 
High cholesterol levels 
alone 
1.90 (1.80 – 2.01) 1.22 (1.15 – 1.29) 0.97 (0.91 – 1.03) 
Depression and high 
cholesterol levels 
2.39 (2.12 – 2.71) 1.74 (1.54 – 1.97) 1.24 (1.09 – 1.41) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, cholesterol, diabetes, family history of CVD, and family history of depression 





Table A 24: Baseline characteristics for participants with depression and/ or low educational attainment 














Male (%) 67,480 (47.6) 3,802 (33.7) 121,717 (44.3) 8,236 (29.1) 
Age (median [IQR]) 55.0 [48.0, 61.0] 55.0 [49.0, 61.0] 58.0 [51.0, 64.0] 57.0 [50.0, 63.0] 
Ethnicity (%) 
   White 132,016 (93.1) 10,788 (95.6) 260,715 (94.9) 27,380 (96.6) 
   Other ethnic groups 9,250 (6.5) 451 (4.0) 13,081 (4.8) 881 (3.1) 
Income (%) 
   Greater than 100,000 15,385 (10.8) 664 (5.9) 5,912 (2.2) 283 (1.0) 
   52,000 to 100,000 43,110 (30.4) 2,476 (21.9) 35,493 (12.9) 2,089 (7.4) 
   31,000 to 51,999 37,068 (26.1) 2,964 (26.3) 60,313 (22.0) 4,769 (16.8) 
   18,000 to 30,999 23,965 (16.9) 2,439 (21.6) 66,591 (24.3) 6,510 (23.0) 
   Less than 18,000 11,374 (8.0) 1,875 (16.6) 60,392 (22.0) 9,831 (34.7) 
Area-based deprivation (%) 
   1 (Least deprived) 32,068 (22.6) 2,395 (21.2) 54,652 (19.9) 4,475 (15.8) 
   2 28,987 (20.4) 2,147 (19.0) 56,077 (20.4) 5,013 (17.7) 
   3 27,699 (19.5) 2,143 (19.0) 56,669 (20.6) 5,358 (18.9) 
   4 28,796 (20.3) 2,328 (20.6) 54,198 (19.7) 5,824 (20.5) 
   5 (Most deprived) 24,140 (17.0) 2,243 (19.9) 52,665 (19.2) 7,630 (26.9) 
Body mass index (%) 
   Under- or normal weight 58,879 (41.5) 3,931 (34.8) 84,819 (30.9) 7,471 (26.4) 
   Overweight 58,006 (40.9) 4,417 (39.1) 119,113 (43.4) 11,164 (39.4) 
   Obese 18,305 (12.9) 1,905 (16.9) 50,182 (18.3) 6,108 (21.6) 
   Severely obese 4,508 (3.2) 652 (5.8) 13,945 (5.1) 2,260 (8.0) 
   Morbidly obese 1,563 (1.1) 309 (2.7) 5,191 (1.9) 1,150 (4.1) 
Physical activity (%) 
   High 17,054 (12.0) 989 (8.8) 22,247 (8.1) 1,723 (6.1) 
   Moderate 93,762 (66.1) 7,026 (62.3) 184,013 (67.0) 16,947 (59.8) 
   Low 28,973 (20.4) 3,058 (27.1) 56,783 (20.7) 8,154 (28.8) 
Alcohol intake (%) 
   Safe drinking 62,500 (44.1) 5,284 (46.8) 122,977 (44.8) 13,939 (49.2) 
   Risky drinking 63,805 (45.0) 4,262 (37.8) 108,594 (39.5) 8,534 (30.1) 
Smoking status (%) 
   Never 87,651 (61.8) 6,230 (55.2) 147,093 (53.6) 13,374 (47.2) 
   Previous 43,969 (31.0) 3,799 (33.7) 95,961 (34.9) 9,896 (34.9) 
   Current 9,971 (7.0) 1,239 (11.0) 30,385 (11.1) 4,946 (17.5) 
Fruit and vegetable intake per day (%) 
   At least five a day 45,824 (32.3) 3,754 (33.3) 80,041 (29.1) 8,384 (29.6) 
   Less than five a day 95,953 (67.6) 7,525 (66.7) 194,149 (70.7) 19,902 (70.2) 
Oily fish intake (%) 
   At least once a week 83,289 (58.7) 6,304 (55.9) 148,183 (54.0) 14,057 (49.6) 
   Less than once per week 47,106 (33.2) 3,826 (33.9) 91,637 (33.4) 9,611 (33.9) 





Table A 24 continued: Baseline characteristics for participants with depression and/ or low educational 














Hypertension (%) 66,532 (46.9) 5,469 (48.5) 159,245 (58.0) 16,425 (58.0) 
Diabetes (%) 4,490 (3.2) 535 (4.7) 12,607 (4.6) 1,875 (6.6) 
High cholesterol levels (%) 16,047 (11.3) 1,705 (15.1) 43,651 (15.9) 5,854 (20.7) 
Family history of cardiovascular disease (%) 
   No 34,575 (24.4) 2,443 (21.6) 64,918 (23.6) 5,815 (20.5) 
   Yes 100,050 (70.5) 8,231 (72.9) 186,491 (67.9) 20,079 (70.8) 
Family history of depression (%) 
   No 116,684 (82.3) 7,752 (68.7) 214,372 (78.1) 18,975 (66.9) 
   Yes 12,868 (9.1) 2,420 (21.4) 20,368 (7.4) 4,863 (17.2) 
* This table shows the baseline characteristics of participants without missing values in the 
education variable prior to imputation (n = 456,071). For more information on the distribution of 
missing values see section 4.4.2 Investigation of missing data mechanism. Data are given as n (%) 
unless specified. 






Table A 25: Baseline characteristics for participants with depression and/ or high area-based deprivation 














Male (%) 139,139 (45.2) 7,579 (28.8) 53,735 (46.1) 4,658 (33.4) 
Age (median [IQR]) 58.0 [50.0, 63.0] 58.0 [51.0, 63.0] 56.0 [48.0, 62.0] 55.0 [48.0, 61.0] 
Ethnicity (%) 
   White 297,090 (96.5) 25,780 (98.0) 101,596 (87.2) 12,916 (92.5) 
   Other ethnic groups 9,500 (3.1) 455 (1.7) 13,850 (11.9) 933 (6.7) 
Income (%) 
   Greater than 100,000 16,381 (5.3) 732 (2.8) 4,899 (4.2) 216 (1.5) 
   52,000 to 100,000 64,327 (20.9) 3,747 (14.2) 14,251 (12.2) 813 (5.8) 
   31,000 to 51,999 75,364 (24.5) 5,938 (22.6) 22,111 (19.0) 1,796 (12.9) 
   18,000 to 30,999 65,521 (21.3) 6,299 (23.9) 25,363 (21.8) 2,667 (19.1) 
   Less than 18,000 41,278 (13.4) 5,758 (21.9) 31,155 (26.7) 6,008 (43.0) 
Highest educational attainment (%) 
   College or university  
   degree 
104,993 (34.1) 7,983 (30.3) 36,697 (31.5) 3,273 (23.4) 
   A levels, O levels, NVQ,  
   or equivalent 
156,772 (50.9) 13,710 (52.1) 51,817 (44.5) 6,457 (46.2) 
   None of the above 40,959 (13.3) 4,247 (16.1) 24,713 (21.2) 3,886 (27.8) 
Body mass index (%) 
   Under- or normal weight 108,525 (35.3) 7,853 (29.8) 37,510 (32.2) 3,702 (26.5) 
   Overweight 133,644 (43.4) 10,758 (40.9) 46,669 (40.0) 5,071 (36.3) 
   Obese 48,507 (15.8) 5,101 (19.4) 21,374 (18.3) 3,064 (21.9) 
   Severely obese 11,932 (3.9) 1,734 (6.6) 6,924 (5.9) 1,244 (8.9) 
   Morbidly obese 3,902 (1.3) 736 (2.8) 2,997 (2.6) 743 (5.3) 
Physical activity (%) 
   High 29,270 (9.5) 1,884 (7.2) 10,272 (8.8) 844 (6.0) 
   Moderate 203,922 (66.3) 16,056 (61.0) 76,332 (65.5) 8,093 (58.0) 
   Low 63,988 (20.8) 7,309 (27.8) 23,616 (20.3) 4,112 (29.4) 
Alcohol intake (%) 
   Safe drinking 135,856 (44.1) 12,769 (48.5) 52,851 (45.3) 6,723 (48.1) 
   Risky drinking 130,241 (42.3) 8,819 (33.5) 44,517 (38.2) 4,126 (29.5) 
Smoking status (%) 
   Never 180,621 (58.7) 14,268 (54.2) 57,971 (49.7) 5,629 (40.3) 
   Previous 102,833 (33.4) 9,138 (34.7) 39,269 (33.7) 4,729 (33.9) 
   Current 23,040 (7.5) 2,808 (10.7) 18,246 (15.7) 3,493 (25.0) 
Fruit and vegetable intake per day (%) 
   At least five a day 93,095 (30.2) 8,234 (31.3) 35,055 (30.1) 4,093 (29.3) 
   Less than five a day 214,175 (69.6) 18,045 (68.6) 80,639 (69.2) 9,772 (70.0) 
Oily fish intake (%) 
   At least once a week 174,332 (56.6) 14,118 (53.6) 61,180 (52.5) 6,561 (47.0) 
   Less than once per  
   week 
103,031 (33.5) 8,992 (34.2) 37,671 (32.3) 4,615 (33.1) 





Table A 25 continued: Baseline characteristics for participants with depression and/ or high area-based 














Hypertension (%) 167,371 (54.4) 14,446 (54.9) 62,678 (53.8) 7,863 (56.3) 
Diabetes (%) 10,921 (3.5) 1,361 (5.2) 6,660 (5.7) 1,121 (8.0) 
High cholesterol levels (%) 42,342 (13.8) 4,703 (17.9) 18,638 (16.0) 3,026 (21.7) 
Family history of cardiovascular disease (%) 
   No 73,863 (24.0) 5,562 (21.1) 27,211 (23.3) 2,817 (20.2) 
   Yes 213,657 (69.4) 19,029 (72.3) 77,377 (66.4) 9,663 (69.2) 
Family history of depression (%) 
   No 249,142 (80.9) 18,338 (69.7) 86,885 (74.5) 8,725 (62.5) 
   Yes 24,242 (7.9) 4,800 (18.2) 9,418 (8.1) 2,574 (18.4) 
* This table shows the baseline characteristics of participants without missing values in the 
deprivation variable prior to imputation (n = 464,640). For more information on the distribution of 
missing values see section 4.4.2 Investigation of missing data mechanism. Data are given as n (%) 
unless specified. 







Table A 26: Hazard ratios (95% CI) of the association between depression and/ or low education and 




Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
No depression, high 
education 
ref. ref. ref. 
Depression alone 1.19 (1.01 – 1.40) 1.29 (1.09 – 1.51) 1.16 (0.99 – 1.37) 
Low education alone 1.53 (1.45 – 1.61) 1.23 (1.16 – 1.31) 1.11 (1.05 – 1.18) 
Depression and low 
education 
1.85 (1.69 – 2.03) 1.69 (1.53 – 1.86) 1.35 (1.23 – 1.49) 
 
No depression, low 
deprivation 
ref. ref. ref. 
Depression alone 1.07 (0.97 – 1.18) 1.21 (1.10 – 1.33) 1.10 (1.00 – 1.22) 
High deprivation alone 1.19 (1.13 – 1.25) 1.18 (1.12 – 1.25) 1.07 (1.02 – 1.13) 
Depression and high 
deprivation 
1.73 (1.56 – 1.92) 1.87 (1.68 – 2.08) 1.46 (1.31 – 1.63) 
Model 1: Age, sex, ethnicity, income, area-based deprivation (binary) 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 
CI: Confidence interval, HR: Hazard ratio, ref.: reference 
 
Table A 27: Hazard ratios (95% CI) of the association between different measures of depression and 
MCVE in unadjusted, partially adjusted and fully adjusted models (complete cases) 
 Unadjusted HR  
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
Depression 1.13 (1.02 – 1.26) 1.26 (1.13 – 1.40) 1.14 (1.02 – 1.27) 
Antidepressant use 1.15 (1.02 – 1.29) 1.28 (1.13 – 1.44) 1.14 (1.00 – 1.28) 
Hospital diagnosis 
with depression 
1.82 (1.35 – 2.46) 1.85 (1.37 – 2.50) 1.60 (1.18 – 2.16) 
Self-reported 
depression 
1.07 (0.94 – 1.23) 1.24 (1.09 – 1.42) 1.14 (0.99 – 1.31) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 







Table A 28: Hazard ratios (95% CI) of the association between depression and stroke and MI (complete 
cases) 
 
Unadjusted HR  
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
Stroke 1.24 (1.06 – 1.46) 1.30 (1.10 – 1.53) 1.21 (1.02 – 1.43) 
Myocardial infarction 1.06 (0.93 – 1.22) 1.24 (1.08 – 1.43) 1.09 (0.95 – 1.26) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 
CI: Confidence interval, HR: Hazard ratio 
 
Table A 29: Hazard ratios (95% CI) of the association between depression and MCVE, stroke, and MI, 
separately for men and women (complete cases) 
 Major cardiovascular 
events 
Stroke Myocardial infarction 
Women 1.28 (1.09 – 1.50) 1.17 (0.93 – 1.48) 1.37 (1.10 – 1.70) 
Men 1.03 (0.88 – 1.20) 1.25 (0.98 – 1.59) 0.93 (0.77 – 1.12) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 
CI: Confidence interval 
 
Table A 30: Hazard ratios (95% CI) of the association between depression and/ or male gender and 
MCVE (complete cases) 
 Unadjusted HR 
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
No depression, female ref. ref. ref. 
Depression alone 1.49 (1.28 – 1.74) 1.43 (1.22 – 1.67) 1.29 (1.10 – 1.51) 
Male alone 2.65 (2.47 – 2.84) 2.64 (2.46 – 2.83) 2.39 (2.22 – 2.58) 
Depression and male 3.16 (2.70 – 3.69) 2.99 (2.56 – 3.49) 2.44 (2.08 – 2.86) 
CI: confidence interval, HR: Hazard ratio, ref.: reference 
 
Table A 31: Hazard ratios (95% CI) of the association between depression and death from causes other 
than stroke or MI in unadjusted, partially adjusted and fully adjusted models (complete cases) 
 
Unadjusted HR  
(95% CI) 
Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
Depression 1.40 (1.28 – 1.52) 1.41 (1.29 – 1.54) 1.30 (1.19 – 1.43) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 





Table A 32: Hazard ratios (95% CI) of the association between depression and/ or different comorbidities 




Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
No depression, no 
hypertension 
ref. ref. ref. 
Depression alone 0.83 (0.65 – 1.07) 0.90 (0.70 – 1.15) 0.82 (0.64 – 1.05) 
Hypertension alone 2.83 (2.62 – 3.04) 1.87 (1.73 – 2.02) 1.79 (1.66 – 1.94) 
Depression and 
hypertension 
3.44 (3.02 – 3.92) 2.55 (2.24 – 2.91) 2.22 (1.94 – 2.54) 
 
No diabetes, no 
depression 
ref. ref. ref. 
Depression alone 1.11 (0.99 – 1.24) 1.25 (1.11 – 1.40) 1.14 (1.02 – 1.28) 
Diabetes alone 2.38 (2.11 – 2.68) 1.58 (1.40 – 1.78) 1.33 (1.17 – 1.51) 
Depression and diabetes 2.53 (1.85 – 3.46) 1.88 (1.37 – 2.57) 1.45 (1.06 – 2.00) 
 
No depression, low 
cholesterol levels 
ref. ref. ref. 
Depression alone 1.02 (0.90 – 1.16) 1.16 (1.02 – 1.32) 1.07 (0.93 – 1.22) 
High cholesterol levels 
alone 
1.95 (1.81 – 2.10) 1.21 (1.12 – 1.31) 0.99 (0.91 – 1.07) 
Depression and high 
cholesterol levels 
2.47 (2.06 – 2.95) 1.75 (1.46 – 2.10) 1.29 (1.08 – 1.56) 
Model 1: Age, sex, ethnicity, education, income, area-based deprivation 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, cholesterol, diabetes, family history of CVD, and family history of depression 







Table A 33: Hazard ratios (95% CI) of the association between depression and/ or low socioeconomic 




Adjusted HR (95% CI) 
Model 1 
Adjusted HR (95% CI) 
Model 2 
No depression, high 
education 
ref. ref. ref. 
Depression alone 1.19 (0.97 – 1.45) 1.28 (1.05 – 1.57) 1.16 (0.95 – 1.42) 
Low education alone 1.46 (1.37 – 1.57) 1.21 (1.12 – 1.30) 1.10 (1.02 – 1.18) 
Depression and low 
education 
1.58 (1.38 – 1.80) 1.51 (1.32 – 1.73) 1.24 (1.07 – 1.42) 
 
No depression, low 
deprivation 
ref. ref. ref. 
Depression alone 0.98 (0.85 – 1.12) 1.11 (0.97 – 1.28) 1.02 (0.89 – 1.17) 
High deprivation alone 1.06 (0.99 – 1.14) 1.10 (1.02 – 1.19) 1.02 (0.94 – 1.10) 
Depression and high 
deprivation 
1.54 (1.30 – 1.81) 1.74 (1.47 – 2.05) 1.39 (1.18 – 1.65) 
Model 1: Age, sex, ethnicity, income, area-based deprivation (binary) 
Model 2: Model 1 + BMI, physical activity, alcohol intake, smoking, fruit and vegetable intake, oily 
fish intake, hypertension, cholesterol, diabetes, family history of CVD, and family history of 
depression 
CI: Confidence interval, HR: Hazard ratio, ref.: reference 
 
Table A 34: Results of formal tests for additive and multiplicative interaction between depression and 







Depression and sex 
-0.24 
(-0.66 to 0.17) 
-0.10 
(-0.28 to 0.08) 
0.86 
(0.65 to 1.13) 




(0.29 to 0.94) 
0.28 
(0.15 to 0.40) 
2.01 
(1.31 to 3.09) 
p < 0.01 
Depression and diabetes 
-0.02 
(-0.51 to 0.48) 
-0.01 
(-0.35 to 0.33) 
0.97 
(0.33 to 2.84) 
p = 0.81 
Depression and high 
cholesterol levels 
0.24 
(-0.03 to 0.52) 
0.19 
(0.002 to 0.37) 
5.67 
(0.21 to 150.57) 




(-0.31 to 0.25) 
-0.02 
(-0.25 to 0.20) 
0.89 
(0.30 to 2.64) 




(0.08 to 0.63) 
0.25 
(0.09 to 0.42) 
9.98 
(0.14 to 720.35) 
p < 0.01 
* Data are presented as estimate (95% confidence interval) 







Table A 35: Participant characteristics at study phase 1, separately for those included and excluded from 
the analysis (page 1 of 2)* 
 Included 
(n = 11,804, 82.9%) 
Excluded 
(n = 2,443, 17.1%) 
p 
Age (median [IQR]) 20.7 [19.5, 22.0] 20.5 [19.4, 21.9] 0.001 
Marital status (%) <0.001 
   Married/ de-facto 2,601 (22.0) 592 (24.2)  
   Separated/ divorced/ widowed 89 (0.8) 45 (1.8)  
   Single 9,062 (76.8) 1,788 (73.2)  
   Missing value 52 (0.4) 18 (0.7)  
Lives alone (%) 0.361 
   Yes 714 (6.0) 138 (5.6)  
   No 10,930 (92.6) 2,264 (92.7)  
   Missing value 160 (1.4) 41 (1.7)  
Area of residence (%) 0.100 
   Metropolitan 6,502 (55.1) 1,361 (55.7)  
   Rural 4,840 (41.0) 964 (39.5)  
   Remote 436 (3.7) 109 (4.5)  
   Missing value 26 (0.2) 9 (0.4)  
University degree (%) <0.001 
   No 10,319 (87.4) 2,271 (93.0)  
   Yes 1,426 (12.1) 150 (6.1)  
   Missing value 59 (0.5) 22 (0.9)  
Ability to manage on income (%) <0.001 
   Difficult/ impossible 2,065 (17.5) 559 (22.9)  
   Difficult some of the time 3,852 (32.6) 854 (35.0)  
   Easy/ not too bad 5,851 (49.6) 1,014 (41.5)  
   Missing value 36 (0.3) 16 (0.7)  
Alcohol intake (%) <0.001 
   Low risk 6,149 (52.1) 1048 (42.9)  
   Non/ rarely 4,910 (41.6) 1,199 (49.1)  
   Risky/ high risk 625 (5.3) 157 (6.4)  
   Missing value 120 (1.0) 39 (1.6)  
Smoking status (%) <0.001 
   Never-smoker 6,061 (51.3) 1,062 (43.5)  
   Ex-smoker 1,729 (14.6) 356 (14.6)  
   Current smoker 3,520 (29.8) 901 (36.9)  
   Missing value 494 (4.2) 124 (5.1)  
Body mass index (kg/m2) (mean (SD)) 22.9 (4.3) 22.5 (4.6) 0.003 
BMI (WHO groups) (%) <0.001 
   Underweight 955 (8.1) 279 (11.4)  
   Acceptable weight 7,163 (60.7) 1,272 (52.1)  
   Overweight 1,640 (13.9) 294 (12.0)  
   Obese 689 (5.8) 123 (5.0)  





Table A 35 continued: Participant characteristics at study phase 1, separately for those included 
and excluded from the analysis (page 2 of 2)* 
 
Included 
(n = 11,804, 82.9%) 
Excluded 
(n = 2,443, 17.1%) 
p 
Diabetes (%) 0.003 
   Yes 108 (0.9) 38 (1.6)  
   No 11,657 (98.8) 2,391 (97.9)  
   Missing value 39 (0.3) 14 (0.6)  
Heart disease (%) 0.178 
   Yes 42 (0.4) 13 (0.5)  
   No 11,717 (99.3) 2,416 (98.9)  
   Missing value 45 (0.4) 14 (0.6)  
Hypertension (%) 0.019 
   Yes 573 (4.9) 149 (6.1)  
   No 11,175 (94.7) 2,278 (93.2)  
   Missing value 56 (0.5) 16 (0.7)  
* Data are given as n (%) unless specified 
IQR: interquartile range, SD: standard deviation 
 
 







Table A 36: Numbers and proportion of women with hypertension, diabetes, and heart disease at any 
point during follow-up 
 
Stable low 




(n = 128) 
p 
Hypertension (%) 575 (7.1) 407 (11.4) 16 (12.5) <0.01 
Diabetes (%) 183 (2.3) 125 (3.5) 1 (0.8) <0.01 
Heart disease (%) 55 (0.7) 51 (1.4) 0 (0.0) <0.01 
* Data are given as n (%) unless specified 
 
Table A 37: Model characteristics of models with increasing numbers of latent classes among those with 






















1 17 -133885.3 14 266,249 267,900 100.0     
2 115 -133827.3 20 266,177 267,839 27.5 72.5    
3 164 -133779.7 26 266,104 267,800 1.0 27.5 71.5   
4 165 -133746.4 32 266,052 267,788 0.9 70.7 0.8 27.6  
5 331 -133718.2 38 266,050 267,788 46.0 49.8 1.1 0.5 2.7 
6 500 Model did not reach convergence 
7 500 Model did not reach convergence 
 
 
Figure A 2: Predicted trajectories of depressive symptoms in models with increasing numbers of latent 






Table A 38: Model characteristics of models with increasing numbers of latent classes in the analysis 











BIC % class 1 % class 2 
1 25 -32,164.2 12 86,348 64,440 100.0  
2 402 -30,975.3 18 86,539 62,119 20.8 79.2 
3 500 Model did not reach convergence 
4 500 Model did not reach convergence 
 
 
Figure A 3: Predicted trajectories of the unique item I felt depressed in models with increasing numbers 
of latent classes 
 
Table A 39: Model characteristics of models with increasing numbers of latent classes in the analysis 











BIC % class 1 % class 2 
1 21 -58,764.0 12 122,265 117,640 100.0  
2 30 -58,466.1 18 122,417 117,100 52.9 47.1 
3 500 Model did not reach convergence 
4 500 Model did not reach convergence 
 
 
Figure A 4: Predicted trajectories of the unique item I felt hopeful about the future in models with 





A.IV. Whitehall II 
Table A 40: Baseline characteristics, separately for those included and excluded from the analyses on 
fatal coronary heart disease or non-fatal myocardial infarction during follow-up* 
 Included 
(n = 10,187, 98.8%) 
Excluded 
(n = 121, 1.2%) 
p 
Male (%) 6,803 (66.8) 92 (76.0) 0.040 
Age (median [IQR]) 44.24 [39.6, 50.3] 50.82 [46.5, 53.6] <0.001 
Ethnicity (%) 0.001 
   White 9,084 (89.2) 97 (80.2)  
   Non-white 1,011 (9.9) 24 (19.8)  
   Missing value 92 (0.9) 0 (0.0)  
Marital status (%) 0.506 
   Married/ cohabiting 7,523 (73.8) 85 (70.2)  
   Other 2,627 (25.8) 35 (28.9)  
   Missing value 37 (0.4) 1 (0.8)  
Occupational position (%) 0.001 
   Administrative 2,996 (29.4) 32 (26.4)  
   Professional/ executive 4,898 (48.1) 45 (37.2)  
   Clerical/ support 2,293 (22.5) 44 (36.4)  
Smoking status (%) 0.094 
   Never smoker 5,023 (49.3) 46 (38.0)  
   Ex-smoker 3,232 (31.7) 49 (40.5)  
   Current smoker 1,861 (18.3) 25 (20.7)  
   Missing value 71 (0.7) 1 (0.8)  
Alcohol intake (%) 0.544 
   Risky drinking 2,394 (23.5) 25 (20.7)  
   Safe drinking 7,701 (75.6) 94 (77.7)  
   Missing value 92 (0.9) 2 (1.7)  
Physical activity (median [IQR]) 3.0 [1.0, 5.0] 2.0 [1.0, 4.0] 0.275 
Fruit and vegetable intake (%) <0.001 
   Less than once a day 4,240 (41.6) 57 (47.1)  
   Daily 4,231 (41.5) 46 (38.0)  
   More than daily 1,686 (16.6) 15 (12.4)  
   Missing value 30 (0.3) 3 (2.5)  
Body mass index (kg/ m2) (median [IQR]) 24.2 [22.3, 26.3] 26.1 [23.8, 28.7] <0.001 
Diabetes (self-report or medication) (%) 95 (0.9) 5 (4.1) 0.002 
Systolic blood pressure (median [IQR]) 122.0 [113.0, 132.0] 124.0 [112.0, 134.0] 0.187 
Diastolic blood pressure (median [IQR]) 76.0 [70.0, 83.0] 79.0 [72.0, 88.0] 0.012 
Total cholesterol levels (median [IQR]) 5.9 [5.2, 6.7] 6.3 [5.6, 7.2] <0.001 
Psychological distress (median [IQR]) 1.0 [0.0, 5.0] 1.0 [0.0, 4.0] 0.618 
Psychological distress (binary) (%) <0.001 
   No 7,372 (72.4) 73 (60.3)  
   Yes 2,721 (26.7) 23 (19.0)  
   Missing value 94 (0.9) 25 (20.7)  






Table A 41: Baseline characteristics, separately for those included and excluded from the analyses on 
fatal or non-fatal stroke during follow-up* 
 
Included 
(n = 10,252, 99.5%) 
Excluded 
(n = 56, 0.5%) 
p 
Male (%) 6,869 (67.0) 26 (46.4) 0.002 
Age (median [IQR]) 44.3 [39.6, 50.3] 48.9 [46.1, 51.6] <0.001 
Ethnicity (%) <0.001 
   White 9,140 (89.2) 41 (73.2)  
   Non-white 1,020 (9.9) 15 (26.8)  
   Missing value 92 (0.9) 0 (0.0)  
Marital status (%) 0.351 
   Married/ cohabiting 7,571 (73.8) 37 (66.1)  
   Other 2,643 (25.8) 19 (33.9)  
   Missing value 38 (0.4) 0 (0.0)  
Occupational position (%) <0.001 
   Administrative 3,022 (29.5) 6 (10.7)  
   Professional/ executive 4,922 (48.0) 21 (37.5)  
   Clerical/ support 2,308 (22.5) 29 (51.8)  
Smoking status (%) 0.451 
   Never smoker 5,044 (49.2) 25 (44.6)  
   Ex-smoker 3,258 (31.8) 23 (41.1)  
   Current smoker 1,878 (18.3) 8 (14.3)  
   Missing value 72 (0.7) 0 (0.0)  
Alcohol intake (%) 0.128 
   Risky drinking 2,412 (23.5) 7 (12.5)  
   Safe drinking 7,747 (75.6) 48 (85.7)  
   Missing value 93 (0.9) 1 (1.8)  
Physical activity (median [IQR]) 3.0 [1.0, 5.0] 2.0 [0.5, 2.5] <0.001 
Fruit and vegetable intake (%) <0.001 
   Less than once a day 4,267 (41.6) 30 (53.6)  
   Daily 4,255 (41.5) 22 (39.3)  
   More than daily 1,700 (16.6) 1 (1.8)  
   Missing value 30 (0.3) 3 (5.4)  
Body mass index (kg/ m2) (median [IQR]) 24.2 [22.3, 26.7] 26.5 [23.2, 28.8] <0.001 
Diabetes (self-report or medication) (%) 98 (1.0) 2 (3.6) 0.191 
Systolic blood pressure (median [IQR]) 122.0 [113.0, 132.0] 126.5 [115.3, 140.3] 0.061 
Diastolic blood pressure (median [IQR]) 76.0 [70.0, 83.0] 81.0 [72.0, 90.0] 0.003 
Total cholesterol levels (median [IQR]) 5.9 [5.2, 6.7] 5.95 [5.4, 7.1] 0.187 
Psychological distress (median [IQR]) 1.0 [0.0, 5.0] 2.00 [0.0, 3.0] 0.590 
Psychological distress (binary) (%)   <0.001 
   No 7,419 (72.4) 26 (46.4)  
   Yes 2,737 (26.7) 7 (12.5)  
   Missing value 96 (0.9) 23 (41.1)  









(n = 10,059, 98.1%) 
Stroke 
(n = 193, 1.9%) 
p 
Male (%) 6,731 (66.9) 138 (71.5) 0.206 
Age (median [IQR])  44.2 [39.6, 50.2] 49.9 [43.5, 53.1] <0.001 
Ethnicity (%)  0.015 
   White  8,979 (89.3) 161 (83.4)  
   Non-white  989 (9.8) 31 (16.1)  
   Missing value 91 (0.9) 1 (0.5)  
Marital status (%)  0.299 
   Married/cohabiting  7,428 (73.8) 143 (74.1)  
   Other  2,595 (25.8) 48 (24.9)  
   Missing value  36 (0.4) 2 (1.0)  
Occupational position (%)  0.234 
   Administrative  2,971 (29.5) 51 (26.4)  
   Professional/ executive  4,833 (48.0) 89 (46.1)  
   Clerical/ support  2,255 (22.4) 53 (27.5)  
Smoking status (%)  0.020 
   Never smoker  4,956 (49.3) 88 (45.6)  
   Ex-smoker  3,204 (31.9) 54 (28.0)  
   Current smoker  1,827 (18.2) 51 (26.4)  
   Missing value 72 (0.7) 0 (0.0)  
Alcohol intake (%)  0.402 
   Risky drinking 2,367 (23.5) 45 (23.3)  
   Safe drinking 7,599 (75.5) 148 (76.7)  
   Missing value 93 (0.9) 0 (0.0)  
Physical activity (median [IQR])  3.0 [1.0, 5.0] 2.0 [1.0, 4.0] 0.124 
Fruit and vegetable intake (%)  0.247 
   Less than once a day  4,199 (41.7) 68 (35.2)  
   Daily  4,164 (41.4) 91 (47.2)  
   More than daily  1,666 (16.6) 34 (17.6)  
   Missing value 30 (0.3) 0 (0.0)  
Body mass index (kg/ m2) (median [IQR])  24.2 [22.3, 26.3] 24.9 [22.7, 27.5] 0.006 
Diabetes (self-report or medication) (%)  94 (0.9) 4 (2.1) 0.216 
Systolic blood pressure (median [IQR])  122.0 [113.0, 132.0] 126.0 [117.0, 138.0] <0.001 
Diastolic blood pressure (median [IQR])  76.0 [70.0, 83.0] 80.0 [72.0, 88.0] <0.001 
Total cholesterol levels (median [IQR])  5.9 [5.2, 6.7] 5.9 [5.3, 6.7] 0.371 
Psychological distress (median [IQR])  1.0 [0.0, 5.0] 2.0 [0.0, 6.3] 0.272 
Psychological distress (binary) (%)  0.489 
   No  7,285 (72.4) 134 (69.4)  
   Yes  2,679 (26.6) 58 (30.1)  
   Missing value 95 (0.9) 1 (0.5)  
Person years at risk (mean (SD))  19.2 (6.4) 14.6 (5.5) <0.001 
Age at diagnosis/ end of follow-up (median [IQR])  64.0 [59.6, 70.3] 63.6 [57.2, 69.2] 0.021 







Figure A 5: Mean predicted trajectories of hypothetical men and women, aged 65 years at year 0 in 
models with increasing numbers of latent classes 
 
  
Figure A 6: Mean predicted trajectories of latent classes among those with fatal or non-fatal stroke 
